[
    "This sample is a phase 2 trial for postmenopausal patients with estrogen receptor-positive breast cancer, recurrent breast cancer, or stage IIIB/IIIC/IV breast cancer, testing the efficacy of fulvestrant and tipifarnib as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of hepatitis C infection, testing the efficacy of drugs such as placebo, scy-635, pegasys, and copegus, with specific eligibility criteria including HCV genotype 1 infection, quantifiable serum levels of HCV-specific RNA, and acceptable laboratory variables.",
    "This sample is a phase 2 clinical trial testing the drugs palonosetron, aprepitant, and dexamethasone in patients with myeloma and lymphoma, who are candidates for high dose chemotherapy and autologous hematopoietic stem cell transplant, with specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory multiple myeloma, testing the combination of dexamethasone, thalidomide, and lenalidomide as a treatment option. The eligibility criteria include specific disease stage, prior treatment history, and certain laboratory parameters. Exclusion criteria include non-secretory MM, prior history of other malignancies, and certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the drug lbh589. The inclusion criteria include a diagnosis of symptomatic multiple myeloma, prior treatment with bortezomib or lenalidomide, and Eastern Cooperative Oncology Group (ECOG) Performance Status \u2264 2. The exclusion criteria include prior therapy with a histone deacetylase inhibitor (HDAC), impaired cardiac function, and concomitant use of certain medications.",
    "This sample is a phase 1/phase 2 trial for patients with castration-resistant prostate cancer (CRPC) who are currently being treated with bicalutamide, and it will test the effectiveness of temsirolimus and casodex (bicalutamide) in combination therapy. The eligibility criteria include having a histologically-confirmed adenocarcinoma of the prostate, a serum PSA level of at least 2 ng/mL, and a castrate level of testosterone.",
    "This sample is a phase 2 clinical trial for patients with squamous cell carcinoma of the head and neck, testing the drug saracatinib. The eligibility criteria include measurable disease, specific blood counts, performance status, and exclusion criteria such as brain metastases and certain medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for Crohn's disease, testing the effectiveness of chondroitin sulfate as a treatment option, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with renal transplant, testing the effectiveness of telmisartan and losartan in reducing blood pressure in patients with stable renal function and on immunosuppressive therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug drospirenone/17\u00df-estradiol (angeliq, bay86-4891) in postmenopausal women with prehypertension, and the study excludes women on hormone therapy.",
    "This sample is a phase 2 trial for patients with Hodgkin's disease, testing the combination of g-csf plus plerixafor as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with B-cell chronic lymphocytic leukemia or prolymphocytic leukemia, testing the drug alvocidib, and includes eligibility criteria such as prior chemotherapy regimen, performance status, and specific laboratory values.",
    "This sample is a phase 2 trial testing the drug gw876008 for the treatment of irritable bowel syndrome, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for liver cancer patients who meet specific eligibility criteria, including having hepatocellular carcinoma, being a candidate for transarterial chemoembolization, and meeting certain patient characteristics. The trial involves the use of doxorubicin-eluting beads and everolimus as potential treatments.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma who have received prior bortezomib-based therapy, and it aims to evaluate the efficacy of bortezomib and pegylated liposomal doxorubicin in treating the disease. The inclusion criteria include confirmed diagnosis of multiple myeloma, prior bortezomib therapy, and a sustained reduction in M-Protein. The exclusion criteria include patients with progressive disease while on an anthracycline-based regimen and those with more than two prior regimens for multiple myeloma.",
    "This sample is a phase 2 clinical trial for patients with hormone refractory prostate cancer (HRPC) who have progressed despite previous chemotherapy regimens, and the drug being tested is vinflunine. The eligibility criteria include having a confirmed diagnosis of adenocarcinoma of the prostate, evidence of disease progression, and adequate organ function.",
    "This sample is a phase 1/phase 2 trial for non-small cell lung cancer (NSCLC) patients who are deemed inoperable, and will be treated with curative intent using the drugs etoposide and cisplatin. The eligibility criteria include having measurable disease, no active malignancy within the past 5 years (except for non-melanoma skin cancers or carcinoma in situ of the cervix), being 18 years or older, having a life expectancy of greater than 6 months, and meeting certain organ and marrow function requirements. The exclusion criteria include having a primary tumor size greater than 6cm, a prior history of thoracic radiotherapy, and not receiving any other study agents.",
    "This sample is a phase 2 trial for the treatment of osteoarthritis of the knee, testing the drugs gefapixant and a sugar pill, with inclusion criteria including clinical and radiographic evidence of chronic knee osteoarthritis and a specific pain score range.",
    "This sample is a phase 2 clinical trial for interstitial cystitis and bladder diseases, testing the effectiveness of dimethyl sulfoxide and ic cocktail in reducing symptoms such as frequency, urgency, and bladder pain, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial testing the drugs nucleomaxx and nucleomaxx placebo in HIV-infected individuals with lipoatrophy, and the eligibility criteria include having stable ART containing zidovudine or stavudine for at least 12 consecutive weeks prior to study entry, viral load of 5,000 copies/ml or less, and lipoatrophy in specific areas of the body.",
    "This sample is a phase 2 trial for patients with upper aerodigestive tract carcinomas who have undergone surgical resection and are eligible for post-operative radiation and cisplatin. The drug being tested is iressa (gefitinib). The inclusion criteria include having a tumoral biopsy stored in liquid nitrogen and receiving post-operative radiation and cisplatin. The exclusion criteria include a previous history of cancer.",
    "This phase 2 trial is testing the drug sorafenib tosylate in patients with metastatic breast cancer who have previously been treated with anthracycline- and/or taxane-containing regimens, and have measurable disease and no brain metastases.",
    "This sample is a phase 2 clinical trial for patients with recurrent or persistent ovarian cancer or primary peritoneal cavity cancer, testing the effectiveness of pemetrexed disodium as a treatment option. The eligibility criteria include prior platinum-based chemotherapy, platinum-resistant or refractory disease, and specific patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with metastatic or advanced stage breast cancer, testing the drug STA-9090, with specific eligibility criteria including prior treatments, disease stability, and adequate organ function.",
    "This sample is a phase 1/phase 2 trial for kidney transplantation, testing the use of c1 esterase inhibitor and placebos as treatment options, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 clinical trial for the drug \"eaa-090\" in patients with diabetes mellitus and painful diabetic neuropathy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with stomach cancer and esophageal cancer, testing the efficacy of placebo, oxaliplatin, leucovorin, and 5-fluorouracil drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for breast cancer patients with primary tumors over 2 cm, testing the drugs bibf + paclitaxel and paclitaxel, and includes eligibility criteria such as HER 2 negativity, measurable disease, and adequate hematologic, renal, and hepatic function.",
    "This sample is a phase 2 trial for patients with stage IV breast cancer, testing the drugs docetaxel and vinorelbine, with eligibility criteria including HER2-positive status and specific patient characteristics.",
    "This sample is a phase 2 trial for gastroesophageal reflux disease (GERD) testing the effectiveness of different doses of ssp-002358 in combination with a proton pump inhibitor (PPI) compared to a placebo + PPI, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 2 trial for patients with colorectal cancer and metastatic cancer, testing the drugs capecitabine and oxaliplatin, with eligibility criteria including resectable hepatic metastases and specific patient characteristics such as age, performance status, and hematopoietic and hepatic function.",
    "This sample is a phase 2 trial testing the effectiveness of dabigatran etexilate and warfarin in patients with thromboembolism and heart valve prosthesis, with specific eligibility criteria including completed study 1160.113 per protocol and exclusion criteria such as uncontrolled hypertension and increased risk of bleeding.",
    "This sample is a phase 2 clinical trial for patients with glioblastoma multiforme and primary brain tumors, testing the effectiveness of temozolomide and bevacizumab as treatment options. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 2 trial for participants with type 2 diabetes, testing the effectiveness of ertugliflozin, sitagliptin, and metformin as potential treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for relapsing-remitting multiple sclerosis, testing the drug mitoxantrone. The inclusion criteria include age, specific disease criteria, MRI activity, disability level, and informed consent, while the exclusion criteria include pregnancy, certain contraceptive methods, specific immunosuppressive therapies, recent relapse or corticosteroid treatment, and certain associated diseases.",
    "This sample is a phase 1/phase 2 trial for subjects with chronic plaque type psoriasis, testing the efficacy of various drugs including ciclosporin, betamethasone, and calcipotriol, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial studying the effects of preladenant, placebo, and anticholinergic agents or propanolol on akathisia, drug-induced movement disorders, in participants with acute psychoses or akathisia caused by haloperidol.",
    "This sample is a phase 2 clinical trial for patients with recurrent or stage IV breast cancer, testing the drug bortezomib, with specific eligibility criteria including hormone receptor status, performance status, and various medical parameters.",
    "This sample is a phase 2 trial for patients with chronic myelogenous leukemia (CML) testing the effectiveness of dasatinib and imatinib mesylate drugs, with eligibility criteria including CML diagnosis within 180 days, Zubrod performance status 0-2, and specific laboratory values within normal limits.",
    "This sample is a phase 2 trial testing the drug riociguat (Adempas) versus placebo in patients with symptomatic pulmonary hypertension due to left ventricular systolic dysfunction, and the eligibility criteria include exclusion of other types of pulmonary hypertension.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the drug capecitabine, with specific eligibility criteria including prior anthracycline and taxane therapy, and progression on trastuzumab or hormone therapy.",
    "This sample is a phase 2 trial for renal transplantation patients, testing the drugs simulect\u00ae, neoral\u00ae, certican\u00ae, myfortic\u00ae, and corticosteroids, with eligibility criteria including receiving a primary renal graft and having a cold ischemia time of less than 30 hours.",
    "This sample is a phase 2 clinical trial for patients with type II diabetes mellitus, testing the drug GFT505 80mg against a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastasized or locally inoperable soft tissue sarcoma, testing the drug pemetrexed, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the use of iron sucrose in elderly patients with unexplained anemia, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the treatment of chronic primary insomnia in elderly subjects, using act-078573 oral capsules at varying doses and matching placebos, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with active rheumatoid arthritis, testing the drugs scio-469 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with migraine, testing the effectiveness of staccato loxapine and staccato placebo in reducing pain, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for the treatment of migraine, testing the drugs tonabersat and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for amyotrophic lateral sclerosis (ALS) patients, testing the efficacy of 40 mg glatiramer acetate compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C infection, testing the efficacy of pegylated interferon and ribavirin as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with recurrent ovarian or primary peritoneal cancer, testing the drugs pemetrexed and carboplatin in combination with eligibility criteria including confirmed diagnosis, sensitivity to platinum therapy, and measurable disease or elevated CA-125 levels.",
    "This sample is a phase 2 clinical trial for patients with rising prostate-specific antigen (PSA) values after local therapy for prostate cancer, testing the drug nordihydroguaiaretic acid (ndga) as a potential treatment option.",
    "This sample is a phase 2 clinical trial for asthma patients, testing the drugs gw685698x and placebo, with eligibility criteria including age, gender, asthma diagnosis, severity of disease, and current anti-asthma therapy.",
    "This sample is a phase 2 trial for patients with metastatic gastroesophageal cancer, testing the effectiveness of lapatinib and lapatinib plus capecitabine as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for gastric cancer, testing the effectiveness of a combination of drugs including docetaxel, oxaliplatin, folinic acid, and 5-fu, with specific eligibility criteria for patients to be included or excluded from the study.",
    "This sample is a phase 2 clinical trial for patients with schizophrenia, testing the drugs ave1625 and placebo. The eligibility criteria include being an outpatient with a diagnosis of schizophrenia, currently on specific antipsychotic medications for at least 2 months, and meeting certain exclusion criteria such as no recent hospitalization, no residence instability, and no substance dependence or abuse.",
    "This sample is a phase 2 clinical trial for non-Hodgkin's lymphoma, testing the drugs pegfilgrastim and pegfilgrastim, with eligibility criteria including histologically proven mantle cell lymphoma or diffuse large B-cell non-Hodgkin's lymphoma, measurable and/or evaluable disease, and previously untreated patients.",
    "This sample is a phase 2 clinical trial for patients with hepatocellular carcinoma, testing the effectiveness of sorafenib and zoledronic acid as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with locally advanced unresectable or distant metastatic gallbladder carcinoma or cholangiocarcinoma, testing the effectiveness of erlotinib hydrochloride and sorafenib tosylate as treatment options. The eligibility criteria include specific disease confirmation, measurable disease, and certain health parameters.",
    "This sample is a phase 2 trial for patients with newly diagnosed de novo GBM, testing the drugs cdx-110 with gm-csf and temozolomide, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the drug \"org 36286\" and a placebo for the treatment of infertility in women with oligomenorrhea or amenorrhea, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients diagnosed with idiopathic Parkinson's disease, testing the combination of safinamide and levodopa as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the treatment of liver cirrhosis and biliary diseases using obeticholic acid (oca) and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for the drug apremilast in patients with atopic dermatitis, with inclusion criteria including disease severity, previous systemic therapy, and washout requirements, and exclusion criteria including history of infections, abnormal chest X-ray, and immunodeficiency.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory diffuse large B-cell non-Hodgkin's lymphoma, testing the efficacy of cytarabine and liposomal cytarabine as treatment options. The eligibility criteria include histologically confirmed lymphoma, CD20-positive disease, bidimensionally measurable disease, and specific hematopoietic, hepatic, and renal requirements.",
    "This sample is a phase 2 clinical trial for patients with small cell lung cancer, testing the drug vinflunine. The inclusion criteria include having measurable or evaluable disease, adequate organ function, and giving written informed consent. The exclusion criteria include CNS involvement, serious active infection or underlying medical condition, and significant history of uncontrolled cardiac disease.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of panitumumab and conatumumab drugs in combination with chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with extensive stage small cell lung cancer, testing the drug bortezomib. The eligibility criteria include prior platinum-based chemotherapy, measurable disease, and specific patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the drug cp-724,714, which is an investigational HER2 inhibitor, and the eligibility criteria include having HER2 gene amplification, prior treatment with chemotherapy, limited disease burden, and adequate organ function.",
    "This sample is a phase 2 clinical trial for patients with aggressive non-Hodgkin's lymphoma, testing the effectiveness of a combination of drugs including chop regimen, cyclophosphamide, doxorubicin hydrochloride, gemcitabine hydrochloride, prednisone, and vincristine sulfate, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for postmenopausal breast cancer patients with locally advanced or recurrent disease, testing the drugs bevacizumab, anastrozole, and fulvestrant, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of osteoporosis using the drug odanacatib and a placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 trial for the treatment of cystic fibrosis using aztreonam for inhalation solution (azli), with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for osteoporosis, testing the drug alendronate, with eligibility criteria including age, weight, fracture history, Tanner stage, and osteoporosis diagnosis, and exclusion criteria including certain medical conditions and pregnancy.",
    "This sample is a phase 2 trial for patients with intermittent allergic rhinitis, testing the efficacy of qav680 + cetirizine and other drug combinations in treating the symptoms, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial testing the drugs cisplatin, gemcitabine hydrochloride, and oxaliplatin for the treatment of extrahepatic bile duct cancer, gallbladder cancer, and liver cancer, with specific eligibility criteria for patients.",
    "This sample is a phase 2 clinical trial for patients with advanced ovarian cancer and positive BRCA1 or BRCA2 status, testing the effectiveness of the drugs ku-0059436 (azd2281)(parp inhibitor) in treating the disease.",
    "This sample is a phase 2 clinical trial for patients with recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cavity cancer, testing the drug temsirolimus. The eligibility criteria include prior treatment with platinum-based chemotherapy, measurable disease, specific laboratory values, and no prior temsirolimus or certain other treatments.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic papillary renal cell carcinoma, testing the effectiveness of sunitinib malate as a treatment option. The eligibility criteria include specific disease characteristics and patient characteristics, while the exclusion criteria include various medical conditions and prior treatments.",
    "This sample is a phase 2 trial for breast and lung cancer patients, testing the use of dexamethasone in combination with docetaxel therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with atrial flutter, testing the drug azd1305 for curative catheter ablation, with specific inclusion and exclusion criteria related to heart rate, potassium levels, and QRS duration.",
    "This sample is a phase 2 clinical trial for patients with relapsing remitting multiple sclerosis, testing the drugs pleneva tm bgc20-0134 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic melanoma and BRAF mutation, testing the drug ro5185426 for the treatment of brain metastases that cannot be surgically removed.",
    "This sample is a phase 2 trial for Fabry disease, testing the drug migalastat hcl, and includes eligibility criteria such as age, body mass index, previous treatment, and cardiac health.",
    "This sample is a phase 2 clinical trial for patients with squamous metastatic non-small cell lung cancer, testing the efficacy of ombrabulin (ave8062) compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for diabetic nephropathy and chronic kidney disease, testing the efficacy of zemplar (paricalcitol) capsules compared to placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with advanced or metastatic adenocarcinoma of the stomach, testing the drug sorafenib. The inclusion criteria include histologically confirmed diagnosis, specific performance scale, measurable lesion size, and adequate organ functions, while exclusion criteria include pregnancy, concurrent cancer, history of other malignancies, neuropathy or brain involvement, and uncontrolled comorbid conditions or previous radiotherapy.",
    "This sample is a phase 2 clinical trial for patients with advanced melanoma, testing the effectiveness of paclitaxel, carboplatin, and temozolomide as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 2 trial is investigating the use of the gamma-secretase/notch signalling pathway inhibitor ro4929097 in patients with various types of melanoma, including acral lentiginous malignant melanoma, lentigo maligna malignant melanoma, and nodular malignant melanoma, among others. The eligibility criteria include having histologically confirmed melanoma of cutaneous or unknown origin, stage IV disease, measurable disease, and specific laboratory values within normal ranges.",
    "This sample is a phase 2 clinical trial for cachectic patients with various diseases, including brain tumors and leukemia, and it aims to evaluate the effectiveness of cyproheptadine hydrochloride and megestrol acetate in treating weight loss.",
    "This sample is a phase 2 clinical trial for the drug GW274150, which aims to treat migraine disorders, specifically targeting patients who have had at least 3 migraine attacks but less than 15 days with headache per month in the three months prior to the screening visit.",
    "This sample is a phase 1/phase 2 trial for kidney transplant recipients, testing the effectiveness of daclizumab, mycophenolate mofetil, prednisone, tacrolimus, ganciclovir, valganciclovir, and trimethoprim and sulfamethoxazole in preventing kidney diseases and complications. The eligibility criteria include being a primary recipient of a kidney transplant, meeting site-specific transplant criteria, having a PRA of 20% or less, and being willing to use acceptable forms of contraception.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the drug trastuzumab emtansine (Kadcyla) in patients who have previously progressed on HER2-directed therapy. The inclusion criteria include having HER2-positive MBC, a history of progression on HER2-directed therapy, and specific blood count and liver function requirements. The exclusion criteria include recent treatment for breast cancer and certain cardiac conditions.",
    "This sample is a phase 2 trial for patients with mild-to-moderate uncomplicated essential hypertension, testing the effectiveness of lcz696, valsartan, ahu377, and placebo in reducing blood pressure.",
    "This sample is a phase 1/phase 2 trial for patients with glioblastoma or gliosarcoma, testing the drugs enzastaurin and temozolomide, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with mantle cell lymphoma, testing the drug everolimus. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 1/phase 2 clinical trial for the drug abt-263 in patients with small cell lung cancer, with specific eligibility criteria including prior chemotherapy treatment and controlled brain metastases.",
    "This sample is a phase 2 clinical trial for patients with pancreatic cancer, testing the efficacy of caprelsa (vandetanib) in combination with chemotherapy, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the drugs placebo and srt2104, with eligibility criteria including stable metformin monotherapy, HbA1c of 6.5%-9.5%, BMI of 22-38 kg/m^2, and normal ECG and blood pressure levels.",
    "This sample is a phase 2 trial for patients with persistent asthma, testing the effectiveness of indacaterol, placebo, and mometasone furoate in improving lung function and asthma control. The inclusion criteria include patients with stable ICS treatment, specific FEV1 values, and ACQ-5 score, while the exclusion criteria include current smokers, chronic lung diseases, and respiratory tract conditions.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes, testing the effectiveness of the drugs ex1000 and biphasic human insulin in combination with oral antidiabetic drugs, with specific eligibility criteria including duration of diabetes, current insulin treatment, BMI, HbA1c levels, and FPG levels.",
    "This sample is a phase 2 trial for restless legs syndrome, testing the effectiveness of pregabalin compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for individuals with type 2 diabetes, testing the effectiveness of dapagliflozin and placebo in combination with insulin and metformin/thiazolidinedione, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with clear cell kidney cancer, testing the drugs everolimus and imatinib mesylate, with eligibility criteria including prior systemic therapy, specific disease characteristics, and various patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with follicular lymphoma, testing the effectiveness of bortezomib in treating the disease, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for post-menopausal osteoporosis, testing the effectiveness of ibandronate, risedronate, and alendronate drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with stable plaque-type psoriasis, testing the efficacy of the drug \"las 41004\" and a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with breast cancer who have progressed after treatment with a bevacizumab-containing regimen, and it aims to evaluate the efficacy of gemcitabine, sorafenib, and capecitabine in comparison to a placebo. The eligibility criteria include having adenocarcinoma of the breast, measurable or evaluable locally advanced or metastatic disease, age \u226518 years, ECOG Performance Status of 0 or 1, and adequate bone marrow, liver, and renal function. Exclusion criteria include patients with HER-2 overexpression, active brain metastases, prior use of gemcitabine/capecitabine or sorafenib, and various other medical conditions.",
    "This sample is a phase 2 trial for smoking cessation, testing the drugs surinabant and placebo, with inclusion criteria including patients over legal age smoking at least 10 cigarettes/day, and exclusion criteria including patients with limited motivation and those dependent on alcohol or illicit drugs.",
    "This sample is a phase 2 trial for patients with rheumatoid arthritis, testing the efficacy of the drug rwj-445380 in comparison to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for female patients with metastatic breast cancer and HER2 overexpression, testing the efficacy of second line chemotherapy and trastuzumab (Herceptin) in patients who have experienced disease progression during or after previous 1st line chemotherapy + Herceptin.",
    "This sample is a phase 2 clinical trial testing the drug temozolomide for patients with metastatic non-small-cell lung cancer and brain neoplasms, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for renal transplantation, testing different doses of sotrastaurin and mycophenolic acid in combination with tacrolimus and standard of care medications, with specific inclusion and exclusion criteria for eligible patients.",
    "This sample is a phase 2 clinical trial for patients with newly diagnosed Ewing's sarcoma family of tumors, testing the effectiveness of a combination of drugs including celecoxib, cyclophosphamide, and doxorubicin hydrochloride, among others, with specific eligibility criteria for patients' age, performance status, and organ function.",
    "This sample is a phase 2 trial for metastatic breast cancer, testing liposomal doxorubicin and myocet/paclitaxel as potential treatments, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for patients with stage IV melanoma, testing the effectiveness of carboplatin, paclitaxel albumin-stabilized nanoparticle formulation, and temozolomide as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 clinical trial for non-small-cell lung cancer, testing the drug ispinesib, and includes eligibility criteria such as having received only one prior platinum-based chemotherapy regimen and adequate blood counts.",
    "This sample is a phase 2 clinical trial testing the drugs odiparcil, warfarin, and coumadin on patients with deep vein thrombosis, atrial fibrillation, venous thromboembolism, and pulmonary embolism. The eligibility criteria include being unable to have children, having a total knee replacement, and not having allergies or reactions to warfarin or coumadin.",
    "This sample is a phase 2 clinical trial for patients with recurrent ovarian, fallopian tube, or primary peritoneal cancer, testing the effectiveness of topotecan hydrochloride as a second-line treatment option. The eligibility criteria include having received only one prior platinum-based chemotherapy regimen, a treatment-free interval of more than 6 months without disease progression, and meeting certain patient characteristics such as age, performance status, and hematopoietic, hepatic, renal, and other health requirements.",
    "This phase 2 trial is testing the effectiveness of capecitabine, celecoxib, cyclophosphamide, docetaxel, and doxorubicin hydrochloride in treating patients with stage II-III invasive breast cancer, who have a primary tumor of at least 3 cm or palpable axillary nodes, and meet various eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with recurrent fallopian tube cancer, recurrent ovarian epithelial cancer, and recurrent primary peritoneal cavity cancer. The trial is testing the drug sjg-136 for patients who are platinum refractory or resistant and have had no more than three prior treatment regimens.",
    "This sample is a phase 2 clinical trial for patients with melanoma, testing the drugs ym155 and docetaxel, with specific inclusion and exclusion criteria, and evaluating various factors such as performance status, life expectancy, and previous malignancy history.",
    "This sample is a phase 2 clinical trial for female patients with breast cancer, testing the effectiveness of docetaxel in combination with other eligibility criteria such as tumor size, hormone receptor status, and patient age.",
    "This sample is a phase 2 clinical trial for patients with aggressive diffuse large B-cell lymphoma, testing the effectiveness of a combination of drugs including carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, ifosfamide, prednisone, and vincristine sulfate, with specific eligibility criteria based on disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 2 trial testing the effectiveness of HAART containing nevirapine in HIV-positive patients with tuberculosis, who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of complicated intra-abdominal infection, testing the drugs cxa-101/ tazobactam and metronidazole and meropenem plus saline placebo, with eligibility criteria including age, specific diagnoses, and the need for surgical intervention within 24 hours of the first dose of study drug.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer metastatic, testing the effectiveness of erlotinib and gemcitabine as a systemic chemotherapy treatment, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is testing the efficacy of linagliptin, a drug used to treat type 2 diabetes mellitus, in combination with metformin in patients with a diagnosis of type 2 diabetes mellitus, HbA1c between 7.0% - 10.0%, and BMI </=45 kg/m2.",
    "This sample is a phase 2 clinical trial for patients with metastatic or locally advanced soft tissue sarcoma, specifically endometrial cancer and sarcoma, and the drug being tested is perifosine. The eligibility criteria include having measurable disease, no brain metastases, and meeting certain patient characteristics such as age, performance status, and hematopoietic, hepatic, renal, and cardiovascular health. Prior concurrent therapies are also specified.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of capecitabine and cetuximab as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with advanced non-small cell lung cancer, testing the drug azacitidine, and includes eligibility criteria such as histologically confirmed tumor, prior cytotoxic regimens, and specific laboratory values.",
    "This sample is a phase 2 clinical trial for patients with stage IV breast cancer and HER-2/neu overexpression, testing the effectiveness of herceptin and gm-csf drugs in patients who have received progressive disease after previous treatments.",
    "This phase 2 trial aims to evaluate the effectiveness of deferoxamine and deferiprone in treating patients with transfusion-dependent beta-thalassemia and cardiovascular diseases, such as heart diseases and beta-thalassemia, who have specific eligibility criteria, including left ventricular ejection fraction, serum ferritin levels, and previous treatment history.",
    "This sample is a phase 1/phase 2 trial for patients with unresectable pancreatic adenocarcinoma, testing the combination of azd0530 and gemcitabine hydrochloride as a treatment option. The eligibility criteria include specific disease characteristics, patient characteristics, and restrictions on prior concurrent therapy.",
    "This sample is a phase 1/phase 2 trial for patients with colorectal cancer, testing the efficacy of drugs such as picoplatin with 5-fu and leucovorin, folpi, and folfox, with specific eligibility criteria including histologically confirmed adenocarcinoma, metastatic disease, and no prior systemic therapy.",
    "This sample is a phase 2 clinical trial for patients with renal cell carcinoma, testing the drugs erlotinib hydrochloride and sirolimus, with specific eligibility criteria including previous treatment failure or intolerance to Sutent\u00ae and/or Nexavar\u00ae, and measurable disease by CT scan or MRI.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the drugs mitoxantrone hydrochloride and prednisone, with eligibility criteria including confirmed prostate cancer, androgen-independent disease, regional or distant metastases, and specific patient characteristics such as age, performance status, and adequate organ function.",
    "This sample is a phase 2 clinical trial for pancreatic cancer patients, testing the effectiveness of gemcitabine as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for asthma patients, testing the effectiveness of fluticasone furoate and fluticasone furoate/vilanterol drugs, with specific eligibility criteria for subjects, such as age, weight, and asthma control.",
    "This phase 2 trial aims to evaluate the efficacy of epirubicin, cyclophosphamide, and docetaxel in treating breast cancer patients who meet specific eligibility criteria, including age, tumor characteristics, and organ function.",
    "This sample is a phase 2 trial for patients with prostate cancer, testing the drug perifosine, and includes eligibility criteria such as confirmed adenocarcinoma, rising PSA levels, and negative scans for metastatic disease.",
    "This sample is a phase 2 trial for subjects with chronic hepatitis C infection, testing the drugs bms-790052 and bms-650032, with inclusion criteria including HCV Genotype 1 and HCV RNA viral load of \u2265 10*5* IU/mL, and exclusion criteria including liver cirrhosis, evidence of HCC, and co-infection with hepatitis B virus or HIV.",
    "This sample is a phase 2 clinical trial for cystic fibrosis patients, testing the efficacy of ciprofloxacin and placebo drugs on subjects with specific inclusion criteria, such as documented diagnosis of CF, chronic colonization with P. aeruginosa, and stable pulmonary status.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of carmoterol and salmeterol drugs compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with unresectable or metastatic urothelial cancer, testing the effectiveness of cisplatin, ifosfamide, and paclitaxel as treatment options. The eligibility criteria include specific disease characteristics, age, performance status, hematopoietic, hepatic, renal, and cardiovascular conditions, as well as prior concurrent therapies.",
    "This sample is a phase 1/phase 2 trial for head and neck cancer patients with locally advanced, unresectable disease or resectable disease with surgery contra-indication. The study will test the effectiveness of carboplatin, rad001, and paclitaxel as treatment options. Eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2/phase 3 trial for patients with esophageal cancer or adenocarcinoma, testing the effectiveness of nimotuzumab, cisplatin, and fluorouracil in combination therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with asthma, testing the effectiveness of different doses of olodaterol and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for endometrial cancer, testing the drug ridaforolimus, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients, testing the effectiveness of oxaliplatin, gemcitabine, and bevacizumab as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with breast cancer, testing the drug \"bms-275291\" in combination with different systemic therapy regimens, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for breast cancer patients with estrogen receptor and/or progesterone positive disease, testing the efficacy of sorafenib, an anti-angiogenic agent, in patients with residual measurable disease after endocrine therapy.",
    "This phase 2 trial is testing the effectiveness of carboplatin and docetaxel in treating breast cancer patients with clinical stage II or III disease, while meeting specific eligibility criteria related to age, sex, performance status, hematopoietic, hepatic, renal, and other factors.",
    "This sample is a phase 2 clinical trial for patients with aneurysmal subarachnoid hemorrhage, testing the effectiveness of tiopronin and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for fibromyalgia, testing the drugs xyrem (sodium oxybate) oral solution and placebo, with inclusion criteria including meeting the American College of Rheumatology criteria for fibromyalgia and having an average VAS pain score > 4, and exclusion criteria including having other rheumatic diseases, uncontrolled medical conditions, recent substance abuse, and certain clinical laboratory results.",
    "This sample is a phase 1/phase 2 trial investigating the use of adefovir dipivoxil and hepatitis B vaccination in recipients of liver transplantation with hepatitis B core antibody positive grafts, who have not reached the 18 month post transplantation period, to prevent hepatitis B surface antigen positivity.",
    "This sample is a phase 2 clinical trial for patients with endometrial cancer, testing the effectiveness of gemcitabine and cisplatin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for obesity, where the drug being tested is \"r256918\" and the eligibility criteria include being obese or overweight, having a stable weight, and having controlled hypertension or dyslipidemia.",
    "This sample is a phase 2 trial for the treatment of rheumatoid arthritis, testing the drug cf101 against a placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 2 trial aims to evaluate the efficacy of clarithromycin, thalidomide, and dexamethasone in patients with refractory multiple myeloma or different stages of multiple myeloma who have undergone high dose melphalan therapy. The eligibility criteria include specific platelet and granulocyte counts, timing of therapy initiation after transplant, and compliance with the FDA-mandated S.T.E.P.S. program. Exclusion criteria involve various medical conditions, allergies, and pregnancy/lactation.",
    "This sample is a phase 2 clinical trial for patients with HER2-positive breast cancer, recurrent breast cancer, or stage IV breast cancer, testing the drug ixabepilone, with specific eligibility criteria including prior therapy and organ function requirements.",
    "This sample is a phase 2 trial for patients with carotid stenosis, testing the effectiveness of fasudil hydrochloride and placebo oral tablets in reducing carotid stenosis in patients scheduled for elective carotid endarterectomy.",
    "This sample is a phase 2 clinical trial for patients with recurrent ovarian, fallopian tube, or primary peritoneal carcinoma, testing the effectiveness of gemcitabine, oxaliplatin, and bevacizumab in combination. The eligibility criteria include measurable disease, platinum-sensitive tumors, Eastern Cooperative Oncology Group score of 0 or 1, and adequate organ function, among others.",
    "This sample is a phase 2 trial for patients with end-stage renal disease undergoing maintenance hemodialysis, testing the efficacy of soluble ferric pyrophosphate in liquid bicarbonate, placebo, erythrocyte stimulating agent, and intravenous iron in maintaining hemoglobin levels within a specific range.",
    "The sample is a phase 2/phase 3 trial for generalized anxiety disorder, testing the drugs pexacerfont, escitalopram, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for peripheral T-cell lymphomas and non-Hodgkin lymphoma, testing the drug Velcade, with specific eligibility criteria including histological confirmation, performance status, age, measurable lesions, laboratory values, and exclusion criteria such as other malignancies and serious comorbid diseases.",
    "This sample is a phase 2 clinical trial for patients with unresectable hepatocellular carcinoma, testing the effectiveness of chemotherapy and embolization therapy as treatment options. The eligibility criteria include specific disease characteristics and patient characteristics, and exclude patients who have undergone recent surgeries or received concurrent chemotherapy or investigational drugs.",
    "This sample is a phase 1/phase 2 clinical trial for patients with advanced non-small cell lung cancer, testing the drug irinotecan. The eligibility criteria include prior chemotherapy treatment, high ISG15 levels, and adequate bone marrow, hepatic, and renal function. Patients with symptomatic brain metastases, pregnant or nursing women, and those with severe medical problems or previous hypersensitivity reactions to camptothecins are excluded from the study.",
    "This sample is a phase 2 trial for glaucoma and ocular hypertension, testing the effectiveness of various bimatoprost ophthalmic solutions, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced ovarian cancer, testing the effectiveness of bevacizumab, carboplatin, docetaxel, gemcitabine, and melphalan as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 trial for rheumatoid arthritis, testing the drug rituximab in combination with methotrexate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the efficacy of the drugs mk0893 and metformin, along with their respective placebos, in improving glucose control. The inclusion criteria include patients not on antihyperglycemic agent therapy or on low-dose combination therapy, while the exclusion criteria include patients with type 1 diabetes mellitus, those taking insulin or thiazolidinedione, and those with a contraindication to metformin.",
    "This sample is a phase 2 clinical trial for obsessive-compulsive disorder (OCD) using n-acetylcysteine and placebo as drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for previously untreated non-cutaneous peripheral T-cell lymphoma, testing the effectiveness of the ACVBP regimen with drugs including velcade, doxorubicin, prednisone, cyclophosphamide, vindesine, and bleomycin, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 2 trial is testing the drug oritavancin for the treatment of complicated skin and skin structure infections caused by gram-positive bacteria, with specific inclusion and exclusion criteria for patient enrollment.",
    "This sample is a phase 1/phase 2 trial for HIV-1 infection, testing the drug tbr-652 and its various dosages, with inclusion criteria including antiretroviral treatment-experienced patients and exclusion criteria including presence of CXCR4- or dual/mixed-tropic HIV 1 virus and active CDC category C disease.",
    "This sample is a phase 2 clinical trial for patients with advanced ovarian carcinoma, fallopian tube carcinoma, or primary peritoneal cancer, testing the drugs bibf1120 and placebo, with eligibility criteria including a response to previous chemotherapy and a treatment-free interval of less than 12 months.",
    "This sample is a phase 2 trial for the treatment of venous thromboembolism using the drug Xarelto (rivaroxaban, bay59-7939) and (LMW) heparin + vitamin k antagonist, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with non-small-cell lung cancer, testing the effectiveness of pemetrexed, cisplatin, and carboplatin as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with attention-deficit/hyperactivity disorder (ADHD), testing the effectiveness of the drug MK0249 (methylphenidate) compared to Concerta (methylphenidate) and a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with recurrent or persistent ovarian, fallopian tube, or primary peritoneal cavity cancer, testing the effectiveness of docetaxel and trabectedin as a second-line treatment option.",
    "This sample is a phase 1/phase 2 clinical trial for patients with previously untreated multiple myeloma, testing the effectiveness of the drugs ixazomib, lenalidomide, and dexamethasone, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2/phase 3 clinical trial for patients with idiopathic pulmonary fibrosis, testing the efficacy of bosentan and placebo drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with metastatic pancreatic cancer, testing the effectiveness of simtuzumab, gemcitabine, and placebo in combination with eligibility criteria for enrollment.",
    "This sample is a phase 2 trial for metastatic breast cancer patients, testing the efficacy of capecitabine in combination with interleukin 7 and placebo, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with coronary artery disease, testing the drugs via-2291 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for adult acute myeloid leukemia (AML) patients, testing the effectiveness of gemtuzumab ozogamicin and vorinostat as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with metastatic or unresectable kidney cancer, testing the effectiveness of gemcitabine hydrochloride and imatinib mesylate as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for the treatment of hepatitis C, using the drugs miravirsen and saline, with eligibility criteria including BMI, HCV genotype, and laboratory findings consistent with a clinical diagnosis of CHC.",
    "This sample is a phase 2 clinical trial for patients with breast cancer, testing the efficacy of paclitaxel, 5-fluorouracil, epirubicin, cyclophosphamide, and rad001 in the neoadjuvant setting, with specific eligibility criteria including histologic confirmation of invasive ER/PR and HER2/neu-negative breast carcinoma, intact primary tumors, stage IIA to IIIC non-inflammatory breast cancer, and adequate bone marrow and liver function.",
    "This sample is a phase 2 trial for type 2 diabetes mellitus, testing the drugs mk-0893, metformin, and placebos, with inclusion criteria including having type 2 diabetes, not currently on antihyperglycemic agents, and a BMI between 20 and 40 kg/m2, and exclusion criteria including history of type 1 diabetes, ketoacidosis, and various other medical conditions.",
    "This sample is a phase 2 trial for patients with locally recurrent or metastatic kidney cancer, testing the drug atrasentan hydrochloride. The eligibility criteria include specific disease characteristics, age, performance status, hematopoietic, hepatic, renal, cardiovascular, and pulmonary conditions, as well as prior concurrent therapies.",
    "This sample is a phase 2 clinical trial for psoriasis, testing the drugs AN2728 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the drug pyrazoloacridine. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 1/phase 2 clinical trial for participants with metastatic colorectal cancer, testing the drugs tivantinib, placebo, cetuximab, and irinotecan, with eligibility criteria including prior chemotherapy, wild-type KRAS gene expression, measurable disease, and specific organ function requirements.",
    "This sample is a phase 2 clinical trial for multiple sclerosis, specifically relapsing-remitting MS, testing the effectiveness of natalizumab and placebo in patients who have been treated with GA for at least 12 months prior to randomization, with specific inclusion and exclusion criteria.",
    "This phase 2 clinical trial aims to evaluate the efficacy of pregabalin in treating acute herpes zoster (HZ) pain, specifically in patients with herpes zoster and postherpetic neuralgia, with inclusion criteria including age, pain duration, pain intensity, weight, and BMI, while excluding patients with certain medical conditions, allergies to pregabalin, previous neurolytic or neurosurgical therapy, and recent use of local anesthetic nerve blocks or experimental drugs.",
    "This sample is a phase 2 trial for patients with locally advanced colorectal cancer, testing the effectiveness of capecitabine, fluorouracil, irinotecan hydrochloride, leucovorin calcium, oxaliplatin, and pyridoxine as treatment options, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs ly2062430 and placebo, with inclusion criteria including age, diagnosis, and language fluency, and exclusion criteria including history of certain diseases and prior participation in an active immunization study.",
    "This sample is a phase 2 trial for heparin-induced thrombocytopenia, testing the drugs fondaparinux and warfarin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with non-small-cell lung carcinoma, specifically those with activating mutations in the EGFR-receptor. The drug being tested is bibw 2992, and the eligibility criteria include having measurable tumor lesions, a life expectancy of at least three months, and an ECOG performance score of 0, 1, or 2.",
    "This sample is a phase 2 trial for patients diagnosed with Tourette's Disorder, testing the effectiveness of pramipexole immediate release (ir) compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced metastatic or unresectable epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer that is relapsed and resistant or refractory to prior platinum-based standard care systemic regimen. The trial will test the effectiveness of birinapant (tl32711) in treating these patients.",
    "This sample is a phase 1/phase 2 trial for patients with rectal cancer or colorectal cancer, testing the effectiveness of cetuximab, oxaliplatin, capecitabine, and diphenhydramine hydrochloride (HCL) as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial testing the drug saracatinib for patients with metastatic adenocarcinoma of the colon or rectum, with specific eligibility criteria including prior chemotherapy and certain laboratory values, and excluding patients with brain metastases or certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with stage IIIb or IV non-small cell lung cancer, testing the effectiveness of bevacizumab, cisplatin, and docetaxel as chemotherapy treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of breast cancer and advanced malignant solid tumors using the drugs neratinib and vinorelbine, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial testing the drugs mk0683, vorinostat, and suberoylanilide hydroxamic acid (saha) for the treatment of breast cancer, colorectal cancer, and non-small-cell lung carcinoma in patients who have relapsed or refractory disease following at least one chemotherapeutic treatment regimen. The eligibility criteria include having a confirmed diagnosis of one of the specified cancers, having a measurable lesion, and having adequate blood, liver, bone marrow, and kidney functions. Exclusion criteria include prior treatment with histone deacetylase (HDAC) inhibitor, recent treatment with investigational agents, active infection, HIV, hepatitis B or C infection, pregnancy or lactation, and allergy to any component of the study drug.",
    "This sample is a phase 1/phase 2 trial for the drug tmc278la in patients with HIV infections, with inclusion criteria including age between 18 to 50 years, absence of significant health problems, and willingness to undergo HIV testing, while exclusion criteria include positive blood screen for HIV antibodies, high-risk behavior for HIV infection, and clinically relevant alcohol or drug use.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease and dementia, testing the drugs nic5-15 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of the drug azd1656 compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with Parkinson's disease, testing the effectiveness of sildenafil and placebo in treating drug-induced dyskinesias, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for non-Hodgkin's lymphoma, testing the effectiveness of CHOP plus rituximab in patients aged 65 and older, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the drug sunitinib for the treatment of ascites in patients with solid tumor malignancy who have failed previous treatments or are unable to receive standard treatment. The eligibility criteria include having ascites, a life expectancy of more than 3 months, and negative pregnancy test for females. Exclusion criteria include congestive heart failure, high creatinine levels, pregnancy or nursing, high ALT levels, high blood pressure, recent gastrointestinal or intra-abdominal hemorrhage, history of prolonged QTc interval, and brain metastasis.",
    "This sample is a phase 2 clinical trial for patients with relapsed and/or refractory acute promyelocytic leukemia (APL), testing the drug tamibarotene. The eligibility criteria include confirmation of diagnosis, previous treatment with ATRA and ATO, and specific organ function requirements.",
    "This sample is a phase 2 trial for rheumatoid arthritis patients, testing the efficacy of sc12267 (4sc-101) in combination with methotrexate and folic acid, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with recurrent uterine sarcoma and uterine carcinosarcoma, testing the drug imatinib mesylate, with specific eligibility criteria and exclusion criteria.",
    "This phase 2 trial is testing the effectiveness of palifosfamide tris and doxorubicin, along with eligibility criteria, in treating soft tissue sarcoma patients who have failed prior regimens and for whom treatment with doxorubicin is considered medically acceptable.",
    "This sample is a phase 2 trial for patients with stage IV colorectal cancer and unresectable liver metastases, testing the efficacy of cetuximab and irinotecan in combination with transarterial chemoembolization.",
    "This sample is a phase 2 clinical trial for patients with advanced or metastatic colorectal cancer, testing the effectiveness of fluorouracil, irinotecan hydrochloride, and leucovorin calcium as first- or second-line therapy, with specific eligibility criteria for patients and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) who are eligible for curative surgery, and the study will test the effectiveness of cisplatin and pemetrexed disodium as treatment options.",
    "This sample is a phase 2 clinical trial for patients with gastrointestinal stromal tumor (GIST) who have progressed on imatinib mesylate therapy, and it aims to evaluate the efficacy of a drug called imatinib mesylate in treating advanced GIST. The eligibility criteria include having measurable disease, a confirmed diagnosis of Kit-expressing advanced GIST, and a performance status of 0-2.",
    "This phase 2 trial is testing the drugs cetuximab and cetuximab for patients with soft tissue sarcoma or bony sarcoma, who have received prior systemic chemotherapy treatment and have documented symptomatic or radiologic progression to their preceding therapy.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the drug azacitidine. The inclusion criteria include a diagnosis of MM, age greater than 17 years, prior lines of therapy, and progressive disease. The exclusion criteria include patients with MGUS or indolent/smouldering MM, hypersensitivity to azacitidine, and certain medical conditions.",
    "This sample is a phase 2 trial for patients with moderate to severe persistent asthma, testing the effectiveness of l-arginine and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with epilepsy, testing the drugs ykp3089 and placebo, with inclusion criteria including a diagnosis of epilepsy, specific concomitant medications, and a reproducible IPS-induced photo-paroxysmal response on EEG, while exclusion criteria include non-epileptic seizures, pregnancy, and certain medications.",
    "This sample is a phase 2 clinical trial for the treatment of dry eye syndrome and dry eye using thymosin beta 4 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for hypertension in children and adolescents, testing the efficacy of telmisartan and placebo in reducing blood pressure, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of pemetrexed and gemcitabine as treatment options, with specific eligibility criteria including histologically verified adenocarcinoma, KRAS mutation, and measurable disease according to RECIST.",
    "This sample is a phase 2 trial for asthma patients, testing the effectiveness of albuterol spiromax\u00ae and proair\u00ae hfa drugs in patients with specific eligibility criteria, such as having asthma for at least 6 months, specific lung function measurements, and being a non-smoker.",
    "This sample is a phase 2 trial for patients with locally advanced breast cancer, testing the drug capecitabine. The eligibility criteria include specific tumor stage, age, performance status, and laboratory values. Exclusion criteria include HER2 positive breast cancer, pregnancy, prior chemotherapy, and other medical conditions that may compromise study participation.",
    "This sample is a phase 2 trial for psoriasis, testing the efficacy of an2728 ointment and ointment vehicle in patients with mild-to-moderate plaque-type psoriasis involving 2-35% of total body surface area, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with rheumatoid arthritis, testing the efficacy of the drugs R788 and placebo in combination with methotrexate, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for attention deficit disorder with hyperactivity, testing the drugs spd503 (guanfacine hcl) and placebo, with inclusion criteria including a primary diagnosis of ADHD and minimum baseline visit ADHD-RS-IV score of 24, and exclusion criteria including comorbid psychiatric diagnosis and history of seizure disorder.",
    "This sample is a phase 2 clinical trial for patients diagnosed with Parkinson's disease, testing the effectiveness of ropinirole prolonged release/extended release (pr/xr) in patients with limited prior exposure to low or moderate doses of L-dopa or dopamine agonists. The inclusion criteria include patients with severity of the Modified Hoehn & Yahr staging at Stage I to III, age 20 or older, and both male and female genders. The exclusion criteria include patients with serious physical signs and symptoms other than those of Parkinson's disease, symptomatic postural hypotension, serious psychiatric symptoms, and various drug treatments.",
    "This sample is a phase 2 trial for ischemic stroke patients, testing the drugs placebo, sa4503 low, and sa4503 high, with key inclusion criteria including age 18 or older, recent stroke, and specific NIHSS scores, and key exclusion criteria including transient ischemic attack and unstable cardiac, hepatic, or renal disease.",
    "This sample is a phase 2 trial for patients with stable coronary artery disease, testing the drugs ticagrelor and clopidogrel, with specific inclusion and exclusion criteria related to previous cardiac events and concurrent diseases.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients, testing the effectiveness of pemetrexed, cisplatin, and bevacizumab as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial for HIV infections, testing the effectiveness of chloroquine phosphate and placebo in HIV-1 infected adults with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with platinum-refractory ovarian cancer, testing the efficacy of vandetanib in combination with pegylated liposomal doxorubicin. The eligibility criteria include having received previous platinum- and taxane-based chemotherapy and having a progression-free interval of 6 to 12 months. Exclusion criteria include brain metastases, concomitant medications that may cause QTc prolongation, and more than two prior lines of chemotherapy.",
    "This sample is a phase 2/phase 3 trial testing the drug tonapofylline and placebo in patients with renal insufficiency and congestive heart failure, with specific inclusion and exclusion criteria provided.",
    "This sample is a phase 1/phase 2 clinical trial for patients with refractory multiple myeloma, testing the effectiveness of obatoclax mesylate and bortezomib drugs, with specific eligibility criteria including prior treatment history, disease progression, and various health parameters.",
    "This sample is a phase 2 clinical trial for patients with HER2/neu positive breast cancer, testing the drug exemestane, and the eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with chronic lymphocytic leukemia (CLL), leukemia, or small lymphocytic lymphoma (SLL) who have achieved a partial or complete response following chemotherapy or chemoimmunotherapy. The study will test the effectiveness of rituximab and alemtuzumab drugs in treating these diseases.",
    "This sample is a phase 2 trial testing the drug vismodegib for the treatment of nodular basal cell carcinoma, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung carcinoma, testing the effectiveness of motexafin gadolinium and pemetrexed as a treatment option. The eligibility criteria include age, disease stage, prior chemotherapy regimen, and performance status.",
    "This sample is a phase 1/phase 2 trial testing the use of smoked cannabis in patients with multiple sclerosis who have moderate or severe spasticity, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial testing the drug imatinib mesylate for patients with relapsed or refractory ovarian, fallopian tube, or primary peritoneal cancer, who have previously received platinum- and taxane-based chemotherapy.",
    "This sample is a phase 2 clinical trial for patients with rheumatoid arthritis, testing the drug revamilast against a placebo comparator, with eligibility criteria including documented history of RA, active RA symptoms, specific laboratory criteria, and stable use of methotrexate for at least 12 weeks prior to screening.",
    "This sample is a phase 2 clinical trial for patients with bladder cancer who have achieved stable disease or better after receiving standard first-line chemotherapy, and are now being treated with the drug Sutent. The eligibility criteria include having a histologic/cytologic diagnosis of urothelial carcinoma, no prior antiangiogenic therapy, and meeting certain medical conditions such as no major surgery within 4 weeks and no unresolved bacterial infection. Pregnant or breastfeeding individuals are excluded from the study.",
    "This sample is a phase 2 trial for HIV-1 infected adults with NNRTI resistance, testing the efficacy of gsk2248761 and etravirine as potential antiretroviral therapies.",
    "This sample is a phase 1/phase 2 trial that focuses on patients with pulmonary disease, chronic obstructive. The trial uses the drug uk-369,003 and has specific inclusion and exclusion criteria, such as GOLD criteria 2 to 4 and a 10 pack year history of smoking.",
    "This sample is a phase 2 trial for the treatment of chronic hepatitis C infection with the drugs abt-450, abt-072, ribavirin, and ritonavir, and includes eligibility criteria such as genotype C/C, liver biopsy within 3 years, and general good health.",
    "This sample is a phase 2 trial testing the effectiveness of epicept np-1 (4% amitriptyline/ 2% ketamine) topical cream versus placebo cream in adult patients with chronic pain due to diabetic peripheral neuropathy (DPN) or neuralgia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with adult diffuse large cell lymphoma, testing the drug sunitinib malate, and includes eligibility criteria such as prior chemotherapy regimens, measurable disease, and specific medical conditions that would preclude study participation.",
    "This sample is a phase 2 trial for the treatment of hepatitis C, testing the drugs alisporivir, peginterferon alfa-2a, ribavirin, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with prostate cancer, testing the effectiveness of ketoconazole, hydrocortisone, and dutasteride in treating hormone-refractory prostate cancer. The eligibility criteria include histologically documented evidence of prostate cancer, progressive disease, specific PSA and testosterone levels, and certain prior treatment requirements.",
    "This sample is a phase 1/phase 2 trial for patients with chronic myelogenous leukemia and philadelphia chromosome positive acute lymphoblastic leukemia, testing the drug dasatinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for idiopathic Parkinson's disease, testing the drugs cvt-301, placebo, and sinemet (carbidopa/levodopa) on patients who meet specific inclusion criteria such as being diagnosed with PD between the ages of 30 and 80 years and experiencing motor fluctuations.",
    "This sample is a phase 1/phase 2 trial for Alzheimer's disease, testing the drugs ly2886721 and placebo, with inclusion criteria including meeting criteria for mild cognitive impairment (MCI) or mild Alzheimer's disease (AD), specific cognitive test scores, absence of other potential causes of cognitive decline, and positive scan for the presence of amyloid beta.",
    "This sample is a phase 2 trial for rectal cancer, testing the efficacy of preoperative induction chemotherapy in combination with bevacizumab followed by combined radiochemotherapy with capecitabine. The eligibility criteria include age 18-80 years, histologic confirmation of rectal adenocarcinoma stage cT3/cT4, and adequate bone marrow, renal, and liver function. Exclusion criteria include other malignant tumors within the last 5 years, contraindications or hypersensitivity to the drugs used, and various medical conditions that may affect treatment.",
    "This sample is a phase 2 trial for the treatment of seasonal allergic rhinitis using drugs such as bepotastine besilate formulation, fluticasone propionate, bepotastine besilate-fluticasone propionate, and a placebo comparator. The eligibility criteria include being at least 12 years old with a history of Mountain Cedar pollen allergy and having no active nasal infection or abnormality.",
    "This phase 2 trial is investigating the efficacy of afq056 and placebo in treating patients with Parkinson's Disease who have L-dopa induced dyskinesia, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients aged 2-15 years with neurogenic detrusor overactivity, testing the effectiveness of darifenacin in improving bladder function and reducing urinary symptoms.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndrome (MDS) who are either low-risk or high-risk according to IPSS. The drug being tested is temsirolimus, and the eligibility criteria include age >18, specific laboratory test results, and not being eligible for immediate allogeneic HSCT or conventional chemotherapy.",
    "This sample is a phase 2 trial for asthma patients, testing the efficacy of fluticasone propionate and lactose powder as treatments, with specific eligibility criteria including age, weight, asthma history, and sensitivity to methacholine and allergens.",
    "This sample is a phase 2 trial for diabetic macular edema, testing the drugs ranibizumab 0.3 mg, ranibizumab 0.5 mg, and sham injection, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial studying the effectiveness of ramelteon, a drug used to treat sleep disorders, in patients with Delayed Sleep Phase Syndrome, and includes detailed inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for females with locally advanced or metastatic HER2/neu+ breast cancer who have progressed after treatment with chemotherapy and trastuzumab. The study aims to evaluate the efficacy and safety of apricoxib, lapatinib, and capecitabine combination therapy compared to placebo, lapatinib, and capecitabine in this patient population.",
    "This sample is a phase 2 clinical trial for non-squamous non-small cell lung cancer, testing the effectiveness of paclitaxel/carboplatin and bavituximab as a systemic chemotherapy treatment option, with specific eligibility and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of iv busulfan and bortezomib drugs in combination with autologous HSCT, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for non-squamous, non-small cell lung cancer patients, testing the combination of bevacizumab and erlotinib, with specific inclusion and exclusion criteria related to the disease, general medical conditions, and bevacizumab-specific factors.",
    "This phase 2 trial is testing the drug CI-1033 in female patients with metastatic breast cancer who have had progressive or recurrent disease following prior therapy, and meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with colorectal cancer, testing the effectiveness of capecitabine and oxaliplatin drugs in combination, with specific eligibility criteria and required medical parameters for participation.",
    "This phase 2 trial is testing the drugs rhumab-vegf and docetaxel in patients with metastatic pancreatic cancer who have received only one prior gemcitabine-containing regimen, and have specific eligibility criteria including measurable disease outside of the pancreas and a performance status of ECOG 0-1.",
    "This sample is a phase 2 trial for the treatment of vulvar vestibulitis, testing the effectiveness of 5% topical lidocaine ointment and placebo cream on women with dyspareunia as their primary complaint, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-Hodgkin lymphoma, testing the effectiveness of chemotherapy and radioimmunotherapy in patients with follicular lymphoma, grades 1, 2, or 3, who have not received prior chemotherapy or monoclonal antibody therapy, and have bulky or symptomatic disease, stage II-IV, with a performance status of 0-2.",
    "This sample is a phase 2 clinical trial for patients with myelodysplastic syndromes and thrombocytopenia, testing the effectiveness of lenalidomide as a treatment option.",
    "This sample is a phase 2 clinical trial for patients with unresectable, locally recurrent, or metastatic breast cancer, testing the effectiveness of gemcitabine and vinorelbine as chemotherapy drugs, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with glioblastoma multiforme, testing the combination of mpc-6827 and carboplatin as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic low back pain, testing the effectiveness of the drug jnj-42160443 in comparison to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of psoriasis, testing the drugs placebo and srt2104, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2/phase 3 trial for patients with metastatic breast cancer, testing the efficacy of capecitabine and vinorelbine tartrate as treatment options, with specific eligibility criteria including prior taxane treatment and hormone receptor status.",
    "This sample is a phase 2 trial for the treatment of gastroparesis in patients with diabetes mellitus, using the drugs 5% dextrose in water and tzp-101, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with pancreatic cancer, testing the effectiveness of gemcitabine and oxaliplatin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the drug capecitabine, and includes eligibility criteria such as confirmed diagnosis, measurable disease, and specific patient characteristics.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic bladder cancer, testing the effectiveness of pemetrexed, gemcitabine, and platinol as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug mifepristone in HIV-infected individuals with specific eligibility criteria, such as CD4 count and viral load requirements, and exclusion criteria, including prior ART treatment and certain medical conditions.",
    "This sample is a phase 2 trial for kidney transplantation, testing the use of rituximab in addition to standard care, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 trial for the treatment of Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) using the drugs ataluren and chronic corticosteroid therapy, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 trial for postmenopausal women with primary breast cancer, testing the drugs fulvestrant and anastrazole, with specific inclusion and exclusion criteria.",
    "This phase 2 clinical trial aims to evaluate the effectiveness of cisplatin, gemcitabine, and bevacizumab in treating previously untreated or relapsed locally advanced or metastatic bladder cancer patients, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for rectal cancer patients, testing the efficacy of the \"ixo regimen\" drug, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial comparing cyclosporine A and mycophenolate mofetil for the treatment of moderate-to-severe psoriasis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with metastatic prostate cancer, testing the drug tanespimycin, and includes eligibility criteria such as prior chemotherapy, castrate levels of testosterone, and specific laboratory values.",
    "This sample is a phase 2 trial testing the effectiveness of paracetamol hot drink and paracetamol tablets in treating the common cold, with specific inclusion criteria related to the duration of symptoms, congestion severity, and number of symptoms experienced.",
    "This phase 2 trial aims to evaluate the efficacy of the drug imexon in treating various types of lymphoma, including follicular lymphoma, small lymphocytic lymphoma, marginal zone lymphoma, lymphoplasmacytic lymphoma, diffuse large B-cell lymphoma, mantle cell lymphoma, and Burkitt's lymphoma, in patients who have relapsed or refractory disease and meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with small cell lung cancer, testing the effectiveness of vorinostat, carboplatin, and etoposide as chemotherapy treatment, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with previously untreated acute myeloid leukemia (AML) who are at least 60 years old, have at least 20% blasts in their bone marrow, and have an ECOG performance status of 0, 1, or 2. The study will test the drug vosaroxin to determine its effectiveness in treating AML.",
    "This sample is a phase 2 clinical trial for patients with advanced non-small cell lung cancer (NSCLC) who have specific EGFR mutations. The study will test the efficacy of the drugs osi-906, erlotinib, and placebo in treating the disease, and includes eligibility criteria such as measurable disease, ECOG performance status, and adequate hematopoietic, hepatic, and renal function.",
    "This sample is a phase 2 clinical trial for patients with head and neck cancer, testing the effectiveness of the drug panitumumab + paclitaxel, with specific eligibility criteria including age, disease confirmation, previous treatments, and various health parameters.",
    "This sample is a phase 2 trial for patients with rheumatoid arthritis, testing the efficacy of different drug combinations (including ustekinumab and methotrexate) in reducing disease activity, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for pancreatic cancer patients with inoperable or metastatic disease, testing the combination of cisplatin and gemcitabine hydrochloride as a treatment option, with specific eligibility criteria for patients' disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 2 clinical trial for the drug ganaxolone in patients with partial epilepsy and catamenial epilepsy, who meet specific inclusion criteria such as having a documented seizure frequency of \u2265 3CPS per 4 weeks on average and being on a stable dose of up to 3 current antiepileptic drugs (AEDs) for 1 month prior to screening.",
    "This sample is a phase 2 trial for patients with pancreatic cancer, testing the effectiveness of gemcitabine hydrochloride and triapine as treatment options, with specific eligibility criteria including disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndrome, testing the combination of azacitidine and oral vorinostat as a treatment option. The eligibility criteria include specific disease classifications, IPSS score, previous treatment response, age, organ function, and other factors. The exclusion criteria include prior HDAC inhibitor treatment, severe infections, HIV or active hepatitis, allergies to study drugs, and other conditions.",
    "This phase 2 trial aims to evaluate the effectiveness of lenalidomide in treating refractory cancer pain in patients with advanced cancer, who have a pain intensity score of 5 or greater on the Edmonton Symptom Assessment scale, and meet various eligibility criteria.",
    "This sample is a phase 2 trial testing the drug radafaxine for the treatment of major depressive disorder, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with stomach neoplasms, testing the drug oxaliplatin, and includes eligibility criteria such as specific disease stage, lab test results, and exclusion criteria like peripheral neuropathy and concomitant diseases.",
    "This sample is a phase 2 clinical trial for attention-deficit/hyperactivity disorder (ADHD) testing the drugs abt-089 and placebo, with inclusion criteria including meeting diagnostic criteria for ADHD and being in good health, and exclusion criteria including having certain psychiatric disorders and requiring ongoing treatment with any psychiatric medication.",
    "This sample is a phase 2 clinical trial for multiple sclerosis, testing the drugs teriflunomide and interferon-\u03b2, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with relapsed multiple myeloma, testing the effectiveness of the drugs velcade, thalidomide, adriamycin, and dexamethasone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of alogliptin and glimepiride in combination with glimepiride alone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of eosinophilic esophagitis using fluticasone and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with major depressive disorder and psychotic disorders, testing the drug org 34517, and includes specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for multiple myeloma patients who are previously untreated, and the drug being tested is Velcade. The inclusion criteria include age < 65, specific performance status, platelet count, liver and renal function, and informed consent. The exclusion criteria include allergies to certain compounds, hypersensitivity to thalidomide or dexamethasone, peripheral neuropathy, cardiovascular disease, severe infection, previous cancer history, pregnancy or breastfeeding, and others.",
    "This sample is a phase 2 clinical trial for patients with biliary cancer, testing the effectiveness of gemcitabine, docetaxel, and capecitabine as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with advanced/metastatic non-small cell lung cancer (NSCLC) testing the effectiveness of dasatinib, a drug used for chronic myeloid leukemia, with specific eligibility criteria including previous chemotherapy, organ function requirements, and concomitant medication restrictions.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the efficacy of erlotinib + sorafenib and erlotinib + placebo as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the treatment of uterine leiomyoma (fibroids) using ulipristal acetate and placebo, with eligibility criteria including symptoms of bleeding, pressure, or pain caused by leiomyoma, uterine size of at least 2 cm, good health, and age between 25 and 50.",
    "This sample is a phase 2 trial for psoriasis, testing the drug ruxolitinib, with inclusion criteria based on psoriatic lesions and exclusion criteria for specific types of lesions.",
    "This sample is a phase 2 trial for the treatment of peripheral neuropathic pain, using the drugs sb681323 and placebo, with specific eligibility criteria including age, gender, pregnancy status, and pain intensity.",
    "This sample is a phase 2 clinical trial for the treatment of childhood lymphomas and leukemia, using a combination of drugs including doxorubicin hydrochloride, cyclophosphamide, methotrexate, rasburicase, leucovorin calcium, prednisone, methylprednisolone, cytarabine, etoposide, vincristine sulfate, and hydrocortisone sodium succinate, with specific eligibility criteria for patients to be included in the study.",
    "This sample is a phase 2 clinical trial for patients with histologically confirmed thyroid carcinoma, assessing the efficacy of celecoxib in treating progressive disease that has failed or is ineligible for standard therapy with iodine I 131 and/or surgery.",
    "This sample is a phase 2 clinical trial for patients with acute myeloid leukemia (AML) who have relapsed following their first complete remission (CR). The study aims to evaluate the efficacy of the drugs cep-701, high-dose cytarabine, and mitozantrone, etoposide, cytarabine (combination chemotherapy) in treating AML patients with FLT-3 activating mutation positive status after relapse. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 1/phase 2 clinical trial testing the drug mln8237 (alisertib) on patients with various advanced nonhematological malignancies, non-small cell lung cancer, small cell lung cancer, metastatic breast cancer, head and neck squamous cell carcinoma, and gastroesophageal adenocarcinoma, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for mantle cell lymphoma, testing the drugs rituximab and first line chemotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with relapsed or recurrent brain metastasis of breast cancer, testing the effectiveness of liposomal doxorubicin as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the drug E7389, and includes eligibility criteria such as disease progression, prior chemotherapy history, performance status, and organ function.",
    "This sample is a phase 2 trial for the treatment of rheumatoid arthritis using the drug cf101, with inclusion criteria including specific disease criteria and eligibility requirements, and exclusion criteria including previous use of certain medications and participation in previous trials.",
    "This sample is a phase 2 clinical trial for patients with sarcoma, testing the drug bortezomib, and includes eligibility criteria such as histologically confirmed sarcoma, soft tissue metastasis or locally recurrent disease, and specific measurement requirements for lesions.",
    "This sample is a phase 2 trial for patients with metastatic triple receptor-negative breast cancer, testing the drug Tarceva (EGFR inhibitor) to determine its effectiveness in patients who are resistant to taxanes and anthracyclines.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients, testing the drug gefitinib. The eligibility criteria include age, disease stage, smoking history, lesion size, performance status, and adequate organ function. Patients with brain metastasis, recent major surgery, other active malignancies, interstitial lung disease, or uncontrolled diabetes are excluded.",
    "This sample is a phase 2 clinical trial for patients with hormone-sensitive prostate cancer, testing the drug lapatinib ditosylate, and includes eligibility criteria such as previous treatment with surgery or radiation therapy, no evidence of metastatic disease, and specific laboratory values within normal limits.",
    "This sample is a phase 2 clinical trial for patients with multi-vessel coronary artery disease scheduled for coronary artery bypass surgery (CABG), testing the drug 6R-BH4. The inclusion criteria include having multi-vessel coronary artery disease, while the exclusion criteria include factors such as inability to provide informed consent, pregnancy, recent acute coronary event, and known hypersensitivity to 6R-BH4.",
    "This sample is a phase 2 clinical trial for patients with recurrent or metastatic colorectal cancer, testing the drug thalidomide, and includes eligibility criteria related to disease characteristics, patient characteristics, prior concurrent therapy, and other medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for cystic fibrosis patients with chronic P.aeruginosa infection, testing the efficacy of Arikayce\u2122 and placebo drugs in improving lung function (FEV1) and other eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced breast cancer and positive BRCA1 or BRCA2 status, testing the effectiveness of the drugs ku-0059436 (azd2281) (parp inhibitor) in treating the disease.",
    "This sample is a phase 2 trial for patients with various types of lymphoma, testing the effectiveness of a combination of drugs (prednisone, cyclophosphamide, doxorubicin, vincristine) in treating stage I or II diffuse large cell lymphoma, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2/phase 3 trial for HIV infections, testing the effectiveness of various antiretroviral drugs (nrtis, nnrtis, and pis) in HIV-infected individuals aged 30 days to 18 years, who have not previously received HAART or anti-HIV drugs for more than 56 consecutive days after birth, and meet other inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndrome (MDS) and the drug being tested is decitabine. The eligibility criteria include specific age range, MDS categories, cardiac and lung function requirements, and performance status. Exclusion criteria include limited life expectancy, presence of other active cancer, uncontrolled infections, previous chemotherapy for MDS/AML, and pregnancy.",
    "This sample is a phase 2 trial for HIV-infected individuals receiving potent ART, testing the efficacy of palifermin and its placebo in improving CD4 count and viral load.",
    "This sample is a phase 2 clinical trial for the treatment of schizophrenia, testing the drugs sca-136 (200 mg), sca-136 (400 mg), olanzapine (15 mg), and placebo, with inclusion criteria including a clinical diagnosis of schizophrenia and the ability to remain hospitalized for at least the first 4 weeks of the study.",
    "This sample is a phase 2 clinical trial for patients with advanced or recurrent endometrial cancer, testing the effectiveness of carboplatin and docetaxel as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with uveal melanoma, testing the effectiveness of carboplatin, paclitaxel, and sorafenib tosylate as systemic treatments, with specific eligibility criteria including disease progression, measurable disease, and various medical conditions.",
    "This sample is a phase 1/phase 2 trial for patients with breakthrough nausea and vomiting and unspecified adult solid tumors, testing the effectiveness of fosaprepitant dimeglumine and systemic chemotherapy in combination with 5-HT3 receptor antagonist antiemetics for managing chemotherapy-induced nausea and vomiting.",
    "This sample is a phase 2 trial for patients with non-Hodgkin's lymphoma, Burkitt lymphoma, and primary effusion lymphomas, testing the combination of pegylated liposomal doxorubicin (doxil) and rituximab as a treatment option. The eligibility criteria include having failed or relapsed after prior chemotherapy treatment, being seropositive for HIV, and meeting certain age and performance status requirements.",
    "This sample is a phase 2 clinical trial for patients with recurrent or persistent ovarian cancer who have received prior chemotherapy. The study aims to evaluate the effectiveness of fulvestrant, an estrogen receptor-positive tumor drug, in treating the disease. The eligibility criteria include specific disease characteristics, performance status, blood count, liver and kidney function, and prior medical history. Hormone replacement therapy and long-term anticoagulation therapy are excluded.",
    "This sample is a phase 2 trial for HIV-1 infected participants on first-line treatment, testing the efficacy of darunavir, ritonavir, and 2 nucleoside reverse transcriptase inhibitors (NRTIs) as a more convenient regimen with eligibility criteria including specific CD4 count and viral load requirements.",
    "This sample is a phase 2 clinical trial for narcolepsy patients, testing the drug \"gsk189254\", with inclusion criteria including narcolepsy patients with a body mass index between 18-32 kg/m2, and exclusion criteria including a history of major psychiatric disorder or depression, recent history of drug or alcohol abuse, and pregnancy or breastfeeding.",
    "This sample is a phase 2 trial for the treatment of sleep initiation and maintenance disorders using the drugs gr205171 and gw597599, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial is investigating the use of afq056 and placebo in outpatients with Parkinson's disease experiencing dyskinesias, who are on a stable anti-parkinsonian treatment regimen, and meet other protocol-defined inclusion/exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with stage III or IV, recurrent or refractory indolent B cell non-Hodgkin's lymphoma. The drug being tested is dexamethasone, and the eligibility criteria include specific disease characteristics and patient characteristics.",
    "This sample is a phase 2 trial for prostate cancer patients with specific inclusion and exclusion criteria, testing the drugs vandetanib and placebo, and focusing on patients who have completed their first hormone treatment and have a screening PSA level within a certain range.",
    "This sample is a phase 2 clinical trial for alcoholism and alcohol abuse, testing the effectiveness of quetiapine fumarate as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with gastrointestinal stromal tumors (GIST) who have received and progressed on imatinib and sunitinib. The study aims to evaluate the efficacy and safety of nilotinib as a treatment option.",
    "This sample is a phase 2 clinical trial for patients with recurrent bladder cancer or transitional cell carcinoma of the bladder, testing the drug sunitinib malate, and includes eligibility criteria such as previous treatment history, laboratory values, and contraception requirements.",
    "This sample is a phase 2 trial for asthma patients, testing the drugs oc000459 and placebo, with inclusion criteria including being a non-smoker and having a history of asthma symptoms increasing in response to external allergens. Exclusion criteria include recent use of inhaled or local corticosteroids and recent receipt of medication.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the effectiveness of oxaliplatin and vinorelbine as second-line chemotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with hormone-refractory prostate cancer, testing the effectiveness of mitoxantrone and GM-CSF as a second-line treatment option after docetaxel, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with colorectal carcinoma and liver metastases, testing the effectiveness of folfox6 cycles 1-3, folfox6 cycles 4 onwards, and bevacizumab cycles 3 onwards as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for asthma patients, testing the drugs gw870086 at different doses, with eligibility criteria including age, weight, disease severity, and medical history.",
    "This sample is a phase 2 clinical trial for patients with HIV, testing the effectiveness of etravirine, ritonavir, and darunavir in combination as a treatment regimen. The eligibility criteria include being on a current HAART regimen for at least 12 weeks, having no more than 2 previous virologic failures, and demonstrating phenotypic sensitivity to the drugs. The exclusion criteria include primary HIV-1 infection, HIV-2 infection, and use of disallowed concomitant therapy.",
    "This sample is a phase 2 clinical trial for relapsing multiple sclerosis, testing the drug atacicept and a placebo, with specific inclusion and exclusion criteria outlined in the protocol.",
    "This sample is a phase 2 clinical trial for patients with rheumatoid arthritis and chronic anemia, testing the drug epoetin alfa, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for allergic rhinitis, testing the drugs qaw039, montelukast, and placebo, with inclusion criteria including a positive skin prick test and a TNSS score of at least 6 during the EEC challenge. Exclusion criteria include the use of other investigational drugs and pregnancy or nursing.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the drugs dutasteride and gadolinium-chelate, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with adult acute myeloid leukemia in remission or acute myeloid leukemia arising from previous myelodysplastic syndrome. The trial aims to evaluate the effectiveness of busulfan, fludarabine phosphate, methotrexate, and tacrolimus as a treatment option. The eligibility criteria include achieving complete remission, specific laboratory values, and the availability of an HLA-identical sibling or a matched unrelated donor for stem cell transplantation.",
    "This sample is a phase 2 clinical trial for patients with hepatocellular carcinoma, testing the effectiveness of arsenic trioxide as a treatment option, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for the treatment of scleroderma using imatinib mesylate, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 trial for metastatic breast cancer patients who are ER-negative, PR-negative, HER2-neu-negative, and EGFR-positive. The drug being tested is erlotinib, and the eligibility criteria include having measurable disease, prior treatment with anthracycline and taxane chemotherapy, and a life expectancy of at least 3 months.",
    "This sample is a phase 2 trial testing the drugs azd9773 and placebo on Japanese adults with severe sepsis and septic shock, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with rheumatoid arthritis, testing the efficacy of a p38 inhibitor drug compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 trial that focuses on cardiovascular disease, aging, and endothelial dysfunction in sedentary elderly individuals. The drug being tested is alt-711, and the inclusion criteria include being healthy and aged 65 years or older, while the exclusion criteria include various cardiovascular and metabolic conditions.",
    "This sample is a phase 2 clinical trial for patients with advanced non-small cell lung cancer, testing the combination of paclitaxel poliglumex and pemetrexed as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for hepatocellular carcinoma, testing the drugs mapatumumab, placebo, and sorafenib, with eligibility criteria including Child-Pugh Class A, Barcelona Clinic Liver Cancer advanced or intermediate stage, and measurable disease on imaging.",
    "This sample is a phase 2 trial for open-angle glaucoma, testing the drug anecortave acetate sterile suspension, 30 mg/ml, with inclusion criteria of a diagnosis of open-angle glaucoma and exclusion criteria of pseudoexfoliation and pigment dispersion component.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic colorectal cancer who have progressed after 1st line therapy. The study aims to evaluate the effectiveness of a combination of drugs including oxaliplatin, 5-fluorouracil, leucovorin, bevacizumab, irinotecan, and cetuximab. The eligibility criteria include specific disease confirmation, measurable disease, performance status, age range, previous treatments, and adequate organ function. Exclusion criteria include certain medical conditions, recent surgeries, central nervous system metastases, and pregnancy.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs chf 5074 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with refractory nasopharyngeal carcinoma, testing the effectiveness of ifosfamide and doxorubicin as a second-line chemotherapy regimen, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of salmeterol xinafoate and serevent\u00ae diskus\u00ae compared to placebos in improving lung function, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the drug bortezomib. The eligibility criteria include having histologically confirmed adenocarcinoma of the breast, measurable lesions, and having been previously treated with one chemotherapy regimen.",
    "This sample is a phase 1/phase 2 clinical trial for patients with hormone refractory prostate cancer, testing the drugs docetaxel and imatinib mesylate, with eligibility criteria including age, specific disease diagnosis, prior treatments, performance status, and organ function.",
    "This sample is a phase 1/phase 2 clinical trial for non-small cell lung cancer, testing the drugs carboplatin, paclitaxel, and medi-575, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with acute promyelocytic leukemia (APL) and includes eligibility criteria such as morphologic diagnosis of APL, specific laboratory values, and exclusion criteria. The study will test the effectiveness of arsenic trioxide, idarubicin, and tretinoin as treatment options.",
    "This sample is a phase 2 clinical trial for patients with metastatic melanoma, testing the drug sutent (sunitinib) in patients with advanced stage III or IV melanoma with aberration of the KIT gene or KIT receptor, and who have measurable disease and meet other eligibility criteria.",
    "This sample is a phase 2 trial for HIV-infected patients with cognitive impairment, testing the effectiveness of minocycline and placebo (tetracycline) in improving neurocognitive decline.",
    "This sample is a phase 2 trial for Parkinson's disease, testing the drugs pym50028 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with highly-malignant non-Hodgkins-Lymphoma, mantle-cell lymphoma or follicular lymphoma 3\u00b0, with CNS relapse, testing the efficacy of combined systemic and intrathecal chemotherapy followed by hd-asct as a treatment option.",
    "This sample is a phase 2/phase 3 trial for asthma patients, testing the drugs vr506 and placebo, with inclusion criteria including age, documented clinical history of asthma, and ability to use the new inhaler correctly, and exclusion criteria including regular use of topical steroids, recent respiratory tract infection, and history of lung cancer.",
    "This sample is a phase 2 clinical trial for patients with recurrent or persistent endometrial adenocarcinoma, testing the drug pemetrexed, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients diagnosed with advanced or metastatic colorectal cancer, testing the drug enzastaurin hcl. The inclusion criteria include being able to visit the doctor's office every 28 days for at least 6 months and being able to swallow tablets. Exclusion criteria include not being pregnant or breastfeeding and having no history of significant heart disease or other medical problems.",
    "This sample is a phase 2 clinical trial for overweight and obesity, testing the effectiveness of pramlintide acetate, metreleptin, and placebos in participants who meet specific inclusion criteria and do not have certain medical conditions or take certain medications.",
    "This sample is a phase 1/phase 2 trial for previously untreated aggressive non-Hodgkin's lymphoma, testing the effectiveness of cyclophosphamide, doxorubicin, vincristine, and prednisone as a treatment option. The eligibility criteria include measurable or evaluable disease, stage I-IV patients, age 18 or older, and no evidence of grade 3 or more neurosensory or neuromotor dysfunction. HIV positive patients, those with inadequate bone marrow and organ function, CNS involvement by lymphoma, uncontrolled intercurrent disease, active infection or fever, inadequate contraceptive precautions, pregnancy, or breastfeeding are excluded from the study.",
    "This sample is a phase 2 clinical trial for asthma patients, testing the effectiveness of the drugs \"gsk573719 active treatment or placebo\" and \"salbutamol/albuterol\" in improving lung function, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with early-stage breast cancer, testing the effectiveness of a combination of drugs including cyclophosphamide, doxorubicin hydrochloride, lapatinib ditosylate, and paclitaxel, with eligibility criteria including HER2 positive status, recent surgery, and specific patient characteristics.",
    "This sample is a phase 2 trial for asthma, testing the drugs placebo, r940343 1mg, and r940343 2mg, with inclusion criteria of clinical history of asthma and ability to perform spirometry, and exclusion criteria of chronic obstructive pulmonary disease or bronchiectasis and upper or lower respiratory infection.",
    "This sample is a phase 2 clinical trial for postmenopausal women with invasive breast cancer, testing the drug fulvestrant, and includes eligibility criteria such as hormone sensitivity and willingness to undergo biopsies.",
    "This sample is a phase 2 clinical trial for type 2 diabetes mellitus, testing the drugs vi-0521 and placebo, with inclusion criteria including informed consent, type 2 diabetes, BMI 27-42, and specified diet/exercise and/or diabetes medications, and exclusion criteria including high blood pressure, recent cardiovascular events, renal/hepatic/psychiatric disease, unstable thyroid disease, nephrolithiasis, genetic/endocrine obesity, participation in weight loss program, glaucoma, pregnancy/breastfeeding, alcohol abuse, eating disorder, and excluded medications.",
    "This sample is a phase 2 clinical trial for chronic obstructive pulmonary disease (COPD) patients, testing the effectiveness of formoterol, salmeterol, and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with gastrointestinal stromal tumor, testing the drug imatinib mesylate, with specific eligibility criteria including confirmed diagnosis, resectable disease, measurable lesions, and certain laboratory values within normal range.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic prostate cancer, testing the effectiveness of dasatinib and docetaxel drugs in combination, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with carcinoma of unknown primary, testing the effectiveness of gemcitabine hydrochloride and irinotecan hydrochloride as treatment options, with specific eligibility criteria and patient characteristics outlined.",
    "This sample is a phase 2 clinical trial for patients with primary peritoneal cavity cancer or recurrent ovarian epithelial cancer, testing the drug imatinib mesylate, with specific eligibility criteria including prior platinum-based chemotherapy and certain performance status and laboratory values.",
    "This sample is a phase 2 clinical trial for patients with Parkinson's disease, testing the drug exenatide. The inclusion criteria include a diagnosis of idiopathic Parkinson's disease, age between 45-70 years, disease onset after age 40, disease duration > 5 years, and being on L-dopa treatment. The exclusion criteria include other causes of parkinsonism, abnormality on brain imaging, concurrent dementia or severe depression, and various medical conditions such as diabetes, renal disease, severe cardiac disease, and gastrointestinal disease.",
    "This sample is a phase 2 clinical trial for amyotrophic lateral sclerosis (ALS) patients, testing the effectiveness of pioglitazone and placebo drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for lupus nephritis, testing the drugs atacicept, mycophenolate mofetil, placebo, and corticosteroids, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of obesity, testing the effectiveness of different combinations of zonisamide sr and bupropion sr drugs, with specific eligibility criteria for participants.",
    "This sample is a phase 2 trial for patients with non-small-cell lung carcinoma, testing the drugs bibw2992 and bibw2992 + paclitaxel, with eligibility criteria including specific disease stage, mutation status, prior treatment history, and various health conditions.",
    "This sample is a phase 2 trial for patients with recurrent or advanced breast cancer, testing the drug tanespimycin, and includes eligibility criteria such as confirmed breast cancer, previous treatment history, and specific medical conditions that would exclude patients from participating in the trial.",
    "This sample is a phase 1/phase 2 clinical trial for patients with fallopian tube cancer, malignant tumor of peritoneum, or recurrent ovarian epithelial cancer. The drug being tested is docetaxel, and the eligibility criteria include having received prior platinum-based chemotherapy and meeting various medical requirements.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes, testing the drugs placebo and ro4876904, with inclusion criteria including age, diabetes diagnosis, and BMI range, and exclusion criteria including type 1 diabetes and recent use of certain medications.",
    "This sample is a phase 2 trial for the treatment of seasonal allergic rhinitis using the drugs vak694, alutard avanz sq, and saline, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, testing the drug ispinesib as a potential treatment option. The eligibility criteria include specific disease types, prior treatment history, and certain health parameters.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic breast cancer, testing the combination of lapatinib and docetaxel drugs, with eligibility criteria including age over 18, confirmed HER positive breast cancer, and no prior systemic investigational agent within the past 30 days.",
    "This sample is a phase 2 clinical trial for the treatment of infectious skin diseases using the drugs radezolid and linezolid, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the effectiveness of gemcitabine in combination with anthracycline and taxane chemotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for infertility in females, testing the drugs degarelix mid-luteal and placebo, with inclusion criteria including age, regular menstrual cycles, and willingness to donate oocytes, and exclusion criteria including abnormal karyotype, known systemic diseases, and previous participation in the study.",
    "This sample is a phase 2 trial for the drug ezetimibe in patients with hyperlipidemia, where the inclusion criteria include being on a stable statin or low dose statin, having stable lipid lowering therapy, and having fasting triglycerides below 400 mg/dL, while the exclusion criteria include having severe heart failure, uncontrolled cardiac arrhythmia, recent cardiovascular events, uncontrolled diabetes, and uncontrolled hypertension.",
    "This sample is a phase 2 clinical trial for patients with asthma, specifically mild asthma, and the drug being tested is gsk256066. The inclusion criteria include having a documented history of bronchial asthma, a pre-bronchodilator FEV1 >75% of predicted, being a non-smoker, and demonstrating a positive reaction to at least one allergen. The exclusion criteria include a history of cardiovascular disease, clinically significant abnormalities in safety laboratory analysis, history of hayfever, testing positive for hepatitis C or B, testing positive for HIV antibodies, positive drugs of abuse test, weighing less than 50kg, participating in a study with a new molecular entity in the previous 3 months, history of being unable to tolerate or complete methacholine and/or allergen challenge tests, risk of non-compliance with study medication or procedures, history of blood donation within 2 months, and regularly consuming excessive alcohol.",
    "This sample is a phase 2 clinical trial for patients with relapsed acute myelocytic leukemia (AML) who have achieved remission for a certain duration. The trial aims to evaluate the effectiveness of cladribine, a drug, in treating relapsed AML. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 2 clinical trial for patients with sleep initiation and maintenance disorders, testing the effectiveness of zolpidem tartrate, sodium oxybate, and matching placebos in improving sleep quality and reducing insomnia symptoms.",
    "This sample is a phase 2 clinical trial for the drug LY2828360 and placebo in male and female participants with osteoarthritis of the knee, with specific inclusion and exclusion criteria, and it includes a list of diseases, ICDCodes, and drugs associated with the trial.",
    "This sample is a phase 2 clinical trial for patients with Waldenstrom's macroglobulinemia, testing the effectiveness of bortezomib, dexamethasone, and rituximab as treatment options, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 2 trial aims to evaluate the efficacy of cisplatin and fluorouracil in combination with primary radiotherapy for patients with histologically confirmed stage I-IVB squamous cell carcinoma of the nasopharynx, who have been treated with primary radiotherapy and meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with recurrent or stage IIIB/IV non-small cell lung cancer, testing the drug eribulin mesylate. The eligibility criteria include prior treatment with platinum-based therapy and a taxane, measurable disease, and specific health requirements.",
    "This sample is a phase 2 clinical trial for patients with migraine, testing the effectiveness of nasal carbon dioxide and placebo as treatments, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) that is not curable by standard methods, testing the effectiveness of gemcitabine, carboplatin, and bevacizumab as a treatment option. The eligibility criteria include specific disease requirements, prior treatment restrictions, and organ function parameters.",
    "This sample is a phase 2 clinical trial for patients with ulcerative colitis, testing the effectiveness of vedolizumab and placebo as treatments, with specific inclusion and exclusion criteria for enrollment.",
    "This sample is a phase 2/phase 3 trial for patients scheduled for elective Cardiac or Thoracic Surgery, testing the drugs desirudin and heparin for the prevention of deep venous thrombosis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic prostate cancer who have received prior chemotherapy and hormone therapy. The study aims to evaluate the effectiveness of a combination of drugs including etoposide, mitoxantrone hydrochloride, prednisone, and vinorelbine tartrate in treating the disease. Eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 2 clinical trial for patients with stage IIIB or IV lung cancer, testing the drug ipi-504. The eligibility criteria include confirmed diagnosis of NSCLC, ALK mutation, measurable disease, and specific baseline studies. Exclusion criteria include recent treatment, concurrent radiation therapy, and certain medical conditions.",
    "This phase 2 trial is testing the effectiveness of cisplatin and 5-fluorouracil in treating pancreatic cancer patients who have undergone a potentially curative gross total resection by pancreaticoduodenectomy, and meet specific eligibility criteria including age, performance status, tumor stage, and organ function.",
    "This sample is a phase 2 clinical trial for osteoarthritis, testing the drugs oxycodone, placebo, and pf-000592379, with inclusion criteria including knee pain due to osteoarthritis and exclusion criteria such as pregnancy and recent participation in another clinical trial.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of paclitaxel and carboplatin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with HIV infection and chronic hepatitis B virus (HBV) infection, testing the effectiveness of emtricitabine in reducing HBV DNA levels in co-infected individuals.",
    "This sample is a phase 2 trial for breast cancer patients, testing the effectiveness of zoledronic acid in combination with adjuvant therapy, with eligibility criteria including age, disease stage, bone marrow aspirate results, renal and liver function, and exclusion criteria such as allergy to bisphosphonates and renal insufficiency.",
    "This sample is a phase 2 clinical trial for irritable bowel syndrome, testing the effectiveness of dronabinol and placebo in patients who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for individuals with either amnestic mild cognitive impairment or mild Alzheimer's Disease, testing the drugs aqw051 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug sunitinib malate for patients with newly diagnosed brain metastases, with specific eligibility criteria and restrictions on prior and concurrent therapies.",
    "This sample is a phase 1/phase 2 trial for patients with locally advanced, inoperable or metastatic pancreatic adenocarcinoma, testing the combination of bay86-9766 and gemcitabine as a potential treatment option.",
    "This sample is a phase 2 clinical trial for patients with gastrointestinal stromal tumor (GIST) who have failed prior tyrosine kinase inhibitors. The drug being tested is regorafenib, and the eligibility criteria include age, disease confirmation, performance status, organ function, and prior cancer therapy.",
    "This sample is a phase 2 clinical trial for patients with leukemia and lymphoma, testing the efficacy of forodesine hydrochloride sterile solution and capsules as a treatment option, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2/phase 3 trial for patients with stage IIIB or IV non-small cell lung cancer, testing the effectiveness of vorinostat and comparing it to paclitaxel, carboplatin, and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for schizophrenia, testing the effectiveness of drugs such as placebo, cariprazine, and risperidone, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for non-small cell lung cancer patients, testing the drugs bevacizumab, erlotinib, and pemetrexed, with eligibility criteria including age, disease stage, performance status, renal and hepatic function, bone marrow function, and prior procedures, while excluding certain histologies, hypercalcemia, infections, and other conditions.",
    "This sample is a phase 2 trial for patients with colorectal liver metastases, testing the effectiveness of 5-fluorouracil, bevacizumab, leucovorin, and oxaliplatin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for primary open-angle glaucoma and ocular hypertension, testing the drugs lx7101 (0.125%), lx7101 (0.25%), and lx7101 vehicle, with inclusion and exclusion criteria specified.",
    "This sample is a phase 2 trial for graft versus host disease, testing the effectiveness of tacrolimus, mycophenolate, etanercept, and methoxsalen as standard prophylaxis drugs, with eligibility criteria including being a candidate for unrelated donor hematopoietic stem cell transplant and receiving a recognized reduced intensity transplant.",
    "This sample is a phase 2 clinical trial for patients with metastatic adenocarcinoma of the colon or rectum, testing the drug folfiri as a second-line treatment option after failure of first-line chemotherapy.",
    "This phase 2 trial is investigating the efficacy of carboplatin, cisplatin, gemcitabine hydrochloride, and paclitaxel in treating bladder and urethral cancer patients who meet specific eligibility criteria, including disease confined to the true pelvis and no extrapelvic metastases.",
    "This sample is a phase 2 trial for patients with metastatic colorectal cancer refractory to at least 2 chemo/biologic regimens, testing the drug rad001, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with pancreatic cancer, testing the drug dasatinib, with specific eligibility criteria including disease confirmation, performance status, blood counts, liver function, cardiac conditions, and prior therapies.",
    "This sample is a phase 2 clinical trial for patients with fallopian tube cancer, ovarian cancer, or malignant tumor of peritoneum, testing the effectiveness of Avastin and docetaxel drugs in combination with specific eligibility criteria.",
    "This sample is a phase 2 trial for the drug perampanel in patients with epilepsy, where the eligibility criteria include having a diagnosis of epilepsy with partial-onset seizures, being on a stable regimen of 1-3 antiepileptic drugs, and having a negative pregnancy test for female subjects.",
    "The sample is a phase 2 clinical trial for glaucoma and ocular hypertension, testing the effectiveness of bimatoprost eye drops compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug \"haelan\" on patients with anorexia, weight loss, and cachexia, with specific inclusion and exclusion criteria.",
    "This phase 2 trial aims to investigate the effectiveness of aliskiren, amlodipine, and placebo in treating high blood pressure, metabolic syndrome, insulin resistance, and endothelial dysfunction in adults aged 18 to 55 years with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the use of estetrol and desogestrel or estetrol and progesterone in healthy women aged 18-40, with specific inclusion and exclusion criteria, to evaluate their effects on ovulation and menstrual cycle.",
    "This sample is a phase 2 trial for previously untreated stage III, IV, or bulky stage II diffuse large B-cell non-Hodgkin's lymphoma patients, testing the efficacy of cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone as a treatment regimen. The eligibility criteria include confirmation of CD20 expression, adequate biopsy for pathology review, measurable disease, bone marrow aspirate and biopsy, CT scan, negative CNS involvement, no previous indolent lymphoma diagnosis, no prior lymphoma therapy, specific laboratory and radiographic test results, and various other medical conditions and history restrictions.",
    "This sample is a phase 2 trial for patients with colorectal cancer and metastases, testing the effectiveness of cetuximab, bevacizumab, leucovorin, oxaliplatin, and fluorouracil in combination with major liver resection for resectable liver metastases. The inclusion criteria include having synchronous or metachronous colorectal metastases, technically resectable liver metastases, and being a medically suitable candidate for major liver resection, among others. The exclusion criteria include abnormal liver function, renal insufficiency, interstitial lung disease, and peripheral neuropathy.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients who are not suitable for surgery or radiotherapy, and it will test the effectiveness of erlotinib and vinorelbine with carboplatin as treatment options.",
    "This sample is a phase 2 clinical trial for patients with non-Hodgkin's lymphoma, testing the drugs pro95780 and rituximab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the drug td-1211 and placebo in patients with opioid induced constipation, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the treatment of acute rhinosinusitis, testing the efficacy of three drugs (ffns 110 mcg qd, ffns 110 mcg bid, and placebo nasal spray) on eligible patients who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs lu ae58054 and placebo, with inclusion criteria including probable AD consistent with NINCDS-ADRDA criteria and stable donepezil treatment for at least 3 months, and exclusion criteria including evidence of other neurodegenerative diseases, certain mental disorders, and clinically significant abnormal vital signs or laboratory values.",
    "This phase 2 trial aims to evaluate the efficacy of topotecan and taxotere in treating recurrent endometrial adenocarcinoma, papillary serous, mixed mullerian tumor, and recurrent ovarian or primary peritoneal cancers, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for psoriasis vulgaris, testing the drugs leo 90100, calcipotriol, and betamethasone, with inclusion criteria including age 18 and above, all skin types, and negative pregnancy test for females of childbearing potential, and exclusion criteria including recent systemic treatments for psoriasis vulgaris and other skin conditions, as well as certain medical conditions and medications.",
    "This sample is a phase 1/phase 2 trial for individuals with pre-hypertension, testing the effectiveness of carvedilol phosphate, lisinopril, and a combination of both drugs, as well as a placebo, in reducing blood pressure and cardiovascular risk factors.",
    "This sample is a phase 2 trial testing the effectiveness of tamsulosin hydrochloride, solifenacin succinate, and placebo in male patients with lower urinary tract symptoms associated with prostatic hyperplasia, who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of recurrent childhood acute lymphoblastic leukemia, using a combination of drugs including l-asparaginase, doxorubicin hydrochloride, and vincristine sulfate, among others. The eligibility criteria include specific diagnosis requirements, performance status, blood count limits, and various other medical conditions.",
    "This sample is a phase 2 trial for patients with recurrent primary CNS non-Hodgkin's lymphoma, testing the efficacy of methylprednisolone and temozolomide as treatment options, with specific eligibility criteria including measurable disease, stable steroid therapy, and various patient characteristics such as age, performance status, and hematopoietic parameters.",
    "This sample is a phase 1/phase 2 trial for patients with glioblastoma multiforme (GBM) recurrence, testing the effectiveness of bcnu wafer, irinotecan, and bevacizumab drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for multiple myeloma patients who are eligible for induction therapy followed by high dose treatment supported by autologous stem cell transplantation, with fludarabine as the drug being tested. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 2 trial for patients with coronary disease, testing the effectiveness of otamixaban, unfractionated heparin, and eptifibatide in reducing ischemic discomfort and preventing myocardial infarction, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for major depressive disorder, testing the drug quetiapine fumarate (seroquel), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of bortezomib as a treatment option. The eligibility criteria include previous diagnosis of multiple myeloma, measurable disease, previous tolerance to bortezomib, and a life expectancy of more than 3 months. The exclusion criteria include recent treatment for multiple myeloma, uncontrolled cardiovascular disease, poorly controlled hypertension or diabetes, and presence of other malignancies within the past 5 years.",
    "This sample is a phase 2 clinical trial for participants with progressive metastatic breast cancer, testing the effectiveness of dexamethasone and trabectedin as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic hormone refractory prostate cancer, testing the drug panobinostat. The eligibility criteria include confirmed diagnosis of adenocarcinoma of the prostate, evidence of disease progression, and willingness to use contraception. Exclusion criteria include history of CNS disease, prior radiotherapy, impaired cardiac function, and liver or renal disease with impaired function.",
    "This sample is a phase 2 clinical trial for esophageal cancer, testing the effectiveness of docetaxel, floxuridine, leucovorin, and oxaliplatin as treatment options, with specific eligibility criteria for patients.",
    "This sample is a phase 2/phase 3 trial for patients with diffuse large B-cell or peripheral T-cell non-Hodgkin's lymphoma, testing the effectiveness of various drugs including chop regimen, epoch regimen, cyclophosphamide, doxorubicin hydrochloride, etoposide, prednisone, and vincristine sulfate, with specific eligibility criteria including age, performance status, hematopoietic, hepatic, renal, cardiovascular, and other factors.",
    "This sample is a phase 2 clinical trial for patients with various types of salivary gland carcinoma, testing the drug lapatinib ditosylate, and includes eligibility criteria such as documented tumors expressing EGFR and/or erbB2, measurable disease, prior therapy interval, and specific medical requirements.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory multiple myeloma, testing the drug lenalidomide, and includes eligibility criteria such as specific disease characteristics and patient characteristics.",
    "This sample is a phase 2 clinical trial for the treatment of psoriasis vulgaris using the drug LEO 90100, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with Parkinson's disease, testing the efficacy of perampanel and placebo as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for non-Hodgkin's lymphoma and mantle cell lymphoma patients, testing the drug bendamustine hydrochloride, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 trial for the treatment of alcohol use disorder, testing the effectiveness of acamprosate compared to placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for major depressive disorder, testing the effectiveness of ketamine and placebo as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer, testing the drugs carboplatin, paclitaxel, and sunitinib, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with non-small cell lung cancer, specifically stage IIIA non-resectable or stage IIIB without pleural effusion, testing the drug S-3304, with specific inclusion and exclusion criteria.",
    "This phase 2 clinical trial aims to evaluate the efficacy of docetaxel, cisplatin, and fluorouracil in treating patients with gastric adenocarcinoma, who meet specific eligibility criteria including histologically proven diagnosis, acceptable hematological and renal function, adequate hepatic and pulmonary function, and no prior chemotherapy for gastric cancer.",
    "This sample is a phase 2 clinical trial for patients with inoperable non small cell lung cancer, testing the effectiveness of gemcitabine and cisplatin as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with incurable esophageal or gastric carcinoma, testing the effectiveness of taxotere, cisplatin, and irinotecan as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with inoperable locally-advanced metastatic adenocarcinoma of the stomach, gastro-oesophageal junction, or distal oesophagus. The trial aims to evaluate the efficacy of the drug aslan001 in patients who have received prior chemotherapy for the treatment of this disease.",
    "This sample is a phase 1/phase 2 trial that aims to evaluate the effectiveness of campath, busulfan, fludarabine, and fk-506 in treating various hematologic diseases, including myelodysplastic and myeloproliferative disorders, acute myelogenous leukemia, acute lymphoblastic leukemia, chronic myelogenous leukemia, multiple myeloma, plasma cell dyscrasia, lymphoproliferative disorders, and other treatable non-malignant hematologic diseases. The study includes specific inclusion and exclusion criteria for eligible patients, such as age, performance status, cardiac and pulmonary function, and the availability of a healthy donor.",
    "This sample is a phase 2 trial for patients with coronary disease who are scheduled for primary CABG surgery, and the study will test the effectiveness of the drug \"ins50589 intravenous infusion\" in reducing bleeding during and after surgery.",
    "This sample is a phase 2 clinical trial for patients with relapsed non-small cell lung cancer, testing the effectiveness of pemetrexed, gemcitabine, and carboplatin as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of chronic hepatitis C, testing the drugs ro5024048, ribavirin, and peginterferon alfa-2a, with specific inclusion and exclusion criteria for eligible patients.",
    "This phase 2 trial is investigating the use of clofarabine in patients with myelodysplastic syndrome (MDS) and leukemia, who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic myeloid leukemia who have shown suboptimal response to imatinib, and it will test the effectiveness of dasatinib in improving their hematologic and cytogenic responses.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC), testing the effectiveness of the drugs tarceva, carboplatin, and paclitaxel in combination with certain eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic melanoma, testing the drug taxoprexin. The eligibility criteria include having confirmed malignant eye melanoma with documented metastatic disease, measurable lesions, and adequate liver, renal, and bone marrow function. Patients must not have received prior taxane therapy and must have an ECOG performance status of 0-2.",
    "This sample is a phase 2 clinical trial for patients with lymphoma who have relapsed after a bone marrow transplant, and it aims to evaluate the effectiveness of a combination of drugs including fludarabine phosphate, melphalan, methotrexate, and tacrolimus in achieving a complete or partial response.",
    "This sample is a phase 2 trial testing the drug panobinostat (lbh589) on patients with cutaneous t-cell lymphoma and leukemia-lymphoma, adult t-cell, who have had disease progression on or following their most recent treatment regimen.",
    "This sample is a phase 2/phase 3 trial for tobacco dependence, testing the effectiveness of s-adenosyl-l-methionine (SAMe) as a treatment option, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the effectiveness of abiraterone acetate and prednisone in combination with chemotherapy for patients who have previously received docetaxel treatment, and meet specific eligibility criteria.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of glycopyrrolate and a comparator drug. The inclusion criteria include age, post-bronchodilator FEV1 value, and previous therapy, while the exclusion criteria include pregnancy, recent exacerbation, and other concomitant diseases impacting safety.",
    "This sample is a phase 1/phase 2 trial for the drug he3286 in patients with rheumatoid arthritis, with specific inclusion and exclusion criteria, and the study will assess the safety and efficacy of the drug in combination with methotrexate.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia or acute lymphoblastic leukemia, testing the drug panobinostat, and includes eligibility criteria related to disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 2 trial for patients with moderate to severe plaque-type psoriasis, testing the efficacy of multiple doses of the drug birb 796 bs compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of paclitaxel/carboplatin/gefitinib and paclitaxel/carboplatin as treatment options. The eligibility criteria include age, cancer stage, ECOG performance status, previous treatments, and various health parameters. Patients with EGFR mutation, brain metastasis, recent major surgery, or other active malignancies are excluded.",
    "This sample is a phase 2 clinical trial for patients with various types of bladder, urethral, ureter, or renal pelvis cancer, testing the drug bortezomib. The eligibility criteria include having received only one prior chemotherapy regimen, measurable disease, and specific performance status and laboratory values.",
    "This sample is a phase 2 trial for patients with Cushing's disease, testing the drug rosiglitazone maleate to control elevated cortisol levels and pituitary tumor growth, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with asthma, testing the efficacy of tiotropium and placebo as add-on therapy to medium doses of inhaled corticosteroids, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with head and neck squamous cell carcinoma, testing the effectiveness of docetaxel+cddp and docetaxel+s-1 as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for Hodgkin lymphoma, testing the effectiveness of prednisone, vinblastine, doxorubicin, and gemcitabine in patients with specific inclusion criteria, such as histologically confirmed diagnosis, specific stage, and no prior therapy for Hodgkin's lymphoma.",
    "This sample is a phase 2/phase 3 trial for patients with acute cortical ischemic stroke, testing the drug ono-2506, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for postherpetic neuralgia, testing the drug \"spm 927\" and evaluating the eligibility criteria for inclusion and exclusion.",
    "This phase 2 trial is testing the effectiveness of erlotinib hydrochloride and gemcitabine hydrochloride in treating metastatic pancreatic cancer patients who meet specific eligibility criteria.",
    "This phase 2 trial is testing the drug paricalcitol in patients with metastatic prostate cancer and bone metastasis, who have androgen refractory disease and secondary hyperparathyroidism, to evaluate its efficacy and safety.",
    "This sample is a phase 2 trial for osteoporosis, testing the drugs ronacaleret, teriparatide, and alendronate, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 clinical trial for patients with progressive or recurrent malignant glioma, testing the drugs ixabepilone and anticonvulsant, with eligibility criteria including specific disease types, prior therapy recovery, performance status, blood counts, organ function, and exclusion criteria such as concurrent infections, pregnancy, and certain medications.",
    "This sample is a phase 2 clinical trial for multiple sclerosis, testing the efficacy of abt-874 (a human monoclonal antibody against IL-12) compared to placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for the treatment of mild, stable allergic asthma using the drugs memp1972a and placebo, with inclusion criteria including a history of episodic wheeze and shortness of breath, and exclusion criteria including a worsening of asthma within 6 weeks preceding the study and a history of significant hepatic or renal impairment.",
    "This sample is a phase 2 trial for patients with multiple myeloma or plasma cell neoplasm who have previously been treated with autologous stem cell transplantation and high-dose melphalan, and it aims to assess the efficacy of melphalan in improving organ function and performance status.",
    "This sample is a phase 2 trial for patients with rheumatoid arthritis, testing the effectiveness of etoricoxib and comparing it to placebo and diclofenac, with specific inclusion and exclusion criteria for participation.",
    "This sample is a phase 2 trial for the drug cr845 and placebo in patients with acute pain, specifically those scheduled for elective primary unilateral first metatarsal bunionectomy surgery, and includes eligibility criteria such as age, ability to provide informed consent, and negative urine drug screen.",
    "This sample is a phase 2 trial for primary insomnia, testing the drugs mk-6096 and dose-matched placebo to mk-6096, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with extensive stage or recurrent small cell lung cancer, testing the drug sorafenib tosylate, and includes eligibility criteria such as previous treatment with cisplatin or carboplatin, measurable disease per RECIST criteria, and specific laboratory values.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of irinotecan hydrochloride as a treatment option, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with squamous cell carcinoma, testing the effectiveness of docetaxel + cddp drugs in treating NSCLC, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with adenocarcinoma of the stomach or gastroesophageal junction, testing the drug saracatinib, with specific eligibility criteria and exclusion criteria.",
    "This phase 2 trial is investigating the effectiveness of trastuzumab emtansine, trastuzumab, and docetaxel in treating patients with locally advanced or metastatic breast cancer who are HER2-positive and have not received prior chemotherapy for their metastatic breast cancer.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the efficacy of ormd-0801 dose # 1, ormd-0801 dose # 2, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer who are scheduled for radical prostatectomy, and the drug being tested is dexamethasone. The eligibility criteria include specific disease characteristics, age, performance status, hematopoietic, hepatic, renal, and other factors. Prior concurrent therapy is also specified.",
    "This sample is a phase 2 clinical trial for small cell lung cancer, testing the drugs amrubicin, cisplatin, and etoposide, with specific eligibility criteria including histologically proven cancer, extensive disease, and normal baseline cardiac function.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the drugs semapimod and placebo, with eligibility criteria including a specific Crohn's Disease Activity Index range and stable medication doses.",
    "This sample is a phase 2 clinical trial for patients with cholangiocarcinoma or gallbladder carcinoma, testing the drug sorafenib tosylate, with specific eligibility criteria including disease confirmation, disease stage, prior therapy, and various medical conditions.",
    "This sample is a phase 1/phase 2 trial for patients with colorectal cancer, specifically adenocarcinoma of the colon or rectum, and it focuses on the use of irinotecan hydrochloride as a treatment option. The eligibility criteria include having received prior chemotherapy, having measurable disease, and meeting certain medical and laboratory requirements.",
    "This sample is a phase 2 trial for asthma, testing the drugs fluticasone furoate, ff/vilanterol, and placebo, with inclusion criteria including BMI range, non-smoking status, and FEV1 level, and exclusion criteria including liver disease, hypertension, and recent respiratory tract infection.",
    "This sample is a phase 2 clinical trial for children with asthma, testing the effectiveness of arformoterol and levalbuterol as drugs, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2/phase 3 trial for patients with HIV infection and chronic hepatitis B, testing the effectiveness of Truvada (emtricitabine + tenofovir df) in combination with other criteria such as stable ARV, CD4 count, and viral load.",
    "This sample is a phase 1/phase 2 clinical trial for patients with ulcerative colitis, testing the effectiveness of the drugs placebo and he3286 in treating the disease, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with epithelial ovarian cancer and primary peritoneal carcinoma, testing the effectiveness of bevacizumab and abraxane in combination therapy, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 2 trial is investigating the effectiveness of irinotecan in treating patients with fallopian tube cancer, ovarian cancer, or primary peritoneal cavity cancer who have relapsed within 6 months after completing front-line platinum and taxane chemotherapy.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of b-cell chronic lymphocytic leukemia and small lymphocytic lymphoma using the drug pci-32765, with specific eligibility criteria for different patient groups.",
    "This sample is a phase 2 trial for patients with advanced hepatocellular carcinoma (HCC), testing the effectiveness of sorafenib plus doxorubicin and doxorubicin/placebo as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for the treatment of intermittent claudication, a symptom of peripheral artery disease (PAD), using trans sodium crocetinate (TSC) and 0.9% normal saline as drugs. The eligibility criteria include age, diagnosis of PAD, stable claudication severity, and stable exercise habits.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the drugs fluoxymesterone and anastrozole, with specific eligibility criteria including age, ER/PR status, disease progression, evaluable disease and symptoms, performance status, and recent mammogram.",
    "This sample is a phase 2 trial for insulin-na\u00efve type 2 diabetes subjects, testing the efficacy of insulin glargine, insulin degludec, and metformin in achieving glycemic control, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with open-angle glaucoma or ocular hypertension, testing the drug brinzolamide/timolol, and includes eligibility criteria for adults of any race and sex with the specified conditions.",
    "This sample is a phase 1/phase 2 trial for the treatment of prostate cancer using drugs such as sunitinib malate, docetaxel, and prednisone, with eligibility criteria including a histological diagnosis of adenocarcinoma of the prostate, metastatic prostate cancer unresponsive to hormone therapy, and adequate hepatic and renal function.",
    "This sample is a phase 2 trial testing the drugs dalcetrapib and placebo in adult patients with coronary heart disease, who are treated for dyslipidemia and clinically stable, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for major depressive disorder, testing the drugs ly2216684, placebo, and escitalopram, with inclusion and exclusion criteria specified.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the drug abiraterone acetate in combination with prednisone. The eligibility criteria include having adenocarcinoma of the prostate, receiving continuous treatment with Gonadotropin-releasing hormone (GnRH) monotherapy, and having a serum testosterone level below 50 ng/dL.",
    "This sample is a phase 2 trial for the treatment of primary testicular CD20-positive diffuse large B-cell non-Hodgkin's lymphoma using rituximab, chop, and intrathecal methotrexate, with specific eligibility criteria including age, performance status, disease stage, and previous therapy.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer, testing the drugs bevacizumab and carboplatin-based chemotherapy, with specific eligibility criteria for patients.",
    "This sample is a phase 2 trial for the treatment of keratoconjunctivitis sicca (dry eye) using the drugs cf101 and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1/phase 2 trial for individuals diagnosed with schizophrenia who are chronic cannabis users and currently being treated with antipsychotic medication. The study aims to investigate the effects of dronabinol, a drug, on this population.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of bevacizumab, eloxatin, capecitabine, and erlotinib as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for cystic fibrosis patients with the G551D-CFTR mutation, testing the effectiveness of ivacaftor and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients with stage IIIAN2 disease, testing the effectiveness of pemetrexed, cisplatin, folic acid, vitamin b12, and dexamethasone as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of overactive bladder, testing the drugs mirabegron and solifenacin succinate against a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for asthma patients aged 5-11 years, testing the effectiveness of fluticasone furoate, a corticosteroid inhaler, in controlling asthma symptoms.",
    "This sample is a phase 2 trial for patients with unresectable, metastatic esophageal cancer, testing the effectiveness of the drugs bortezomib, carboplatin, and paclitaxel, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial testing the drug levetiracetam (add-on) for the treatment of status epilepticus, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is testing the drug erlotinib hydrochloride in patients with sarcoma, specifically malignant peripheral nerve sheath tumor, malignant schwannoma, or neurofibrosarcoma, who have unresectable or metastatic disease, and meet various eligibility criteria related to age, performance status, hematopoietic, hepatic, renal, ophthalmic, gastrointestinal, and other factors.",
    "This sample is a phase 2 trial for patients with Stage IIIA or IIIB non-small cell lung cancer, testing the efficacy of induction and consolidation chemotherapy with carboplatin and paclitaxel. The eligibility criteria include measurable disease, positive mediastinal lymph nodes, specific laboratory values, and evaluation by thoracic surgery, medical oncology, and radiation oncology.",
    "This sample is a phase 1/phase 2 trial for atopic dermatitis, testing the efficacy of dpk-060 1% ointment compared to placebo, with specific inclusion and exclusion criteria for eligible patients.",
    "This sample is a phase 2 trial for patients with advanced stage IV or unresectable stage III melanoma, testing the efficacy of a combination of drugs including temozolomide, velban, cisplatin, interleukin-2, intron-a, and thalidomide, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for adult patients with CD20+ chronic lymphocytic leukemia (CLL), testing the effectiveness of rituximab and chlorambucil as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of melanoma using Normothermic Isolated Limb Infusion (ILI) of melphalan, with inclusion criteria including signed informed consent, measurable disease, and availability for N-cadherin expression testing, and exclusion criteria including prior use of ADH-1, stage IV melanoma, and recent chemotherapy or major surgery.",
    "This sample is a phase 2 clinical trial for patients with glioblastoma multiforme or anaplastic astrocytoma, testing the drug ls11 (talaporfin sodium) for tumor resection, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for type 2 diabetes, testing the drugs xoma 052 and placebo, with eligibility criteria including specific blood glucose levels, HbA1c range, stable disease, age range, weight range, BMI range, negative pregnancy test for females, and restrictions on certain medications.",
    "This sample is a phase 2 trial investigating the use of intravenous sildenafil in treating persistent pulmonary hypertension and respiratory failure in newborns, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for pancreatic cancer, testing the drugs gefitinib and gemcitabine, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial is testing the drug lapatinib in patients with metastatic breast cancer who have previously responded to hormonal therapy, and it includes specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the effectiveness of gemcitabine and cisplatin as treatment options, with specific inclusion and exclusion criteria for participation in the study.",
    "This sample is a phase 2 clinical trial for patients with biliary tract cancer, testing the effectiveness of gemcitabine and cisplatin as chemotherapy drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the effectiveness of the drug bi 10773 at different doses, along with eligibility criteria such as stable basal insulin treatment and specific glycemic control levels.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the drugs cp-690,550 and placebo, with inclusion criteria including age, duration of disease, and disease severity, and exclusion criteria including current use of certain medications and evidence of hematopoietic disorders or active/latent TB.",
    "This sample is a phase 2 clinical trial for pancreatic cancer, testing the effectiveness of gemcitabine, erlotinib, and oxaliplatin in patients who meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 trial for patients with prostate cancer, testing the drugs taxotere and doxil, with eligibility criteria including specific disease progression markers, previous cytotoxic therapy, age, performance status, and adequate organ function.",
    "This sample is a phase 2 clinical trial for patients with Waldenstrom's macroglobulinemia, testing the effectiveness of cyclophosphamide, doxorubicin, prednisone, and vincristine in combination therapy, with specific eligibility criteria including bone marrow lymphoplasmacytosis, measurable disease, impaired bone marrow function, and symptomatic presentation.",
    "This sample is a phase 2 clinical trial for patients with malignant mesothelioma, testing the drug dasatinib, and includes eligibility criteria such as confirmed histology, measurable disease, prior treatment with pemetrexed disodium, and specific patient characteristics.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs lecozotan sr and donepezil, with inclusion criteria including a diagnosis of probable AD and the ability to give informed consent, and exclusion criteria including recent use of medications for cognitive enhancement and significant neurologic diseases other than AD.",
    "This sample is a phase 2 clinical trial for the treatment of diabetic gastroparesis using the drugs 10 mg tzp-102 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for lung cancer patients with specific inclusion and exclusion criteria, where the drug sorafenib will be tested.",
    "This sample is a phase 2 clinical trial for patients with inoperable advanced gastric adenocarcinoma, testing the effectiveness of taxteral, 5-fluorouracil, and leucovorin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with prostate cancer, testing the drug tak-700, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 trial for patients with asthma and status asthmaticus, testing the effectiveness of different drug doses (dose group 1, mn-221 placebo, dose group 2, dose group 3) in combination with standard treatment criteria for acute exacerbation of asthma.",
    "This sample is a phase 2 clinical trial for the treatment of postherpetic neuralgia and pain using a transdermal patch containing bupivacaine, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 2 trial is investigating the effectiveness of ziprasidone (geodon) compared to placebo in treating bipolar disorder type II and unipolar major depressive disorder, with specific eligibility criteria for participants.",
    "This sample is a phase 2 trial testing the efficacy of different oral contraceptives, including 91-day levonorgestrel, 28-day levonorgestrel, and 28-day desogestrel, in premenopausal women aged 18-40 years old with a regular menstrual cycle, and the eligibility criteria include BMI, contraindications, and thrombophilia history.",
    "This sample is a phase 1/phase 2 clinical trial for patients with chronic lymphocytic leukemia (CLL) who have relapsed or refractory disease, and it will test the efficacy of bendamustine, rituximab, and lenalidomide as a treatment regimen. The eligibility criteria include specific age requirements, confirmed diagnosis of CLL, previous response to bendamustine, and various health parameters.",
    "This sample is a phase 2 clinical trial for patients with stage IV Renal Cell Carcinoma, testing the effectiveness of recombinant interleukin-21 and sunitinib as potential treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the drug abiraterone acetate. The eligibility criteria include prior therapy with ketoconazole, metastatic disease, ongoing androgen deprivation therapy, and specific laboratory values. Exclusion criteria include prior chemotherapy, certain medications, and medical conditions.",
    "This sample is a phase 2 clinical trial for the treatment of glaucoma and ocular hypertension using the drugs 0.25% ar-12286 / 0.004% travoprost and 0.5% ar-12286, 0.004% travoprost. The eligibility criteria include being 18 years or older, having a diagnosis of open angle glaucoma or ocular hypertension, and having unmedicated intraocular pressure above a certain threshold.",
    "This sample is a phase 2 trial for patients with chronic lymphocytic leukemia (CLL) and includes the drug alemtuzumab as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with acute lymphoblastic leukemia or lymphoblastic lymphoma, testing the use of asparaginase erwinia chrysanthemi for those who have a hypersensitivity reaction to other asparaginase treatments.",
    "This sample is a phase 2 clinical trial for patients with advanced kidney cancer, testing the drug everolimus. The eligibility criteria include specific histology, risk factors, and measurable metastatic sites, among others.",
    "This sample is a phase 2 trial for the treatment of chronic moderate to severe plaque psoriasis, testing the drugs tofacitinib and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for participants with type 2 diabetes mellitus, testing the effectiveness of ranolazine and placebo in combination with non-insulin antidiabetic therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with head and neck cancer or lung cancer who have undergone surgery or definitive local treatment, and are eligible if they meet certain criteria. The drug being tested is celecoxib, and the study aims to characterize the occurrence of recurrent or second primary tumors in patients with a prior history of a definitively treated stage I/II head and neck or non-small cell cancer who are current or former smokers.",
    "This sample is a phase 2 trial for the treatment of type 2 diabetes mellitus, testing the efficacy of the drug amg 151 in combination with metformin, with specific eligibility criteria including age, HbA1c levels, BMI, and previous treatment with metformin.",
    "This sample is a phase 2 clinical trial for patients with recurrent or metastatic head and neck cancer, testing the drug cabazitaxel. The eligibility criteria include having measurable lesions, adequate hematologic function, and being affiliated with a Social Security System. Exclusion criteria include active concurrent malignancy and severe uncontrolled medical diseases.",
    "The sample is a phase 2/phase 3 trial for the treatment of dry eye using carboxymethylcellulose sodium and glycerin eye drops, with inclusion criteria of mild, moderate, or severe dry eye symptoms and reduced tear stability or tear production, and no exclusion criteria specified.",
    "This sample is a phase 2 clinical trial for previously untreated chronic lymphocytic leukemia patients, testing the combination of abt-263 and rituximab drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for primary insomnia, testing the drug neu-p11, and includes eligibility criteria such as age range, specific sleep symptoms, medication history, and exclusion criteria related to other sleep disorders and medical conditions.",
    "This sample is a phase 2 trial for the drug z-338 in patients with dyspepsia, with inclusion criteria including a positive diagnosis of functional dyspepsia and no history of the condition.",
    "This sample is a phase 2 clinical trial for patients with hepatocellular carcinoma, testing the effectiveness of oxaliplatin, fluorouracil, and leucovorin as a palliative systemic chemotherapy treatment, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with non ST-elevation myocardial infarction, testing the drugs ro4905417 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the use of sildenafil citrate in patients with subarachnoid hemorrhage and cerebral vasospasm, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with sarcoma, specifically osteosarcoma, who are refractory to conventional therapy or have high-risk disease. The drug being tested is ifosfamide, and the eligibility criteria include measurable disease, specific performance status, and various blood count and kidney function requirements.",
    "This sample is a phase 1/phase 2 trial for patients with non-small cell lung cancer (NSCLC), testing the drugs tlk286, carboplatin, and paclitaxel, with specific eligibility criteria including age, disease stage, ECOG status, and adequate organ function.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of carmoterol and salmeterol drugs compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients diagnosed with rheumatoid arthritis, testing the effectiveness of the drug cnto 136 in combination with methotrexate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. The drug being tested is iniparib, and the eligibility criteria include previous platinum/taxane combination therapy, confirmed BRCA1 or BRCA2 status, and measurable lesions.",
    "This sample is a phase 2 trial for chronic hepatitis C, testing the effectiveness of telaprevir, peg-ifn-alfa-2a, peg-ifn-alfa-2b, ribavirin (rbv) tablet, and ribavirin (rbv) capsule as potential treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for the treatment of chronic hepatitis C infection using drugs such as abt-450, abt-333, ribavirin, and ritonavir, with specific eligibility criteria including previous treatment response and BMI range.",
    "This sample is a phase 2 clinical trial for patients with fibrolamellar hepatocellular carcinoma, testing the drug Sutent, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with rheumatoid arthritis, testing the efficacy of fostamatinib disodium (r935788) compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 2 trial is testing the combination of docetaxel and azd6244 versus docetaxel and placebo in patients with unresectable stage 3 or 4 melanoma, who have wt BRAF status, and meet specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for participants with hypercholesterolemia, testing the efficacy of alirocumab, placebo, and atorvastatin in reducing LDL-C levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for diabetic nephropathies, testing the drugs pf-00489791 and placebo, with inclusion criteria including type 2 diabetes and stages 3a, 3b or 4 CKD, and exclusion criteria including CKD resulting from type 1 diabetes or non-diabetic CKD, poorly controlled diabetes mellitus, and subjects on combination ACE inhibitor/ARB therapy.",
    "This sample is a phase 1/phase 2 trial for patients with follicular lymphoma, testing the effectiveness of rituximab, bortezomib, and ibritumomab tiuxetan as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This phase 2 trial aims to evaluate the efficacy of nitazoxanide, placebo, and ribavirin in treating chronic hepatitis C patients who have failed to respond to previous treatment with peginterferon and ribavirin.",
    "This sample is a phase 2 trial for breast cancer patients who are candidates for adjuvant chemotherapy and Trastuzumab, with eligibility criteria including HER-2 positive breast cancer, specific tumor size and stage, and certain laboratory values, and the drug being tested is paclitaxel.",
    "This sample is a phase 2 trial testing the drug azd2281 in patients with ovarian carcinoma and breast cancer, who meet specific eligibility criteria.",
    "This sample is a phase 2 trial that aims to evaluate the efficacy of strontium chloride hexahydrate and placebo in reducing moderate-to-severe pain in patients with lower limb amputation stumps, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is investigating the use of Procrit and placebo in patients with anemia resulting from a blunt multi-system traumatic injury, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with breast cancer, testing the effectiveness of nab paclitaxel, cyclophosphamide, and trastuzumab in combination. The eligibility criteria include specific tumor characteristics, normal cardiac function, and adequate organ function, among others.",
    "This sample is a phase 2 trial for patients with advanced colorectal cancer or adenocarcinoma of the colon or rectum, testing the effectiveness of drugs such as abt-869, bevacizumab, oxaliplatin, folinic acid, and fluorouracil, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial for patients with non-Hodgkin lymphoma or chronic lymphocytic leukemia, testing the effectiveness of cyclophosphamide and fludarabine phosphate drugs in combination with related HLA-haploidentical natural killer cell adult donors.",
    "This sample is a phase 2 trial for patients with chronic low back pain, testing the effectiveness of drugs such as naproxen, placebo, and pf-04383119 (rn624), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the drug jnj-39758979 in patients with moderate atopic dermatitis, with specific inclusion and exclusion criteria, and involves the assessment of pruritus and body surface area involvement.",
    "This sample is a phase 1/phase 2 trial testing the drugs everolimus and gefitinib for patients with glioblastoma multiforme or castrate metastatic prostate cancer, who have shown progressive disease despite standard therapy, and meet specific eligibility criteria.",
    "This phase 2 trial is testing the drug temozolomide for patients with stage IV malignant melanoma with brain metastases, who have no standard therapy available, and meet specific eligibility criteria.",
    "This sample is a phase 2/phase 3 trial testing the drugs fenofibrate, metformin, and placebo on patients with type 2 diabetes and dyslipidemia, with exclusion criteria of type 1 diabetes.",
    "This sample is a phase 1/phase 2 clinical trial testing the drug gs-9219 on patients with relapsed or refractory non-hodgkin's lymphoma, chronic lymphocytic leukemia, or multiple myeloma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for esophageal cancer, testing the effectiveness of cisplatin, fluorouracil, hydroxyurea, and leucovorin calcium as treatment options, with specific eligibility criteria for patients.",
    "This sample is a phase 2 clinical trial for the drug trabectedin in patients with malignant mesothelioma, testing its effectiveness in treating the disease based on specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with chronic kidney disease and anemia, testing the drug fg-4592, with specific eligibility criteria including age, body weight, and exclusion criteria such as infections, liver disease, and history of malignancy.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of paclitaxel (genexol\u00ae) and paclitaxel loaded polymeric micelle (genexol-pm\u00ae) as palliative chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with previously untreated diffuse large B-cell lymphoma, testing the effectiveness of bendamustine and rituximab as an alternative to CHOP-R chemotherapy for patients who are poor candidates for CHOP-R.",
    "This sample is a phase 2 clinical trial for the treatment of overactive bladder, testing the effectiveness of drugs such as vibegron and tolterodine er, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for Huntington's disease, testing the effectiveness of minocycline and a matching placebo in patients who are 18 years or older, have clinical features or a family history of HD, are independently walking and self-sufficient, and able to take medication orally.",
    "This sample is a phase 1/phase 2 trial for patients with inoperable stage III or IV malignant melanoma, testing the drugs imexon and dtic, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic melanoma, testing the effectiveness of the drugs paclitaxel, carboplatin, and everolimus, with eligibility criteria including confirmed diagnosis, specific disease stage, performance status, and various health parameters.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C, genotype 1 or 4, using drugs such as ro5024048, danoprevir, peginterferon alfa-2a, ribavirin, and ritonavir, with specific inclusion and exclusion criteria including liver biopsy confirmation of cirrhosis and compensated cirrhosis.",
    "This sample is a phase 2 trial for breast cancer patients, testing the drug nexavar (sorafenib), with eligibility criteria including tumor size, disease stage, cardiac function, and laboratory requirements.",
    "This sample is a phase 2 clinical trial for patients with unresectable esophageal cancer, testing the efficacy of docetaxel and cisplatin as a treatment option, with specific eligibility criteria including disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with non-small cell lung cancer involving the superior sulcus, testing the effectiveness of cisplatin, docetaxel, and etoposide as potential treatments, with specific eligibility criteria including tumor involvement, lymph node involvement, and absence of certain conditions.",
    "This sample is a phase 2 trial for patients with type 2 diabetes and metabolic syndrome, testing the drug nc-503 (eprodisate disodium) to evaluate its effectiveness in improving metabolic syndrome characteristics and glycemic control.",
    "This sample is a phase 2 trial for asthma patients, testing the effectiveness of various drugs including placebo, olodaterol, and formoterol, with specific eligibility criteria such as age, FEV1 levels, and previous use of inhaled corticosteroids.",
    "This sample is a phase 2 trial for patients with prostate neoplasms, testing the effectiveness of abiraterone acetate and prednisone in combination therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial testing the effectiveness of bisoprolol and placebo in treating symptomatic heart failure patients with left ventricular systolic dysfunction and moderate or severe chronic obstructive pulmonary disease.",
    "This sample is a phase 2 clinical trial for patients with diffuse large B cell Non-Hodgkin's lymphoma, testing the effectiveness of the drugs gm-csf, chop, and rituximab, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic adenocarcinoma of the pancreas, testing the drug temsirolimus. The eligibility criteria include specific disease stage, performance status, blood counts, liver and kidney function, and absence of certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with metastatic or locally recurrent squamous cell carcinoma of the head and neck, testing the effectiveness of pemetrexed and bevacizumab as treatment options. The eligibility criteria include having measurable disease, a performance status of 0-1, and meeting certain laboratory values. Exclusion criteria include prior chemotherapy or biologic therapy, prior use of pemetrexed or bevacizumab, and certain medical conditions.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the effectiveness of bevacizumab, docetaxel, and trastuzumab in combination, with specific eligibility criteria including HER2/neu positivity, no prior chemotherapy for metastatic breast cancer, and normal cardiac function.",
    "This sample is a phase 2 clinical trial for patients with relapsed or progressive multiple myeloma, testing the drug Velcade\u2122. The eligibility criteria include measurable disease, specific performance status, platelet and neutrophil counts, renal and hepatic function, and signed informed consent. Exclusion criteria include recent chemotherapy or radiotherapy, previous bortezomib therapy, significant neurotoxicity, low platelet count or ANC, certain syndromes, hypersensitivity to the drug, hepatic dysfunction, heart failure or recent myocardial infarction, non-secretory multiple myeloma, active infection, history of ventricular cardiac arrhythmias, poorly controlled hypertension or diabetes, and pregnancy or breastfeeding.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the efficacy of tivozanib, bevacizumab, and mfolfox6 as treatment options, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with psoriasis, specifically plaque-type psoriasis, who have not responded to standard systemic therapy or are unable to receive it. The drug being tested is apremilast, and the inclusion criteria include having a history of psoriasis, a certain severity score, and meeting specified laboratory criteria. The exclusion criteria include various medical conditions and recent use of certain therapies.",
    "This sample is a phase 2 clinical trial for attention-deficit/hyperactivity disorder (ADHD) testing the drugs abt-089 and placebo, with inclusion criteria including meeting diagnostic criteria for ADHD and being in good health, and exclusion criteria including having certain mental disorders or ongoing medical problems.",
    "This sample is a phase 2 trial for the treatment of diabetic neuropathy, with drugs including placebo and different doses of a drug called pregabalin, and eligibility criteria including documented medical diagnosis of diabetes, stable glycemic control, and specific symptoms of neuropathy.",
    "This sample is a phase 2/phase 3 trial for patients with esophageal cancer, testing the drugs capecitabine and cisplatin. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 2 trial for patients with recurrent melanoma, stage III melanoma, and stage IV melanoma, testing the drug tanespimycin, with specific eligibility criteria including measurable disease, performance status, blood counts, and no prior allergic reactions to similar compounds.",
    "This sample is a phase 2 trial for the treatment of opioid-induced constipation (OIC) using the drugs placebo and NKTR-118, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for patients with moderate to severe rheumatoid arthritis, testing the effectiveness of ocrelizumab and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for asthma patients, testing the drugs placebo and setipiprant, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for multiple sclerosis, testing the efficacy of the drug abatacept (brand name BMS 188667) compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for the treatment of gastroparesis in patients with type I or II diabetes mellitus, using the drug gsk962040 or placebo, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is testing the effectiveness of g-csf plus plerixafor in patients with non-Hodgkin's lymphoma or multiple myeloma who are eligible for autologous transplantation, and have not had more than 3 prior regimens of chemotherapy. The study includes specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 clinical trial for multiple sclerosis, testing the effects of inhaled cannabis, oral THC, and placebos on spasticity in patients who meet specific inclusion criteria and do not have certain pre-existing conditions.",
    "This sample is a phase 2/phase 3 trial for patients with pancreatic cancer, testing the effectiveness of fluorouracil, gemcitabine hydrochloride, irinotecan hydrochloride, leucovorin calcium, and oxaliplatin as treatment options. The eligibility criteria include specific disease characteristics, age range, performance status, hematopoietic and hepatic function, and absence of certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) who have undergone surgical resection and are eligible for cisplatin-based adjuvant chemotherapy. The study will evaluate the effectiveness of cisplatin and docetaxel as treatment options.",
    "This phase 2 trial aims to evaluate the efficacy of desvenlafaxine succinate sustained-release tablets (dvs sr), an antidepressant, in treating major depressive disorder in children and adolescents aged 7 to 17 years.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) who have a positive mutational status for the KRAS, NRAS, BRAF, or MEK1 gene. The study aims to evaluate the efficacy of the drugs gsk1120212 and docetaxel in treating advanced stage/metastatic NSCLC.",
    "This sample is a phase 2 trial for patients with asthma, testing the effectiveness of different formulations of clenil\u00ae modulite\u00ae in combination with various spacers, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with high-risk adenocarcinoma of the prostate, testing the effectiveness of multiple drugs including bicalutamide, estramustine, etoposide, flutamide, goserelin, leuprolide, nilutamide, and paclitaxel, with eligibility criteria including specific disease characteristics and patient characteristics.",
    "This sample is a phase 2 clinical trial for ulcerative colitis, testing the drugs krp203 and placebo matching krp203, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 clinical trial for patients with follicular lymphoma, testing the effectiveness of 90y ibritumomab tiuxetan and rituximab as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for post-menopausal women with breast adenocarcinoma, testing the drugs ave1642 and fulvestrant as a last hormonal treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for major depressive disorder, testing the effectiveness of cariprazine and placebo in patients who have had an inadequate response to antidepressant therapy.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic or recurrent breast cancer who overexpress the HER-2 gene, testing the combination of vorinostat and trastuzumab as a treatment option. The eligibility criteria include various medical and treatment history requirements, such as no active infections, no history of allergic reactions to similar compounds, and specific time intervals since prior therapies.",
    "This sample is a phase 2 trial for smoking cessation, testing the use of nicotine as a drug, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with relapsed diffuse large B-cell lymphoma (DLBCL) who have received 2 cycles of second-line therapy and have a positive FDG-PET scan. The study aims to evaluate the effectiveness of a combination of drugs including rituximab, carmustine, etoposide, filgrastim, and others, in combination with a bone marrow transplant from a matched donor.",
    "This sample is a phase 2 trial for lymphoma patients suitable for an autologous PBPC transplant, testing the drugs pegfilgrastim 12 mg, filgrastim, and pegfilgrastim 6 mg, with eligibility criteria of no previous bone marrow or PBPC transplant.",
    "This sample is a phase 2 trial for patients with non-Hodgkin's lymphoma who have previously undergone autologous stem cell transplant. The study aims to evaluate the efficacy and safety of rituximab and aldesleukin as treatment options. The eligibility criteria include specific disease stage, performance status, age, time since transplant, and laboratory values. Exclusion criteria include certain medical conditions, infections, and previous organ transplants.",
    "This sample is a phase 2 clinical trial for patients with cirrhosis of the liver, testing the efficacy of gi262570 and placebo drugs in achieving sustained virologic response (SVR) in patients who have previously failed interferon/ribavirin treatment. The eligibility criteria include age between 40 and 70 years, positive serology for HCV antibody, HCV RNA positive with Genotype 1, Ishak fibrosis score of 2, 3 or 4, and specific requirements for female participants regarding contraception. Exclusion criteria include various medical conditions, pregnancy, and use of certain medications.",
    "This sample is a phase 2 clinical trial for patients with pancreatic adenocarcinoma, testing the effectiveness of gemzar, th-302, and gemcitabine in combination with radiation therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial testing the drugs febuxostat and placebo on patients with renal impairment and gout, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with advanced pancreatic neoplasms who have progressed on gemcitabine or a gemcitabine-containing combination, and it will test the drug px-12. The eligibility criteria include a Karnofsky Performance Status of \u2265 70%, adequate organ function, and measurable disease by CT scan.",
    "This sample is a phase 2 clinical trial for patients with refractory testicular or extragonadal germ cell cancer, testing the effectiveness of arsenic trioxide as a treatment option, with specific eligibility criteria and patient characteristics outlined.",
    "This sample is a phase 2 clinical trial for gastric cancer and esophageal cancer patients, testing the effectiveness of irinotecan, cisplatin, floxuridine, and capecitabine as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 clinical trial for males with type 2 diabetes and hypogonadism, testing the effectiveness of androgel (testosterone gel) in improving their condition.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast adenocarcinoma who have developed acquired resistance to letrozole, and it aims to evaluate the efficacy of bibw 2992 in combination with letrozole in treating the disease.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs simvastatin and placebo, with specific inclusion and exclusion criteria, such as age range, family history of Alzheimer's disease, and contraindications to statins and lumbar puncture.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndromes (MDS) who have failed hypomethylating therapy, and it will test the drug panobinostat. The inclusion criteria include a documented diagnosis of MDS, age >= 18 years old, and specific laboratory values. The exclusion criteria include prior treatment with an HDAC inhibitor, prior intensive chemotherapy, and impaired cardiac function.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of the drugs int131 besylate, pioglitazone hcl, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of at-101 and docetaxel compared to a placebo and docetaxel, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of carfilzomib, cyclophosphamide, and dexamethasone as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the treatment of chemotherapy-induced nausea and vomiting using carbamazepine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the drug arbaclofen in the treatment of Autism Spectrum Disorders (ASD), with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for psoriatic arthritis, testing the drugs amg 827 140, placebo, amg 827 280, and amg 827 210, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2/phase 3 trial for HIV infections, testing the drug tipranavir. The eligibility criteria include having completed a previous tipranavir/ritonavir trial, adherence to dosing protocol and visit requirements, and acceptable baseline organ function. Exclusion criteria include pregnancy, substance abuse, medical conditions that interfere with participation, and hypersensitivity to tipranavir or ritonavir.",
    "This phase 2 trial is testing the effectiveness of rituximab in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have received prior therapies, and the eligibility criteria include specific disease stages, prior treatments, age, performance status, and organ function.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, non-hodgkin's lymphoma, and hodgkin's disease, testing the drug tg-0054. The eligibility criteria include age, pathology diagnosis, previous chemotherapy, blood counts, organ function, contraception, and informed consent. Exclusion criteria include previous radiation therapy, lenalidomide cycles, stem cell collection failure, previous stem cell transplantation, recent G-CSF use, history of other cancers or hematologic disorders, cardiovascular or pulmonary disease, sickle cell anemia, retinopathy, uncontrollable malignancy or infection, pregnancy or breastfeeding, and previous treatment with TG-0054.",
    "This sample is a phase 2 clinical trial for patients with unresectable/metastatic renal cell carcinoma (RCC), testing the efficacy of sorafenib escalated dose and sorafenib standard dose as treatment options. The eligibility criteria include age \u226518 years old, diagnosis of RCC, Karnofsky Performance Status of 50% or greater, and adequate bone marrow, liver, and renal function. Exclusion criteria include prior systemic anticancer treatment, prior treatment with bevacizumab, sunitinib, or sorafenib, and active malignancy other than RCC within 5 years of enrollment.",
    "This sample is a phase 2 clinical trial for the treatment of dry eye, testing the efficacy of mim-d3 ophthalmic solution and placebo ophthalmic solution, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for asthma patients, testing the effectiveness of budesonide, an inhaled corticosteroid, in combination with long-acting \u03b2-agonists, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial testing the effectiveness of celecoxib and placebo in treating oral mucositis in patients receiving radiation therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with fallopian tube cancer, ovarian cancer, or primary peritoneal cavity cancer, testing the drugs 7-hydroxystaurosporine and topotecan hydrochloride, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This phase 2 clinical trial aims to evaluate the efficacy of carboplatin, gemcitabine hydrochloride, and thalidomide in treating non-small cell lung cancer (NSCLC) patients with stage II or IIIA disease, who have measurable disease and meet specific eligibility criteria.",
    "This sample is a phase 2 trial for epilepsy patients who have completed a previous study and are expected to benefit from an open-label extension study with the drug lacosamide, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs bea 2180 br and tiotropium. The eligibility criteria include having stable, moderate to severe airway obstruction, a certain level of lung function, being 40 years or older, and having a smoking history. Patients with other significant diseases, asthma, or allergic rhinitis will be excluded.",
    "This sample is a phase 1/phase 2 trial for patients with melanoma, testing the drugs sunitinib and dacarbazine, with eligibility criteria including specific disease stage, organ function requirements, and exclusion criteria such as recent major surgery or radiation therapy.",
    "This sample is a phase 2 trial for patients with glioblastoma multiforme, testing the drugs bevacizumab and metronomic temozolomide, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C, testing the efficacy of peginterferon alfa2a + ribavirin treatment, with the inclusion criteria including age 18-65 years and signed informed consent, and the exclusion criteria including hepatic cirrhosis or carcinoma, low leucocytes or platelets count, and baseline mental disorders requiring antidepressants. The drugs being tested are escitalopram and placebo.",
    "This sample is a phase 2 trial for patients with histiocytosis, langerhans-cell, who have progressive disease after previous treatments, and are eligible for reduced-intensity hematopoietic cell transplantation. The drugs being tested are fludarabine phosphate and melphalan.",
    "This sample is a phase 2 trial for patients with metastatic colorectal cancer, testing the efficacy of a combination chemotherapy regimen (FOLFOX or FOLFIRI) along with aprepitant, dexamethasone, fluorouracil, irinotecan hydrochloride, leucovorin calcium, oxaliplatin, and palonosetron hydrochloride, in reducing emesis and nausea during chemotherapy treatment.",
    "This sample is a phase 1/phase 2 trial for HIV infections, testing the effectiveness of gpo-vir z30 tablet, lamivudine, nevirapine, and zidovudine in children weighing between 6 and 30 kilograms who are receiving HAART regimen of NVP and 2 NRTIs, and meet other eligibility criteria.",
    "This sample is a phase 2 trial testing the drug gft505 80mg versus placebo in patients with insulin resistance and abdominal obesity, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic myelogenous leukemia, testing the drug danusertib. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 2 clinical trial for liver cancer patients, testing the effectiveness of doxorubicin hydrochloride and sunitinib malate drugs, with specific eligibility criteria including liver involvement, tumor burden, and patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with squamous cell carcinoma of the head and neck, testing the drugs zd6474 and docetaxel. The eligibility criteria include having histologically documented SCCHN, being 18 years or older, having evaluable or measurable disease, and having a life expectancy of at least 3 months.",
    "This sample is a phase 1/phase 2 clinical trial for adult patients with glioblastoma or gliosarcoma, testing the effectiveness of sorafenib tosylate and temsirolimus as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial testing the drug sunitinib malate for patients with refractory or relapsed extragonadal germ cell tumors, ovarian cancer, teratoma, or testicular germ cell tumors, who have progressive disease after prior cisplatin-based chemotherapy and meet specific eligibility criteria.",
    "This sample is a phase 2 trial for patients with recurrent glioblastoma, testing the drug panobinostat, and includes eligibility criteria such as age, prior treatments, and medical conditions.",
    "This sample is a phase 2 clinical trial for patients with gastric adenocarcinoma or gastroesophageal junction adenocarcinoma, testing the drug edotecarin, and includes eligibility criteria such as previous treatment history, performance status, and baseline test limits.",
    "This sample is a phase 2 trial for women with metastatic or locally advanced metastatic HER2/neu negative breast cancer, testing the efficacy of non pegylated liposomal doxorubicin and docetaxel as a treatment option.",
    "This sample is a phase 2 trial testing the effectiveness of lidocaine 5% medicated plaster versus placebo topical plaster in treating moderate to severe chronic daily postoperative neuropathic pain, with inclusion and exclusion criteria specified.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes mellitus, testing the drugs xoma 052 and placebo. The inclusion criteria include having a diagnosis of T2D, specific HbA1c levels, and being on a stable regimen of metformin. The exclusion criteria include uncontrolled hypertension, history of malignancy, and allergies to monoclonal antibodies.",
    "This sample is a phase 2 trial for patients with lymphoma, testing the effectiveness of rituximab, adriamycin, bleomycin, vinblastine, and dacarbazine in combination for Hodgkin's disease patients who relapse after radiation therapy alone and previously untreated patients with stage II bulky, III and IV who are eligible for ABVD. The inclusion criteria include having a histologically proven diagnosis of Hodgkin's disease, bidimensionally measurable disease, and being older than 16 years of age, among others. The exclusion criteria include being HIV positive, pregnant or not practicing adequate contraception, having prior chemotherapy, and having severe pulmonary disease.",
    "This sample is a phase 1/phase 2 trial for patients with prostate cancer, testing the drugs docetaxel, prednisone, and vatalanib, with eligibility criteria including histologically documented adenocarcinoma of the prostate, progressive systemic disease, and castrate levels of testosterone.",
    "This sample is a phase 2 clinical trial for patients with non-Hodgkin's lymphoma, testing the combination of ibritumomab tiuxetan (zevalin) and rituximab as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients, testing the drug carboplatin. The eligibility criteria include having stage IIIB or IV NSCLC, measurable disease, ECOG performance status 0-1, and being at least 18 years old. Women of childbearing potential must use contraception, and certain physical and laboratory test findings must be met. Exclusion criteria include pregnancy, prior malignancy within 5 years, significant cardiac or neurological disease, and prior chemotherapy or therapy targeting the EGFR pathway.",
    "This sample is a phase 1/phase 2 trial for rheumatoid arthritis, testing the efficacy of abatacept or placebo (both as iv & sc solution) in patients who meet ARA criteria for diagnosis of RA with active disease and have been diagnosed for at least 1 year, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the drug ulodesine for the treatment of gout and hyperuricemia, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for asthma patients, testing the effectiveness of two drugs, levalbuterol hfa mdi followed by racemic albuterol hfa mdi, and racemic albuterol followed by levalbuterol hfa mdi, in improving respiratory function. The eligibility criteria include being at least 12 years old, having a documented diagnosis of asthma for at least 6 months, and being in good health except for reversible airways disease.",
    "This sample is a phase 1/phase 2 trial for patients with confirmed HER2+ ve metastatic breast cancer who have previously been treated with trastuzumab and progressed. The study will test the effectiveness of panobinostat and trastuzumab as potential treatments, and includes specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with osteoarthritis of the knee, testing the effectiveness of ketoprofen, an NSAID, in reducing pain. The inclusion criteria include having completed a previous study or having osteoarthritis in both knees for at least six months, while the exclusion criteria include allergies to certain medications and recent knee procedures.",
    "This sample is a phase 2 clinical trial for the treatment of macular degeneration using pazopanib eye drops, with specific eligibility criteria including age, visual acuity, and absence of certain eye conditions.",
    "This sample is a phase 2 clinical trial for patients with HER2-positive breast cancer, testing the efficacy of trastuzumab emtansine (T-DM1) in combination with anthracycline-based chemotherapy as neoadjuvant or adjuvant treatment.",
    "This sample is a phase 2 clinical trial for peripheral T-cell lymphoma, testing the drug alemtuzumab, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 2 clinical trial for patients infected with HIV-1, specifically targeting those with lipohypertrophy, and testing the effectiveness of the drug combination raltegravir-maraviroc in reducing viral load. The inclusion criteria include stable antiretroviral therapy for at least 5 years, undetectable viral load, and clinical lipohypertrophy. Exclusion criteria include certain tropism of the HIV virus, hepatitis B or C, and other medical conditions.",
    "This sample is a phase 2 clinical trial for patients with myelodysplastic syndrome (MDS) who are eligible for allogeneic transplantation, and the drug being tested is treosulfan. The inclusion criteria include having an HLA-identical sibling or unrelated donor, specific graft size requirements, age between 18 and 60, and a Karnofsky Index above 80%. The exclusion criteria include previous AML-induction therapy, previous allogeneic transplantation, severe concomitant illnesses, and impaired liver or renal function.",
    "This sample is a phase 2 trial for patients with coronary artery disease and dyslipidemia, testing the efficacy of the drug rvx000222 compared to a placebo, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for HIV infections, testing the effectiveness of the drugs tenofovir and abacavir in antiretroviral-na\u00efve patients with specific eligibility criteria, such as CD4+ cell count > 200 cells/mm3 and HIV-1 RNA level > 5000 copies/mL.",
    "This sample is a phase 2 clinical trial for patients with overactive bladder and urinary incontinence, where the drug being tested is a placebo. The eligibility criteria include age, diagnosis duration, weight, willingness to record bladder function, and completion of the study. Exclusion criteria include not currently catheterizing and no previous use of botulinum toxin type A.",
    "This sample is a phase 1/phase 2 trial for patients with non-small-cell lung cancer (NSCLC) who have failed prior treatment. The study will test the effectiveness of vorinostat and erlotinib drugs in treating NSCLC, and includes eligibility criteria such as confirmed disease, time since previous treatments, normal lab results, and exclusion criteria such as prior treatment with vorinostat or erlotinib, and certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with urothelial carcinoma or bladder cancer, testing the drug sunitinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the effectiveness of different doses of pf-04937319 and sitagliptin as compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C genotype 1a or 1b, testing the efficacy of drugs such as copegus, pegasys, ro5024048, danoprevir, and ritonavir, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with schizophrenia, testing the drugs iti-007, placebo, and risperidone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for ovarian cancer patients who have progressed following platinum and paclitaxel chemotherapy, and it involves the drugs cc-5013 and topotecan. The eligibility criteria include age >18, measurable metastatic disease, and ECOG performance status of 0 or 1.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic breast cancer, testing the efficacy of cdx-011 and \"investigator's choice\" chemotherapy in patients who have previously received at least two but no more than seven prior chemotherapy treatments. The study also includes specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 2 trial is testing the drug pazopanib hydrochloride in patients with advanced malignant mesothelioma, localized malignant mesothelioma, or recurrent malignant mesothelioma, who meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed or refractory multiple myeloma, testing the drug Revlimid, with specific eligibility criteria including previous treatment regimens, disease stage, and laboratory values.",
    "This sample is a phase 2 trial for asthma patients, testing the drug amg 853 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for Japanese asthmatic patients, testing the drugs indacaterol, placebo, and salmeterol, with inclusion and exclusion criteria specified.",
    "This sample is a phase 2 trial for the treatment of chronic hepatitis C using the drugs albuferon and ribavirin, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory small cell lung cancer, testing the drug gefitinib, with inclusion criteria including written informed consent, histologically confirmed SCLCr, and age 18 or over with a life expectancy of more than 2 months, and exclusion criteria including clinically active interstitial lung disease and other co-existing malignancies diagnosed within the last 5 years.",
    "The sample is a phase 2 trial for patients with metastatic or inoperable locally advanced colorectal cancer, testing the effectiveness of capecitabine, oxaliplatin, and bevacizumab as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with HIV infections, testing the effectiveness of enfuvirtide and optimized background ARV therapy in adult patients with virologic failure and viral load >1000 RNA copies/mL, who have been on the same stable HAART for >4 weeks and are Fuzeon-naive.",
    "This sample is a phase 2 trial for the drug Gleevec in patients with idiopathic pulmonary arterial hypertension, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with idiopathic Parkinson's disease, testing the drug E2007, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug pulmozyme (dornase alfa) versus placebo in patients with sinusitis and cystic fibrosis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with adenocarcinoma of the gastroesophageal junction or gastric cancer, testing the effectiveness of cisplatin, fluorouracil, and leucovorin calcium as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 trial for patients with polycythemia vera, testing the effectiveness of dasatinib, an oral medication, in controlling the disease. The eligibility criteria include age, previous therapies, organ function, ability to take oral medication, and pregnancy status. The exclusion criteria include recent treatments, cardiac problems, bleeding disorders, and concomitant medications.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung carcinoma, testing the efficacy of docetaxel and cisplatin as a treatment option, with specific eligibility criteria including disease stage, age, performance status, and various laboratory requirements.",
    "This sample is a phase 2 clinical trial for patients with rheumatoid arthritis, testing the drug \"isis crp rx or placebo\" in combination with methotrexate, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with platinum-sensitive ovarian cancer, testing the effectiveness of docetaxel and carboplatin as a second-line chemotherapy regimen, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for pre-menopausal women with advanced breast cancer, testing the effectiveness of goserelin acetate in combination with other drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with cutaneous T-cell lymphoma, testing the drug romidepsin (depsipeptide, fk228) as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with peripheral T-cell lymphoma, testing the effectiveness of denileukin diftitox, cyclophosphamide, doxorubicin, vincristine, and prednisone as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with chronic myelogenous leukemia (CML) in different phases, testing the effectiveness of homoharringtonine and imatinib mesylate drugs in patients who have failed prior imatinib mesylate therapy, with specific eligibility criteria outlined.",
    "This sample is a phase 2 clinical trial for the drug nbi-98854 in the treatment of tardive dyskinesia, a movement disorder associated with certain psychiatric and gastrointestinal disorders. The eligibility criteria include having a stable dose of antipsychotic medication, negative urine drug screen, and good general health. Exclusion criteria include a history of substance abuse, neuroleptic malignant syndrome, and allergy to tetrabenazine.",
    "This sample is a phase 2 trial investigating the use of drugs such as du-176b and enoxaparin sodium for patients undergoing unilateral total hip arthroplasty, with a focus on venous thromboembolism and thrombosis. The eligibility criteria include age range and exclusion of subjects with hemorrhage or thromboembolic risks, low body weight, and pregnancy.",
    "This sample is a phase 2 trial investigating the use of cyclophosphamide, tacrolimus, and mycophenolate mofetil in patients with malignant neoplasm who are eligible for allogeneic hematopoietic stem cell transplantation, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with biopsy-proven stage I/II non-small cell lung cancer, testing the drug Tarceva (erlotinib) to determine its effectiveness in treating the disease. The study includes specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with esophageal carcinoma, testing the efficacy of cetuximab and chemotherapy in treating the disease, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 2 trial aims to evaluate the effectiveness of thalidomide in treating chronic prostatitis and pelvic pain in male subjects who are refractory to other therapies, with specific inclusion and exclusion criteria, including the requirement for subjects to comply with the FDA-mandated S.T.E.P.S.\u00e2 program.",
    "This sample is a phase 2/phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) and symptoms such as cough, sputum production, and shortness of breath. The trial aims to evaluate the effectiveness of indacaterol maleate, a drug, in improving lung function in patients with COPD. The inclusion criteria include age between 40-75 years, a smoking history of at least 10 pack years, FEV1 less than 65% of predicted normal value, and pre-bronchodilator FEV1/FVC less than 70%. Exclusion criteria include a history of asthma or COPD diagnosis before the age of 40, recent hospitalization for COPD exacerbation, respiratory tract infection, use of long-term oxygen therapy, and certain medical conditions.",
    "This sample is a phase 2 clinical trial for prostate cancer patients who have undergone radical prostatectomy, and it aims to evaluate the effectiveness of zoledronic acid and docetaxel in preventing PSA relapse and metastases.",
    "This sample is a phase 2 clinical trial for allergic asthma, testing the effectiveness of omalizumab and placebo drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the effectiveness of gemcitabine and paclitaxel chemotherapy drugs in Chinese female patients who have previously received anthracycline-based chemotherapy in the adjuvant/neoadjuvant setting with subsequent disease relapse.",
    "This phase 2 trial is testing the effectiveness of enzastaurin and placebo in patients with non-small cell lung cancer and small cell lung cancer who have brain metastases and have received whole brain radiotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of partial epilepsy, testing the drugs ykp3089 and placebo. The eligibility criteria include a diagnosis of treatment-resistant partial epilepsy, a history of epilepsy for at least 2 years, and a minimum frequency of seizures per month.",
    "This sample is a phase 2 clinical trial for lung cancer patients, testing the effectiveness of erlotinib and bevacizumab drugs, with specific eligibility criteria including histological proof of non-small cell lung cancer, no prior chemotherapy or hormonal therapy, and measurable disease according to RECIST.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the efficacy of the drug gsk256073 in combination with metformin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial testing the effectiveness of topical testosterone gel in treating aging men with low testosterone levels, high waist circumference, and insulin resistance, while excluding individuals with certain medical conditions and taking specific medications.",
    "This sample is a phase 2 clinical trial that aims to study the effects of the drug sr141716 (rimonabant) on healthy participants who are between 21 and 45 years old, with specific weight and BMI ranges, normal vital signs, and normal laboratory results. The study also includes various exclusion criteria, such as the presence of certain diseases or allergies, history of drug dependence, and positive results in screening for drugs of abuse.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer, testing the combination of pazopanib plus paclitaxel as a first-line therapy for patients with Stage IIIB or Stage IV NSCLC, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with stage IV or recurrent adenocarcinoma of the breast, testing the effectiveness of docetaxel and erlotinib hydrochloride as treatment options, with specific eligibility criteria for patient characteristics and prior concurrent therapy.",
    "This sample is a phase 2/phase 3 trial for endometriosis, where the drug being tested is pioglitazone, and the eligibility criteria include being a healthy woman aged 18-45 with regular cycles, pelvic pain for at least 3 months, and scheduled for surgery to confirm endometriosis diagnosis.",
    "This sample is a phase 2 trial for new-onset type 1 diabetes mellitus, testing the effectiveness of antithymocyte globulin and placebo in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of salmeterol, tiotropium, and gsk233705 drugs in treating moderate COPD. The inclusion criteria include females of non-childbearing potential or postmenopausal, a history of COPD, and being a current or ex-smoker, while the exclusion criteria include no unstable COPD, limited use of inhaled steroids, and no B-blockers.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs bea 2180 br and tiotropium. The eligibility criteria include having stable, moderate to severe airway obstruction, an increase in FEV1 after inhalation of Atrovent MDI, being 40 years or older, and having a smoking history of more than 10 pack years. Patients with other significant diseases, asthma, or allergic rhinitis will be excluded.",
    "This sample is a phase 2 trial for patients with severe depressive episode with psychotic features, testing the effectiveness of the drugs \"org 34517\" and placebo in combination with usual treatment consisting of an antidepressant, antipsychotic, or mood stabilizer.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of bortezomib and dexamethasone as second or third line therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic pancreatic cancer, testing the efficacy of gemcitabine and albumin-bound paclitaxel as a first-line treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the treatment of type 2 diabetes mellitus, testing the drugs gsk189075 and placebo, with eligibility criteria including subjects with a documented diagnosis of T2DM and HbA1c \u22657.0% and \u22649.5%.",
    "This sample is a phase 2/phase 3 trial for patients with type 2 diabetes, testing the drugs rivoglitazone, pioglitazone, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD) who are being admitted to the hospital for treatment of an exacerbation. The study will compare the effectiveness of open-label, placebo-control arm 0.9% sodium chloride, and odsh drugs. The inclusion criteria include being 40 years of age or older with a diagnosis of COPD, while the exclusion criteria include certain diseases (such as asthma, lung cancer, and pneumonia), certain medications (such as Plavix, Warfarin, and certain antibiotics), and severe exacerbations requiring intubation and mechanical ventilation. Women who are pregnant or breastfeeding, or unable or unwilling to provide informed consent and follow study procedures, are also excluded.",
    "This sample is a phase 2 clinical trial for idiopathic pulmonary fibrosis, testing the effectiveness of pirfenidone and placebo in patients who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with rectal cancer, testing the effectiveness of capecitabine and cetuximab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with chronic myelogenous leukemia (CML) who have demonstrated resistance to STI571 therapy. The study aims to evaluate the efficacy of the drugs campath and fludarabine in treating CML patients eligible for allogeneic hematopoietic stem cell transplant.",
    "This sample is a phase 2 clinical trial for the treatment of dry eye syndrome, testing the efficacy of \"pro-148 ophthalmic solution\" compared to \"systane \u00ae ophthalmic solution\" as an active comparator, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for small cell lung carcinoma, testing the drug sagopilone (bay86-5302, zk 219477), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drugs valsartan and placebo on patients with carotid artery diseases and atherosclerosis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial that focuses on patients with various types of cancer, including ovarian cancer, fallopian tube cancer, and bladder cancer. The trial aims to evaluate the effectiveness of belinostat, paclitaxel, and carboplatin as potential treatments. The eligibility criteria include signed consent, confirmed solid carcinomas with no known curative therapy, acceptable liver, renal, and bone marrow function, and acceptable coagulation status.",
    "The sample is a phase 2 clinical trial for the drug radafaxine, testing its effectiveness in treating major depressive disorder (MDD) in patients who have not responded to previous antidepressant therapy, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory systemic Anaplastic Large Cell Lymphoma (ALCL) or mature T-cell lymphoma, testing the drug ucn-01 (7-hydroxystaurosporine) as a potential treatment option. The eligibility criteria include age, performance status, creatinine levels, bilirubin levels, ANC, platelet count, HIV status, and previous treatments.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of folfox4 (oxaliplatin) and cetuximab in combination, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with pancreatic cancer, testing the drug capecitabine. The eligibility criteria include having clinically staged I-III adenocarcinoma of the pancreas, no prior therapy for pancreatic cancer, and adequate organ function. Pregnant or lactating women and patients with comorbid conditions with a life expectancy of less than 6 months are excluded from the study.",
    "This sample is a phase 2 clinical trial for allergic asthma, testing the drugs roflumilast and placebo, with eligibility criteria including symptoms of asthma, specific lung function requirements, positive methacholine inhalation challenge, and documented allergy to common aeroallergens.",
    "This sample is a phase 2 clinical trial for patients with uterine cancer, testing the effectiveness of the drug combination paclitaxel and carboplatin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with operable primary muscle invasive bladder cancer, testing the effectiveness of cisplatin, fluorouracil, paclitaxel, and gemcitabine as treatment options, with specific eligibility criteria including histological confirmation, tumor stage, bladder function, prior surgery, and various patient characteristics.",
    "This sample is a phase 1/phase 2 trial for HIV-infected individuals with specific genotypic or phenotypic resistance mutations, testing the effectiveness of lopinavir/ritonavir and saquinavir as protease inhibitors.",
    "This sample is a phase 2 trial for patients with acute myelogenous leukemia (AML) who have not achieved complete remission after induction cycles, or have relapsed AML with low disease burden. The study will test the effectiveness of drugs such as allopurinol, fludarabine, cyclophosphamide, levetiracetam, and busulfan in treating the disease. Eligibility criteria include age, organ function, performance status, and prior exposure to antibody therapy.",
    "This sample is a phase 2 trial for patients with esophageal cancer or gastroesophageal cancer, testing the effectiveness of 5-fluorouracil and oxaliplatin as treatment options, with specific eligibility criteria including tumor stage, organ function, and prior therapy history.",
    "This sample is a phase 2/phase 3 trial for non-small cell lung cancer, testing the use of chemotherapy +/- disulfiram in previously untreated patients with metastatic disease, who have an ECOG performance status of 0-1 and normal liver function tests.",
    "This sample is a phase 2 clinical trial for patients with Huntington's disease and chorea, testing the effectiveness of atomoxetine and a matching placebo in improving attention in individuals with mild Huntington's disease.",
    "This sample is a phase 2 clinical trial for patients with cutaneous T-cell lymphoma (CTCL) who have not responded to standard therapies, and it will test the effectiveness of bexarotene and gemcitabine hydrochloride as potential treatments.",
    "This sample is a phase 2/phase 3 trial for multiple sclerosis, testing the drug colecalciferol, with specific inclusion and exclusion criteria related to the disease and drug.",
    "This sample is a phase 2 trial for the treatment of type 2 diabetes mellitus, testing the drugs gsk189075 and pioglitazone, with eligibility criteria including subjects with a documented diagnosis of T2DM and HbA1c levels between \u22657.0% and \u22649.5%.",
    "This sample is a phase 2 clinical trial for patients with stage IV breast cancer, testing the drug vorinostat (SAHA) to determine its efficacy and safety in treating the disease. The eligibility criteria include specific disease types, measurable disease, prior treatment history, and certain health parameters. The study also has exclusion criteria, such as recent chemotherapy or radiotherapy, uncontrolled illnesses, and pregnancy.",
    "This sample is a phase 2 trial for the drug tak-442 in patients with acute coronary syndrome, with specific inclusion and exclusion criteria, and the use of a placebo as a control.",
    "This phase 2 trial aims to investigate the effectiveness of org 36286, puregon\u00ae, orgalutran\u00ae, and pregnyl\u00ae in females with infertility undergoing IVF or IVF/ICSI, with specific inclusion and exclusion criteria related to ovarian function, hormone levels, and other medical conditions.",
    "This sample is a phase 2 trial for patients with advanced, persistent, or recurrent uterine leiomyosarcoma, testing the effectiveness of docetaxel and gemcitabine hydrochloride as treatment options, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This phase 2 trial is testing the drug saracatinib in patients with metastatic melanoma, with specific eligibility criteria including measurable disease, no brain metastases, and normal organ function.",
    "This sample is a phase 2 trial for patients with anaplastic thyroid cancer or recurrent thyroid cancer, testing the drug sorafenib tosylate. The eligibility criteria include specific disease characteristics, performance status, blood counts, cardiac function, and absence of certain medical conditions or treatments.",
    "This sample is a phase 1/phase 2 trial for the drug imatinib in healthy male non-smoking subjects with seasonal allergic rhinitis, who must meet specific inclusion criteria such as a positive skin prick test to Timothy grass pollen and symptomatic worsening after nasal allergen challenge. There are also exclusion criteria, including the use of certain medications and history of renal insufficiency or abnormal liver function.",
    "This sample is a phase 1/phase 2 trial for patients with non-small-cell lung cancer (NSCLC) who have progressed after prior treatment. The study will test the drugs abt-751, pemetrexed, and placebo, and includes specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with hepatocellular carcinoma (HCC) testing the effectiveness of sorafenib and tegafur/uracil (ufur\u00ae) drugs, with specific eligibility criteria including age, ECOG PS, disease status, liver function, blood counts, and exclusion criteria such as prior treatments and medical conditions.",
    "This sample is a phase 2 clinical trial for the treatment of migraine headaches, testing the drugs nps 1776 (800 mg) and nps 1776 (400 mg) against a placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial aims to investigate the effectiveness of botulinum toxin type A and normal saline in treating benign prostatic hyperplasia, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with glioblastoma or gliosarcoma, testing the effectiveness of avastin, temozolomide, and irinotecan as treatment options, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the efficacy of ixabepilone in combination with other drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of secondary hypogonadism in adult males using the drugs 25 mg androxal and testim 1%, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the effectiveness of the drug ph-797804 compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with breast neoplasms, testing the drug docetaxel as a treatment option, with specific eligibility criteria including prior chemotherapy and normal organ function.",
    "This sample is a phase 1/phase 2 trial testing the drug combretastatin a4 phosphate for the treatment of age-related macular degeneration (AMD) with choroidal neovascularization (CNV), and the eligibility criteria include age 50 or older, specific ophthalmic criteria, and various medical conditions that would exclude patients from participating in the trial.",
    "This sample is a phase 2 trial for pancreatic neoplasms, testing the drug tnp-470, and includes eligibility criteria such as no prior chemotherapy or irradiation, baseline Karnofsky performance status of at least 60, and adequate bone marrow reserve.",
    "This sample is a phase 2 clinical trial for patients with mantle cell lymphoma, testing the effectiveness of a combination of drugs including bortezomib, cyclophosphamide, doxorubicin hydrochloride, prednisone, and vincristine sulfate, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung cancer, testing the efficacy of docetaxel plus bavituximab or placebo as a second-line treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with uterine papillary serous carcinoma (UPSC), testing the effectiveness of carboplatin and paclitaxel with pelvic radiation therapy or radiation therapy as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the effectiveness of ciprofloxacin and placebo in patients who have undergone ileal or ileo-colonic resection, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with transfusional iron overload due to beta-thalassemia, testing the drug spd602 (fbs0701, ssp-004184) as a potential treatment. The inclusion criteria include having a serum ferritin greater than 500 ng/mL, being transfusion-dependent, and requiring chronic treatment with iron chelation therapies. The exclusion criteria include significant renal insufficiency, cardiac left ventricular ejection fraction outside of protocol requirements, and known sensitivity to certain substances.",
    "This sample is a phase 2 clinical trial for patients with non-Hodgkin lymphoma, specifically diffuse large B-cell lymphoma, testing the effectiveness of rituximab and cytarabine in treating primary cerebral or oculocerebral NHL with cerebral and/or neuromeningeal involvement at diagnosis.",
    "This sample is a phase 2 clinical trial for patients with relapsed and refractory multiple myeloma, testing the drug cc-5013, with specific eligibility criteria including measurable levels of myeloma paraprotein and an Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2.",
    "This sample is a phase 1/phase 2 trial testing the drugs mrx-801 and placebo on patients with acute ischemic stroke, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of chronic hepatitis C infection using the drugs abt-450/r/abt-267, abt-333, and ribavirin (rbv), with specific inclusion and exclusion criteria for subjects participating in the study.",
    "This sample is a phase 2 trial for a vaccine to prevent HIV infection in healthy, high-risk adults, with inclusion and exclusion criteria specified, and the comparator drug being a placebo.",
    "This sample is a phase 2 trial for the treatment of postherpetic neuralgia (PHN) using gabapentin (GEN) at different doses and a placebo, with inclusion and exclusion criteria specified.",
    "This sample is a phase 2 trial testing the drug epoetin alfa in HIV-positive individuals with anemia, who are on a stable antiretroviral regimen, and have a hemoglobin level below 12.0 g/dL.",
    "This phase 2 trial is investigating the effectiveness of preladenant, l-dopa, and other parkinson's disease treatments in participants with moderate to severe idiopathic Parkinson's disease who have been on a regimen of L-Dopa and/or a dopamine agonist, while excluding participants with drug-induced or atypical parkinsonism, cognitive impairment, or psychosis, as well as those taking tolcapone or participating in any other clinical study.",
    "This sample is a phase 2 clinical trial for patients with head and neck cancer, testing the drug irinotecan hydrochloride. The eligibility criteria include histologically confirmed medullary thyroid cancer, measurable disease, and adequate lab functions. Patients with elevated calcitonin levels, unstable cardiovascular or respiratory disease, or other severe systemic diseases are excluded from the study.",
    "This sample is a phase 2 trial for rheumatoid arthritis, testing the drug abatacept, and the inclusion criteria require subjects to have completed the short term portion of IM101-101.",
    "This sample is a phase 2 clinical trial for kidney transplantation, testing the drugs aeb071, certican, and neoral, with inclusion criteria including male and female patients 18 years or older who are recipients of their first kidney transplant from a deceased or living not related donor, and exclusion criteria including patients with heart disease, HIV, Hepatitis B or C, high immunological risks, a history of cancer, and other protocol-defined criteria.",
    "This sample is a phase 2 clinical trial for patients with B-cell chronic lymphocytic leukemia (CLL) who are refractory or have relapsed after first-line therapy. The study will test the effectiveness of fludarabine phosphate, a drug, in treating CLL patients who meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with renal cell carcinoma, testing the drugs ec17 (folate-fitc), interleukin-2, and interferon-alpha, with specific eligibility criteria including histologically confirmed diagnosis, relapsed or Stage IV disease, measurable metastatic disease sites, and adequate hematologic, renal, and hepatic function.",
    "This sample is a phase 2 trial for heart failure patients, testing the drug istaroxime against a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial testing the drugs vorapaxar, placebo, aspirin, and clopidogrel on patients with atherosclerosis, myocardial ischemia, and myocardial infarction, who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 2 trial for patients with pancreatic adenocarcinoma who have progressed following first-line therapy, and it involves the use of sunitinib malate as a treatment option. The eligibility criteria include having measurable disease, prior treatment with gemcitabine, and no prior therapy with other antiangiogenic agents.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer (NSCLC) patients, testing the effectiveness of docetaxel, gemcitabine, and carboplatin as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with moderate to severe non-malignant chronic pain, testing the effectiveness of matrix transdermal fentanyl/chadd drug delivery system and placebo patch in managing breakthrough pain episodes.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the drug triptorelin (decapeptyl\u00ae) for hormonal deprivation therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with ovarian neoplasms, testing the effectiveness of ip chemotherapy, with specific eligibility criteria including age, disease stage, blood counts, kidney and liver function, performance status, and survival expectancy.",
    "This sample is a phase 2 clinical trial for participants with non-small cell lung cancer, testing the drugs docetaxel and ly2181308, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of opioid-induced constipation, testing the drugs alks 37 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial aims to evaluate the efficacy of tonabersat and placebo in patients with migraine with aura, who meet specific inclusion criteria and do not have any exclusion criteria, in order to assess the potential benefits of tonabersat as a prophylactic treatment for migraine.",
    "This sample is a phase 2 trial for the treatment of psoriasis using the drug wbi-1001, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for asthma patients, testing the effectiveness of various drugs including fp mdpi, fs mdpi, advair diskus, and albuterol, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the effectiveness of gemcitabine and cisplatin in treating transitional cell carcinoma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the effects of the drugs \"sh t04769g\" and \"ethinyl estradiol / dienogest (sh d00659 af)\" on healthy female volunteers aged 18-35 years, specifically focusing on the use of oral contraceptives for the treatment of the disease \"oral contraceptive\". The study includes inclusion and exclusion criteria, such as confirming ovulation, normal blood values, and contraindications for the use of oral contraceptives.",
    "This sample is a phase 2 clinical trial for patients with inoperable, locally advanced, or metastatic colorectal cancer, testing the efficacy of the drugs s-1, irinotecan, and bevacizumab, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with HIV infections, testing the drug tmc114 (darunavir) / ritonavir, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for postmenopausal osteoporosis, testing the efficacy of pth analog, placebo, and forsteo (teriparatide) drugs, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for patients with Philadelphia chromosome or BCR-ABL positive acute lymphoblastic leukemia, testing the drug dasatinib, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is investigating the use of triptorelin, a gonadotrophin-releasing hormone agonist, in premenopausal women with early-stage breast cancer who are scheduled to receive adjuvant or neoadjuvant systemic chemotherapy. The study aims to evaluate the impact of triptorelin on ovarian function and fertility preservation.",
    "This sample is a phase 2 trial for insulin-na\u00efve type 2 diabetes subjects, testing the efficacy of insulin degludec/insulin aspart, insulin glargine, and metformin in achieving glycemic control, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with Waldenstrom's macroglobulinemia, testing the drug simvastatin, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for Huntington's disease, testing the drugs pbt2 and placebo, with eligibility criteria including a CAG repeat number \u2265 36, Total Functional Capacity between 6 and 13, and cognitive impairment demonstrated by a MoCA score of \u2265 12.",
    "This sample is a phase 2 clinical trial for patients with schizophrenia, testing the drugs bitopertin [ro4917838], olanzapine, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with histologically confirmed esophageal carcinoma, testing the efficacy of erlotinib, 5-fluorouracil, leucovorin, and oxaliplatin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with a history of dry cough, where the drugs being tested are \"sch 486757\" and \"placebo dose 1\". The eligibility criteria include ruling out gastroesophageal reflux disease, postnasal drip, and asthma as potential causes of the cough.",
    "This sample is a phase 2 clinical trial for women with locally advanced or metastatic breast cancer who have demonstrated resistance to anthracycline. The trial will test the effectiveness of capecitabine (Xeloda) and docetaxel (Taxotere) as treatment options. The eligibility criteria include having at least one target lesion and having undergone at least two regimens of chemotherapy for advanced/metastatic disease.",
    "This sample is a phase 2 clinical trial for patients with cervical cancer, testing the effectiveness of cisplatin chemotherapy in combination with radiation therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial testing the drugs lcz696, amlodipine, and placebo on subjects with mild to moderate essential hypertension and concurrent obesity, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-squamous non-small cell lung cancer, testing the drugs ro5083945, cisplatin, gemcitabine, and pemetrexed, with specific eligibility criteria including the presence of EGFR in tumor tissue and adequate hematological, renal, and liver function.",
    "This phase 2 trial is testing the drug ispinesib in patients with metastatic adenocarcinoma of the prostate who have previously received taxane-containing chemotherapy and have evidence of disease progression, with various eligibility criteria including performance status, blood counts, organ function, and exclusion of other illnesses or medications.",
    "This sample is a phase 2 trial for patients with melanoma and skin neoplasms, testing the drug axitinib [ag-013736], with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug azd2171 for patients with gastrointestinal stromal tumors and soft tissue sarcomas that are resistant to imatinib mesylate or refractory to standard therapies, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs orm-12741 and placebo for orm-12741, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung cancer, testing the effectiveness of pemetrexed and cisplatin as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with peritoneal cancer, ovarian cancer, neoplasms, and fallopian tube cancer. The trial is testing the drug GW786034 and has specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for menopausal women with symptoms of estrogen and/or androgen deficiency, testing the effectiveness of esterified estrogens 1.25 mg and methyltestosterone 2.5 mg and esterified estrogens 1.25 mg in controlling these symptoms.",
    "This sample is a phase 2 clinical trial for patients with renal cell carcinoma, testing the effectiveness of pazopanib and sunitinib as systemic therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with recurrent or metastatic soft tissue sarcoma, specifically excluding certain types of sarcoma, with measurable disease and no brain metastases. The study will test the drug dolastatin 10 as a treatment option.",
    "This sample is a phase 2 clinical trial for patients with stage IV breast cancer, testing the combination of abi-007 (abraxane) and bevacizumab, with specific eligibility criteria including confirmed adenocarcinoma, measurable disease, and certain blood count and chemistry levels.",
    "This sample is a phase 1/phase 2 clinical trial for patients with chronic lymphocytic leukemia, testing the combination of gleevec and chlorambucil drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with intermittent claudication and peripheral artery disease, testing the efficacy of drugs including placebo, 375 mg ck-2017357, and 500 mg ck-2017357, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastatic colorectal cancer, testing the effectiveness of bevacizumab, irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with advanced non-small cell lung cancer (NSCLC) who have failed prior chemotherapy and erlotinib treatment. The study aims to evaluate the efficacy of the drugs pf-00299804 in treating NSCLC. The inclusion criteria include measurable disease, ECOG performance status 0-2, and tissue availability for KRAS/EGFR testing, while exclusion criteria include recent chemotherapy, radiotherapy, and intolerance to erlotinib therapy.",
    "This sample is a phase 1/phase 2 clinical trial for ovarian cancer patients who have achieved at least a partial response after standard dose chemotherapy, and it aims to evaluate the effectiveness of carboplatin, cyclophosphamide, etoposide, paclitaxel, and topotecan hydrochloride as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for advanced or metastatic breast cancer, testing the combination of gefitinib and fulvestrant as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the treatment of depression using the drug combination of naltrexone sr 32 mg/ bupropion sr 360 mg daily, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with psoriasis, testing the effectiveness of the drug bicillin l-a in treating the disease, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with stage IV cutaneous melanoma, testing the effectiveness of lapatinib, a tyrosine kinase inhibitor, as a treatment option. The eligibility criteria include having measurable disease, no more than two oncogenic somatic ERBB4 mutations, and no prior chemotherapy or radiation therapy.",
    "This sample is a phase 2 trial for patients with relapsed or progressing chronic lymphocytic leukemia/small lymphocytic lymphoma or non-Hodgkin lymphoma who have undergone allogeneic hematopoietic cell transplantation, and it aims to evaluate the efficacy of lenalidomide in this population.",
    "This sample is a phase 1/phase 2 trial for patients with b-cell chronic lymphocytic leukemia, small lymphocytic lymphoma, prolymphocytic leukemia, or Richter's transformation, testing the drugs pci-32765 and ofatumumab, with eligibility criteria including prior failed therapies, CD20 expression, ECOG performance status, and organ function requirements.",
    "This sample is a phase 2 clinical trial for the treatment of cutaneous T-cell lymphoma (CTCL) using the drug vorinostat, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with stage IV or unresectable stage III non-ocular malignant melanoma, testing the drug cp-4055 (elacyt), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for renal transplantation, testing the drugs Campath 1H\u00ae, rituximab, and mycophenolate mofetil, with inclusion criteria being renal transplant recipients and exclusion criteria including hypersensitivity to the drugs.",
    "This sample is a phase 2 clinical trial for the treatment of chronic hepatitis C genotype 1 infection, using drugs such as abt-450, abt-333, abt-267, ribavirin, and ritonavir, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial is investigating the efficacy of saracatinib in patients with extensive stage small cell lung cancer, lung metastases, malignant pleural effusion, or recurrent small cell lung cancer, who have previously untreated disease or stable disease after platinum-based chemotherapy, and meet various eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with esophageal cancer, testing the drugs fluorouracil and oxaliplatin, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for the treatment of overactive bladder using the drugs ym178 and placebo, with specific inclusion and exclusion criteria.",
    "This phase 2 trial aims to evaluate the effectiveness of 5-fluorouracil, oxaliplatin, cetuximab, and docetaxel in treating newly diagnosed adenocarcinoma of the esophagus or gastroesophageal junction, with specific eligibility criteria including tumor stage, performance status, blood counts, and other medical conditions.",
    "This sample is a phase 2 trial testing the drugs art-123 and placebo on patients with sepsis and disseminated intravascular coagulation, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with Burkitt's lymphoma or B-cell lymphoma unclassified, testing a combination of drugs including cyclophosphamide, cytarabine, doxorubicin hydrochloride, etoposide, ifosfamide, leucovorin calcium, liposomal cytarabine, methotrexate, therapeutic hydrocortisone, and vincristine sulfate, with specific eligibility criteria for disease risk, HIV status, and various patient characteristics.",
    "This sample is a phase 2 clinical trial for adult acute myeloid leukemia and myelodysplastic syndromes, testing the drug cediranib maleate, with specific eligibility criteria including age, previous treatment, and disease characteristics.",
    "This sample is a phase 2 clinical trial for patients with metastatic adenocarcinoma of the colon or rectum who have failed previous therapies, and it will test the effectiveness of gemcitabine and capecitabine as treatment options.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory Hodgkin's lymphoma, testing the drug entinostat, and includes eligibility criteria such as confirmed pathology, radiographically measurable disease, previous treatment history, and specific laboratory values.",
    "This sample is a phase 2 clinical trial for patients with metastatic renal cell carcinoma, testing the effectiveness of temsirolimus, bevacizumab, sunitinib, and interferon alpha-2a as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastatic colorectal cancer who have failed previous treatment, and it aims to evaluate the efficacy of vandetanib and the folfox regimen in this population.",
    "This sample is a phase 2 trial for individuals with glucose intolerance, testing the effectiveness of sitagliptin at different doses, including placebos, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for small cell lung cancer (SCLC) patients who have progressed after one prior platinum-containing chemotherapy regimen. The study aims to evaluate the efficacy of at-101 and topotecan as potential treatments for SCLC.",
    "This sample is a phase 2 clinical trial for patients with hepatitis C, testing the drugs lcq908 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with pulmonary arterial hypertension (PAH) and includes the drugs simvastatin, aspirin, and placebo, with eligibility criteria related to pulmonary function, pregnancy, and medication usage.",
    "This sample is a phase 2 trial for Friedreich's Ataxia, testing the drugs alpha-tocopherolquinone and placebo, with inclusion criteria of genetically confirmed Friedreich's Ataxia and impaired glucose tolerance.",
    "This sample is a phase 2 clinical trial for melanoma patients with a c-kit mutation, testing the drugs imatinib and interferon. The eligibility criteria include specific disease stage, performance status, age, and various laboratory values, while excluding patients with certain medical conditions or prior treatments.",
    "This sample is a phase 2 trial for the treatment of migraines, testing the drugs rimegepant, placebo, and sumatriptan, with eligibility criteria including a minimum 1-year history of migraines, no more than 8 attacks per month, and less than 15 days of headache per month.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer who have previously been treated with erlotinib, and it aims to evaluate the efficacy of sorafenib and erlotinib as a combination therapy. The eligibility criteria include histologically confirmed stage IIIB/IV or relapsed non-small cell lung carcinoma, no more than 2 prior lines of therapy, evidence of progressive disease on erlotinib, and a clinical benefit from prior therapy with erlotinib for a period of 8 weeks.",
    "This phase 2 trial is investigating the efficacy of amg 386 and paclitaxel in treating ovarian cancer, fallopian tube cancer, and primary peritoneal cancer, with eligibility criteria including documented progression of disease and a maximum of 3 previous regimens of anti-cancer therapy.",
    "This sample is a phase 2 trial for postmenopausal osteoporosis, testing the drugs bazedoxifene and placebo, with inclusion criteria based on postmenopausal status and diagnosis of osteoporosis, and exclusion criteria related to diseases affecting bone metabolism.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the drugs actos, placebo, and aleglitazar, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic malignant melanoma, testing the drugs karenitecin and valproic acid, with inclusion criteria including age greater than or equal to 18, ECOG performance status 0-2, and no major impairment of hematological function, and exclusion criteria including evidence of significant active infection, adequate renal and normal hepatic function, and exclusion of pregnant and nursing women.",
    "This sample is a phase 2/phase 3 trial for patients with active rheumatoid arthritis who have an incomplete response to methotrexate. The study will test the efficacy of ce-224,535, a drug, compared to a placebo in treating the disease.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) who are not suitable for chemotherapy, testing the effectiveness of erlotinib, an oral medication, as a treatment option. The inclusion criteria include a histological or cytological diagnosis of inoperable NSCLC, chemo-na\u00efve status, measurable disease, ECOG performance status of 0-3, and a life expectancy of at least 12 weeks. Exclusion criteria include prior systemic antitumor therapy, unstable systemic diseases, and brain metastasis or spinal cord compression that has not been definitively treated.",
    "This sample is a phase 2 trial for Crohn's disease, testing the effectiveness of interferon beta-1a in maintaining remission in patients who have previously used corticosteroids, with exclusion criteria of any other treatment for maintaining remission.",
    "This sample is a phase 2 clinical trial for patients with breast cancer and HER-2 overexpression, testing the effectiveness of trastuzumab (Herceptin) in treating brain metastasis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic clear cell renal cell cancer, testing the combination of gemcitabine, capecitabine, and bevacizumab as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for multiple sclerosis, relapsing-remitting, using interferon beta 1b (betaseron, bay86-5046) as the drug, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with ER positive endometrial carcinoma who have progressed after one line of chemotherapy. The drug being tested is bn83495, and the eligibility criteria include being postmenopausal or ovariectomised and having at least one measurable disease site.",
    "This sample is a phase 2/phase 3 trial that includes patients with chronic myelogenous leukemia, malignant melanoma, and renal cell carcinoma. The trial involves the drugs pegylated interferon alfa-2a and recombinant interferon alfa 2a, and the eligibility criteria include previous completion of specific protocols and response to treatment.",
    "This sample is a phase 2 clinical trial for the treatment of clostridium difficile infection using miya-bm fine granules and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the drugs zd1839 and docetaxel. The eligibility criteria include confirmed lung cancer, prior chemotherapy regimen, and disease progression within 6 months of last chemotherapy dose. Exclusion criteria include prior use of Iressa or docetaxel, unresolved chronic toxicity from previous therapy, and certain co-existing malignancies.",
    "This sample is a phase 2/phase 3 trial for breast neoplasm, testing the effectiveness of paclitaxel weekly in combination with capecitabine and docetaxel every 3 weeks in combination with capecitabine, with eligibility criteria including morphologically proven breast carcinoma, measurable and/or evaluable disease, age 18 years or older, and adequate cardiac, hematological, renal, and hepatic functions.",
    "This phase 2 trial is testing the efficacy of ixabepilone, paclitaxel, and carboplatin in treating advanced/metastatic non-small cell lung cancer, with specific eligibility criteria for patients to be included or excluded from the study.",
    "This sample is a phase 2 trial for patients with chronic myeloid leukemia (CML) who have been treated with imatinib mesylate for at least 1 year, and the study aims to evaluate the efficacy of hydroxychloroquine and imatinib mesylate in maintaining major cytogenetic response (MCyR) in these patients.",
    "This sample is a phase 1/phase 2 trial testing the combination of temsirolimus and sunitinib in patients with renal cell carcinoma, with specific inclusion and exclusion criteria for each phase of the trial.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs gw642444m, gw642444h, and placebo. The inclusion criteria include being a smoker or ex-smoker, having a history of COPD, and having a body weight between 50 kg and a BMI of 18-32 kg/m2. The exclusion criteria include having a primary asthma diagnosis, recent respiratory tract infection, poorly controlled COPD, and history of drug or alcohol abuse.",
    "This sample is a phase 2 clinical trial for patients with cervical cancer, testing the effectiveness of isotretinoin and paclitaxel as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with newly diagnosed stage Ia-IIb resectable non-small cell lung cancer, testing the effectiveness of pioglitazone, an oral drug, as a pre-surgery treatment option. The eligibility criteria include age greater than or equal to 18, ECOG performance score of less than or equal to 2, and normal organ and marrow function. Pregnant or lactating women, patients undergoing chemotherapy or radiation therapy, and patients with certain medical conditions are excluded from the study.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of the drugs bortezomib, dexamethasone, and pd 0332991, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with anterior cruciate ligament injury and osteoarthritis, testing the effectiveness of hyaluronan as a treatment option, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for individuals with type 2 diabetes mellitus, testing the effectiveness of pb1023 or placebo in improving glucose control, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for pancreatic cancer patients with non-metastatic, unresectable disease, testing the effectiveness of cetuximab, gemcitabine, oxaliplatin, and capecitabine as treatment options, with specific eligibility criteria outlined.",
    "This phase 2 trial aims to evaluate the effectiveness of gemcitabine, docetaxel, and doxorubicin in treating high-risk uterine leiomyosarcoma patients who have undergone surgical resection and have no evidence of residual disease.",
    "This sample is a phase 2 trial testing the effectiveness of bupivacaine lozenge and lidocaine-adrenalin injection in reducing pain and discomfort during scaling and root planning of patients with periodontitis, who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for breast cancer patients who have previously received Herceptin treatment, with the inclusion criteria of measurable disease and the exclusion criteria of previous chemotherapy for metastatic breast cancer and brain metastases. The study will test the effectiveness of trastuzumab and taxane drugs in treating the disease.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic breast cancer, testing the drug edotecarin. The eligibility criteria include having received previous chemotherapy, evidence of tumor resistance, and adequate organ function.",
    "This sample is a phase 2 clinical trial for patients with stage IIIB or stage IV non-small cell lung cancer, testing the effectiveness of tamibarotene and placebo drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with gastroesophageal reflux disease (GERD) symptoms, testing the drug pumosetrag. The inclusion criteria include patients with a history of GERD symptoms, between the ages of 18-70, who develop symptoms following a refluxogenic meal and can take a stable Proton Pump Inhibitor (PPI) regimen. The exclusion criteria include pregnant or lactating women and those allergic to pumosetrag or its excipients.",
    "This sample is a phase 2 trial for patients with chronic myeloid leukemia who have the T315I BCR-ABL gene mutation and have failed prior imatinib therapy. The drug being tested is omacetaxine mepesuccinate.",
    "This sample is a phase 1/phase 2 trial for patients with progressive or recurrent glioblastoma, testing the drug tandutinib, with eligibility criteria including histologically confirmed glioblastoma, measurable disease, and specific medical conditions and exclusions.",
    "This sample is a phase 2 clinical trial for participants with HIV-1 infection failing their current antiretroviral therapy, testing the efficacy of TMC114 and ritonavir as potential treatments.",
    "This sample is a phase 2 trial for attention-deficit/hyperactivity disorder (ADHD) using the drugs td-9855 and placebo, with eligibility criteria including meeting DSM-IV-TR criteria for ADHD, specific scores on the AISRS and CGI-S scales, and the use of highly effective birth control for female participants.",
    "In this sample, the phase of the trial is phase 2 and the disease being studied is obsessive compulsive disorder (OCD). The icd-10 codes associated with OCD are F42.8, F42.9, and F60.5. The drugs being tested are agomelatine a and placebo. The inclusion criteria for the trial include having a Y-BOCS total score of at least 20 and a duration of OCD symptoms of at least one year. The exclusion criteria include having bipolar disorder, schizophrenic or psychotic disorder, severe or uncontrolled organic diseases, neurological disorder, and being a woman of childbearing potential who is not using effective contraception.",
    "This sample is a phase 2 clinical trial for non-Hodgkin's lymphoma, testing the effectiveness of bortezomib, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced ovarian epithelial cancer and symptomatic malignant ascites, testing the drug aflibercept (ziv-aflibercept, ave0005, vegf trap, zaltrap\u00ae) as a potential treatment option for platinum and topotecan/liposomal doxorubicin-resistant disease.",
    "This sample is a phase 2 trial for patients with active seropositive rheumatoid arthritis, testing the effectiveness of tru-015, methylprednisolone, and prednisone in combination with methotrexate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic prostate cancer who have failed previous treatments, and it aims to evaluate the effectiveness of the drug he3235 in treating the disease. The eligibility criteria include having confirmed adenocarcinoma of the prostate, disease progression despite hormone therapy, and specific PSA levels or evidence of disease progression.",
    "This sample is a phase 1/phase 2 trial for patients with AML or high-risk MDS, testing the drugs idarubicin, sorafenib, and ara-c, with eligibility criteria including age, serum biochemical values, ability to take oral medication, and performance status.",
    "This sample is a phase 2 trial for patients with post herpetic neuralgia, neuropathy, or nerve pain, testing the efficacy and safety of epicept-np-1 cream, gabapentin capsules, and placebo as potential treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the drug cetuximab on patients with advanced cancer, with specific inclusion and exclusion criteria listed.",
    "This sample is a phase 2 clinical trial for patients with medulloblastoma, testing the effectiveness of cisplatin, cyclophosphamide, etoposide, lomustine, and vincristine as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 trial for head and neck cancer, testing the effectiveness of induction chemotherapy, cisplatin, and fluorouracil as treatment options, with specific eligibility criteria for patients.",
    "This sample is a phase 2 clinical trial for the drug \"gsk1120212\" in patients with metastatic cutaneous melanoma that have a positive BRAF mutation, and it includes specific inclusion and exclusion criteria for enrollment.",
    "This sample is a phase 2 trial for patients with poorly-controlled asthma, testing the effectiveness of pioglitazone and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for the treatment of osteoarthritis of the knee, testing the drugs fx005, placebo 1 (carrier), and placebo 2 (diluent), with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 clinical trial for patients with stage IIIB or stage IV non-small cell lung cancer, testing the effectiveness of paclitaxel, carboplatin, and vorinostat as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for patients with locally advanced and non-metastatic rectal adenocarcinoma, testing the drugs S-1 and oxaliplatin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients primarily diagnosed with post-traumatic stress disorder (PTSD), using paroxetine as the drug, and includes eligibility criteria such as age, diagnosis, and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with Parkinson's disease experiencing troublesome dyskinesia following levodopa dosing, and the drug being tested is ads-5102 (extended release amantadine hcl).",
    "This sample is a phase 2 trial for patients with newly diagnosed prostate cancer, testing the drugs capecitabine and docetaxel, with eligibility criteria including clinical stage, PSA levels, Gleason's sum, and restrictions on prior treatments and medical conditions.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs azd3480 and donepezil, with inclusion criteria including informed consent, probable Alzheimer's diagnosis, and a caregiver visiting at least three times weekly, and exclusion criteria including other neurologic diseases or dementia, major depressive disorder, recent use of certain Alzheimer's medications, and impaired vision or hearing.",
    "This sample is a phase 2 trial testing the drug azd2171 on patients with advanced solid tumors that are refractory to standard therapies, and the eligibility criteria include histological or cytological confirmation of the tumor and no prior treatment with a VEGF inhibitor.",
    "This sample is a phase 2 clinical trial for patients with recurrent or progressive glioblastoma multiforme (GBM), testing the efficacy of cilengitide in combination with EMD 121974, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for metastatic colorectal cancer, colon cancer, and rectal cancer, testing the drugs placebo, amg 655, modified folfox6, and bevacizumab, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with cutaneous T-cell lymphoma, testing the drug bexarotene, and includes eligibility criteria such as specific disease stage, age, performance status, and various medical conditions.",
    "This sample is a phase 2 clinical trial for patients with acute lymphoblastic leukemia, testing the effectiveness of a combination of drugs including bortezomib, vorinostat, dexamethasone, methotrexate, and imatinib mesylate, with specific eligibility criteria for age, organ function, and prior therapy.",
    "This sample is a phase 2 clinical trial for chronic constipation, testing the effectiveness of linaclotide acetate and a matching placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial testing the effectiveness of ambroxol spray and placebo spray in treating sore throat due to acute pharyngitis, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial is testing the effectiveness of ritonavir and lopinavir, two drugs used to treat HIV, in patients with progressive or recurrent high grade glioma, a type of brain tumor. The eligibility criteria include having a Karnofsky performance status of at least 60%, normal hematologic, renal, and liver function, and being able to provide written informed consent.",
    "This sample is a phase 2 clinical trial for lung cancer patients who have progressed after first-line chemotherapy, testing the drug sunitinib, with specific eligibility criteria including histologic confirmation of small cell lung cancer, resolution of prior therapy toxic effects, and adequate organ and cardiac function.",
    "This sample is a phase 2 clinical trial for ovarian cancer, testing the effectiveness of bevacizumab, docetaxel, and oxaliplatin in participants who meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the efficacy of interferon beta-1a and placebo in subjects aged 50-75 with a diagnosis of AD and MMSE score of 20-26, with various inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial investigating the use of lansoprazole and placebo in patients with gastroesophageal reflux and asthma, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial testing the drug lcz696 and placebo in patients with mild to moderate essential hypertension, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with melanoma, testing the drugs bosentan and placebo, with eligibility criteria including age, disease stage, prior therapy, performance status, and exclusion criteria related to liver function, blood pressure, heart failure, prior treatments, and contraindications for the use of DTIC.",
    "This sample is a phase 2 clinical trial for patients with locally advanced unresectable biliary tract or gallbladder adenocarcinoma, testing the effectiveness of capecitabine, oxaliplatin, and bevacizumab as treatment options. The eligibility criteria include specific medical conditions, age, performance status, and various blood test results.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) and it will test the effectiveness of carboplatin, paclitaxel, and zactima as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and restrictions on prior and concurrent therapies.",
    "This sample is a phase 2 clinical trial for psoriasis, testing the drugs cp-690,550 and placebo, with eligibility criteria including a diagnosis of plaque psoriasis for at least 6 months, coverage of at least 15% of the body, and willingness to comply with study procedures.",
    "This sample is a phase 2 trial for patients with active rheumatoid arthritis, testing the drug sbi-087 in combination with methotrexate, and the eligibility criteria include meeting the ACR criteria for RA, having active RA symptoms, being seropositive, and receiving a stable dose of methotrexate.",
    "This sample is a phase 2/phase 3 trial for patients with venous thromboembolism, testing the drug fondaparinux sodium, and includes eligibility criteria such as age \u2265 18 years old and having at least one risk factor for VTE.",
    "This sample is a phase 2 trial investigating the use of the drug \"tr701 fa\" for the treatment of major cutaneous abscess, cellulitis, and erysipelas, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck, testing the effectiveness of bortezomib and doxorubicin hydrochloride as treatment options. The eligibility criteria include specific disease confirmation, measurable disease, and various health parameters.",
    "This sample is a phase 2 trial for patients with follicular lymphoma, testing the efficacy of lenalidomide and r-chop as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with pancreatic adenocarcinoma, testing the effectiveness of gemcitabine, oxaliplatin, and erlotinib as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for systemic lupus erythematosus (SLE) and lupus, testing the drugs pravastatin, aspirin, ramipril, and vitamins B6, B12, and folate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for sickle cell disease, testing the effectiveness of sodium nitrite injection, usp in relieving severe pain in patients aged 8-23 years old, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-Hodgkin's lymphoma, testing the effectiveness of the drugs bortezomib, bendamustine, and rituximab, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for Parkinson's disease patients who experience end-of-dose deterioration despite optimal levodopa therapy, and it will test the efficacy of the drugs placebo, bia 9-1067, and levodopa/carbidopa in improving symptoms.",
    "This sample is a phase 2 trial for patients with follicular lymphoma, testing the effectiveness of drugs such as ofatumumab, cyclophosphamide, doxorubicin, vincristine, and prednisolone or prednisone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with gastric cancer, testing the drug abi-007 in patients who have received prior treatment and developed disease progression or recurrence. The eligibility criteria include confirmation of gastric adenocarcinoma, age between 20-74, and at least one measurable lesion. Exclusion criteria include a history of Taxans use, presence of another active malignancy, pre-existing peripheral neuropathy of Grade 2, 3, or 4, and chronic treatment with steroids.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of bio-11006 inhalation solution and placebo in improving lung function and reducing symptoms.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the drug cc-5013. The eligibility criteria include a diagnosis of Crohn's disease, specific disease activity levels, and stable medication use. Exclusion criteria include certain medical conditions, recent medication use, and history of alcohol or drug abuse.",
    "This sample is a phase 2 trial for asthma patients, testing the drugs ff/gw642444m, gw642444m, fluticasone furoate, and placebo, with eligibility criteria including BMI range, non-smoking status, and specific lung function measurements.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the effectiveness of pegylated liposomal doxorubicin and epirubicin as chemotherapy drugs, with specific eligibility criteria for inclusion and exclusion.",
    "In this phase 2 trial, the drug du-176b is being tested for its effectiveness in preventing venous thromboembolism and deep vein thrombosis in patients undergoing unilateral total knee arthroplasty, with specific exclusion criteria including risks of hemorrhage, thromboembolic risks, weight less than 40 kg, and pregnancy.",
    "This sample is a phase 2 clinical trial for the treatment of chronic hepatitis C, testing the efficacy of ribavirin, pegylated interferon alfa 2a, placebo, and telaprevir, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 trial testing the drugs rosuvastatin and atorvastatin for the treatment of hyperlipidemia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the drug alogliptin and voglibose, with inclusion criteria requiring completion of a previous study and exclusion criteria related to hepatic and renal impairment.",
    "This sample is a phase 2 clinical trial for interstitial cystitis, testing the lidocaine releasing intravesical system - liris\u00ae as a potential treatment, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for patients with HER2+ and ER+ metastatic breast cancer or resistant locally advanced breast cancer, testing the drug AUY922, with eligibility criteria including age, laboratory values, hormonal status, stage of disease, prior treatments, and measurable lesions.",
    "This sample is a phase 2 clinical trial for patients with HIV infections, hepatitis C, and liver disease, testing the effectiveness of peginterferon alfa-2a and ribavirin in treating these conditions. The eligibility criteria include specific requirements for HIV viral load, CD4 count, HCV treatment history, liver biopsy results, and liver enzyme levels.",
    "This sample is a phase 2 clinical trial for patients with advanced stage cervical and uterine cancer, testing the effectiveness of bevacizumab and paclitaxel drugs, with specific eligibility criteria including measurable disease, adequate bone marrow and renal function, and exclusion criteria such as prior treatment with taxane agents and bevacizumab, inadequate hypertension control, and history of certain medical conditions.",
    "This sample is a phase 2 trial for patients with lung adenocarcinoma and other related diseases, testing the effectiveness of drugs such as carboplatin, erlotinib, and paclitaxel, with specific eligibility criteria including histologic documentation, stage of disease, prior treatments, and non-smoking status.",
    "This sample is a phase 2 clinical trial for patients with B-cell chronic lymphocytic leukemia, testing the drug fludarabine phosphate, and includes eligibility criteria such as specific diagnosis, lymphocyte count, bone marrow examination, lymphocyte phenotype, disease stage, and other medical conditions.",
    "This sample is a phase 2 clinical trial for polycystic ovary syndrome (PCOS) testing the effectiveness of lipitor and placebo in women with PCOS who have 8 or fewer menstrual periods per year, elevated serum total testosterone, and elevated LDL cholesterol, while excluding those who are currently pregnant or breastfeeding, using oral contraceptives or progestins, insulin sensitizing medications, have thyroid disease, hyperprolactinemia, active liver disease, type 1 or type 2 diabetes.",
    "This sample is a phase 2 clinical trial for patients with stage III or IVA squamous cell carcinoma of the head and neck, testing the effectiveness of gefitinib (iressa) and cisplatin in combination as a treatment option.",
    "This sample is a phase 2 clinical trial for the drug cinaciguat (bay58-2667) in patients with acute heart failure, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for breast cancer patients who are post-menopausal and have metastatic or locally advanced estrogen receptor positive and HER-2 negative breast cancer. The study aims to evaluate the efficacy of ridaforolimus + dalotuzumab, exemestane, ridaforolimus, and dalotuzumab as treatment options. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 2/phase 3 trial for Alzheimer's disease using the drug talsaclidine, with specific inclusion and exclusion criteria, and excluding patients with certain medical conditions or on certain concomitant therapies.",
    "This phase 2 trial aims to evaluate the efficacy of HQK-1001, a potential treatment for sickle cell disease, in reducing the frequency of pain crises and other acute complications in patients aged 12 to 60 years who have experienced at least one episode of SCD pain crisis, acute chest syndrome, or leg ulcers in the past year.",
    "This sample is a phase 2 trial for the treatment of eosinophilic esophagitis using the drug flovent, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for hormone refractory prostate cancer, testing the drugs at-101, prednisone and docetaxel, and placebo, prednisone and docetaxel, with eligibility criteria including confirmed adenocarcinoma of the prostate, disease progression despite androgen deprivation, and a testosterone level \u2264 50 ng/dL.",
    "This sample is a phase 2 clinical trial for cervical cancer patients, testing the drugs velcade (bortezomib) and irinotecan, with eligibility criteria including age > 18, Karnofsky performance status > 60%, and measurable disease on clinical exam or by RECIST criteria.",
    "This sample is a phase 2 clinical trial for patients with irresectable, metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction, testing the efficacy of docetaxel, oxaliplatin, and capecitabine as a treatment option. The eligibility criteria include specific disease stage, measurable disease, ECOG performance status, and adequate bone marrow, hepatic, and renal function. Exclusion criteria include prior cytotoxic chemotherapy or radiotherapy, peripheral neuropathy, and concurrent malignancies.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the effectiveness of exenatide and placebo in combination with metformin for glycemic control, with various inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for systemic lupus erythematosus, testing the effectiveness of corticosteroids, abatacept, and mycophenolate mofetil in patients with active proliferative lupus glomerulonephritis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with unresectable or locally advanced adenocarcinoma of the pancreas, testing the effectiveness of oxaliplatin, fluorouracil, and gemcitabine hydrochloride as treatment options. The eligibility criteria include specific disease characteristics, performance status, blood counts, liver function, and exclusion of other medical conditions or prior treatments.",
    "This sample is a phase 2 trial for postherpetic neuralgia, testing the drugs adl5747, placebo, and pregabalin, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for postmenopausal osteoporosis, testing the efficacy of different forms of abaloparatide (transdermal and injection) compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for patients with multiple sclerosis and cognition disorders, testing the drug memantine. The inclusion criteria include a diagnosis of multiple sclerosis, age between 18 and 65 years, and demonstrated cognitive dysfunction. The exclusion criteria include a history of major depression or psychosis, visual impairments, non-English speaking patients, recent MS exacerbation, pregnancy, renal insufficiency, history of seizures, and use of certain medications or substances.",
    "This sample is a phase 2 clinical trial for the drug lupuzor in patients with systemic lupus erythematosus (SLE), with specific inclusion and exclusion criteria, and the study aims to evaluate the safety and efficacy of the drug in treating SLE.",
    "This sample is a phase 2 clinical trial testing the effectiveness of ondansetron and palonosetron in reducing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.",
    "This sample is a phase 2 trial for the treatment of hepatitis C using the drug pf-00868554 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for previously-untreated patients with classical Hodgkin Lymphoma, testing the effectiveness of brentuximab vedotin and ABVD chemotherapy regimen, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of clostridium difficile infection and diarrhea, testing the drugs cb-183,315, placebo, and vancomycin, with specific eligibility and exclusion criteria outlined.",
    "This phase 2 trial aims to evaluate the efficacy of lenalidomide and placebo in treating complex regional pain syndrome type I, with specific inclusion and exclusion criteria, and requirements for contraception for women of childbearing potential.",
    "This sample is a phase 2 trial testing the drugs azd1386, naproxen, and placebo for patients scheduled for surgical removal of impacted mandibular third molars, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with coronary artery disease, testing the drugs varespladib and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with chronic myeloid leukemia blast crisis or acute myeloid leukemia, testing the effectiveness of imatinib mesylate and clag drugs in refractory or relapsed AML patients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with stage II-III head and neck cancer, testing the efficacy of 5-fluorouracil, hydroxyurea, and bevacizumab as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This phase 2 trial is testing the drug decitabine on patients with acute myeloid leukemia, chronic myelomonocytic leukemia, or myelodysplastic syndrome who have failed therapy with azacitidine, and have specific eligibility criteria including age, performance status, and adequate hepatic and renal functions.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of the drugs ixabepilone, fluoropyrimidine, and irinotecan in combination, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 2 trial testing the drugs gtx-024 and placebo on patients with cachexia, who have been diagnosed with certain types of cancer and meet specific eligibility criteria.",
    "This sample is a phase 2 trial for patients with recurrent glioblastoma, testing the drug bibf1120, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with locally advanced rectal cancer, testing the effectiveness of capecitabine and oxaliplatin as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the efficacy of drugs such as placebo, pioglitazone, and ccx140-b, with specific eligibility criteria including BMI, HbA1c levels, and exclusion criteria such as history of diabetes complications or certain medications.",
    "This phase 2 trial is testing the effectiveness of cisplatin and docetaxel in treating non-small cell lung cancer patients with stage IIIB or IV disease, measurable lesions, and specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic prostate cancer, testing the combination of sagopilone and prednisone as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for postmenopausal women with vulvovaginal atrophy, testing the efficacy of estradiol compared to placebo in relieving symptoms such as vaginal dryness, painful intercourse, and irritation/itching.",
    "This sample is a phase 2 trial for patients with psoriasis, testing the drugs \"birt 2584 xx\" and \"placebo\" to determine their efficacy in treating the disease. The eligibility criteria include age, disease severity, and previous treatment history, among others.",
    "This sample is a phase 2 clinical trial for patients with malignant mesothelioma, testing the drugs bortezomib and cisplatin, with eligibility criteria including confirmed pleural mesothelioma, measurable or evaluable disease, and specific patient characteristics.",
    "This sample is a phase 1/phase 2 clinical trial for patients with glioblastoma multiforme, testing the drug aee788, and includes eligibility criteria such as confirmed GBM, adequate organ function, age \u2265 18 years, Karnofsky performance status score \u2265 70%, and life expectancy \u2265 12 weeks.",
    "This sample is a phase 2 trial for chronic hepatitis C, testing the drugs boceprevir, peginterferon-alfa 2b, ribavirin, and ribavirin (low-dose), with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung cancer, testing the efficacy of oxaliplatin and docetaxel as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for individuals with Asperger's Disorder or Pervasive Developmental Disorder, testing the drug aripiprazole, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is testing the use of a placebo drug in patients with HIV infection and gastrointestinal symptoms, who meet specific eligibility criteria including stable CD4 count and HIV-1 RNA levels, and have adequate laboratory parameters.",
    "The sample is a phase 2/phase 3 trial for allergic rhinoconjunctivitis, testing the drugs avanz phleum pratense and placebo, with inclusion criteria including a history of grass pollen allergy and positive skin prick and Immunoglobulin E tests to grass, and exclusion criteria including other allergies overlapping the grass pollen season and severe asthma.",
    "This sample is a phase 2 trial for patients with Stage IIIB NSCLC or Stage IV disease, testing the effectiveness of fosbretabulin, carboplatin, paclitaxel, and bevacizumab in combination, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic graft-versus-host disease (GVHD) who have failed previous treatments, and it aims to evaluate the effectiveness of lenalidomide in treating the disease.",
    "This sample is a phase 2 trial for the treatment of stroke using the drugs na-1 and placebo, with eligibility criteria including a diagnosis of a suitable brain aneurysm for repair, absence of ongoing ischemic symptoms, and normal or abnormal but not clinically significant physical examination findings.",
    "This sample is a phase 2 clinical trial testing the drug vardenafil (Levitra) and a placebo in men with benign prostate hypertrophy requiring surgical treatment, with various exclusion criteria including unstable medical or psychiatric disorders, history of previous prostatectomy, and cardiovascular conditions.",
    "This sample is a phase 2 clinical trial for patients with peritoneal cancer, ovarian cancer, neoplasms, ovarian, and fallopian tube cancer. The trial will test the effectiveness of topotecan and gemcitabine in patients who have had one prior platinum-based chemotherapy regimen and meet certain eligibility criteria.",
    "This sample is a phase 2 clinical trial for adult T-cell leukemia-lymphoma, testing the drug vcap/amp/vecp(mlsg15) in patients who meet specific inclusion criteria and do not meet certain exclusion criteria.",
    "This phase 2 trial is testing the effectiveness of various drugs, including 5-fu, folfox regimen, and bevacizumab, in combination with other treatments for patients with metastatic colorectal cancer, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for the treatment of allergic rhinitis, with the drugs wf10 and nacl solution being tested. The eligibility criteria include a history of persistent allergic rhinitis, positive allergen skin test, and baseline Total Nasal Symptom Score (TNSS) of at least 6. Exclusion criteria include non-allergic rhinitis, recent nasal surgery, and use of certain medications.",
    "This sample is a phase 2 clinical trial for patients with esophageal cancer, testing the drug erlotinib hydrochloride. The eligibility criteria include specific disease characteristics, patient characteristics, and restrictions on prior concurrent therapy.",
    "This sample is a phase 1/phase 2 trial for patients with severe combined immunodeficiency disease, severe primary immunodeficiency disorder, undefined T cell deficiency disorder, or Wiskott-Aldrich syndrome. The drug being tested is fludarabine, and the inclusion criteria include availability of a family member or unrelated donor for transplantation, normal creatinine levels, life expectancy greater than 6 weeks, and a Lansky/Karnofsky score of at least 70%.",
    "This sample is a phase 2 clinical trial for patients with locally advanced esophageal cancer, testing the drug gefitinib, with eligibility criteria including prior curative therapy, specific disease characteristics, and various patient characteristics and prior concurrent therapies.",
    "This sample is a phase 2 clinical trial for the treatment of interstitial cystitis, painful bladder syndrome, and pain using oxycodone naloxone prolonged release tablets compared to placebo tablets, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with myelofibrosis, testing the drug bevacizumab (avastin) as a therapy option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the effectiveness of different doses of the drug den in comparison to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with mucosal melanoma, recurrent melanoma, or stage IV melanoma, testing the effectiveness of temsirolimus and selumetinib drugs in combination, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the drugs pf-03187207 and latanoprost 0.005% for the treatment of primary open angle glaucoma and ocular hypertension, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients suffering from moderate to severe Major Depressive Disorder (MDD), testing the effectiveness of citalopram and pipamperone combination or citalopram alone as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with invasive breast cancer, specifically those with Stage IV disease and confirmed amplification of ErbB2. The study aims to evaluate the efficacy and safety of lapatinib/nab-paclitaxel combination treatment in this patient population. The eligibility criteria include specific requirements for prior treatments, disease status, organ function, and pregnancy status.",
    "This sample is a phase 2 clinical trial for patients with chronic hepatitis C (genotype 1) who have previously received pegylated interferon alfa 2a with ribavirin. The study aims to evaluate the efficacy of telaprevir, ribavirin, pegylated interferon alfa 2a, and a matching placebo in treating the disease. The eligibility criteria include age between 18 and 70, detectable plasma HCV RNA, good general health, absence of HIV or hepatitis B infection, and no drug or alcohol abuse in the last year. Effective birth control is required for female participants, and pregnant or nursing women are excluded from the study.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C virus (HCV) infection, testing the efficacy of daclatasvir, peg-interferon alfa-2a, and ribavirin as potential treatments, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the treatment of symptomatic osteoarthritis of the knee using the drug lacosamide, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of AC-201, a drug, in reducing HbA1c levels, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with myelodysplastic syndromes (MDS) or leukemia, testing the effectiveness of azacitidine and lenalidomide as treatment options, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with hormone refractory prostate cancer, testing the drug patupilone. The eligibility criteria include prior chemotherapy and hormone therapy, specific laboratory requirements, and exclusion criteria such as brain metastases and peripheral neuropathy.",
    "This sample is a phase 2 clinical trial for patients with recurrent or stage IV melanoma, testing the effectiveness of carboplatin and paclitaxel as treatment options, with specific eligibility criteria including measurable disease, performance status, blood counts, organ function, and exclusion of certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with primary peritoneal carcinoma or recurrent ovarian carcinoma, testing the drug cositecan, with specific eligibility criteria including platinum-resistant disease and measurable lesions.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic melanoma, testing the combination of mpc-6827 and temozolomide as a treatment option. The eligibility criteria include having histologically proven melanoma, measurable metastases, and a performance score meeting certain criteria. Exclusion criteria include hypersensitivity to Cremophor EL and certain medical conditions such as cardiovascular disease and uncontrolled hypertension.",
    "This sample is a phase 2 clinical trial for lung cancer patients, testing the drugs enzastaurin, pemetrexed, cisplatin, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the drug pegylated liposomal doxorubicin (doxil), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for attention deficit hyperactivity disorder (ADHD) testing the drugs mk-8777 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for patients with malignant melanoma, testing the drug pivanex, and includes eligibility criteria such as previous treatment with chemotherapy or IL-2, measurable disease, adequate renal and liver function, and a predicted life expectancy of at least 6 months.",
    "This sample is a phase 1/phase 2 trial for pancreatic adenocarcinoma, testing the drugs pimasertib, gemcitabine, and placebo, with eligibility criteria including confirmed metastatic adenocarcinoma of the pancreas and availability of tumor sample, age \u2265 18 years, and negative pregnancy test for women of childbearing potential.",
    "This phase 2 trial is investigating the efficacy of asp8825 and placebo in treating restless legs syndrome, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for attention-deficit/hyperactivity disorder (ADHD) using the drugs abt-089 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with relapsed or recurrent colorectal cancer, testing the effectiveness of multiple drugs including irinotecan, capecitabine, folfox, capeox/xelox, and folfiri, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 trial for osteoporosis, testing the drugs 100 mg amg 162, 60 mg amg 162, 14 mg amg 162, and placebo, with specific inclusion and exclusion criteria for postmenopausal women.",
    "This sample is a phase 2 trial for patients with iron overload who have undergone prior allogeneic hematopoietic stem cell transplantation, and it aims to evaluate the efficacy of deferasirox in reducing serum ferritin levels.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the drug STA-5326, and includes eligibility criteria such as age, disease diagnosis, CDAI score, and medication history.",
    "This sample is a phase 2 clinical trial for patients with pancreatic cancer, testing the combination of gemcitabine and erlotinib as a potential treatment option, with specific eligibility criteria outlined.",
    "This sample is a phase 2/phase 3 trial for the treatment of cytomegalovirus infections in pediatric solid organ transplant recipients, using valganciclovir (Valcyte) as the study drug. The inclusion criteria include age range, type of transplant, ability to tolerate oral medication, and being at risk of developing CMV disease. The exclusion criteria include previous participation in the study, participation in another clinical trial, severe uncontrolled diarrhea, and pregnancy or lactation.",
    "This sample is a phase 2 clinical trial for patients with colorectal cancer, testing the effectiveness of gemcitabine, avastin, 5fu/folinic acid, and oxaliplatin as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial testing the drugs rapamycin and methotrexate in patients with systemic sclerosis, who meet specific inclusion criteria such as satisfying the American College of Rheumatology classification criteria and having skin thickening proximal to the elbows and/or knees.",
    "This sample is a phase 1/phase 2 trial for HIV infections, testing the effectiveness of raltegravir poloxamer film coated tablet, raltegravir chewable tablet, and raltegravir oral granules for suspension in participants with HIV-1 infection who are on unchanged therapeutic regimen or treatment experienced. The study includes eligibility criteria such as documentation of HIV-1 infection, HIV RNA of 1,000 copies/mL or greater, and willingness to take assigned raltegravir preparation. Exclusion criteria include known Grade 3 or higher laboratory tests, clinical evidence of pancreatitis, and prior treatment with another experimental HIV integrase inhibitor.",
    "This sample is a phase 2 clinical trial for patients with dementia associated with Parkinson's disease or dementia with Lewy bodies, testing the effectiveness of memantine and placebo in treating mild-to-moderate or moderate dementia. The inclusion criteria include a diagnosis of Parkinson's disease or dementia, a written informed consent, and a reliable caregiver, while the exclusion criteria include other brain diseases causing dementia, mental retardation, terminal illness with a life expectancy shorter than 6 months, and various medical conditions such as epilepsy, major depression, renal impairment, heart disease, and hepatic impairment.",
    "This sample is a phase 2 clinical trial for patients with metastatic pancreatic cancer, testing the effectiveness of bortezomib and carboplatin as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for ovarian cancer patients who have previously received platinum-based chemotherapy and have measurable disease, and it will test the drug bsi-201 (a PARP inhibitor) for its effectiveness in treating the disease.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC), testing the effectiveness of cisplatin, etoposide, and irinotecan hydrochloride as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and restrictions on prior concurrent therapy.",
    "This sample is a phase 1/phase 2 clinical trial for kidney transplantation, testing the drug aeb071, with inclusion criteria including adult recipients of a functioning kidney within 24 hours post transplant, and exclusion criteria including patients infected with Hepatitis B, C, or HIV, and patients with a history of cancer within the last 5 years.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the effectiveness of docetaxel, liposomal doxorubicin, and cyclophosphamide as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the drugs azd6244 and capecitabine in patients who have failed previous chemotherapeutic regimens. The inclusion criteria include having colorectal cancer, previous treatment failure, and a WHO performance status of 0-2, while the exclusion criteria include previous therapy with certain inhibitors and severe concomitant conditions.",
    "This sample is a phase 2 clinical trial for patients with locally advanced/metastatic or recurrent epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. The trial aims to evaluate the effectiveness of the drugs mm-121 and paclitaxel in patients who have received prior platinum-based chemotherapy and are platinum-resistant or refractory. The eligibility criteria include adequate liver and kidney function, being 18 years of age or above, and being eligible for weekly paclitaxel.",
    "This sample is a phase 2 trial for psoriatic arthritis, testing the drugs abatacept and placebo, with key inclusion criteria including meeting classification criteria for psoriatic arthritis, prior failure of therapy with disease-modifying antirheumatic drugs, and disease activity defined by joint counts and synovitis.",
    "This sample is a phase 2 clinical trial for patients with colorectal cancer, testing the effectiveness of the drugs capecitabine and oxaliplatin in combination with folfox chemotherapy regimen, with specific eligibility criteria for patients and exclusion criteria for comorbidities.",
    "This sample is a phase 2 clinical trial for patients with head and neck cancer, testing the effectiveness of Abraxane and cetuximab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial for type 2 diabetes mellitus, testing the efficacy of various drug combinations (alogliptin and glimepiride, alogliptin and metformin) with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with non-Hodgkin lymphoma and Hodgkin disease, testing the effectiveness of g-csf plus plerixafor drugs in combination with salvage chemotherapy as a treatment option. The eligibility criteria include specific disease diagnoses, previous treatment history, performance status, blood counts, liver function, and other factors. Exclusion criteria include certain medical conditions, previous experimental therapy, and pregnancy.",
    "This sample is a phase 2 trial for patients with leukemia and lymphoma, testing the effectiveness of a combination of drugs including cyclophosphamide, cyclosporine, fludarabine phosphate, methotrexate, mycophenolate mofetil, and tacrolimus, for nonmyeloablative transplantation candidates with a specific HLA identical sibling donor, and with certain eligibility criteria including age, performance status, and organ function.",
    "This sample is a phase 2 clinical trial for patients with hormone refractory prostate cancer, testing the effectiveness of metformin hydrochloride, docetaxel, and prednisone as treatment options. The eligibility criteria include age, life expectancy, performance status, bone marrow and hepatic function, and confirmed prostate cancer with increasing PSA levels. Patients with symptomatic brain metastases, on insulin, or with severe medical problems are excluded from the trial.",
    "This sample is a phase 2 clinical trial for endometrial cancer patients, testing the combination of carboplatin and pegylated liposomal doxorubicin hydrochloride as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 trial testing the drugs bol-303259-x and latanoprost for their effectiveness in reducing intraocular pressure in patients with open angle glaucoma or ocular hypertension, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients diagnosed with rheumatoid arthritis (RA), testing the drug mtx (methotrexate) as a potential treatment option. The inclusion criteria include being male or female patients aged 18 or older with a diagnosis of RA, while the exclusion criteria include pregnant females and any other clinically significant disease or disorder that may put the subject at risk.",
    "This sample is a phase 2 trial for HIV-infected individuals who are treatment-experienced and have limited treatment options available. The drug being tested is kp-1461, and the eligibility criteria include having a certain level of HIV-1 RNA and CD4 cell count.",
    "This sample is a phase 1/phase 2 trial for head and neck cancer patients, testing the effectiveness of cisplatin, doxorubicin hydrochloride, and fosbretabulin disodium drugs, with specific eligibility criteria including disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with triple negative locally advanced non-resectable and/or metastatic breast cancer, testing the drugs ixabepilone and ixabepilone + cetuximab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of lenalidomide and dexamethasone as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with cystic fibrosis and pulmonary infection caused by pseudomonas aeruginosa. The drug being tested is amitriptyline, and the eligibility criteria include age, disease confirmation, absence of certain conditions, and ability to undergo full therapy.",
    "This sample is a phase 2 trial for the treatment of detrusor muscle hyperactivity, using a placebo drug, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML), testing the combination of voreloxin injection and cytarabine as a treatment option. The eligibility criteria include specific disease subtypes, prior treatment history, and certain laboratory values.",
    "This sample is a phase 2/phase 3 trial for systemic lupus erythematosus (SLE) using drugs such as rituximab, placebo, prednisone, acetaminophen, and diphenhydramine, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for the treatment of urinary tract infection using the drugs lactin-v and placebo, with eligibility criteria including pre-menopausal women aged 18-40 years who have had prior symptomatic UTIs and agree to abstain from certain activities during the study.",
    "This sample is a phase 2 trial for melanoma patients, testing the effectiveness of ipilimumab and corticosteroids in treating brain metastasis, with specific eligibility criteria including histologically confirmed melanoma, measurable brain lesions, and certain laboratory values.",
    "This sample is a phase 2 trial for the drug gsk1349572 and placebo in patients with human immunodeficiency virus (HIV) infection, with inclusion criteria including age, CD4+ cell count, and HIV-1 infection, and exclusion criteria including prior treatment with an integrase inhibitor, treatment with radiation therapy or cytotoxic chemotherapeutic agents, and history of sensitivity to study medications.",
    "This sample is a phase 2 clinical trial for bladder cancer patients, testing the drugs oxaliplatin and taxotere, with eligibility criteria including prior therapy, measurable disease, specific performance and age limits, and various health parameters.",
    "This sample is a phase 2 clinical trial for patients with recurrent or persistent epithelial ovarian or primary peritoneal carcinoma, testing the drug enzastaurin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for untreated childhood brain stem glioma, testing the drug tipifarnib, with specific eligibility criteria including age, performance scale, prior therapy, blood counts, kidney and liver function, and exclusion criteria such as disseminated glioma, anticonvulsant use, allergies, and uncontrolled infection.",
    "This phase 2 trial is testing the drug oxaliplatin in patients with advanced or metastatic breast cancer who have failed prior anthracycline/taxane based chemotherapy, and have not developed brain metastases.",
    "This sample is a phase 2 clinical trial for rheumatoid arthritis, testing the drugs clazakizumab and placebo, with eligibility criteria including a diagnosis of active RA, inadequate response to TNF inhibitors, and specific joint count and inflammation markers.",
    "This sample is a phase 2 clinical trial for the drug sb-681323 in patients with rheumatoid arthritis, with specific inclusion and exclusion criteria, such as stable RA medication and no history of liver disease or active infections.",
    "This sample is a phase 2 trial for major depressive disorder, testing the effectiveness of esketamine and placebo as treatments, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial aims to evaluate the effectiveness of Adderall XR and Concerta in treating depression, neurotoxicity, and unspecified childhood solid tumors in patients aged 6-17 who have been cancer-free for at least 6 months and have a proficiency in English.",
    "This sample is a phase 2 clinical trial for patients with primary refractory or relapsed acute myeloid leukemia (AML), testing the drug as1411, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial that aims to test the effectiveness of varenicline (chantix), bupropion (zyban), and nicotine patches in helping Duke employees and their dependents quit smoking, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients with specific histology and radiological evidence of disease progression, testing the drugs ec145, ec145 + docetaxel, docetaxel, and ec20, with eligibility criteria including age, performance status, organ function, and prior therapy.",
    "This phase 2 trial is testing the drug alemtuzumab for the treatment of leukemia, MDS, aplastic anemia, and T-LGL, with eligibility criteria including previous treatment, organ function, performance status, contraception use, and indication for therapy.",
    "This sample is a phase 2 clinical trial for atopic dermatitis, testing the efficacy of multiple drugs including an2728 ointment and an2898 ointment, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for asthma, testing the effectiveness of drugs such as fp mdpi, flovent diskus, albuterol/salbutamol, and placebo mdpi, with eligibility criteria including age, asthma diagnosis, severity of disease, and current asthma therapy.",
    "This sample is a phase 2 clinical trial for the drug nbi-98854, testing its effectiveness in treating tardive dyskinesia, a movement disorder associated with schizophrenia or schizoaffective disorder. The inclusion criteria include having moderate or severe symptoms of tardive dyskinesia and being in good general health, while the exclusion criteria include having certain medical conditions or a history of substance abuse.",
    "This sample is a phase 2 clinical trial for patients with squamous cell carcinoma of the head and neck, testing the efficacy of lapatinib oral tablets compared to a placebo, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 2 trial is investigating the efficacy of l-alanosine in treating various types of advanced cancers including lung cancer, malignant mesothelioma, pancreatic cancer, and sarcoma, with specific eligibility criteria for each disease.",
    "This sample is a phase 2 trial for rheumatoid arthritis patients who have failed treatment with at least one DMARD, and are now being tested with rituximab and methotrexate to assess their response.",
    "This phase 2 trial aims to evaluate the use of txa127, a drug, in patients with hematologic malignancy or inherited metabolic disease who are eligible for cord blood transplant, and meet specific inclusion criteria such as age, HLA-matching, and organ function.",
    "This sample is a phase 2 clinical trial for patients with kidney diseases, testing the effectiveness of lanthanum carbonate and placebo in reducing serum phosphorus levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for attention deficit hyperactivity disorder (ADHD) patients who have not responded well to stimulant treatment, and it will test the effectiveness of aripiprazole and a sugar pill as potential treatments.",
    "This sample is a phase 2 trial for rheumatoid arthritis, testing the drugs ak106-001616 and an active comparator, with inclusion criteria of a diagnosis of RA and stable dose of methotrexate, and exclusion criteria of pregnancy or breastfeeding and abnormal screening laboratory test values.",
    "This sample is a phase 2/phase 3 trial for patients with house dust mite induced persistent mild to moderate asthma, testing the effectiveness of various drugs including salbutamol inhaler, budesonide/formoterol inhaler, prednisone tablet, desloratadine tablet, and budesonide nasal spray, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for HER2-positive breast neoplasm, testing the efficacy of doxorubicin, cyclophosphamide, paclitaxel, trastuzumab and pld, cyclophosphamide, trastuzumab, paclitaxel as treatment options, with specific eligibility criteria for participants.",
    "This phase 2 trial aims to evaluate the efficacy of ferumoxytol and iron sucrose in treating iron deficiency anemia in patients with chronic kidney disease, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the treatment of steatohepatitis, where patients with definite NASH are eligible and certain exclusion criteria apply, including the use of specific anti-NASH agents and non-stable doses of other anti-NASH agents.",
    "This sample is a phase 2 clinical trial for schizophrenia patients, where the drugs being tested are al-108 and placebo, and the eligibility criteria include a DSM IV/DSM IV TR diagnosis of schizophrenia, specific symptom and cognitive performance criteria, and exclusion criteria such as current treatment with certain antipsychotics and history of head injury or significant medical disorders.",
    "This sample is a phase 2 clinical trial for patients with stomach neoplasms, testing the effectiveness of different drug combinations (docetaxel + oxaliplatin, docetaxel + oxaliplatin + 5-fu, docetaxel + oxaliplatin + capecitabine) in treating metastatic or locally recurrent disease, with specific eligibility criteria for patient inclusion and exclusion.",
    "This phase 2 trial is testing the combination of temozolomide and abt-888 in patients with colorectal cancer who have progressed on or are intolerant to standard therapies, and have no brain metastases or a history of previously treated brain metastases.",
    "This sample is a phase 2 clinical trial for the treatment of exudative age-related macular degeneration using esba1008 solution and aflibercept, with specific inclusion and exclusion criteria outlined in the protocol.",
    "This sample is a phase 2 trial for the treatment of diabetic neuropathy, painful, using the drug agn 203818 and a placebo capsule, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with Parkinson's disease and dyskinesias, testing the drugs afq056 and placebo, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is testing the drug trabectedin for the treatment of recurrent or refractory sarcoma tumors, including rhabdomyosarcoma, nonrhabdomyosarcomatous soft tissue sarcoma, and Ewing's sarcoma, in patients aged 12 months to 21 years.",
    "This sample is a phase 1/phase 2 trial for patients with type 2 diabetes mellitus, testing the drug ta-7284 and its placebo, with specific eligibility criteria including stable diabetes, BMI range, blood glucose levels, and blood pressure range.",
    "This sample is a phase 2 clinical trial for HER2-overexpressing unresectable or metastatic breast cancer, testing the effectiveness of lapatinib and bevacizumab in combination, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of hypercholesterolemia, testing the drug ISIS 301012 or placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with incurable unresectable stage III or IV melanoma, testing the efficacy of the drugs AKT inhibitor MK2206 and selumetinib, with specific eligibility criteria including prior therapy with a selective BRAF inhibitor and measurable disease.",
    "This sample is a phase 2 clinical trial for patients with mild to moderate knee osteoarthritis, testing the drug pg-530742 at different doses, along with a placebo, to assess its impact on knee pain and mobility.",
    "This sample is a phase 2 clinical trial for the drug ptc124 in patients with cystic fibrosis, where the eligibility criteria include completion of a previous study, specific lung function requirements, and willingness to comply with study procedures.",
    "This sample is a phase 2 trial for patients with primary soft tissue sarcoma of the upper or lower extremity, testing the effectiveness of chemotherapy as a treatment option.",
    "This sample is a phase 2/phase 3 trial for hypertension, testing the drugs irbesartan and atenolol, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for chronic hepatitis B, testing the drugs tenofovir df, ftc, and placebo, with inclusion criteria including chronic HBV infection, HBeAg positivity, and HBV DNA \u2265 10^8 copies/mL, and exclusion criteria including pregnancy, decompensated liver disease, and coinfection with hepatitis C virus, HIV, or hepatitis D virus.",
    "This sample is a phase 2 clinical trial for myeloma patients who have completed standard first-line induction treatment, and it aims to evaluate the efficacy of various drug combinations, including vinorelbine, g-csf, and plerixafor, in preparation for high-dose chemotherapy with melphalan and autologous stem cell support.",
    "This sample is a phase 2 clinical trial for patients with BRAF mutation positive melanoma or colorectal cancer, testing the drugs gsk2118436 and gsk1120212, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for primary open angle glaucoma, testing the drugs t2345 and prostaglandin on untreated bilateral newly diagnosed patients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with chronic lymphocytic leukemia (CLL), testing the effectiveness of fludarabine, cyclophosphamide, alemtuzumab, and rituximab as treatment options, with specific eligibility criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of two drugs (500mcg/25mcg once daily and placebo once daily) on various eligibility criteria, including age, smoking history, lung function, and exclusion criteria such as asthma, other respiratory disorders, and certain medications.",
    "This sample is a phase 2 clinical trial for patients with metastatic nasopharyngeal carcinoma, testing the drug celecoxib, and includes eligibility criteria such as confirmed NPC, measurable disease, and specific patient characteristics.",
    "This sample is a phase 2 trial for obesity, testing the drugs exenatide and placebo, with inclusion criteria of having a BMI >= 30kg/m^2 and exclusion criteria including previous participation in exenatide studies or GLP-1 analogs, diabetes mellitus diagnosis or previous use of anti-diabetic medications, recent changes in lipid-lowering or blood pressure agents, recent use of weight loss drugs, recent participation in a weight loss program, history of chronic use of drugs affecting gastrointestinal motility, recent treatment with anti-diabetic medications or systemic glucocorticoid therapy, and history of bariatric surgery or organ transplant.",
    "This sample is a phase 2 clinical trial for patients with refractory or recurrent hepatoblastoma, testing the drug irinotecan hydrochloride, with specific eligibility criteria including measurable disease and certain patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the drug carfilzomib. The eligibility criteria include measurable disease, prior response to first-line therapy, and specific laboratory values. There are also exclusion criteria, such as previous treatment with carfilzomib and certain concurrent conditions.",
    "This sample is a phase 2 clinical trial for patients with metastatic pancreatic cancer who have failed first-line gemcitabine treatment, and it evaluates the efficacy of capecitabine, ruxolitinib, and placebo as potential treatments. The eligibility criteria include age, diagnosis, performance status, and previous treatment history.",
    "This sample is a phase 1/phase 2 trial for the treatment of type 2 diabetes mellitus, using the drug gk1-399 (formerly ttp399) and a placebo, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is testing the drug ci-1040 in patients with colorectal neoplasms, breast neoplasms, carcinoma non-small-cell lung, and pancreatic neoplasms, and the eligibility criteria include age, prior chemotherapy, tumor tissue availability, renal/liver/bone marrow function, and gastrointestinal disorders.",
    "This sample is a phase 2 trial testing the drug \"gft505 80mg\" versus a placebo in individuals with impaired glucose tolerance and abdominal obesity, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with non-small cell lung cancer (NSCLC) and includes eligibility criteria such as specific disease characteristics, performance status, hematopoietic, hepatic, renal, cardiovascular, and pulmonary requirements, as well as prior concurrent therapy restrictions. The drugs being tested in this trial are carboplatin, cediranib maleate, and paclitaxel.",
    "This sample is a phase 2 clinical trial for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, testing the effectiveness of docetaxel, capecitabine, and premedication as a treatment option.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the effectiveness of tamoxifen, anastrozole, letrozole, exemestane, and fulvestrant as antiestrogen therapy for postmenopausal women who have received prior antiestrogen therapy and experienced disease progression.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) who have progressed after receiving prior chemotherapy. The study aims to evaluate the efficacy of everolimus and gefitinib as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2/phase 3 clinical trial for patients with chronic sinusitis and nasal polyps, testing the effectiveness of S8 sinus implant and mometasone furoate nasal spray in reducing symptoms and improving quality of life.",
    "This sample is a phase 2 clinical trial for patients with localized pancreatic cancer, testing the effectiveness of gemcitabine as a treatment option, with specific eligibility criteria and patient characteristics outlined.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the drug clofarabine. The eligibility criteria include having measurable levels of monoclonal protein, prior therapies for multiple myeloma, and acceptable organ and marrow function.",
    "This sample is a phase 2/phase 3 clinical trial for newly diagnosed acute myeloid leukemia (AML) patients aged 18-60 years, testing the effectiveness of a combination of drugs including cytarabine, idarubicin, etoposide, all-trans retinoic acid, and pegfilgrastim, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for diabetic neuropathy, testing the efficacy of an experimental drug compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the effectiveness of different doses of pf-04991532 and sitagliptin 100 mg compared to a placebo, with inclusion criteria including stable background medication and a BMI between 22.5 and 45.5 kg/m2, and exclusion criteria including type 1 diabetes, recent heart attack or stroke, uncontrolled blood pressure, and significant kidney disease.",
    "This sample is a phase 2 trial for rheumatoid arthritis, testing the drugs cetrorelix and placebo, with inclusion criteria including moderate to severe disease activity and exclusion criteria including pregnancy or breastfeeding and use of biologic therapy or prednisolone >7.5mg.",
    "This sample is a phase 2 trial for HIV-1 infection, testing the efficacy of efv/ftc/tdf, calcium carbonate, vitamin d3, and placebos, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the efficacy of exenatide once weekly and exenatide once monthly suspension in combination with other medications, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the combination of gefitinib and sunitinib in patients with histologically confirmed renal cell carcinoma with metastases, and includes eligibility criteria such as failure of prior immunotherapy or no prior systemic therapy for metastatic RCC.",
    "This sample is a phase 2 trial for patients with metastatic colorectal cancer, testing the effectiveness of cetuximab, irinotecan, oxaliplatin, and uft as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for newly diagnosed Acute Lymphoblastic Leukemia patients, testing the efficacy of a combination of drugs including cyclophosphamide, cytarabine, dexamethasone, doxorubicin hydrochloride, imatinib mesylate, methotrexate, methylprednisolone, pegaspargase, and vincristine sulfate, with specific eligibility criteria and exclusion criteria.",
    "This phase 2 trial is testing the effectiveness of cyclophosphamide, doxorubicin, vincristine, prednisone, dexamethasone, and il-2 in treating patients with mantle cell lymphoma, specifically those with stage II, III, or IV disease, and no symptomatic brain metastasis.",
    "This sample is a phase 2 clinical trial for patients with Parkinson's disease, testing the drug sr57667b, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the effects of allopurinol and placebo on hypertension in renal transplant recipients, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with endometrial cancer who are refractory to standard therapy, and the drug being tested is pemetrexed disodium. The eligibility criteria include histologically confirmed endometrial adenocarcinoma, measurable disease, and having received 1 prior chemotherapy regimen for endometrial cancer.",
    "This sample is a phase 2 trial for type 2 diabetes, testing the drugs rivoglitazone hcl and pioglitazone hcl, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with essential hypertension, testing the drugs lcz696, amlodipine, and hydrochlorothiazide (hctz), with inclusion criteria including successful completion of a previous protocol and good medication compliance.",
    "This sample is a phase 2 clinical trial for patients with mild cognitive impairment or Alzheimer's disease, testing the effectiveness of regular insulin and placebo in improving memory impairment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug patiromer for patients with chronic kidney disease, hypertension, and hyperkalemia, with specific eligibility criteria including age, diabetes diagnosis, kidney function, blood pressure, and medication history.",
    "This sample is a phase 2 clinical trial for the drug ono-4641 in patients with relapsing-remitting multiple sclerosis, with inclusion criteria including a definite diagnosis of the disease and exclusion criteria including a history of malignancy and clinically significant chronic disease of the immune system.",
    "This sample is a phase 2 clinical trial for idiopathic pulmonary fibrosis, testing the drugs qax576 and placebo, with inclusion criteria including a diagnosis of IPF and a 6-minute walk test distance of at least 50 meters.",
    "This sample is a phase 2 trial for patients with hypertension, testing the drug clonidine, and includes specific inclusion and exclusion criteria for participation in the study.",
    "This sample is a phase 2 trial for the treatment of prostatic hyperplasia using tamsulosin and uk-369,003 drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with neurofibromatosis type 1 and extensive plexiform and/or paraspinal neurofibromas, testing the drug cediranib maleate to evaluate its effectiveness in reducing tumor growth and improving symptoms.",
    "This sample is a phase 2 trial testing the drug riociguat (Adempas, Bay63-2521) versus placebo in patients with symptomatic pulmonary hypertension due to left ventricular systolic dysfunction, with specific inclusion and exclusion criteria. The diseases being studied are hypertension, pulmonary and ventricular dysfunction, left, with corresponding ICD-10 codes provided.",
    "This sample is a phase 2 clinical trial for patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma, testing the efficacy of docetaxel and oxaliplatin as treatment options. The eligibility criteria include specific disease characteristics, age, performance status, hematopoietic, hepatic, renal, and cardiovascular conditions, as well as prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for the treatment of hypercholesterolemia using alirocumab and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for the treatment of schizophrenia, testing the drugs risperidone, placebo, and ly2140023, with specific inclusion and exclusion criteria for eligible patients.",
    "In this phase 2 trial, the drug combination of cp-195,543, celecoxib, and methotrexate will be tested for the treatment of rheumatoid arthritis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with acute myeloid leukemia (AML) who have been exposed to prior leukemogenic chemotherapy or radiotherapy, or have a diagnosis of myelodysplastic syndrome (MDS). The study aims to evaluate the efficacy and safety of amonafide l-malate and cytarabine as treatment options. The inclusion and exclusion criteria outline the eligibility requirements for participants in the trial.",
    "This sample is a phase 2 trial for depressive disorder, major, testing the effectiveness of sertraline, [s,s]-reboxetine, and placebo as treatments, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial is investigating the effectiveness of capecitabine and oxaliplatin in treating head and neck cancer patients who are incurable by surgery or radiation therapy, with specific eligibility criteria and organ function requirements.",
    "This sample is a phase 2 clinical trial for patients with hepatitis C, testing the effectiveness of the drugs merimepodib, peg-interferon-alpha 2a, and ribavirin in patients who have previously been treated with pegylated interferon and ribavirin but did not respond to the treatment. The eligibility criteria include having a diagnosis of hepatitis C, being a non-responder to previous treatment, and not having used illegal drugs or had significant alcohol use in the past year.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) who are not eligible for surgery. The study aims to evaluate the effectiveness of carboplatin and paclitaxel in combination with radiotherapy for the treatment of NSCLC.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs abt-384, donepezil, and placebo, with inclusion criteria including age between 55 and 90, meeting NINCDS/ADRDA criteria for probable AD, and having a MMSE score of 10 to 24.",
    "This sample is a phase 2 trial for the treatment of diabetic macular edema using the drug danazol, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 clinical trial for patients with multiple myeloma who have relapsed or are refractory to prior treatments, and it aims to evaluate the efficacy and safety of hll1-dox, a doxorubicin conjugate of milatuzumab, as a potential treatment option.",
    "This sample is a phase 2 trial for the treatment of chronic hepatitis C, testing the drugs sovaprevir, ach-3102, rbv, and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for ovarian cancer patients who have not received previous chemotherapy or radiation therapy, and the study aims to evaluate the effectiveness of sorafenib, paclitaxel, and carboplatin as treatment options. The eligibility criteria include specific requirements for disease stage, cytoreductive surgery results, measurable disease, performance status, blood counts, liver and kidney function, and pregnancy status. There are also exclusion criteria related to age, cardiac disease, CNS metastases, hypertension, infections, bleeding events, wound healing, allergies, and medication use.",
    "This sample is a phase 2/phase 3 trial for patients with atrial flutter, testing the effectiveness of vernakalant injection 20 mg/ml in treating dysrhythmic symptoms lasting between 3 hours and 45 days, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with sickle cell disease and pulmonary hypertension, testing the effectiveness of sildenafil and placebo drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with non-small cell lung cancer, testing the drug celecoxib, and includes eligibility criteria such as specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with recurrent uterine sarcoma and uterine carcinosarcoma, testing the drug temsirolimus. The eligibility criteria include specific disease confirmation, prior treatment restrictions, and required laboratory values. Exclusion criteria include prior therapy with temsirolimus, certain medications, and untreated central nervous system metastases.",
    "This sample is a phase 2 clinical trial for patients with gastrointestinal cancer, testing the combination of capecitabine and oxaliplatin as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial for patients with inoperable or stage I-III non-small cell lung cancer, testing the effectiveness of cisplatin and vinorelbine tartrate in combination with radical radiotherapy treatment.",
    "This sample is a phase 2 clinical trial for patients with radiotherapy-induced nausea and vomiting (RINV), testing the effectiveness of the drug syb d-0701 compared to a placebo in reducing symptoms.",
    "This sample is a phase 2 trial for the treatment of induced panic attack, testing the effectiveness of inhaled alprazolam and iv doxapram compared to an inhaled placebo, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 2 clinical trial for patients with bladder cancer, transitional cell cancer of the renal pelvis and ureter, and urethral cancer. The drug being tested is sunitinib malate, and the eligibility criteria include specific disease characteristics and patient characteristics.",
    "This sample is a phase 1/phase 2 trial for patients with chemotherapy-refractory metastatic castration-resistant prostate cancer (CRPC), testing the drug temsirolimus, and includes eligibility criteria such as confirmed adenocarcinoma of the prostate, evidence of disease progression, and specific medical parameters.",
    "This sample is a phase 2 trial for the treatment of postherpetic neuralgia (PHN) using gabapentin. The inclusion criteria include being 18 years or older, having a documented medical diagnosis of PHN, and having a baseline 24-hour average pain intensity score of at least 4.0. The exclusion criteria include having other chronic pain conditions not associated with PHN, hepatic impairment, impaired renal function, uncontrolled hypertension, and current or chronic history of liver disease or significant psychiatric disorders.",
    "This phase 2 trial aims to investigate the effectiveness of r-hlh + r-hfsh, r-hfsh, recombinant human choriogonadotropin (r-hcg), and gnrh antagonist in treating infertility and ovulation induction in premenopausal women aged 35 to 42 years, who have regular menstrual cycles and meet specific inclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with chronic lymphocytic leukemia, testing the effectiveness of multiple drugs including busulfan, cyclophosphamide, and fludarabine phosphate, among others, in combination with stem cell transplant. The eligibility criteria include specific disease characteristics, availability of a donor, and various patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the drugs erlotinib + docetaxel and docetaxel, with eligibility criteria including histologically proven NSCLC, wild type or unknown EGFR mutational status, stage IV disease with measurable target lesions, normal hepatic and renal function, and a life expectancy of more than 12 weeks.",
    "This sample is a phase 2 clinical trial for patients with advanced or metastatic non-small cell lung cancer, testing the drug sunitinib. The eligibility criteria include having no more than 2 prior chemotherapy treatments, measurable disease, and an ECOG performance status of 0 or 1. The exclusion criteria include previous treatment with anti-angiogenesis agents, brain metastases, and current treatment on another clinical trial.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the effectiveness of Avastin, Gemcitabine, and Abraxane in combination, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs aclidinium/formoterol 400/12\u03bcg and formoterol, with inclusion criteria including current or former cigarette smokers with a smoking history of at least 10 pack-years and a diagnosis of stable moderate to severe COPD, and exclusion criteria including recent hospitalization for COPD exacerbation, respiratory tract infections, clinically significant respiratory conditions other than COPD, asthma, chronic use of oxygen therapy, clinically significant cardiovascular conditions, and hypersensitivity reactions to certain inhaled medications.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C, testing the effectiveness of pioglitazone, interferon alfa-2a, and ribavirin as treatment options, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with high-risk superficial bladder cancer, testing the drug apaziquone, and includes eligibility criteria such as histologically confirmed carcinoma in situ, absence of upper urinary tract tumor, and performance status of 0-2.",
    "This sample is a phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis (NASH) using silymarin 700 mg and silymarin 420 mg, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with metastatic or recurrent colorectal cancer, testing the drug capecitabine, with specific eligibility criteria including age, performance status, hematopoietic, hepatic, renal, and other factors.",
    "This sample is a phase 2 trial for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) of nonsquamous histology, testing the drugs pemetrexed and erlotinib as a second-line treatment option after failure of platinum-based chemotherapy. The eligibility criteria include a histological or cytological diagnosis of NSCLC, good performance status, and adequate bone marrow, renal, and hepatic functions.",
    "This sample is a phase 2 clinical trial for patients with histologically confirmed squamous cell carcinoma of the head and neck, allowing any disease stage, and the drug being tested is capecitabine. The eligibility criteria include specific disease characteristics, performance status, hematopoietic, hepatic, renal, cardiovascular, gastrointestinal, and other patient characteristics, as well as prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with recurrent small cell lung cancer, testing the drug imatinib mesylate, and includes eligibility criteria such as histological confirmation of SCLC, prior treatment regimen, c-Kit positivity, measurable lesion size, and various medical conditions that exclude participation.",
    "This sample is a phase 2 trial for psoriasis vulgaris, testing the efficacy of drugs such as leo 90100, betamethasone plus calcipotriol, and ointment vehicle, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial testing the drug rivaroxaban/placebo for patients with acute coronary syndrome, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients, testing the effectiveness of bavituximab plus paclitaxel and carboplatin as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with various types of bladder cancer, testing the drug sorafenib tosylate, and includes eligibility criteria such as prior chemotherapy, radiotherapy, and surgery, as well as specific medical requirements and restrictions.",
    "This sample is a phase 2 clinical trial for patients with recurrent glioblastoma multiforme, gliosarcoma, or other grade 4 astrocytoma variants, testing the effectiveness of vorinostat and bortezomib drugs in combination therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease and cognitive impairment, testing the effectiveness of sodium oligo-mannurarate and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for Parkinson's disease, testing the drugs biib014 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for the treatment of moderate to severe interstitial cystitis using the drugs pf-04383119 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for nicotine dependence, testing the effectiveness of extended treatment in adolescents aged 14-18 who smoke at least 10 cigarettes per day and have made at least one quit attempt in the previous 6 months. The study has inclusion and exclusion criteria related to age, smoking habits, mental health disorders, drug use, pregnancy, and current medication.",
    "This phase 2 trial is testing the drug azd4877 in patients with urothelial cancer (bladder, renal pelvis, ureter, or urethra) who have stage IV disease that cannot be treated with curative surgery or radiotherapy, and have had a maximum of 2 prior chemotherapeutic regimens.",
    "This phase 2 trial is testing the drug dlbs1033 and placebo on healthy male participants aged 18-55 with specific inclusion and exclusion criteria related to cardiovascular health, blood parameters, and lifestyle factors.",
    "This sample is a phase 2 trial for patients with malignant pleural effusion and non-small cell lung cancer, testing the effectiveness of zoledronic acid in combination with chemotherapy for the treatment of lung cancer.",
    "This sample is a phase 2 trial for patients with atrial fibrillation, testing the effectiveness of vernakalant (oral) compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with primary myelofibrosis or fibrosis, bone marrow, testing the drug ipi-926, with inclusion criteria including age \u226518, confirmed diagnosis of PMF or post ET/PV MF, and ECOG performance of 0-2, and exclusion criteria including prior treatment with hedgehog pathway inhibitors and inadequate hepatic or renal function.",
    "This phase 2 trial is testing the drugs gsk2330672, placebo, and metformin in patients with type 2 diabetes mellitus, who meet specific inclusion criteria such as age, documented T2DM diagnosis, and stable metformin use, and exclude those with certain medical histories or conditions.",
    "This sample is a phase 2 clinical trial for patients with recurrent or metastatic squamous cell carcinoma of the head and neck. The study aims to evaluate the efficacy of bortezomib and irinotecan hydrochloride as treatment options, and includes eligibility criteria such as prior chemotherapy, histological confirmation of the disease, and specific disease subtypes.",
    "This sample is a phase 2 clinical trial testing the drugs int-747 and placebo on patients with type 2 diabetes and presumed non-alcoholic fatty liver disease (NAFLD), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with chronic atopic dermatitis, testing the drug WBI-1001, and includes specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with bladder cancer, testing the drug paclitaxel, nanoparticle albumin-bound, in patients with recurrent bladder cancer refractory to standard intravesical therapy, who meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial testing the drug methoxsalen for the treatment of graft-versus-host disease (GvHD) in patients who are corticosteroid refractory, dependent, or intolerant, and have documented skin disease classical for chronic GvHD.",
    "This sample is a phase 2 clinical trial for the treatment of psoriasis using qrx-101 75 mcg/g ointment applied bid and vehicle (placebo) applied bid, with specific inclusion and exclusion criteria.",
    "This phase 2 clinical trial aims to evaluate the effectiveness of docetaxel, cisplatin, and 5-fluorouracil in treating squamous cell carcinoma of the oral cavity, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the drug paquinimod in patients with systemic sclerosis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for smoking cessation, testing the effectiveness of the x-22 smoking cessation product and active control cigarettes in subjects between 18 and 65 years old with a history of smoking at least 10 cigarettes per day for at least 1 year, and who plan to quit smoking within the next 3 months.",
    "This phase 2 trial is testing the effectiveness of docetaxel and vandetanib in treating patients with metastatic gastric adenocarcinoma or gastroesophageal junction cancer, and the eligibility criteria include specific disease characteristics and patient characteristics.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C, testing the effectiveness of drugs such as sofosbuvir, gs-0938, rbv, and placebos, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for the treatment of malignant pleural mesothelioma and solid tumors, using drugs pemetrexed, cisplatin, and cbp501, with eligibility criteria including confirmed diagnosis, measurable disease, and adequate organ function.",
    "This sample is a phase 2 clinical trial for patients with malignant pleural mesothelioma, testing the drugs morab-009 (amatuximab), pemetrexed, and cisplatin, with specific eligibility criteria including confirmed diagnosis, measurable disease, and certain tumor characteristics.",
    "This sample is a phase 2 clinical trial for locally advanced or metastatic breast cancer patients who are resistant to aromatase inhibitors, and it involves the drugs enzastaurin, placebo, and fulvestrant. The eligibility criteria include being postmenopausal, having a performance status of 0, 1, or 2, and having adequate organ function.",
    "This sample is a phase 2 trial for patients with Parkinson's disease, testing the drug fipamezole, and includes specific eligibility criteria for participants.",
    "This sample is a phase 2 trial for patients with colorectal cancer, testing the effectiveness of capecitabine (xeloda) and bevacizumab. The eligibility criteria include having stage IV disease, no prior chemotherapy for metastatic colorectal cancer, and specific laboratory values within certain ranges. Exclusion criteria include prior chemotherapy or treatment with an anti-angiogenic agent, presence of neuropathy > grade 2, and other medical or psychiatric disorders that would contraindicate the use of the drugs.",
    "This sample is a phase 2 clinical trial for patients with metastatic or unresectable locally recurrent clear cell renal carcinoma, testing the drug pazopanib. The eligibility criteria include having only one previous targeted agent therapy, an ECOG performance status of 0 or 1, and specific laboratory values within normal ranges. There are also exclusion criteria, such as previous treatment with certain targeted agents, concurrent cancer therapy, and certain medical conditions.",
    "This sample is a phase 1/phase 2 trial testing the drug td-1211 and placebo on healthy subjects and subjects with opioid-induced constipation, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for chronic obstructive pulmonary disease (COPD) patients, testing the effectiveness of indacaterol 300\u03bcg and placebo drugs on subjects aged 40 to 80 years with specific inclusion and exclusion criteria.",
    "This phase 2 trial aims to evaluate the efficacy of ipx159 and placebo in treating restless legs syndrome (RLS) in adults aged 18-70, with specific inclusion and exclusion criteria, including the exclusion of subjects using certain medications and those with certain medical conditions.",
    "This sample is a phase 2 trial for patients with previously treated, therapy-refractory or -intolerant, Stage III or Stage IV melanoma, and the drugs being tested are ipilimumab (mdx-010, bms-734016) and ipilimumab.",
    "This sample is a phase 2 clinical trial for esophageal cancer patients, testing the effectiveness of 5-fu, cisplatin, and taxotere drugs, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with metastatic adenocarcinoma of the prostate, testing the effectiveness of docetaxel as a treatment option. The eligibility criteria include hormone-resistance, elevated PSA levels, and specific patient characteristics.",
    "This sample is a phase 2 trial for obsessive-compulsive disorder (OCD) using ketamine as the drug, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the drugs mk-0646 and placebo, with specific eligibility criteria including measurable disease, adequate organ function, and exclusion criteria such as prior chemotherapy or uncontrolled medical conditions.",
    "This sample is a phase 2 trial for patients with locally advanced and unresectable adenocarcinoma of the pancreas, testing the effectiveness of gemcitabine, amg 479, and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with congestive heart failure and edema, testing the drug OPC-41061 (tolvaptan) to evaluate its effectiveness in reducing extracellular volume expansion. The eligibility criteria include specific symptoms, age range, stable body weight, and exclusion criteria such as unstable heart failure, implanted ventricular assist device, recent heart surgery, and various other medical conditions.",
    "This sample is a phase 1/phase 2 trial for patients with non-alcoholic steatohepatitis and increased iron storage/disturbed distribution, testing the drug exjade (Deferasirox) for its effectiveness in reducing liver enzymes and serum ferritin levels, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial testing the drug pazopanib hydrochloride for the treatment of various types of bladder and urethral cancer, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 2 clinical trial for patients with low- or intermediate-1-risk MDS (myelodysplastic syndromes) using azacytidine and gm-csf drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drugs rapamycin and tacrolimus for graft versus host disease in patients who have received an allogeneic MSD or MUD PBSCT, and are currently on Tacrolimus for GVHD prophylaxis. The eligibility criteria include being 18 years or older, 24 weeks post SCT, and deemed eligible for tapering off of Tacrolimus by the primary BMT physician.",
    "This sample is a phase 2 clinical trial for patients with marginal zone B-cell lymphoma, testing the drug gemcitabine. The inclusion criteria include histologically confirmed lymphoma, specific performance status, age, measurable lesions, and specific laboratory values, while the exclusion criteria include other malignancies, serious comorbid diseases, and pregnancy or breastfeeding.",
    "This sample is a phase 2 clinical trial for patients with follicular lymphoma, testing the drug enzastaurin, and includes eligibility criteria such as histologically confirmed diagnosis, disease stage, prior treatment history, and exclusion criteria such as concurrent antitumor therapy and serious systemic disorders.",
    "This sample is a phase 2 clinical trial for patients with renal cell carcinoma, testing the effectiveness of sunitinib malate (sutent) as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for pediatric patients with acute lymphoblastic leukemia, testing the drug clofarabine, and includes specific eligibility criteria for participation.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drug huperzine a, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for arthritis, rheumatoid, with the icd-10 codes M06.9, M05.9, M06.08, M06.00, M06.011, M06.012, M06.019. The drugs being tested are placebo and cp-690,550, and the inclusion criteria require subjects to have failed an adequate trial of therapy with at least 1 DMARD due to lack of efficacy or toxicity.",
    "This sample is a phase 2 trial for individuals diagnosed with panic disorder, testing the efficacy of the drugs \"org 25935\" and \"placebo\" in combination with cognitive behavioral therapy (CBT) as a treatment option. The study has specific inclusion and exclusion criteria, and participants must be willing to discontinue any psychotropic medications prior to the trial.",
    "This sample is a phase 1/phase 2 trial testing the drugs droxidopa, atenolol, and placebos for the treatment of postural orthostatic tachycardia syndrome and orthostatic intolerance, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes, testing the effectiveness of the drug mk0533 compared to placebo and pioglitazone in controlling blood glucose levels. The eligibility criteria include age range, previous medication usage, and exclusion criteria related to other medical conditions and medications.",
    "The sample is a phase 1/phase 2 trial for metastatic colorectal cancer, testing the drugs azd2171, folfox, and placebo cediranib, with inclusion criteria including WHO performance status 0-1 and a life expectancy of 12 weeks or longer.",
    "This sample is a phase 2 trial for patients with primary peritoneal carcinoma or recurrent ovarian carcinoma, testing the drug sorafenib tosylate, with specific eligibility criteria including prior platinum-based chemotherapy and certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with hepatocellular carcinoma (HCC) who have discontinued sorafenib treatment, and it will test the efficacy of the drug tac-101 compared to a placebo in treating advanced unresectable HCC.",
    "This phase 2 trial is investigating the efficacy of carboplatin, gm-csf (sargramostim), and interferon gamma in patients with potentially platinum-sensitive M\u00fcllerian carcinomas (ovarian, fallopian tube, or peritoneal cancer) who have had a response to platinum-based chemotherapy and have a chemotherapy treatment-free interval of at least 6 months.",
    "This sample is a phase 2 trial for patients with metastatic hormone refractory prostate cancer, testing the drugs dexamethasone and doxorubicin, with eligibility criteria including resistance to previous therapies, symptoms related to the disease, and adequate organ function.",
    "This sample is a phase 2 clinical trial for patients with ovarian cancer who have relapsed within 6 months after primary therapy with platin and taxan. The study aims to evaluate the effectiveness of topotecan in treating these patients.",
    "This sample is a phase 2 trial for chronic cough, with the drug gefapixant and placebo being tested, and includes inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial investigating the safety and effectiveness of Xeomin\u00ae injections in treating troublesome sialorrhea in patients with Parkinson's disease and amyotrophic lateral sclerosis (ALS), with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial testing the drugs pf-3512676 + erlotinib and erlotinib for the treatment of advanced, EGFR-positive non-small-cell lung carcinoma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with moderate to severe ulcerative colitis, testing the efficacy of natura-alpha capsules compared to a placebo capsule, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial that includes patients with various types of lymphoid malignancies, such as extranodal nk/t-cell lymphoma, anaplastic large cell lymphoma, and mantle cell lymphoma. The trial aims to evaluate the efficacy of drugs like vorinostat, ifosfamide, carboplatin, and etoposide in treating these diseases. The eligibility criteria include having measurable disease, specific laboratory values, and a performance status of 0, 1, or 2. Patients with certain medical conditions or prior treatments are excluded from the study.",
    "This sample is a phase 2 clinical trial for the treatment of plaque psoriasis using mometasone furoate, nortriptyline hcl, and a placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 trial testing the efficacy of bupivacaine collagen sponge versus placebo collagen sponge for postoperative pain management in patients undergoing unilateral inguinal herniorrhaphy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drugs bps804 and placebo on postmenopausal women with low bone mineral density, specifically osteopenia and osteoporosis, to evaluate their effectiveness in preventing osteoporotic fractures.",
    "This sample is a phase 2 trial for postmenopausal women with hormone receptor-positive early breast cancer, testing the drugs fulvestrant and anastrozole, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with stage IV invasive breast cancer and HER2 overexpression, testing the effectiveness of gemcitabine and trastuzumab as treatment options.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients, testing the effectiveness of bevacizumab, sunitinib, carboplatin, and paclitaxel as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with metastatic or recurrent breast cancer, testing the drugs enzastaurin, placebo, and capecitabine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with malignant glioma, including glioblastoma multiforme, anaplastic astrocytoma, anaplastic oligodendroglioma, and anaplastic mixed oligoastrocytoma. The trial will test the drug talampanel and includes eligibility criteria such as tumor progression, prior radiation therapy, and adequate organ function.",
    "This sample is a phase 2/phase 3 trial for patients with colorectal cancer and liver metastases, testing the effectiveness of various drugs (folfiri, folfox-4, folfiri-hd, folfox-7, folfirinox) in combination with eligibility criteria including histologically proven adenocarcinoma, unresectable metastases, and WHO performance status 0-1.",
    "This sample is a phase 2 trial for metastatic breast cancer patients who are ER negative, PgR negative, and HER2 less than 3+ expression, and it will test the efficacy of cetuximab and cisplatin in treating the disease.",
    "This sample is a phase 2 trial for major depressive disorder, testing the drugs azd7268, escitalopram, placebo capsules, and placebo tablets, with specific inclusion and exclusion criteria for patient enrollment.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndromes, acute myeloid leukemia, or chronic myelomonocytic leukemia in complete remission, testing the effectiveness of clofarabine, cytarabine, and thymoglobulin as part of a stem cell transplant procedure, with specific eligibility criteria for patients and donors.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the drugs ain457 and placebo, with inclusion criteria including a diagnosis of Crohn's disease for at least 3 months and moderately active disease, and exclusion criteria including a body mass index over 34 and evidence of active pulmonary disease or latent tuberculosis.",
    "This sample is a phase 2 clinical trial for the treatment of endometriosis, testing the efficacy of active treatment with a high dose of bgs649, active treatment with a low dose of bgs649, and placebo treatment. The eligibility criteria include premenopausal women with moderate to severe endometriosis, laparoscopically proven diagnosis, and a minimum score on the numerical rating scale for pelvic pain, menstrual pain, or dyspareunia.",
    "This phase 2 trial is testing the drugs EGT0001442 and placebo in subjects diagnosed with type 2 diabetes, with specific inclusion and exclusion criteria related to diabetes management, kidney function, hypertension, and other factors.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes and fatty liver, testing the drug exenatide to determine its effectiveness in treating the conditions. The inclusion criteria include age, specific diabetes medication, body mass index, and liver function tests, while the exclusion criteria include liver disease, alcohol use, and certain medications.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of paclitaxel and cisplatin as a treatment option. The eligibility criteria include specific disease stage, age, ECOG score, blood counts, liver function, and kidney function, while excluding patients with previous chemotherapy or radiotherapy, brain metastasis, allergies to the drugs, pregnancy or nursing, uncontrolled illnesses, HIV positivity, and previous splenectomy.",
    "This sample is a phase 2 clinical trial for rheumatoid arthritis, testing the drugs mdx-1100 and placebo in combination with methotrexate (MTX) for patients who meet specific inclusion criteria, including having active RA and being seropositive for rheumatoid factor.",
    "This sample is a phase 2 trial for type 2 diabetes, testing the drug incb013739 and metformin as a comparator, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer who have not responded to previous chemotherapy regimens, and it aims to evaluate the effectiveness of docetaxel in treating the disease. The inclusion criteria include histologically proven prostate adenocarcinoma, previous chemotherapy regimen failure, castration levels of testosterone, and specific laboratory requirements. The exclusion criteria include recent chemotherapy or anti-androgen therapy, concurrent treatment with other experimental drugs, and other serious illnesses or medical conditions.",
    "This sample is a phase 2 trial testing the drugs apixaban and placebo on patients receiving first- or second-line chemotherapy for various types of cancer, with eligibility criteria including no history of deep vein thrombosis or pulmonary embolism, and exclusion criteria such as uncontrolled hypertension and serious hemorrhage within 4 weeks of study entry.",
    "This sample is a phase 2 clinical trial for prostate cancer, testing the drug ipi-504, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with Fanconi anemia or severe aplastic anemia, testing the drug fludarabine, with specific eligibility criteria including diagnosis confirmation and availability of a matched stem cell donor.",
    "In this sample, the phase 2 trial is testing the drug dorzolamide-timolol-brimonidine for the treatment of primary open angle glaucoma and ocular hypertension, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for bladder cancer patients after transurethral resection of bladder tumor (TURBT), testing the effectiveness of mitomycin c and chemophase drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug tesofensine on overweight to obese subjects with BMI 28-35 kg/m\u00b2, and the eligibility criteria include being otherwise healthy, male aged 18-50, and able to comply with study procedures.",
    "This sample is a phase 2 trial for patients with acute myeloid leukemia (AML) who have received prior chemotherapy and have an HLA-identical sibling donor available. The study will test the effectiveness of cyclosporine, fludarabine, and mycophenolate mofetil as treatment options.",
    "This sample is a phase 1/phase 2 trial for patients diagnosed with myelofibrosis, polycythemia vera, or thrombocytosis, using the drug ruxolitinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for relapsing multiple sclerosis, testing the drug cdp323 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with mild to moderate allergic asthma, testing the drugs tpi-1020 and budesonide. The eligibility criteria include age, smoking history, and current treatment with inhaled bronchodilators. Exclusion criteria include certain medical conditions, pregnancy, recent corticosteroid use, and use of other asthma-related medications.",
    "This sample is a phase 2 trial for asthma, testing the drugs jnj 40929837, placebo, and montelukast, with inclusion criteria including mild atopic asthma and positive prick skin test to allergens.",
    "This sample is a phase 2 trial for patients with mesothelioma, testing the effectiveness of bevacizumab, cisplatin, and pemetrexed as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the treatment of atopic dermatitis using drugs such as gw870086 and fp 0.05%, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for patients with stage IIIB or IV non-small cell lung cancer, testing the drug bortezomid (Velcade\u00ae) as a potential treatment option. The eligibility criteria include no prior chemotherapy or therapy with systemic anti-tumor therapy, measurable disease as defined by RECIST criteria, and a performance status of 0-2.",
    "This sample is a phase 2 trial testing the effectiveness of methylphenidate and placebo in helping smokers between the ages of 18 to 65 quit smoking, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for breast cancer patients who have undergone surgery, and it aims to evaluate the effectiveness of ac regimen, cyclophosphamide, and doxorubicin hydrochloride in postmenopausal women with specific disease characteristics and patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with newly diagnosed muscle-invasive bladder cancer, testing the efficacy of neoadjuvant chemotherapy as a treatment option, with eligibility criteria including age, tumor type, and expression of hCG-\u03b2, while excluding patients with previous systemic chemotherapy or radiation for bladder cancer, certain allergies, concurrent immunosuppressive treatment, and certain infections.",
    "This sample is a phase 2 clinical trial for patients with metastatic malignant melanoma, testing the drug tanespimycin, and includes eligibility criteria such as measurable disease, performance status, and various medical conditions that exclude patients from participating in the trial.",
    "This sample is a phase 1/phase 2 trial for chronic pancreatitis, testing the drug human secretin, and includes eligibility criteria such as age, documented chronic pancreatitis, contraception requirements for females, negative pregnancy test, use of opioid analgesics, and exclusion criteria such as age, recent acute pancreatitis, severe cardiac or pulmonary disease, severe renal disease, previous adverse drug event to secretin, ongoing illicit drug or alcohol use, recent pancreatitis or pancreatic surgery, pregnancy or nursing, use of certain medications, and inability to give consent.",
    "This sample is a phase 2 clinical trial for the treatment of impetigo using topical minocycline foam, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with chronic prosthetic knee joint pain, testing the effectiveness of botulinum toxin A and normal saline as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the effectiveness of various drugs including linagliptin and sitagliptin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with recurrent non-small cell lung cancer, testing the effectiveness of triapine and gemcitabine hydrochloride drugs, with specific eligibility criteria including prior chemotherapy failure and certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with malignant glioma, testing the drug enzastaurin. The inclusion criteria include being at least 18 years old, having a recurrent brain tumor diagnosed by MRI or CT scan, and being able to swallow the tablets. The exclusion criteria include being pregnant or breastfeeding and having significant heart, liver, kidney, or psychiatric disease.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma and plasma cell neoplasm, testing the effectiveness of cyclophosphamide, dexamethasone, and lenalidomide as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 trial for the treatment of rheumatoid arthritis, testing the drugs birb 796 bs (low dose and high dose) and placebo, with eligibility criteria including a diagnosis of RA, failure of at least one DMARD, and specific RA activity criteria.",
    "This sample is a phase 1/phase 2 clinical trial for non-Hodgkin's lymphoma, testing the effectiveness of rituximab, dhap, tec, and autologous stem cell transplantation in patients aged 18-65 with first relapse or primary refractory disease, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug epoetin alfa in patients with chronic anemia, aged over 65, with specific eligibility criteria, and excluding patients with certain conditions or previous treatments.",
    "This sample is a phase 2 clinical trial for patients with pancreatic ductal adenocarcinoma, testing the drug inno-206, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for Burkitt lymphoma and atypical Burkitt lymphoma, testing the effectiveness of rituximab, cyclophosphamide, doxorubicin, vincristine, methotrexate, leucovorin, ifosfamide, etoposide, cytarabine, and mesna as treatment options, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with Parkinson's disease, testing the effectiveness of topiramate in reducing levodopa-induced dyskinesias. The inclusion criteria include specific diagnostic criteria and the presence of stable dyskinesias, while the exclusion criteria include various medical conditions and the use of certain medications.",
    "This sample is a phase 2 trial for patients with acute coronary syndrome, testing the drugs via-2291 and placebo, with inclusion criteria including recent ACS event and carotid or ascending aorta artery plaque inflammation, and exclusion criteria including renal insufficiency, cirrhosis, and heart failure.",
    "This sample is a phase 2 trial for HIV infections, testing the drugs rosiglitazone and placebo in patients with lipoatrophy who have been on thymidine sparing ARV for at least 24 weeks and prior thymidine NRTIs for at least 12 months, with exclusion criteria including diabetes, heart failure, liver disease, and hormonal therapies.",
    "This sample is a phase 2 clinical trial for patients with atrial fibrillation, testing the effectiveness of dronedarone and placebo in treating the condition, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for patients with hematologic malignancies, testing the drugs bortezomib (velcade), tacrolimus, and methotrexate, with eligibility criteria including high risk of complications after transplantation, mismatched donor, age 18 or older, performance status 0-2, life expectancy > 100 days, and exclusion criteria such as HIV infection, elevated bilirubin and AST levels, active hepatitis B or C, and prior stem cell transplant.",
    "This sample is a phase 2 clinical trial for rheumatoid arthritis, testing the drugs incb018424 and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 trial for the treatment of chronic hepatitis C, with the drugs being tested being bilb 1941 zw and placebo. The eligibility criteria include having a confirmed HCV genotype 1, minimal to mild liver fibrosis, and a high HCV RNA load.",
    "This sample is a phase 2 clinical trial for pre-menopausal women with ER+ breast cancer, testing the effectiveness of goserelin acetate in combination with radical surgery, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of multiple myeloma using carfilzomib, lenalidomide plus dexamethasone, and the eligibility criteria include newly diagnosed, previously untreated multiple myeloma patients with measurable disease and specific laboratory values, among other requirements.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic prostate cancer, testing the efficacy of metformin as a treatment option. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for the treatment of sepsis using intravenous gr270773- phospholipid emulsion, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast adenocarcinoma, testing the effectiveness of vinorelbine and lapatinib in combination with previous treatment regimens, including trastuzumab, for locally advanced or metastatic disease.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndrome (MDS) using the drug lbh589, and it includes eligibility criteria such as specific laboratory values, prior therapy restrictions, and exclusion criteria related to cardiac function and other medical conditions.",
    "This sample is a phase 2 trial testing the drugs beloranib and placebo on obese volunteers with a BMI between 30 and 50 kg/m2, with inclusion criteria including stable body weight and the allowance of type 2 diabetes mellitus.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndrome, testing the drug dn-101 (calcitriol), and the eligibility criteria include a diagnosis of low or intermediate-1 risk MDS, dependence on monthly blood transfusions, and no recent history of cancer, heart attack, stroke, or kidney stones.",
    "This sample is a phase 2 clinical trial for patients with advanced, persistent, or recurrent uterine leiomyosarcoma, testing the drug trabectedin, with specific eligibility criteria and prior concurrent therapy requirements.",
    "This sample is a phase 2 clinical trial for patients with pulmonary arterial hypertension (PAH), testing the drug tezosentan. The inclusion criteria include patients with PAH in specific subgroups, modified NYHA functional class II-III, and specific hemodynamic diagnosis. The exclusion criteria include patients with PAH in other subgroups, hypotensive patients, patients with certain medical conditions, and those who have received certain medications within 28 days of baseline.",
    "This sample is a phase 2 clinical trial for esophageal cancer, testing the drugs cisplatin, fluorouracil, and iressa, with eligibility criteria including specific disease characteristics, patient characteristics, and restrictions on prior concurrent therapy.",
    "This sample is a phase 2 trial for lupus erythematosus, systemic and lupus, testing the drug medi-545 and placebo, with eligibility criteria including meeting ACR classification criteria for SLE, positive ANA test, and specific BILAG index or SELENA-SLEDAI score, among others.",
    "This sample is a phase 2 clinical trial testing the effectiveness of paroxetine, a drug used to treat anxiety disorders, compared to a placebo, in patients diagnosed with Generalized Anxiety Disorder (GAD) according to DSM-IV criteria. The study has specific inclusion and exclusion criteria, and aims to evaluate the safety and efficacy of paroxetine in treating GAD.",
    "This sample is a phase 2 trial for relapsing-remitting multiple sclerosis (RRMS) using the drugs ain457 and placebo, with eligibility criteria not specified.",
    "This sample is a phase 2 clinical trial for patients with recurrent ovarian cancer or primary peritoneal cavity cancer, testing the efficacy of carboplatin as a platinum-based chemotherapy regimen, with specific eligibility criteria and patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with chronic lymphocytic leukemia (CLL), testing the effectiveness of the drugs ofatumumab and lenalidomide in combination with certain eligibility criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the effectiveness of different doses of pf-04937319 and glimepiride in combination with metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of alogliptin and metformin in combination with specific diet and exercise therapies, with inclusion and exclusion criteria related to metformin use and history of lactic acidosis.",
    "This sample is a phase 2 clinical trial for patients with overactive bladder, testing the effectiveness of tarafenacin 0.2 mg and tarafenacin 0.4 mg compared to a placebo, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma and renal insufficiency, testing the drug carfilzomib. The eligibility criteria include having relapsed or progressive disease, measurable disease levels, and meeting certain health requirements.",
    "This sample is a phase 2 clinical trial for the treatment of Rett syndrome using the drugs epi-743 and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with relapsed non-small cell lung cancer, testing the efficacy of pralatrexate and erlotinib as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial investigating the use of oxaliplatin, fludarabine, cytarabine, rituximab, and pegfilgrastim in patients with Richter's transformation, leukemia, or relapsed/refractory B-cell chronic lymphocytic leukemia, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with stage III or IVa-b squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx. The trial will test the effectiveness of cisplatin and panitumumab in combination with chemoradiation therapy.",
    "This sample is a phase 2 clinical trial for patients with stage III or IV squamous cell carcinoma of the head and neck, testing the drug docetaxel. Eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial testing the drug PS433540 for the treatment of hypertension in males and females aged 30-80 years, with specific blood pressure criteria for inclusion and exclusion, and requiring the use of contraception for sexually active participants.",
    "This sample is a phase 2 clinical trial for patients with operable stage IIIB non-small cell lung cancer, testing the effectiveness of taxotere/cisplatin as a treatment option. The eligibility criteria include specific disease characteristics, age range, performance status, hematopoietic, hepatic, renal, and cardiovascular requirements, as well as restrictions on prior and concurrent therapies.",
    "This sample is a phase 2 trial for patients with colorectal cancer who have failed prior regimens and have specific disease characteristics, and it will test the drug simvastatin as a potential treatment option.",
    "This sample is a phase 2 clinical trial for patients with unresectable stage III or stage IV non-small cell lung cancer (NSCLC), testing the effectiveness of erlotinib and satraplatin as systemic therapy. The eligibility criteria include age \u2265 70 years old, ECOG performance status 0-1, and no prior EGFR targeted therapy or platinum agent. Adequate hematological, hepatic, and renal function are also required. Exclusion criteria include concurrent invasive malignancy requiring ongoing therapy, metastatic brain or meningeal tumors, previous treatment with platinum-based chemotherapy or EGFR targeting agents, and certain medical conditions such as peripheral neuropathy, hearing loss, and obstructive pulmonary disease.",
    "This sample is a phase 2 trial for the treatment of severe congenital hemophilia A with rituximab, where participants must have a historical inhibitor titer to factor VIII of at least 5 BU/mL and meet various inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for kidney transplantation, testing the drugs alefacept, tacrolimus, basiliximab, mycophenolate mofetil, and corticosteroids, with inclusion and exclusion criteria specified.",
    "This sample is a phase 2 clinical trial for the treatment of myasthenia gravis, testing the drugs eculizumab and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1/phase 2 clinical trial for patients with locally advanced or metastatic pancreatic adenocarcinoma, testing the efficacy of capecitabine and PHY906 drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with relapsed/refractory multiple myeloma, testing the drug syb l-0501. The eligibility criteria include specific disease progression criteria, measurable lesions, prior chemotherapy history, organ function requirements, and age range. Exclusion criteria include infections, serious complications, cardiac disease, gastrointestinal symptoms, and other medical conditions.",
    "In this phase 2 trial, the combination therapy of irinotecan with 5-fu, leucovorin plus bevacizumab will be tested in the neoadjuvant setting for patients with colorectal neoplasms and liver neoplasms, who meet the specified inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for adult patients with acute myelogenous leukemia (AML) and unfavorable risk cytogenetics, testing the drug decitabine. The inclusion criteria include patients in first or subsequent complete response (CR) or complete remission without full platelet recovery (CRp), with a performance status of 0, 1, or 2, and adequate organ function. The exclusion criteria include pregnancy or lactation, HIV positivity, active and uncontrolled disease/infection, inability or unwillingness to sign the consent form, and no other investigational therapy within the past 14 days.",
    "This sample is a phase 2 trial testing the effectiveness of alvimopan in treating opioid-induced constipation in cancer patients who are on opioid therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) and it aims to evaluate the effectiveness of cisplatin, docetaxel, and pemetrexed disodium as treatment options. The eligibility criteria include specific staging criteria for NSCLC, performance status, blood counts, organ function, and absence of certain medical conditions. Prior chemotherapy or radiotherapy for NSCLC is not allowed, and patients should not be concurrently participating in another therapeutic investigational study.",
    "This sample is a phase 2 clinical trial for metastatic breast cancer, testing the drugs wx-671 and placebo, with eligibility criteria including age, confirmed diagnosis, HER2 status, performance status, and normal organ function.",
    "This sample is a phase 2 clinical trial for patients with epithelial ovarian cancer, testing the drug voreloxin injection. The eligibility criteria include having completed at least one Platinum Based Therapy regimen and evidence of platinum-resistant disease.",
    "This sample is a phase 2 clinical trial for patients with myasthenia gravis, testing the efficacy of three different drugs (placebo, 250 mg ck-2017357, and 500 mg ck-2017357) in improving muscle weakness, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for the treatment of migraine headaches, testing the effectiveness of drugs such as placebo, esl 1200 mg, and esl 800 mg, with specific eligibility criteria including the number and frequency of migraine attacks, and exclusion criteria such as hypersensitivity to the drugs or other medical conditions that may compromise the subject's safety.",
    "This phase 2 trial is testing the drug docetaxel in female patients with stage IV HER2-negative breast cancer, who have not received prior chemotherapy for metastatic breast cancer, and meet various eligibility criteria.",
    "This sample is a phase 2 trial for the drug bicifadine in patients with diabetic peripheral neuropathy, with specific inclusion and exclusion criteria provided.",
    "This sample is a phase 2/phase 3 trial testing the drugs telmisartan and bisoprolol versus placebo in patients with diabetes mellitus, heart failure, and coronary artery disease. The eligibility criteria include age > 18 years, known diabetes mellitus > 6 months, increased Nt-proBNP above 125pg/ml, and informed consent. Exclusion criteria include other diseases with a life expectancy below 1 year, chronic infection or malignant disease, women in childbearing age without contraceptive, history of cardiac disease, systemic cortisone treatment, and patients on chronic or acute hemodialysis, ultrafiltration, or peritoneal dialysis.",
    "This sample is a phase 2 trial for the treatment of staphylococcal skin infection, using the drugs td-1792 and vancomycin, with specific inclusion and exclusion criteria related to the severity of the infection and the patient's medical history.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the effectiveness of docetaxel as first-line chemotherapy, with specific eligibility criteria including age, disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for breast cancer patients with specific icd-10 codes, testing the effectiveness of gemcitabine, paclitaxel, and bevacizumab in treating the disease, with detailed inclusion and exclusion criteria provided.",
    "This sample is a phase 2 trial for patients with metastatic renal cell carcinoma, testing the drug bevacizumab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with hypercholesterolemia, testing the effectiveness of drugs ezetimibe and eprotirome in reducing LDL-cholesterol levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with relapsed or refractory lymphoma, specifically DLBCL and follicular lymphoma, testing the drug mgcd0103. The eligibility criteria include measurable disease, prior treatment failure, related disease symptoms, ECOG performance status of 0 or 1, and specific laboratory requirements. Exclusion criteria include active cancer, pregnancy or lactation, uncontrolled illness or infections, pericardial disease, significant cardiac abnormalities, and other medical conditions that may interfere with the study.",
    "This sample is a phase 2 trial testing the drug saf312 and placebo for patients with neurogenic detrusor overactivity due to spinal cord lesions, who are inadequately managed by antimuscarinic medication and have a cystometric bladder capacity of max. 400 mL.",
    "This sample is a phase 2 clinical trial for knee osteoarthritis, testing the drugs sar113945 and placebo, with specific inclusion and exclusion criteria based on diagnosis and patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with lung cancer, specifically non-small cell lung cancer (NSCLC), who have failed at least one front-line metastatic NSCLC chemotherapy regimen. The drug being tested is sorafenib, and the eligibility criteria include having a diagnosis of pathologically confirmed NSCLC, measurable tumor, adequate hematologic and hepatic function, and being disease-free from a previously treated malignancy for greater than two years.",
    "This sample is a phase 2 clinical trial for the treatment of ankylosing spondylitis, testing the drugs sarilumab and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for patients with type 2 diabetes, testing the drug aliskiren to treat incipient or overt diabetic nephropathy, with specific eligibility criteria including age, BMI, blood pressure, and medication history.",
    "This sample is a phase 2 clinical trial for the treatment of atopic dermatitis using fluocinonide cream, targeting patients with mild to severe atopic dermatitis, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of gastroparesis using the drug GSK962040, with eligibility criteria including age, mechanical ventilation, nasogastric tube feeding, and liver function, while excluding subjects with certain medical conditions or who have received specific medications.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the effectiveness of sagopilone (zk 219477) in combination with other drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer (NSCLC) patients who have not received prior chemotherapy, molecular therapy, immunotherapy, biological therapy, or radiotherapy. The study will test the effectiveness of pemetrexed, cisplatin, and gefitinib as treatment options.",
    "This sample is a phase 2 trial for patients with colorectal adenocarcinoma and liver metastases, testing the effectiveness of perioperative chemotherapy in treating stage IV colorectal cancer isolated to the liver.",
    "This sample is a phase 2 clinical trial for patients with colorectal cancer, testing the drugs capecitabine and celecoxib, with specific eligibility criteria including disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 2 clinical trial for postmenopausal women with HER2-positive, ER-positive and/or PR-positive breast cancer, testing the efficacy of Faslodex (fulvestrant) as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with asthma, testing the efficacy of tiotropium bromide as an add-on therapy to inhaled corticosteroids, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small-cell lung carcinoma, testing the drugs chr-2797 (tosedostat) and erlotinib, with eligibility criteria including confirmed NSCLC, disease progression after platinum-based chemotherapy, and specific laboratory values within normal ranges.",
    "This sample is a phase 2 clinical trial for patients with colorectal cancer, testing the drug romidepsin, and includes eligibility criteria such as previous chemotherapy regimens, performance status, and various medical conditions.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of the drugs bortezomib, cyclophosphamide, and dexamethasone in treating relapsed or refractory disease after initial chemotherapy. The inclusion criteria include age \u2265 18 years, stage II-III multiple myeloma, and a WHO performance status of 0-2, among others. Exclusion criteria include previous treatment with bortezomib and pre-existent polyneuropathy.",
    "This sample is a phase 2 clinical trial for patients with metastatic or unresectable colorectal cancer, testing the effectiveness of the drug celecoxib in combination with cetuximab, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for female patients with breast cancer who have CNS progression after radio-surgery or whole brain radiotherapy, and it aims to evaluate the efficacy of capecitabine (Xeloda) in treating these patients.",
    "This sample is a phase 1/phase 2 clinical trial for ovarian cancer patients who have previously received platinum-based chemotherapy, and it involves the drugs lenvatinib, carboplatin, and gemcitabine. The eligibility criteria include specific age, cancer type, relapse criteria, performance status, and various laboratory values.",
    "This sample is a phase 2 clinical trial for patients with relapsed, refractory, or previously untreated low-grade non-Hodgkin lymphoma, testing the effectiveness of mitoxantrone/cyclophosphamide, fludarabine, rituximab, and gm-csf as a treatment option. The eligibility criteria include specific subtypes of lymphoma, while exclusion criteria include prior treatment with purine analogs and inability to confirm the diagnostic/histologic subtype.",
    "This sample is a phase 2 trial testing the drugs pentostatin and alemtuzumab for the treatment of various T-lymphoid malignancies, including T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, with specific eligibility criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the drug fulvestrant. The eligibility criteria include having received an aromatase inhibitor, having measurable or nonmeasurable disease, and meeting certain patient characteristics such as being post-menopausal and having specific blood test results.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drug rosiglitazone, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with pulmonary arterial hypertension (PAH) who meet specific inclusion criteria, including having a documented hemodynamic diagnosis of PAH and being in modified NYHA functional class II-III. The drug being tested is act-050089, and the study aims to evaluate its effectiveness in treating PAH.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the drugs docetaxel and capecitabine, with inclusion criteria including histologically confirmed breast carcinoma and early stage breast cancer, and exclusion criteria including prior chemotherapy or radiation therapy for breast cancer.",
    "This sample is a phase 2 clinical trial for patients with ovarian cancer, testing the drug temsirolimus. The eligibility criteria include having received first-line platinum-based chemotherapy, documented CA125 progression, and no evidence of measurable or evaluable disease.",
    "This sample is a phase 2 clinical trial for patients with advanced ovarian, peritoneal, or fallopian tube cancer, testing the efficacy of gemcitabine and pertuzumab compared to a placebo, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of bi 1744 cl/tiotropium bromide fixed dose combination and tiotropium bromide as treatments, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs GSK961081, salmeterol, and placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 trial for patients with neoplasms and pain, testing the effectiveness of methadone and morphine in treating moderate to severe cancer-related pain, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for HIV-1 infection, testing the efficacy of pro 140 (humanized monoclonal antibody to ccr5) compared to a placebo comparator, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for attention deficit disorder with hyperactivity, testing the effectiveness of lobeline sulfate, methylphenidate hcl, and placebo in participants aged 21 to 45 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for gastrointestinal cancer patients, testing the efficacy of amg 386 and cisplatin/capecitabine combination therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug cetuximab for patients with histologically proven squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of chronic hepatitis C, testing the drugs gs-5885, gs-9451, ribavirin tablet, and gs-9451 placebo, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drug placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the drug cetuximab 5mg/ml. The eligibility criteria include age, diagnosis, tumor presence, functional status, life expectancy, and previous treatment history. Exclusion criteria include certain medical conditions, prior treatments, and participation in other clinical trials.",
    "This sample is a phase 2 clinical trial for patients with hormone refractory prostate cancer, testing the effectiveness of the drugs sargramostim, docetaxel, and prednisone, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of carboplatin and pemetrexed as treatment options, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for the treatment of rheumatoid arthritis using the drug amg 108 and placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 trial for patients with relapsing-remitting multiple sclerosis (MS) and includes eligibility criteria such as confirmed relapses, disability level, and neurologically stable patients. The trial will test the efficacy of ofatumumab and placebo as potential treatments for MS.",
    "This sample is a phase 2 clinical trial for patients with malignant mesothelioma, testing the drug bortezomib. The eligibility criteria include confirmed diagnosis of mesothelioma, certain treatment history requirements, and specific patient characteristics. Prior concurrent therapy restrictions apply, and patients must not have received bortezomib or extensive radiation therapy, systemic chemotherapy, or other antineoplastic therapy within 4 weeks before enrollment.",
    "This sample is a phase 2 trial testing the efficacy of zoledronic acid versus placebo in patients with low back pain, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced ovarian cancer and positive BRCA1 or BRCA2 status, testing the effectiveness of the drugs azd2281 and liposomal doxorubicin in treating the disease.",
    "This sample is a phase 2 clinical trial for osteoarthritis, testing the effectiveness of the drug pf-04191834 and naproxen in comparison to placebos, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with metastatic or recurrent colorectal cancer, testing the effectiveness of gemcitabine hydrochloride and oxaliplatin as a second-line chemotherapy regimen, with specific eligibility criteria for disease characteristics and patient characteristics.",
    "This sample is a phase 2 trial for patients with Major Depressive Disorder, testing the effectiveness of drugs such as duloxetine and escitalopram, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with clear cell renal cell carcinoma who have experienced disease progression on sorafenib or sunitinib. The trial will test the efficacy of perifosine as a treatment option.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C, testing the efficacy of interferon-alpha lozenges and placebo lozenges as treatment options, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for HIV infections, testing the drugs pro 140 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with oestrogen receptor negative primary breast cancer, testing the drug gefitinib, and includes specific eligibility criteria for participation.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic squamous cell carcinoma or adenocarcinoma of the lung, testing the drugs axl1717 and docetaxel, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed or refractory acute lymphoblastic leukemia, testing the efficacy of vincristine sulfate liposomes injection and dexamethasone as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the treatment of hyperlipidemia using the drug ezetimibe, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial that includes patients with various diseases such as acute myeloid leukemia, chronic lymphocytic leukemia, and non-Hodgkin lymphoma, and the study aims to evaluate the effectiveness of drugs like rituximab, mycophenolate mofetil, and tacrolimus in allogeneic hematopoietic cell transplantation.",
    "This phase 2 trial aims to evaluate the efficacy of single low dose cyclophosphamide in patients with unresectable stage III non-small-cell lung carcinoma who have undergone primary therapy of chemo-radiation treatment, with specific eligibility criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with recurrent uterine corpus carcinoma, testing the drug gefitinib, and includes eligibility criteria such as prior chemotherapy, measurable lesions, and specific laboratory values.",
    "This phase 2 trial aims to evaluate the effectiveness of levalbuterol hfa mdi and racemic albuterol in treating asthma and bronchoconstriction in children aged 6 to 11 years, with specific inclusion and exclusion criteria outlined in the study.",
    "This sample is a phase 2/phase 3 trial for multiple sclerosis (MS) patients with primary progressive MS (PPMS) and includes eligibility criteria, such as disease duration, EDSS score, and CSF specimen analysis. The study will test the efficacy of rituximab and placebo as potential treatments for PPMS.",
    "This sample is a phase 2 clinical trial for patients with stage IV melanoma cancer, testing the efficacy of disulfiram and chelated zinc as a second-line therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic renal cell carcinoma (RCC) testing the effectiveness of the drugs everolimus and bevacizumab, with specific inclusion and exclusion criteria, including no more than 2 prior systemic therapies and no prior treatment with bevacizumab or any mTOR inhibitor.",
    "This sample is a phase 2 clinical trial for patients with non-operable and/or metastatic soft tissue sarcoma, testing the effectiveness of the drugs doxorubicin and trabectedin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with radioiodine-refractory metastatic or unresectable locally-advanced thyroid cancer, testing the drug ag-013736, and excluding patients with thyroid lymphoma or previous treatment with anti-angiogenesis agents, as well as those with certain cardiovascular conditions.",
    "This sample is a phase 2 clinical trial for patients with unresectable Stage IIIB, IV, or recurrent bronchoalveolar carcinoma (BAC) involving the lungs bilaterally or unilaterally, testing the drug paclitaxel as a treatment option. The eligibility criteria include specific disease characteristics, age range of 18 to 75, ECOG performance status of 0-2, and various medical requirements such as hematopoietic, hepatic, renal, and cardiovascular conditions. Prior concurrent therapies are also specified.",
    "This sample is a phase 2 clinical trial for patients with unresectable or metastatic kidney cancer, testing the effectiveness of erlotinib hydrochloride and sunitinib malate as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and restrictions on prior and concurrent therapies.",
    "This sample study is a phase 1/phase 2 trial investigating the use of aliskiren, a drug used to treat hypertension, in patients with type 2 diabetes and incipient or overt nephropathy. The study aims to assess the safety and efficacy of aliskiren in reducing blood pressure and improving kidney function in these patients.",
    "This sample is a phase 2 trial for patients with chronic genotype 1 hepatitis C virus (HCV) infection, testing the efficacy of drugs such as tmc435, psi-7977 (gs7977), and ribavirin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of carboplatin, nitroglycerin, and paclitaxel as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 trial for patients with Parkinson's disease and movement disorder syndrome, testing the drug istradefylline (kw-6002) in patients who meet specific inclusion criteria and do not have certain exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of indacaterol and placebo in Japanese individuals aged 40 to 75 years old with a smoking history of at least 20 pack years.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the drugs d9421-c (9mg and 15mg) and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced non-clear cell renal cell carcinoma, testing the efficacy of pemetrexed and gemcitabine as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with graft versus host disease (GvHD) who have failed corticosteroid treatment, and it aims to evaluate the effectiveness of pentostatin as a potential therapy.",
    "This sample is a phase 1/phase 2 clinical trial for patients with refractory melanoma, testing the drug tki258, and includes eligibility criteria such as confirmed diagnosis, measurable disease, age requirement, baseline laboratory requirements, and exclusion criteria such as concurrent therapy with other investigational agents, uncontrolled central nervous system metastases, impaired cardiac function, recent therapy with chemotherapy or targeted therapy, and other medical or psychiatric conditions that may increase risk or interfere with study results.",
    "This sample is a phase 2 clinical trial for metastatic colorectal cancer, testing the effectiveness of oxaliplatin, capecitabine, and bevacizumab as treatment options, with specific eligibility criteria for participants.",
    "This sample is a phase 2 trial for rheumatoid arthritis, testing the drugs placebo and amg 719, with eligibility criteria including being diagnosed with rheumatoid arthritis, having a disease duration of at least 24 weeks, receiving methotrexate, and having no recent history of substance or alcohol abuse.",
    "This sample is a phase 1/phase 2 trial testing the drug imatinib mesylate for the treatment of recurrent melanoma, stage III melanoma, stage IV melanoma, and unspecified adult solid tumors, with specific eligibility criteria including no CNS disease, ECOG performance status 0-1, and various laboratory values within normal limits.",
    "This sample is a phase 2/phase 3 trial testing the drug sertraline for the treatment of depressive disorder, major, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with peripheral T-cell non-Hodgkin's lymphoma, testing the effectiveness of cisplatin, etoposide, gemcitabine, and methylprednisolone as treatment options, with specific eligibility criteria and patient characteristics outlined.",
    "This sample is a phase 2 clinical trial for patients with aggressive non-Hodgkin lymphoma, testing the effectiveness of gemcitabine hydrochloride, lenalidomide, and oxaliplatin as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 clinical trial for the drug lde225, which is being tested for the treatment of locally advanced and metastatic basal cell carcinoma. The eligibility criteria include having adequate bone marrow, liver, and renal function, and excluding patients who have had major surgery within 4 weeks, are unable to take oral drugs, have concurrent medical conditions, neuromuscular disorders, or are on concurrent treatment with other anti-neoplastic agents. Pregnant or nursing women, women of childbearing potential not using contraception, and fertile males not using condoms are also excluded.",
    "This phase 2 trial is testing the drug cilengitide for the treatment of recurrent adult brain tumors, specifically glioblastoma multiforme, in patients who have failed prior radiotherapy and require surgical tumor removal.",
    "This sample is a phase 2 trial for patients with coronary heart disease, testing the drugs dalcetrapib and placebo, with inclusion criteria being patients who have completed treatment on study NC19453 and exclusion criteria being any significant lymph node abnormalities at the end of study NC19453.",
    "This phase 2 trial is testing the effectiveness of tipranavir, ritonavir, and saquinavir in treating HIV infections in patients who have experienced clinical failure while on a current PI-containing regimen, have been exposed to the current PI therapy for at least 6 months, and have stable CD4+ cell count and acceptable baseline organ function.",
    "This sample is a phase 2 clinical trial for adult acute myeloid leukemia (AML) patients, testing the effectiveness of vorinostat, a drug used to treat relapsed or untreated AML, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 clinical trial for the drug YM178, which is being tested for its effectiveness in treating overactive bladder (OAB). The inclusion criteria include patients over 18 years old who have been suffering from OAB for more than 3 months, while pregnant and breastfeeding women are excluded from the study.",
    "This sample is a phase 2/phase 3 trial investigating the use of sodium bicarbonate and sodium chloride in cardiac surgical patients with risk factors for postoperative acute kidney injury. The trial includes specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with lung cancer, testing the effectiveness of gemcitabine hydrochloride and imatinib mesylate as treatment options, with specific eligibility criteria and prior concurrent therapy requirements.",
    "This sample is a phase 2 clinical trial for patients with recurrent glioblastoma multiforme, testing the effectiveness of bevacizumab (Avastin) and fotemustine as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with primary open angle glaucoma or ocular hypertension, testing the effectiveness of different doses of pf-04217329 and latanoprost in reducing intraocular pressure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with cystic fibrosis-related diabetes, testing the effectiveness of sitagliptin and placebo in treating the disease. The eligibility criteria include being 19 years or older and having cystic fibrosis-related diabetes with or without fasting hyperglycemia.",
    "This sample is a phase 1/phase 2 trial for advanced breast cancer patients with HER2 positive breast cancer, testing the drugs hki-272 and trastuzumab, and includes eligibility criteria such as specific disease stage, prior treatment history, and adequate organ function.",
    "This sample is a phase 2 trial for major depressive disorder, testing the drugs alks 5461 and placebo, with inclusion criteria including a diagnosis of major depressive episode, history of inadequate response to antidepressant treatments, and exclusion criteria including certain psychiatric disorders and recent psychotherapy.",
    "This sample is a phase 2 trial for patients with clear cell renal cell carcinoma, recurrent renal cell cancer, or stage IV renal cell cancer, testing the drug cediranib maleate, with specific eligibility criteria including measurable disease, performance status, blood counts, organ function, and exclusion of certain medical conditions.",
    "This sample is a phase 2 trial for patients with histologically proven adenocarcinoma, testing the drugs pemetrexed and gemcitabine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of lymphoma using cyclophosphamide, with specific eligibility criteria including histologically confirmed stage III or IV indolent B-cell lymphoma and no prior therapy for lymphoma.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the combination of lapatinib and metformin as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with nasopharyngeal cancer, testing the effectiveness of gemcitabine, carboplatin/cisplatin, and erlotinib as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for lung cancer patients, testing the effectiveness of cisplatin, etoposide, and sorafenib tosylate drugs, with specific eligibility criteria including no untreated brain metastases and certain patient characteristics.",
    "This sample is a phase 2 trial for diabetes, testing the drug vi-0521, and includes inclusion and exclusion criteria such as completing a previous trial, using contraception, and being compliant with study procedures.",
    "This sample is a phase 2 clinical trial for patients with newly diagnosed, localized adenocarcinoma of the prostate, testing the drug everolimus. The eligibility criteria include specific disease characteristics and patient characteristics, and there are various exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for lung adenocarcinoma patients who have received treatment with erlotinib, testing the efficacy of erlotinib with cetuximab as a potential treatment option.",
    "This sample is a phase 2 trial for patients with cerebral infarction, testing the efficacy of vorapaxar and aspirin as potential treatments, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 clinical trial for patients with recurrent epithelial ovarian cancer, primary peritoneal carcinomatosis, or fallopian tube cancer, testing the drug decitabine. The eligibility criteria include having platinum-resistant or platinum refractory disease, measurable or detectable disease, being at least 18 years old, and having acceptable organ function.",
    "This sample is a phase 1/phase 2 trial for patients with unresectable locally advanced or metastatic non-small-cell lung carcinoma (NSCLC). The drug being tested is patupilone, and the eligibility criteria include prior treatment with a platinum-containing regimen, age \u226518 years, performance status of 0-1, and specific hematologic and blood chemistry values. Patients with brain metastases are eligible if they meet certain criteria.",
    "This sample is a phase 2 trial for patients with liver cancer (HCC) who have previously been treated with sorafenib, and it aims to evaluate the effectiveness of lenalidomide as a treatment option. The eligibility criteria include having confirmed HCC, AFP > 200 ng/ml, radiologically assessable tumor, and meeting certain laboratory test results. Additionally, females of childbearing potential must have a negative pregnancy test and agree to use two methods of birth control. The exclusion criteria include serious medical conditions, pregnancy or breastfeeding, hypersensitivity to thalidomide, and concurrent use of other anti-cancer agents or treatments.",
    "This sample is a phase 2 trial for rheumatoid arthritis (RA) patients with active disease, testing the drug nnc0142-0002 in combination with methotrexate (MTX) as a potential treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer, testing the drugs enzastaurin, pemetrexed, docetaxel, and carboplatin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with migraine without aura or migraine with aura, testing the effectiveness of tonabersat and placebo in reducing the frequency of migraine attacks.",
    "This sample is a phase 2/phase 3 trial for patients with inoperable advanced gastric adenocarcinoma, testing the efficacy of the drugs s-1 + irinotecan and irinotecan as second-line chemotherapy after first-line treatment with S-1 alone, S-1 + Cisplatinum, or S-1 + taxane.",
    "This sample is a phase 1/phase 2 trial for pediatric patients with relapsed or refractory acute lymphoblastic leukemia (ALL), testing the efficacy of drugs such as abt-751, dexamethasone, peg-asparaginase, doxorubicin, cytarabine, methotrexate, cyclophosphamide, and 6-thioguanine, with specific eligibility criteria including age, diagnosis, prior therapy, reproductive function, and exclusion criteria such as drug allergies, renal and liver/pancreatic function, cardiac function, and active infections.",
    "This sample is a phase 2 clinical trial for patients with breast cancer (ICD-10 codes: C79.81, D24.1, D24.2, D24.9, D49.3, C44.501, D48.60) who overexpress ErbB2 and have measurable or clinically evaluable skin disease. The study aims to evaluate the efficacy of lapatinib, paclitaxel, 5-fluorouracil (5-fu), epirubicin, and cyclophosphamide in treating inflammatory breast cancer (IBC) and identify pathways of therapy resistance through biopsies.",
    "This sample is a phase 2 clinical trial for patients with newly diagnosed primary acute myeloid leukemia (AML), testing the effectiveness of a combination of drugs including asparaginase, busulfan, cyclophosphamide, and others, with specific eligibility criteria for patients' disease characteristics, age, performance status, and organ function.",
    "This sample is a phase 2 trial for patients with prostate cancer, testing the drugs abiraterone acetate and prednisolone, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is investigating the efficacy of brostallicin and doxorubicin hydrochloride in treating various types of sarcoma, including liposarcoma, fibrosarcoma, leiomyosarcoma, and others, in patients with relapsed, refractory, and/or metastatic disease.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the efficacy of growth hormone and corticosteroid drugs in children aged 5 years and above, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with unresectable stage IV malignant melanoma, testing the effectiveness of everolimus and temozolomide as potential treatments.",
    "This sample is a phase 2 clinical trial for the treatment of vulvodynia and vulvar vestibulitis using the drug pregabalin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for the drug tak-442 in patients with venous thromboembolism, with eligibility criteria including being scheduled for knee replacement surgery and not having any contraindications or previous exposure to the study drug or certain medications that may increase bleeding risk.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs pf-04494700 (low dose and high dose) and a placebo comparator, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic melanoma, testing the drug bevacizumab as a first-line treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with kidney cancer who have progressed after receiving a multikinase inhibitor regimen, and it aims to evaluate the efficacy of talabostat mesylate as a treatment option. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 2 clinical trial testing the use of high intensity focused ultrasound (HIFU) in combination with thermodox for the treatment of painful bone metastases, breast carcinoma, non-small cell lung cancer, small cell lung cancer, and adenocarcinoma. The eligibility criteria include histological confirmation of the specified cancers, presence of bone metastases in specific locations, and failure or ineligibility for external beam radiation therapy. Exclusion criteria include prior high doses of doxorubicin, low left ventricular ejection fraction, significant cardiac history, brain metastases, contraindication for MR imaging, and known intolerance or allergy to MRI contrast agents.",
    "This sample is a phase 2 clinical trial for patients with locally advanced unresectable or metastatic kidney cancer, testing the effectiveness of gemcitabine hydrochloride and irinotecan hydrochloride as treatment options, with specific eligibility criteria for patients' disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 2 clinical trial for patients with advanced hepatocellular carcinoma, testing the combination of sorafenib and gemcitabine as a treatment option, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with stage IIIA or IIIB non-small-cell lung cancer (NSCLC), testing the effectiveness of docetaxel and carboplatin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial testing the drugs bc-3781 and vancomycin for the treatment of bacterial infections, specifically acute bacterial skin and skin structure infections, with inclusion criteria of patients over 18 years old and exclusion criteria of uncomplicated skin and skin structure infections.",
    "This sample is a phase 2 clinical trial for patients with bipolar I disorder, testing the effectiveness of eslicarbazepine acetate at different doses compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with coronary heart disease, testing the drugs placebo and dalcetrapib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with systemic sclerosis, focusing on the treatment of skin fibrosis using the drug bosentan (tracleer), with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for fibromyalgia, testing the effectiveness of drugs such as droxidopa, carbidopa, and droxidopa/carbidopa, as well as a placebo, on patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of benign prostatic hypertrophy (BPH) using the drugs ozarelix/placebo. The eligibility criteria include age, clinical signs and symptoms of BPH, IPSS score, peak urinary flow rate, and agreement not to use other BPH treatments. Exclusion criteria include a history of prostate cancer, prior surgeries or radiation, and certain bladder volume and residual urine volume measurements.",
    "This phase 2 trial aims to evaluate the efficacy of zoledronate and atorvastatin in patients with renal cell carcinoma and bone metastases, who have controlled impending complications and meet certain eligibility criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug nesiritide versus placebo in subjects with heart failure or asymptomatic systolic dysfunction, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic kidney disease, testing the drugs ly2623091 and eplerenone, with eligibility criteria including specific renal function criteria, stable blood pressure medication use, and acceptable serum potassium levels.",
    "This sample is a phase 2 trial for patients with lymphoma, testing the drugs sgn-40, placebo, rituximab, etoposide, carboplatin, and ifosfamide, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the drugs ldp-02 and placebo, with inclusion criteria including age 18-80, Crohn's disease of at least 6 months' duration, and a CDAI score between 220 and 400. Exclusion criteria include current GI infection, serious underlying diseases, impaired liver or renal function, and previous or current treatment with a monoclonal antibody.",
    "This sample is a phase 2 clinical trial for patients with refractory colorectal cancer, testing the drug everolimus, targeting those with mutations in the PI3K gene, and requiring specific eligibility criteria for participation.",
    "This sample is a phase 2 trial for patients with chronic lymphocytic leukemia (CLL), testing the effectiveness of ofatumumab and fludarabine in treating the disease, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with relapsed or non-responsive diffuse large B-cell non-Hodgkin's lymphoma, testing the effectiveness of bortezomib, dexamethasone, ifosfamide, mesna, cisplatin, etoposide, and rituximab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for atopic dermatitis, testing the efficacy of different doses of the drug jnj-26113100, with eligibility criteria including a negative pregnancy test for female participants and good general health for all participants.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndrome (MDS) who are transfusion-dependent and not responding to erythropoietin stimulating agents (ESA). The study will test the drugs lbh589 and epoetin alfa to evaluate their effectiveness in improving the condition of patients with MDS.",
    "This sample is a phase 2 clinical trial for patients with newly diagnosed primary CNS lymphoma, testing the effectiveness of a combination of drugs including cytarabine, etoposide, leucovorin calcium, methotrexate, and temozolomide, with specific eligibility criteria for patients including age, performance status, hematopoietic and hepatic function, and prior concurrent therapy.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of bevacizumab, pemetrexed, and carboplatin as treatment options, with specific eligibility criteria for participation.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung carcinoma, lung neoplasms, lung cancer, and respiratory tract neoplasms, testing the drug gefitinib. The eligibility criteria include Asian ethnicity, specific performance status, and confirmation of the disease, among others.",
    "This sample is a phase 2 trial for patients with metastatic or recurrent breast cancer, testing the efficacy of celecoxib in combination with prior chemotherapy, with specific eligibility criteria including prior treatment history, disease characteristics, and patient characteristics.",
    "This phase 2 trial aims to evaluate the efficacy and safety of irinotecan hydrochloride, gefitinib, leucovorin calcium, and fluorouracil in patients with advanced or recurrent adenocarcinoma of the colon or rectum, who meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for major depression, testing the drugs cimicoxib and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with recurrent prostate cancer, testing the effectiveness of pazopanib hydrochloride, leuprolide acetate, and goserelin acetate in patients who have undergone definitive local therapy for prostate cancer and have progressive disease.",
    "This sample is a phase 2 clinical trial for patients with mantle cell lymphoma, testing the effectiveness of a combination of drugs including bortezomib, cyclophosphamide, doxorubicin hydrochloride, vincristine, and dexamethasone, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 1/phase 2 clinical trial for patients with adenocarcinoma of the pancreas, recurrent pancreatic cancer, or stage IV pancreatic cancer, testing the drugs vismodegib and gemcitabine hydrochloride, with specific eligibility criteria including age, performance status, blood counts, liver function, and contraceptive use.",
    "This sample is a phase 2/phase 3 trial for patients with Parkinson's disease and excessive daytime somnolence, testing the effects of caffeine and placebo on sleepiness levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for HIV-1 infection, testing the drug FTC/RPV/TDF, with eligibility criteria including undetectable HIV-1 RNA levels, no known resistance to study agents, normal ECG and liver function, and the use of highly effective contraception methods.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory ovarian, fallopian tube, or peritoneal cancer, testing the drug vandetanib, with specific eligibility criteria including age, disease confirmation, measurable disease, performance status, and organ function.",
    "This sample is a phase 2/phase 3 trial for lupus erythematosus and lupus nephritis, testing the effectiveness of infliximab compared to placebo in patients with biopsy-proven membranous glomerulonephritis, who have proteinuria despite adequate therapy with ACE inhibitors and steroids.",
    "This sample is a phase 2 clinical trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the effectiveness of the drugs nva237, placebo, and tiotropium in improving lung function. The inclusion criteria include age, smoking history, and specific lung function measurements, while the exclusion criteria include pregnancy, recent respiratory tract infection, and certain medical conditions.",
    "This sample is a phase 2/phase 3 trial for hepatocellular carcinoma, testing the drugs menatetrenone and placebo, with eligibility criteria including age, performance status, diagnosis confirmation, liver function, and exclusion criteria such as extrahepatic metastasis and previous treatments for hepatocellular carcinoma or hepatitis.",
    "This sample is a phase 2 trial for the treatment of rheumatoid arthritis using drugs such as apremilast and placebo, with specific eligibility criteria including disease duration, joint counts, lab requirements, and previous treatment history.",
    "This sample is a phase 2 clinical trial for the drug erlotinib in patients with unresectable locally advanced or metastatic non-small cell lung cancer (NSCLC), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with sarcoidosis and pulmonary arterial hypertension, testing the effectiveness of bosentan and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for asthma patients, testing the drugs gw685698x and placebo, with eligibility criteria including age, gender, contraception use, asthma diagnosis, severity of disease, and current anti-asthma therapy.",
    "This sample is a phase 1/phase 2 clinical trial for patients with high-risk myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML), testing the drug mgcd0103, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with head and neck cancer, testing the drug fenretinide. The eligibility criteria include specific disease characteristics and patient characteristics, and prior therapy toxicities are taken into account.",
    "This sample is a phase 1/phase 2 trial for patients with sickle cell disease and pulmonary hypertension, testing the effectiveness of hydroxyurea in reducing tricuspid regurgitant jet velocity.",
    "This sample is a phase 2 trial for breast cancer patients, testing the efficacy of cyclophosphamide, docetaxel, doxorubicin, and nov 002 in combination, with specific eligibility criteria including tumor size, receptor status, cardiac health, and prior treatment history.",
    "This sample is a phase 2 clinical trial for the drug lamotrigine in children and adolescents with bipolar disorder, with specific inclusion and exclusion criteria, including age range, ability to swallow tablets, and exclusion of certain medical conditions and medications. The study also includes an fMRI component with additional criteria related to body weight, pregnancy, contraindications, and IQ level.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drug abt-089 and placebo, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 2 clinical trial for patients with cystic fibrosis, testing the drugs mp-376 and placebo. The eligibility criteria include age, confirmed diagnosis of cystic fibrosis, positive sputum culture for P. aeruginosa, lung function requirements, previous use of inhaled antimicrobials, stability of health status, and ability to produce sputum and perform spirometry. Exclusion criteria include recent antibiotic use, hypersensitivity to certain medications, recent respiratory infections, and abnormal liver or kidney function.",
    "This sample is a phase 2 trial for acromegaly patients who have achieved biochemical control with pasireotide and did not experience adverse events, with specific exclusion criteria related to optic chiasm compression and cardiovascular issues.",
    "This sample is a phase 2 clinical trial for gastric cancer patients, testing the effectiveness of capecitabine and oxaliplatin as a neoadjuvant treatment before curative resection, with specific eligibility criteria for patients' disease characteristics and medical conditions.",
    "This sample is a phase 2 clinical trial for patients with myelodysplastic syndromes and chronic myelomonocytic leukemia, testing the drug sorafenib, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with kidney neoplasms, testing the drugs thalidomide and capecitabine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with relapsing multiple sclerosis (MS) and includes eligibility criteria such as having at least two documented relapses in the previous 2 years, an Expanded Disability Status Scale (EDSS) score of 0-6, and a positive Gd-enhanced MRI scan. The study involves the drugs fty720 and placebo, and excludes patients with other chronic diseases, malignancies, and pregnant or nursing women.",
    "This phase 2 trial is investigating the efficacy of sunitinib malate in patients with various connective tissue neoplasms, including adult malignant fibrous histiocytoma of bone, desmoid tumor, endometrial cancer, ovarian cancer, sarcoma, and small intestine cancer, who have metastatic, locally advanced, or locally recurrent disease and meet specific eligibility criteria.",
    "This sample is a phase 2 trial for patients with overactive bladder and detrusor overactivity, testing the effectiveness of vardenafil hcl (Levitra, Bay38-9456) compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for multiple sclerosis, testing the drug mycophenolate mofetil (cellcept), and includes eligibility criteria such as age, disease duration, prior treatments, and medical conditions.",
    "This sample is a phase 2 trial for the drug febuxostat in patients with gout, with specific inclusion and exclusion criteria, and the study aims to evaluate the safety and efficacy of the drug in reducing serum uric acid levels.",
    "This sample is a phase 2 clinical trial for diabetic foot, testing the drugs metformin 500mg and glucophage 500mg, with inclusion criteria including healthy adult males aged 18-45, normal BMI, and absence of significant diseases, and exclusion criteria including history of significant diseases, alcohol or drug abuse, and difficulty in swallowing tablets.",
    "In this phase 2 trial, patients with HIV infections who are protease inhibitor naive, have a wild type genotype, CD4 count greater than 200/mm3, and viral load between 10,000 copies/ml and 750,000 copies/ml will be eligible to participate. The study will test the effectiveness of fosamprenavir and saquinavir in treating these patients.",
    "This sample is a phase 2 clinical trial for the treatment of chronic hepatitis C, testing the drugs gsk2336805, pegylated interferon alfa-2a, ribavirin, and a placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with metastatic or recurrent squamous cell carcinoma of the head and neck, testing the effectiveness of cisplatin, panitumumab, and docetaxel as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 trial for the treatment of iron deficiency anemia using ferric carboxymaltose (fcm) and iron dextran injection, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 trial for patients with type 1 diabetes mellitus, testing the effectiveness of ly2605541 and insulin glargine in managing blood glucose levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug dasatinib for the treatment of recurrent skin cancer, squamous cell carcinoma of the skin, and stage 0-I chronic lymphocytic leukemia, with specific eligibility criteria including disease stage, performance status, laboratory values, and exclusion criteria for certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic non-small cell lung cancer, testing the effectiveness of gemcitabine plus pemetrexed and paclitaxel plus gemcitabine as chemotherapy treatments, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 trial testing the drugs aprepitant and granisetron for the treatment of nausea and vomiting in patients with bone metastases receiving palliative radiotherapy, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the effectiveness of irinotecan hydrochloride as a treatment option. The eligibility criteria include having histologically confirmed adenocarcinoma of the breast, measurable disease, and no known CNS metastasis. Patients must also meet certain patient characteristics, such as having an ECOG performance status of 0-2 and a life expectancy of more than 3 months. Prior concurrent therapy restrictions include no more than 2 prior chemotherapy regimens in the metastatic setting and no prior therapy with irinotecan hydrochloride or certain other drugs.",
    "This sample is a phase 2 clinical trial for prostate cancer patients, testing the drug thalidomide, with eligibility criteria including high-risk disease characteristics and specific patient characteristics.",
    "This sample is a phase 2 trial for individuals with type 2 diabetes mellitus, testing the effectiveness of omarigliptin, pioglitazone, and metformin as compared to placebos, with specific eligibility criteria including age, body mass index, and current medication usage.",
    "This sample is a phase 2 clinical trial that aims to evaluate the effectiveness of zonisamide, a mood stabilizer medication, in reducing or stopping drinking in individuals with bipolar disorder and alcohol use disorders. The study includes eligibility criteria such as age, diagnosis of bipolar disorder and alcohol use disorders, and the use of specific medications. Exclusion criteria include the presence of other major psychiatric disorders, drug dependence, and certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with acquired immunodeficiency syndrome (AIDS) or HIV infections, testing the efficacy of the drugs e/c/f/tdf and e/c/f/taf in combination with placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial that focuses on stem cell transplantation for various genetic diseases, including thalassemia and diamond-blackfan anemia, using different levels of cyclophosphamide as a drug. The eligibility criteria include age range, histocompatible sibling or related donor, and adequate physical function and vital organ function. Exclusion criteria include certain performance status, infections, and end-organ dysfunction.",
    "This sample is a phase 2 clinical trial for postmenopausal patients with histologically confirmed, recurrent or metastatic endometrial carcinoma. The drug being tested is fulvestrant, and the eligibility criteria include being hormone receptor positive and not having received previous treatment with fulvestrant or endocrine therapy for endometrial carcinoma.",
    "This sample is a phase 2 clinical trial for the treatment of psoriasis vulgaris using pth (1-34) gel, and the eligibility criteria include having stable plaque psoriasis for at least 3 months, a minimum of 2% affected body surface area, and specific disease severity scores.",
    "This sample is a phase 2 clinical trial for patients with salivary gland malignancy, testing the efficacy of postoperative radiotherapy and panitumumab as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This phase 2 trial aims to evaluate the effectiveness of capsaicin dermal patch in treating conditions such as herpes zoster, neuralgia, pain, HIV infections, and peripheral nervous system diseases, with specific eligibility criteria including successful completion of a previous trial of NGX-4010 and a washout period for topical pain medications.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer, testing the effectiveness of docetaxel, oxaliplatin, and bevacizumab as a treatment option, with specific eligibility criteria for participants.",
    "This sample is a phase 2 trial for patients with pulmonary fibrosis, testing the efficacy of different doses of bibf1120 and a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for HIV infections, testing the drugs bms-663068 and ritonavir, with eligibility criteria including specific CD4+ lymphocyte count and plasma HIV RNA levels, and excluding individuals with certain medical conditions or recent drug/alcohol abuse.",
    "This phase 2 trial is testing the drug abi-007 (abraxane\u00ae) in patients with metastatic or locally recurrent urothelial cancer or bladder cancer who are not eligible for higher priority trials, and have specific eligibility criteria including measurable disease, certain organ and marrow function levels, and a life expectancy of at least 12 weeks.",
    "This sample is a phase 2 trial for attention deficit disorder with hyperactivity, testing the drugs nrp104, adderall xr, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial testing the drug palonosetron hydrochloride for patients with various gastrointestinal cancers, and the eligibility criteria include specific disease characteristics and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with chronic Hepatitis C, genotype 1 and 4, testing the drugs copegus, danoprevir, and pegasys, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with acute myelogenous leukemia (AML) who are older than or equal to 60 years and meet specific eligibility criteria, including adequate renal and hepatic function, and adequate cardiac function. The study will test the effectiveness of the drugs clofarabine and cytarabine in treating AML.",
    "This sample is a phase 2 clinical trial for bladder cancer patients who are former smokers, testing the drug erlotinib hydrochloride. The eligibility criteria include having no evidence of disease, adequate bone marrow function, and satisfactory renal and hepatic function. Exclusion criteria include prior chemotherapy or radiotherapy, significant medical or psychiatric conditions, and involvement of the upper urinary tract prior to or at the time of initial tumor resection.",
    "This phase 2 trial is investigating the effectiveness of bicalutamide, leuprolide acetate, and squalamine lactate in treating locally advanced prostate cancer with high-risk characteristics, such as a large, hard tumor and aggressive cancer cells, in patients with a prostate-specific antigen level greater than 10 ng/mL.",
    "This sample is a phase 1/phase 2 trial for asthma patients, testing the effectiveness of active and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer, testing the drugs endostar and paclitaxel/carboplatin in patients with stage IIIA or IIIB disease who have not received prior chemotherapy, radiation therapy, immunotherapy, or biologic therapy. The inclusion criteria include histologically proven non-small cell lung cancer, presence of measurable disease, ECOG performance status 0-1, and signed informed consent. The exclusion criteria include carcinoid tumor, small cell carcinoma of lung, distant metastasis, history of another malignancy (except cured basal cell carcinoma of skin and cured carcinoma in-situ of uterine cervix), contraindication for radiotherapy, pregnancy or lactation, and lack of adequate contraception.",
    "This sample is a phase 2 clinical trial testing the drug combination of jx-594 followed by sorafenib in patients with hepatocellular carcinoma (HCC) who are not eligible for surgical resection, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the drug \"agn 203818\" in patients with painful bladder syndrome/interstitial cystitis, with specific inclusion and exclusion criteria.",
    "This phase 2 clinical trial aims to evaluate the effectiveness of latanoprost and travatan z in reducing intraocular pressure in patients with ocular hypertension, open angle glaucoma, or chronic angle closure glaucoma, and the eligibility criteria include being at least 18 years old, having a documented diagnosis of the specified eye conditions, and agreeing to use contraception during the study period.",
    "This sample is a phase 2 trial for the treatment of hypercholesterolemia, testing the drugs etc-1002, placebo, and atorvastatin, with specific inclusion and exclusion criteria related to LDL-C levels and cardiovascular health.",
    "This sample is a phase 2 clinical trial for patients with progressive or recurrent stage IV non-small cell lung cancer (NSCLC) with brain metastases, testing the drug temozolomide. Eligibility criteria include specific disease characteristics, patient characteristics, and restrictions on prior and concurrent therapies.",
    "This sample is a phase 2 trial for postmenopausal females with locally advanced or metastatic breast cancer, testing the drug TAS-108, with specific eligibility criteria and required laboratory documentation.",
    "This sample is a phase 1/phase 2 trial for the treatment of psoriasis using the drug Humira, along with 3 B vitamins, and the eligibility criteria includes adults with moderate to severe plaque psoriasis, negative pregnancy test, and no evidence of active or latent tuberculosis.",
    "This sample is a phase 2 trial testing the effectiveness of bupropion hydrochloride, an antidepressant, in treating major depressive disorder, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for major depressive disorder, testing the efficacy of drugs such as eb-1010 and SSRI active, with specific eligibility criteria including a history of inadequate response to previous SSRI or SNRI treatments and a minimum score on the Hamilton Rating Scale for Depression.",
    "This sample is a phase 2 clinical trial for patients with acute myeloid leukemia (AML) in the second salvage setting, testing the drug troxatyl\u2122 (troxacitabine) for those who have not responded to previous leukemia therapies. The eligibility criteria include specific disease diagnosis, previous treatment history, organ and immune function requirements, and exclusion criteria such as CNS involvement, uncontrolled infection, and intolerance to the drug.",
    "This sample is a phase 2 clinical trial for patients with metastatic or locally recurrent colorectal cancer, testing the drug irofulven. The eligibility criteria include specific disease characteristics, patient characteristics, and restrictions on prior concurrent therapy.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer, testing the drug ps-341 (velcade-drug), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with ovarian cancer, fallopian tube cancer, or malignant tumor of peritoneum, testing the effectiveness of paclitaxel, topotecan, and carboplatin as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for endometriosis, testing the drugs proellex 25 mg, placebo, and proellex 50 mg, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for asthma patients, testing the drugs azd5423, budesonide 200 microgram, and placebos, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic bladder cancer, testing the effectiveness of gemcitabine hydrochloride and irinotecan hydrochloride as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drug hf0220, with inclusion criteria including a diagnosis of probable Alzheimer's disease, mild to moderate dementia severity, and written consent from the patient and responsible carer, while exclusion criteria include other types of dementia, significant medical conditions, recent use of hepatotoxic drugs, and malnourishment.",
    "This sample is a phase 1/phase 2 trial testing the combination of belinostat and erlotinib in patients with non-small cell lung cancer, with specific eligibility criteria including signed consent, suitable histological or cytological confirmation, performance status \u2264 2, acceptable liver, kidney, and bone marrow function, and negative pregnancy test for women of childbearing age.",
    "This sample is a phase 1/phase 2 trial for patients with advanced lung adenocarcinoma, testing the efficacy of erlotinib hydrochloride and hsp90 inhibitor auy922 in patients who have previously responded to erlotinib or gefitinib or have a documented mutation in the EGFR gene. The study has specific inclusion and exclusion criteria, and patients must meet certain medical conditions and have negative pregnancy tests to be eligible.",
    "This sample is a phase 2 trial for patients with metastatic cancer and malignant ascites, testing the drug mitomycin c, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of single and multiple low dose cyclophosphamide drugs, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 trial for major depressive disorder, testing the drugs azd6765 iv and placebo, with inclusion criteria including inadequate response to at least 3 antidepressants and exclusion criteria including a history of bipolar disorder or schizophrenia.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast carcinoma (stage IV) that are HER2 overexpressing. The study will test the effectiveness of pegylated liposomal doxorubicin, docetaxel, and trastuzumab as treatment options. The eligibility criteria include specific age range, prior chemotherapy restrictions, measurable lesions, and various laboratory requirements.",
    "This sample is a phase 2 clinical trial for patients with urothelial cancer, specifically bladder, renal pelvis, ureter, or urethra cancer, who are either previously untreated with metastatic or locoregionally advanced disease or have locally recurrent carcinoma after radiotherapy or cystectomy. The study will test the effectiveness of gemcitabine hydrochloride and paclitaxel as treatment options. Eligible patients must meet certain criteria, including age between 60 and 70, Zubrod performance status of 0-2, and specific hematopoietic, hepatic, renal, and other health requirements.",
    "This sample is a phase 2 clinical trial for ulcerative colitis, testing the efficacy of interferon-beta-1a and placebo in moderately active UC patients with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with resectable pancreatic cancer, testing the efficacy of gemcitabine and abraxane as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for irritable bowel syndrome, testing the drugs ym060 and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with castration-resistant prostate cancer, testing the efficacy of cabazitaxel plus bavituximab as a second-line chemotherapy regimen, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with pancreatic ductal adenocarcinoma, testing the drug GDC-0449. The inclusion criteria include having a tissue diagnosis of pancreatic ductal adenocarcinoma, eligibility for a Whipple's or distal pancreatectomy procedure, and meeting certain organ function requirements. The exclusion criteria include known hypersensitivity to GDC-0449, active cardiac ischemic disease, and concurrent participation in another clinical trial using an investigational medicinal product.",
    "This sample is a phase 2 clinical trial for irritable bowel syndrome with diarrhea, testing the effectiveness of placebo, mesalamine granules 750 mg, and mesalamine granules 1500 mg as potential treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for psoriatic arthritis, testing the effectiveness of apremilast and placebo drugs, with specific inclusion and exclusion criteria for eligible participants.",
    "This phase 2 clinical trial aims to evaluate the effectiveness of gemcitabine and oxaliplatin in treating patients with metastatic or recurrent nasopharyngeal carcinoma, who have not received prior chemotherapy for their condition. The study includes specific inclusion and exclusion criteria, such as measurable lesions, performance status, and adequate hematological, renal, and hepatic functions. Prior treatment with oxaliplatin or gemcitabine, persistent neuropathy or ototoxicity, central nervous system metastasis, life-threatening infections, recent use of investigational drugs, pregnancy, and breastfeeding are among the exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with recurrent or metastatic squamous cell carcinoma of the head and neck. The study aims to evaluate the efficacy of the drugs rad001, cetuximab, cisplatin, and carboplatin in treating the disease. The eligibility criteria include specific disease diagnosis, measurable disease, no prior monoclonal antibodies or small molecule tyrosine-kinase inhibitors, and normal organ and marrow function.",
    "This sample is a phase 2 clinical trial for patients with complex regional pain syndromes, testing the effectiveness of placebo and ethosuximide as additional pain control, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the efficacy of the drug MSDC-0602 in comparison to placebo and pioglitazone, with specific inclusion and exclusion criteria for enrollment.",
    "This sample is a phase 2 trial testing the effectiveness of gemcabene, a drug used to treat hypercholesterolemia and hypertriglyceridemia, in patients with low HDL-C levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with unresectable or metastatic hepatocellular carcinoma, testing the drug rad001 (an mTor inhibitor) to evaluate its efficacy and safety, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the effectiveness of the drug linagliptin compared to a placebo and glimepiride, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for HIV infection, testing the drugs GW873140 and Combivir, with specific eligibility criteria for participants.",
    "This sample is a phase 2 trial for patients with metastatic renal cell carcinoma, testing the effectiveness of sorafenib and interferon as second-line treatment after sunitinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for participants with hypercholesterolemia, testing the effectiveness of alirocumab and atorvastatin in reducing low-density lipoprotein cholesterol levels. The eligibility criteria include participants receiving lipid-lowering treatment other than atorvastatin or not at a stable dose of atorvastatin 10 mg for at least 6 weeks prior to screening, or drug-naive participants with primary hypercholesterolemia likely to have LDL-C \u2265 100 mg/dL at the end of the run-in treatment period. Exclusion criteria include participants with LDL-C < 100 mg/dL, participants not previously instructed on a cholesterol-lowering diet, participants with type 1 diabetes, participants with type 2 diabetes treated with insulin, participants with type 2 diabetes and HbA1c \u2265 8.5% at screening visit, and pregnant or breastfeeding women.",
    "This sample is a phase 2 clinical trial for rheumatoid arthritis patients who have failed treatment with anti-TNF-\u03b1 therapies, and it will test the efficacy of the drug mk-8457 in combination with methotrexate.",
    "This sample is a phase 2 trial testing the drugs azd1940, naproxen, and placebo for patients scheduled for surgical removal of impacted mandibular third molar, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the efficacy of sufentanil nanotab and placebo nanotab in patients scheduled for bunion surgery, with acute pain as the disease of interest, and excluding patients with daily opioid use, drug or alcohol abuse, and pregnant or breastfeeding women.",
    "This sample is a phase 2/phase 3 trial for metastatic colorectal cancer, testing the drugs cmab009 plus irinotecan and irinotecan-only and sequential-cmab009, with specific eligibility criteria including histologically confirmed metastatic colorectal adenocarcinoma, KRAS wild-type tumors, and failure of fluoropyrimidine and oxaliplatin treatment.",
    "This sample is a phase 2 clinical trial for breast neoplasm, testing the effectiveness of the drugs epirubicin, cyclophosphamide, docetaxel, and trastuzumab in combination, with specific eligibility criteria for participants.",
    "This sample is a phase 2 trial for the treatment of gout, testing the drugs febuxostat and placebo for febuxostat, with eligibility criteria including a history of gout, hyperuricemia, and a maximum of 2 flares.",
    "This sample is a phase 2 clinical trial for the treatment of idiopathic restless legs syndrome using the drug \"spm 962\", with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 trial for the drug diclofenac in patients with knee osteoarthritis, with specific inclusion and exclusion criteria listed.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer and brain neoplasms, testing the effectiveness of bevacizumab and chemotherapy agents as first- or second-line systemic therapy, with specific eligibility criteria and exclusion criteria.",
    "This phase 2 trial is testing the drug sta-9090 in patients with metastatic colorectal cancer, and the eligibility criteria include having received prior treatment for metastatic disease, having adequate hematologic and hepatic function, and having a life expectancy of more than 3 months.",
    "This sample is a phase 2 trial for obesity, focusing on patients with a BMI between 27 and 40, using the drug topiramate, and having specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of major depressive disorder, recurrent, using the drugs filorexant and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer who have failed 1 or 2 lines of chemotherapy, and the drug being tested is crlx101. The eligibility criteria include specific disease characteristics, performance status, and various laboratory values.",
    "This sample is a phase 2/phase 3 trial for the treatment of benign prostatic hyperplasia using tadalafil and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the drug pd-0325901, and includes eligibility criteria such as documented cancer stage, adequate organ function, and evidence of disease progression.",
    "This sample is a phase 2 clinical trial for patients with atherosclerosis and coronary artery disease, testing the drugs rvx000222 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial studying the use of clopidogrel in patients with myocardial infarction or percutaneous coronary intervention, with specific inclusion and exclusion criteria related to age, indication for clopidogrel use, stability following MI or PCI, and conditions affecting platelet function or bleeding risk.",
    "This sample is a phase 2 trial for seasonal allergic rhinitis, testing the effectiveness of drugs such as bilastine, fexofenadine, cetirizine, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with chronic kidney disease, testing the effectiveness of sevelamer hcl and sbr759 in reducing serum phosphate levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with colorectal neoplasms, testing the efficacy of regorafenib, oxaliplatin, folinic acid, and 5-fu (mfolfox6) as first-line metastatic treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with high-risk primary gastrointestinal stromal tumor (GIST), testing the effectiveness of imatinib mesylate as a treatment option. The eligibility criteria include specific tumor size and resection requirements, positive staining for the Kit receptor tyrosine kinase, and certain laboratory values. Patients with prior chemotherapy, radiation therapy, or investigational treatment are excluded from the study.",
    "This sample is a phase 2 trial for psoriasis, testing the effectiveness of cp-690,550 ointment and its vehicle in treating mild to moderate chronic plaque psoriasis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for osteoarthritis, testing the effectiveness of ibuprofen and placebo in patients aged 40 years and older, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the drug nbi-98854 in the treatment of tardive dyskinesia in patients with schizophrenia or schizoaffective disorder, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 trial testing the drugs placebo and romosozumab for the treatment of fracture healing in patients aged 55 to 95 years with fresh unilateral low energy intertrochanteric or femoral neck fractures, and includes specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with hormone refractory prostate cancer and bone metastases, testing the drug radium-223 dichloride (bay88-8223) to assess its effectiveness in reducing bone pain and improving overall survival.",
    "This sample is a phase 2 clinical trial for patients with colorectal neoplasms, testing the effectiveness of drugs such as sunitinib, mfolfox6, bevacizumab, and mfolfox6, with specific inclusion and exclusion criteria.",
    "This phase 2 trial aims to evaluate the efficacy of pt005 mdi, formoterol fumarate 12 \u03bcg (foradil\u00ae aerolizer\u00ae), and formoterol fumarate 24 \u03bcg (foradil\u00ae aerolizer\u00ae) in patients aged 40-80 with chronic obstructive pulmonary disease (COPD) who have a clinical history of COPD with airflow limitation that is not fully reversible, a measured post-bronchodilator FEV1/FVC ratio of \u22640.70, and a measured post-bronchodilator FEV1 \u2265750ml or 30% predicted and \u226480% of predicted normal values.",
    "This sample is a phase 1/phase 2 trial for HIV infections, testing the drugs tenofovir df and tenofovir alafenamide, with inclusion criteria including specific HIV-1 RNA levels, CD4 count, and serum creatinine levels, and exclusion criteria including prior treatment with antiretroviral therapy and recent immunization.",
    "This sample is a phase 1/phase 2 trial for the treatment of diabetic macular edema using ranibizumab, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with squamous cell carcinoma, testing the effectiveness of paclitaxel and carboplatin chemotherapy drugs, with specific eligibility criteria including age, performance status, tumor size, and various medical conditions.",
    "This sample is a phase 2 trial for postmenopausal women with hormone receptor positive advanced breast cancer, testing the drugs cp-751,871, exemestane, and fulvestrant, with inclusion criteria of HbA1c <5.7% and exclusion criteria of previous treatment for advanced disease.",
    "This sample is a phase 2 trial for patients with type 1 diabetes, testing the effectiveness of regular insulin (humulin) and insulin lispro (humalog) in controlling blood sugar levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for adult females with inflammatory breast cancer and HER2-positive tumors, testing the effectiveness of standard chemotherapy, bevacizumab (Avastin), and trastuzumab (Herceptin) as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial testing the drug vortioxetine and placebo for the treatment of major depressive disorder, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the treatment of allergic rhinitis using the drugs gsk256066 and azelastine hydrochloride, with eligibility criteria including a history of seasonal allergic rhinitis, positive skin prick test and RAST for grass pollen, and specific age and weight ranges.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs ssr180711c, donepezil, and placebo, with inclusion criteria of outpatients with mild AD and exclusion criteria including previous treatment with acetylcholinesterase inhibitors and/or memantine, medical conditions that may interfere with the study, history of epileptic seizures, lens opacity, and lack of reliable caregiver.",
    "This sample is a phase 2 clinical trial for the treatment of migraines, testing the drug mk3207 at various doses, with the inclusion criteria being men and women aged 18-65 with a history of migraines lasting 4-72 hours, and the exclusion criteria including pregnancy, inability to distinguish migraines from tension headaches, and a history of cardiovascular disorder within the last 6 months.",
    "This sample is a phase 2 trial for patients with non-Hodgkin's lymphoma localized in the central nervous system, cranial nerves, or eyes. The study aims to evaluate the effectiveness of high dose methotrexate and high dose cytarabine as treatment options. The eligibility criteria include specific diagnostic requirements, age range, performance status, and various health parameters.",
    "This sample is a phase 2 trial for HIV-1 and hepatitis C co-infection, testing the efficacy of pioglitazone, peginterferon, and ribavirin in participants who have exhibited no response to previous treatment with PEG-IFN alfa-2a or alfa-2b. The eligibility criteria include specific laboratory values, CD4 count, HCV RNA levels, and documentation of HCV genotype 1. Participants must also be on stable or no antiretroviral therapy and meet certain criteria for hepatic cirrhosis.",
    "This sample is a phase 2 trial for patients who develop hypocalcemia after thyroid surgery, testing the effectiveness of teriparatide, calcium, and calcitriol in treating the condition.",
    "This sample is a phase 2 trial for patients with end stage renal disease or chronic kidney disease stage 5, testing the drugs azd1722 and placebo in both in-patient and out-patient settings, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2/phase 3 trial for multiple myeloma, CLL/SLL, non-Hodgkin's lymphoma, Waldenstroms, and mantle cell lymphoma, using the drug fludarabine, with specific eligibility criteria for patients.",
    "This sample is a phase 2 clinical trial for the treatment of seasonal allergic rhinitis using the drug histamine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with essential hypertension, testing the drug rostafuroxin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with histologically confirmed squamous cell carcinoma of the head and neck, testing the efficacy of cisplatin and docetaxel as treatment options, with specific eligibility criteria and patient characteristics outlined.",
    "This sample is a phase 1/phase 2 trial for patients with castration-resistant prostate cancer, testing the drug MDV3100, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for HIV-negative individuals testing the effectiveness of dapivirine (tmc120) vaginal gel in preventing HIV infections, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for rheumatoid arthritis, testing the drugs azd9056, etanercept, and placebo, with eligibility criteria including a diagnosis of RA with active disease and receiving methotrexate for at least 6 months prior to randomization.",
    "This sample is a phase 2 trial for patients with pancreatic cancer who have progressed on gemcitabine-based chemotherapy, and it aims to evaluate the efficacy of RAD001 (everolimus), an mTOR inhibitor, as a potential treatment option.",
    "This sample is a phase 2 clinical trial for patients with head and neck cancer, testing the use of amifostine as a protective agent during radiation therapy, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients diagnosed with late stage malignant melanoma, testing the drugs azd6244 and temozolomide, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug epoetin alfa in patients with chronic anemia, aged 65 or older, with specific eligibility criteria, and excluding patients with certain conditions or previous treatments.",
    "This sample is a phase 2 trial for sarcoma patients, testing the drugs cisplatin and etoposide, with eligibility criteria including histologically confirmed Ewing's family tumor and specific patient characteristics such as age, performance status, and hematopoietic, hepatic, renal, and cardiovascular requirements.",
    "This sample is a phase 2 clinical trial for patients with locally advanced squamous cell carcinoma of the head and neck. The study aims to evaluate the effectiveness of amifostine, carboplatin, and taxol as treatment options. The eligibility criteria include specific TNM stages, performance status, absence of distant metastatic disease, and no previous radiation or chemotherapy. Adequate renal and bone marrow function, evidence of measurable disease, and signed informed consent are also required. Exclusion criteria include preexisting neuropathy, current use of antiarrhythmic medications, poorly-controlled hypertension or heart conditions, and pregnancy or lactation.",
    "This sample is a phase 2 trial for lung cancer patients with specific disease characteristics and patient characteristics, where the drug being tested is pemetrexed.",
    "This sample is a phase 2 trial for patients with stage IV prostate cancer, testing the effectiveness of cediranib maleate, docetaxel, and prednisone in combination therapy, with specific eligibility criteria for patient selection.",
    "This sample is a phase 1/phase 2 trial for the treatment of type 1 diabetes mellitus using the drug lisofylline, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 trial testing the effects of risperidone and mifepristone on individuals with a BMI between 18 and 23 kg/m2, with various inclusion and exclusion criteria, and the study aims to evaluate the impact on weight and appetite.",
    "This sample is a phase 2 clinical trial for patients with recurrent or metastatic breast cancer, testing the drugs su011248 and chemotherapy in patients who have previously received anthracycline and taxane treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the drug tesetaxel for patients with adenocarcinoma of the stomach or esophagogastric junction, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic or recurrent breast cancer, testing the drug temsirolimus, and includes eligibility criteria such as positive hormone receptor status, measurable disease, and specific laboratory values.",
    "This sample is a phase 1/phase 2 clinical trial for patients with acute myeloid leukemia and acute promyelocytic leukemia, testing the drugs clofarabine and cytarabine, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes mellitus, testing the drug phx1149t, and the eligibility criteria include specific disease duration, BMI range, and current treatment with metformin or TZD.",
    "This sample is a phase 2 clinical trial for patients with neuroendocrine tumors metastatic to the liver, testing the efficacy of octreotide acetate in reducing symptoms and tumor size.",
    "This sample is a phase 2 clinical trial for patients with recurrent or persistent endometrial cancer, testing the drug topotecan, and includes eligibility criteria such as prior chemotherapy regimen, age, measurable lesions, and screening laboratory criteria.",
    "This sample is a phase 2 trial for patients between 12 and 17 years old with moderate persistent asthma, testing the efficacy of tiotropium bromide compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for type II diabetes, testing the drugs placebo, sitagliptin, and lez763, with eligibility criteria including age, weight, BMI, and diabetes diagnosis.",
    "This sample is a phase 2 trial testing the effectiveness of multiple drugs (las41003, las189962, las189961) in treating super-infected or impetiginized eczema, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the drugs ly2599506, glyburide, and placebo, with inclusion criteria including HbA1c value between 7% and 10%, and exclusion criteria including use of insulin or any antidiabetic agent other than metformin or sulfonylurea.",
    "This sample is a phase 2 trial for participants with chronic hepatitis C virus (HCV) genotype 2 or 3, testing the efficacy of drugs such as daclatasvir, pegylated interferon alfa-2a, and ribavirin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients diagnosed with multiple myeloma, testing the effectiveness of the drugs bortezomib, lenalidomide, and dexamethasone, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for the treatment of secondary hyperparathyroidism, testing the drugs etelcalcetide and placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 trial for the treatment of vulvodynia, a condition characterized by chronic pain in the vulva. The study will test the effectiveness of lidocaine/diphenhydramine, lidocaine, and placebo drugs in relieving symptoms. The inclusion criteria require patients to have sought medical care for the condition and have menstrual cycles, while the exclusion criteria include not having any vaginal infections, not being pregnant or nursing, and not receiving any other medicinal therapies or medications that could interfere with the study's outcome.",
    "This sample is a phase 2 clinical trial for patients with diffuse large B-cell lymphoma, testing the drugs sar3419 and rituximab in patients who have relapsed or are refractory to standard treatment including rituximab. The eligibility criteria include a histological diagnosis of DLBCL, CD19 and CD20 positive disease, and the presence of measurable lesions by CT scan.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic melanoma, testing the combination of dasatinib and dacarbazine (dtic) as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of capecitabine, irinotecan, oxaliplatin, and cetuximab as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of various doses of salmeterol and placebos delivered through HandiHaler\u00ae and Diskus\u00ae devices, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with congenital adrenal hyperplasia (CAH) who are currently treated with hydrocortisone. The trial aims to evaluate the efficacy of hydrocortisone modified release capsules in treating CAH.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C infection, testing the drugs bms-790052, placebo, peginterferon alfa-2b, and ribavirin, with key inclusion criteria including HCV genotype 1 and HCV RNA viral load \u226510*5* IU/mL at screening.",
    "This sample is a phase 2 trial for patients with HIV infection and hypercholesterolemia, testing the effectiveness of pravastatin in reducing cholesterol levels in HIV patients on antiretroviral therapy.",
    "This sample is a phase 2 trial for patients with unresectable adenocarcinoma of the pancreas, testing the effectiveness of capecitabine, fluorouracil, and gemcitabine hydrochloride as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with breast cancer and bone metastases, testing the drug radium-223 chloride (bay88-8223) to determine its effectiveness in treating the disease. The eligibility criteria include specific requirements for patients' medical history, previous treatments, and laboratory results.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of the drugs enzastaurin, pemetrexed, carboplatin, bevacizumab, and placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with growth hormone deficiency, testing the drugs tv-1106 and recombinant human growth hormone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for attention deficit hyperactivity disorder (ADHD) using d-amphetamine transdermal system and placebo patch as drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the drugs belotaxel and belloxa. The eligibility criteria include specific disease stage, age, performance status, and various laboratory values, while excluding patients with prior chemotherapy treatment, active infections, and certain medical conditions.",
    "This sample is a phase 2 trial for rheumatoid arthritis, testing the effectiveness of canakinumab, placebo, and methotrexate as treatments, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for rheumatoid arthritis, testing the drugs ssr150106 and placebos, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 2 trial aims to evaluate the effectiveness of the drug abt-894 compared to placebo and duloxetine in treating diabetic neuropathy, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 trial for major depressive disorder, testing the drugs lu aa24530, duloxetine, and placebo, with inclusion criteria including a major depressive episode lasting at least 3 months and moderate to severe depression.",
    "This sample is a phase 2 trial for patients with chronic myelogenous leukemia who have failed to respond to imatinib mesylate (im) therapy, and it will test the effectiveness of imatinib mesylate (im) and tall-104 cells as potential treatments.",
    "This sample is a phase 2 trial for patients with aggressive non-Hodgkin's lymphoma, testing the effectiveness of palonosetron, an anti-emetic drug, in preventing chemotherapy-induced nausea and vomiting.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of lenalidomide, pegylated liposomal doxorubicin, and dexamethasone as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 2 trial aims to evaluate the efficacy of prasugrel and clopidogrel in patients with coronary arteriosclerosis and acute coronary syndrome, who have a recent history of an ACS event and are taking daily aspirin and maintenance dose 75-mg clopidogrel.",
    "This sample is a phase 1/phase 2 trial for relapsed CD20-positive B-cell non-Hodgkin's lymphoma, testing the efficacy of drugs such as Zevalin, Rituxan, BCNU, VP-16, Ara-C, Melphalan, and G-CSF, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs losmapimod and placebo. The inclusion criteria include specific clinical history and lung function measurements, while the exclusion criteria include conditions like asthma and liver disease.",
    "This sample is a phase 2 trial for patients with active rheumatoid arthritis who have had an inadequate response to methotrexate, and the study will test the effectiveness of the drug cp-690,550 in treating the disease.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of the drugs bortezomib, lenalidomide, and dexamethasone, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 trial for the treatment of hepatitis C using the drugs sofosbuvir, placebo, peg, and rbv, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for postherpetic neuralgia, testing the drugs z160 and placebo, with inclusion criteria including a diagnosis of PHN, pain score between 3 and 8, and willingness to comply with study procedures. Exclusion criteria include severe pain from other diseases, recent neurolytic or neurosurgical therapy for PHN, history of seizure or stroke, and various mental health conditions.",
    "This sample is a phase 2/phase 3 clinical trial for patients with chronic hepatitis C and liver fibrosis, testing the effectiveness of ribavirin and ribavirin-placebo in combination with interferon for antiviral treatment. The study includes eligibility criteria and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with low or intermediate-1 IPSS risk category MDS, testing the effectiveness of lenalidomide and darbepoetin alfa in treating transfusion-dependent anemia.",
    "This sample is a phase 2 clinical trial for patients with advanced colorectal cancer, testing the effectiveness of fluorouracil, leucovorin calcium, and oxaliplatin as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 trial for the treatment of chronic hepatitis C, testing the drugs bms-791325 and placebo, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is investigating the efficacy of vintafolide and etarfolatide in treating advanced, progressive adenocarcinoma of the lung, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial testing the effectiveness of ropinirole, a dopamine agonist, in combination with physical therapy for stroke patients who meet specific inclusion criteria and do not have certain exclusion criteria.",
    "This sample is a phase 2 clinical trial for lung cancer patients, testing the effectiveness of topotecan and docetaxel drugs, with specific eligibility criteria for inclusion and exclusion.",
    "This phase 2 trial is testing the drugs fulvestrant and selumetinib in patients with breast cancer that is not amenable to curative therapy, and who have relapsed or progressed after aromatase inhibitor treatment, with specific eligibility criteria for disease characteristics and patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung cancer, testing the effectiveness of gemcitabine, cisplatin, docetaxel, vinorelbine, and pemetrexate as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 trial testing the effectiveness of sildenafil citrate and placebo in patients with chronic obstructive pulmonary disease (COPD) or emphysema, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial investigating the use of zoledronic acid and alendronate in patients who have undergone heart or liver transplantation and have diseases related to bone resorption. The eligibility criteria include age, race, and exclusion of certain conditions such as hyperparathyroidism and cancer.",
    "This sample is a phase 2 clinical trial for patients with stage IIIb or stage IV non-small cell lung cancer, testing the drugs zd6474, carboplatin, and paclitaxel, with eligibility criteria including an ECOG performance status of 0-1 and specific requirements for hepatic, renal, and bone marrow function.",
    "This sample is a phase 2 trial for asthma patients, testing the drug gw685698x in combination with eligibility criteria including age, gender, asthma diagnosis, severity of disease, reversibility of disease, concurrent anti-asthma therapy, and exclusion criteria such as history of life-threatening asthma, use of certain asthma medications, respiratory infection, asthma exacerbation, and concurrent diseases/abnormalities.",
    "This sample is a phase 1/phase 2 trial testing the drugs opa-6566, placebo, and latanoprost for the treatment of primary open-angle glaucoma and ocular hypertension, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-Hodgkin's lymphoma, testing the drug intravenous t900607-sodium, with eligibility criteria including prior chemotherapy, measurable disease, and specific lab values.",
    "This sample is a phase 2 trial that aims to investigate the effectiveness of orlistat, a weight loss medication, compared to a placebo in adolescents with obesity-related comorbid conditions such as diabetes mellitus, hypertension, metabolic disease, obesity, and sleep apnea syndrome. The eligibility criteria include age between 12 to 17 years, specific BMI and triceps skinfold measurements, and the absence of certain medical conditions.",
    "This sample is a phase 2 trial for the drug ONO-2506PO in patients with amyotrophic lateral sclerosis (ALS), with inclusion criteria including previous randomization in a previous study and exclusion criteria related to various medical conditions that may pose a risk to the patient.",
    "This sample is a phase 2 clinical trial for patients with ovarian cancer, fallopian tube cancer, and peritoneal cancer. The trial will test the effectiveness of topotecan and bevacizumab in patients who have received primary taxane and platinum-based chemotherapy and have platinum resistant disease. The eligibility criteria include measurable disease, elevated CA-125 levels, and a performance status greater than or equal to 70%.",
    "This sample is a phase 1/phase 2 trial for left ventricular diastolic dysfunction, testing the drugs bnp (nesiritide) and placebo, with inclusion criteria including subjects with ejection fraction greater than 50% and moderate or severe diastolic dysfunction, and exclusion criteria including recent myocardial infarction, unstable angina, and severe congenital heart diseases.",
    "This sample is a phase 2 clinical trial for patients with platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, testing the drug ly573636-sodium, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for metastatic or relapsed locally advanced breast cancer patients who are HER2-positive, with eligibility criteria including no prior chemotherapy for metastatic disease, normal left ventricular ejection fraction, bidimensionally measurable disease, and oxygen saturation > 90% on room air. The drugs being tested are bevacizumab and herceptin.",
    "In this phase 2 trial, the drugs mirabegron and placebo are being tested for their effectiveness in treating lower urinary tract symptoms and bladder outlet obstruction in men aged 45 and older with documented bladder outlet obstruction, while excluding those with a history of urinary retention or symptomatic and recurrent urinary tract infection.",
    "This sample is a phase 2 clinical trial for ovarian cancer patients who have failed prior chemotherapy and have a treatment-free interval of more than 6 months. The study will test the efficacy of docetaxel, carboplatin, and liposomal doxorubicin in treating the disease.",
    "This sample is a phase 2 clinical trial for patients with stage IV malignant melanoma, testing the drug thalidomide, and includes eligibility criteria such as no brain metastases, prior systemic therapy, and specific patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with hormone refractory prostate cancer and metastasis, testing the drug radium-223 dichloride (bay88-8223) to evaluate its effectiveness in reducing PSA levels and improving overall survival.",
    "This sample is a phase 2 clinical trial for patients with Philadelphia chromosome-positive chronic myelogenous leukemia (CML) who have failed prior treatment with imatinib mesylate or are intolerant to it, and it aims to evaluate the efficacy of bortezomib as a potential treatment option.",
    "This sample is a phase 2 trial for sickle cell disease patients experiencing vaso-occlusive crisis, testing the effectiveness of the drug gmi-1070 compared to a placebo, with specific eligibility criteria for enrollment.",
    "This sample is a phase 2 clinical trial for patients with ovarian cancer who have shown resistance to platinum-based chemotherapy, and it aims to evaluate the effectiveness of glufosfamide as a treatment option.",
    "This sample is a phase 2 clinical trial for patients with HER2-overexpressing breast cancer, testing the efficacy of trastuzumab and pf03512676 drugs in combination with other therapies, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial testing the efficacy of pazopanib and placebo comparator in patients with stage II-IV epithelial ovarian, fallopian tube, or primary peritoneal carcinoma who have undergone surgical debulking and platinum-taxane doublet chemotherapy. The eligibility criteria include age, disease stage, previous treatment, performance status, and various hematologic, hepatic, and renal function parameters. The exclusion criteria include certain medical conditions, surgeries, bleeding disorders, and hypersensitivity reactions.",
    "This sample is a phase 2 trial for patients with squamous cell carcinoma of the head and neck cancer, testing the effectiveness of cetuximab and emd 1201081 as a second-line treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 2 trial is investigating the efficacy of s-1 and s-1 plus leucovorin in patients with inoperable or advanced pancreatic cancer who have failed one prior gemcitabine-based regimen, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the treatment of phenylketonuria (PKU) using the drug Kuvan, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for the treatment of seasonal allergic rhinitis and asthma, using various drugs such as bi 67100, montelukast, and fluticasone propionate nasal spray, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with multiple sclerosis, testing the drugs fty720 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with hypertension that is not adequately controlled despite treatment with three antihypertensive agents, and it aims to test the effectiveness of spironolactone as an additional treatment option.",
    "This sample is a phase 1/phase 2 trial for metastatic breast adenocarcinoma patients without HER2 overexpression or gene amplification, testing the efficacy of docetaxel, epirubicin, and bevacizumab as treatment options. The eligibility criteria include age between 18-75 years, no previous therapy for metastatic breast cancer, and adequate liver, renal, and bone marrow function.",
    "This sample is a phase 2 clinical trial for patients with breast cancer and metastasis, testing the effectiveness of paclitaxel and capecitabine drugs in combination with previous chemotherapy and hormonal therapy, with specific eligibility and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of plaque psoriasis, testing the efficacy of the drug fp187 compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial testing the use of doxycycline hyclate in adult patients with acute leukemia to prevent mucositis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the effectiveness of bosentan and placebo in reducing albuminuria, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for restless legs syndrome, testing the efficacy of pramipexole 0.125 mg tablets and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 trial for women with breast cancer, testing the effects of melatonin and placebo on post-operative sleep quality and depression.",
    "This sample is a phase 2 trial for patients with inoperable adenocarcinoma of the pancreas, testing the effectiveness of different drug combinations including gemcitabine and endotag-1, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia, testing the drugs ly2181308 sodium, cytarabine, and idarubicin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed or refractory acute lymphoblastic leukemia (ALL), testing the efficacy of a combination therapy including bortezomib, dexamethasone, peg-asparaginase, doxorubicin, cytarabine, methotrexate, vincristine, and triple it therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for epilepsy, testing the drug brivaracetam, with inclusion criteria including a clinical diagnosis of epilepsy and having at least 1 seizure in the 3 weeks before the first visit, and exclusion criteria including pregnancy, concomitant use of Levetiracetam, and history of status epilepticus.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the drugs mb07803 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with recurrent small-cell lung cancer (SCLC) testing the combination of oral hycamtin (topotecan) capsules and IV avastin (bevacizumab) as a treatment option, with specific eligibility and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with recurrent mantle cell lymphoma, testing the effectiveness of bortezomib and lenalidomide as treatment options, with specific eligibility criteria including histological confirmation of the disease, prior therapy with traditional cytotoxic agents, and measurable disease presence.",
    "This sample is a phase 2 trial for hormone receptor-positive breast cancer patients, testing the combination of vandetanib and anastrozole, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with rectal cancer, testing the drug capecitabine. The eligibility criteria include having clinical stage T4 or recurrent adenocarcinoma of the rectum, confirmed histology, no distant metastatic disease, and certain health parameters within normal range. Exclusion criteria include prior pelvic radiotherapy, pregnancy or lactation, recent treatment for other carcinomas, uncontrolled intercurrent illness, and major surgery within 4 weeks.",
    "This sample is a phase 2 trial for patients with advanced or metastatic breast cancer, testing the effectiveness of gemcitabine, paclitaxel, and docetaxel as potential treatments, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with breast cancer and metastatic bone disease, testing the drugs za and odanacatib, along with their matching placebos, to determine their effectiveness in treating the disease. The eligibility criteria include having histologically or cytologically-confirmed breast cancer and documented skeletal metastases, while exclusion criteria include current or recent use of oral bisphosphonate therapy.",
    "This sample is a phase 2 clinical trial for psoriasis, testing the effectiveness of the anti-IL-12 monoclonal antibody/abt-874 drug compared to a placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of carboplatin and docetaxel as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 clinical trial for patients with follicular lymphoma, testing the effectiveness of a combination therapy including bortezomib, rituximab, fludarabine, mitoxantrone, and dexamethasone, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for macular degeneration, testing the effectiveness of brimonidine tartrate implants in patients with geographic atrophy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with rheumatoid arthritis, testing the combination of cdp 6038 sc and methotrexate as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs abt-126 and placebo, with eligibility criteria including age, diagnosis, medication history, cognitive and depression scores, and overall good health.",
    "This sample is a phase 2 clinical trial for patients with gastric or gastroesophageal junction adenocarcinoma, testing the drug sunitinib, and includes specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial testing the efficacy of activated recombinant human factor vii and placebo in treating acquired bleeding disorder and trauma patients who have received a specific amount of PRBC transfusions, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with bladder cancer, testing the effectiveness of gemcitabine and cisplatin plus sorafenib as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with chronic lymphocytic leukemia, testing the effectiveness of maintenance lenalidomide as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of moderate to severe ulcerative colitis, testing the drugs placebo and rhumab beta7, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with refractory/relapsed indolent lymphomas, testing the drugs zevalin, rituximab, and ^111 in ibritumomab tiuxetan, with eligibility criteria including no anti-cancer therapy for three weeks prior to study initiation, signed informed consent, and expected survival of at least 3 months.",
    "This sample is a phase 1/phase 2 clinical trial for patients with HER-2-overexpressing breast cancer and metastatic disease, testing the efficacy of trastuzumab and rad001 drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with stage IIIB or IV non-small cell lung cancer (NSCLC) who have failed first-line chemotherapy. The study will test the effectiveness of gemcitabine hydrochloride and oxaliplatin as treatment options. Eligible patients must meet certain disease and patient characteristics criteria, and should not have any other malignancy within the past year.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of a combination of drugs including 5-fluorouracil, leucovorin, oxaliplatin, and avastin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of lapatinib and capecitabine as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for prostate cancer patients with metastases, testing the drugs zd6474 (vandetanib), bicalutamide, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with persistent asthma, testing the drug indacaterol maleate. The inclusion criteria include age range, daily treatment with a bronchodilator, and specific lung function measurements. Exclusion criteria include tobacco use, COPD, recent asthma attacks or hospitalizations, and respiratory tract infections.",
    "This sample is a phase 2 trial for adult asthmatics with mild to moderate persistent asthma, testing the effectiveness of various drugs including map0010 low dose, map0010 high dose, budesonide inhalation suspension 0.25mg, and budesonide inhalation suspension 0.5mg, based on specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the effectiveness of nicotine lower dose, nicotine higher dose, and placebo in smoking cessation for generally healthy smokers who smoke more than 5 cigarettes per day, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with breast cancer, testing the drugs ptk787 and trastuzumab, with specific eligibility criteria including HER2 gene amplification and restrictions on prior treatments and medical conditions.",
    "This sample is a phase 2 clinical trial for ustekinumab in patients with primary biliary cirrhosis, testing the efficacy of different doses of the drug compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with ovarian cancer or peritoneal cavity cancer, testing the effectiveness of lapatinib and topotecan as treatment options, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with non-small cell lung cancer, testing the drug pazopanib, with specific eligibility criteria including age, performance status, disease stage, and laboratory values.",
    "This sample is a phase 2 trial that aims to evaluate the efficacy of the drug AP214 compared to a placebo in patients undergoing cardiac surgery, valve surgery, or surgery of the aortic root or ascending part of the aorta, as well as patients with stage III chronic kidney disease. The eligibility criteria include age, type of surgery, kidney function, and exclusion criteria such as previous dosing with AP214 and participation in other clinical trials.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed or refractory CD20-positive B-cell non-Hodgkin's lymphoma, testing the efficacy of pegylated liposomal doxorubicin hydrochloride as a treatment option. The eligibility criteria include specific disease characteristics, performance status, hematopoietic, hepatic, renal, and cardiovascular requirements, as well as restrictions on prior concurrent therapies and other medical conditions.",
    "This sample is a phase 2 trial for castrate-resistant metastatic prostate cancer, testing the drugs cabazitaxel, prednisone, and granulocyte colony-stimulating factor (g-csf), with eligibility criteria including previous therapy with docetaxel, progressive disease, and Eastern Cooperative Oncology Group (ECOG) performance status 0-1.",
    "This sample is a phase 2 trial for HIV infection, testing the efficacy of tenofovir disoproxil fumarate and placebo in healthy biologic males aged 18-60, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with Crohn's disease, testing the effectiveness of naltrexone-hcl compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the effectiveness of bevacizumab, sunitinib, and paclitaxel as potential treatments, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with lung cancer and metastatic cancer, testing the drug pemetrexed disodium, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial that aims to evaluate the efficacy of various drugs, such as busulfan, clofarabine, and fludarabine, in treating hematologic malignancies, including acute myelogenous leukemia, acute lymphocytic leukemia, chronic lymphocytic leukemia, and multiple myeloma, among others. The study includes patients under 65 years old who require stem cell transplant but lack a HLA-matched sibling donor, and have specific inclusion criteria based on their disease stage and previous treatments.",
    "This sample is a phase 2 clinical trial testing the effectiveness of oral nicotine and placebo in treating smoking dependence and smoking-related diseases, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for bipolar disorder, testing the effectiveness of mcn36 (nutritional supplement) and placebo in patients who meet the criteria for bipolar disorder I or II, are symptomatic on the Hamilton Depression Scale and the Young Mania Rating Scale, and are free of medications or herbal/nutritional supplements with primarily central nervous system activity.",
    "This sample is a phase 2 trial for patients with prostate cancer, testing the drugs abr-215050 and tasquinimod against a placebo, with eligibility criteria including confirmed diagnosis, evidence of metastatic disease, and castrate levels of testosterone.",
    "This sample is a phase 2 clinical trial testing the drugs vorinostat and bortezomib in patients with relapsed or refractory T-cell non-Hodgkin lymphoma, with specific eligibility criteria including prior systemic treatment, measurable disease, and adequate organ function.",
    "This sample is a phase 2 clinical trial for asthma patients, testing the effectiveness of interferon beta 1a and placebo drugs, with eligibility criteria including symptoms of asthma, bronchodilator reversibility, bronchial hyper-responsiveness, previous hospital admission, exacerbation caused by respiratory virus, regular use of inhaled corticosteroids, and specific lung function measurements.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer who have shown at least a partial response to a salvage regimen, and it aims to evaluate the effectiveness of etoposide, ifosfamide, and topotecan hydrochloride as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with recurrent adult acute lymphoblastic leukemia, testing the effectiveness of a combination of drugs including asparaginase, methotrexate, dexamethasone, leucovorin calcium, mercaptopurine, and vincristine, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 trial for patients with adenocarcinoma of the lung, bronchoalveolar cell lung cancer, or non-small cell lung cancer, testing the drug bortezomib, with eligibility criteria including specific disease stage, performance status, organ function, and prior treatment history.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic breast cancer who have received prior chemotherapy regimens and are resistant to anthracycline and taxane. The study aims to evaluate the efficacy of hydroxychloroquine and ixabepilone as treatment options.",
    "This sample is a phase 2 clinical trial testing the combination of erlotinib plus digoxin in patients with non-small cell lung cancer, with specific eligibility criteria including prior chemotherapy regimen, serum creatinine levels, CT scan requirements, and exclusion criteria such as pregnancy, cardiac conditions, hypersensitivity to the drugs, and abnormal levels of K, Mg, and/or Ca.",
    "This sample is a phase 2 trial for HER2-positive breast cancer patients who have progressed on trastuzumab-based therapy, and it evaluates the efficacy of pertuzumab and trastuzumab as treatment options. The eligibility criteria include age, previous treatments, and cardiac health.",
    "This sample is a phase 2 trial for patients diagnosed with chronic hepatitis C genotype I who are not responsive to previous treatments, and it aims to evaluate the effectiveness of Debio 025, peginterferon alpha-2a, and ribavirin in treating the disease. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 2 trial for the treatment of bacterial pneumonia, testing the effectiveness of tigecycline and imipenem/cilastatin in patients with acute hospital-acquired pneumonia (HAP) or ventilator-associated pneumonia (VAP). The eligibility criteria include specific symptoms, chest x-ray findings, and exclusion of subjects with certain underlying conditions or contraindications to the test articles.",
    "This sample is a phase 2 trial for knee arthroplasty, testing the drugs ym150 and warfarin, with inclusion criteria including being scheduled for elective primary knee arthroplasty and having obtained written informed consent, and exclusion criteria including a history of previous VTE, increased risk of VTE, active bleeding or conditions associated with increased risk of bleeding, and planning to have surgery on the contralateral knee within 6 weeks after enrollment into the study.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD) and pulmonary hypertension, testing the effectiveness of iloprost and placebo in improving exercise capacity and symptoms.",
    "This sample is a phase 2 clinical trial for patients with recurrent adult Burkitt lymphoma or recurrent adult diffuse large cell lymphoma, testing the drug belinostat. The eligibility criteria include having measurable disease, not being eligible for stem cell transplantation, and meeting various medical requirements such as blood counts and organ function.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the drugs AndroGel and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for rectal cancer, testing the combination of capecitabine and bevacizumab as a treatment. The eligibility criteria include age, tumor status, previous treatments, performance status, and various health parameters. Exclusion criteria include previous radiotherapy or chemotherapy, other malignancies, contraindications or hypersensitivity to the drugs, and certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory B cell lymphoma, testing the drug ps341 (bortezomib), and includes eligibility criteria such as measurable disease, specific blood counts, HIV negative status, and exclusion criteria such as platelet and ANC levels within a certain range, and grade 3 peripheral neuropathy.",
    "This sample is a phase 2 clinical trial for patients with endometrial cancer, testing the drug lenvatinib. The eligibility criteria include confirmed diagnosis of endometrial carcinoma, evidence of disease progression, measurable disease, and specific health conditions.",
    "This sample is a phase 2 clinical trial for constipation predominant irritable bowel syndrome, testing the drug rdx5791, with inclusion criteria including meeting Rome III criteria for IBS-C and exclusion criteria including having IBS-D or IBS-M according to Rome III criteria.",
    "This phase 2 trial is testing the efficacy of the drug mk-6096 compared to a placebo in patients with migraine and headache, who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the combination of erlotinib and capecitabine as a treatment option, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is investigating the use of epoetin alfa in subjects with anemia and diabetes mellitus, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for depression, testing the drugs org 24448 and placebo, with eligibility criteria including a history of depression, specific depressive symptoms, and previous failed antidepressant trials.",
    "This sample is a phase 2 clinical trial for lupus erythematosus, systemic, testing the effectiveness of different doses of belimumab compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for the treatment of attention deficit hyperactivity disorder (ADHD) using the drug modafinil, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for primary central nervous system lymphoma in patients aged 60 years or older, testing the efficacy of methotrexate and temozolomide or methotrexate, procarbazine, vincristine, and cytarabine as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic or recurrent esophageal cancer, testing the effectiveness of pemetrexed and carboplatin as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with recurrent glioblastoma, gliosarcoma, anaplastic astrocytoma, anaplastic oligodendroglioma, or anaplastic oligoastrocytoma. The trial will test the drug bibf 1120 to determine its effectiveness in treating these diseases. The eligibility criteria include having measurable disease on MRI, a life expectancy of at least 12 weeks, and normal organ and marrow function.",
    "This sample is a phase 2 clinical trial for patients with symptomatic multiple myeloma, testing the drugs dexamethasone and pomalidomide, with eligibility criteria including measurable disease, ECOG performance status, ANC and platelet count, and no active infections or other active malignancies.",
    "This phase 2 trial is testing the effectiveness of g-csf plus plerixafor in patients with non-Hodgkin's lymphoma or multiple myeloma who are eligible for autologous transplantation, and have not had more than 3 prior regimens of chemotherapy. The inclusion criteria include specific blood counts, performance status, and organ function, while the exclusion criteria include previous treatment failures, certain medical conditions, and recent experimental therapy.",
    "This sample is a phase 2 trial for asthma patients, testing the efficacy of ff(100mcg)/vilanterol(25mcg) am and pm, as well as placebo am and pm, in replacing current asthma treatments. The inclusion criteria include subjects with persistent asthma, using an inhaled corticosteroid for at least 12 weeks, and having a screening pre-bronchodilator FEV1 \u2265 60% of predicted. The exclusion criteria include a history of life-threatening asthma within the last 5 years, recent asthma exacerbation requiring oral corticosteroids, and any clinically significant, uncontrolled condition or disease.",
    "This sample is a phase 2 clinical trial for patients with ErbB2-positive cancer, specifically ovarian, gastric/esophageal adenocarcinoma, uterine serous papillary, or bladder cancer, who have documented tumor progression after receiving all standard chemotherapies. The study aims to evaluate the efficacy of oral lapatinib tablets in these patients.",
    "This sample is a phase 2 trial that aims to investigate the effectiveness of cyproheptadine hydrochloride in treating unintended weight loss in children with cancer or malnutrition.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the effectiveness of dapagliflozin, metformin, and placebo in improving glycemic control, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with stage IV non-small cell lung cancer, testing the drug paclitaxel albumin-stabilized nanoparticle formulation, and includes eligibility criteria such as measurable disease, specific performance status, and normal organ function.",
    "This sample is a clinical trial for patients with advanced metastatic gastric cancer or recurrent gastric cancer, testing the drug paclitaxel in phase 1/phase 2, with specific eligibility criteria including ECOG performance status \u2264 2 and proper bone marrow, kidney, and liver function.",
    "This sample is a phase 2 trial for the drug talnetant, which aims to treat irritable colon (IBS) based on specific inclusion and exclusion criteria, and permits the use of certain medications while prohibiting others.",
    "This phase 2 clinical trial is investigating the efficacy of ixabepilone in treating various types of recurrent or refractory childhood and adult sarcomas, including rhabdomyosarcoma, synovial sarcoma, osteosarcoma, Ewing sarcoma, and Wilms tumor, among others.",
    "This phase 2 trial aims to evaluate the efficacy of theophylline, placebo, and budesonide in patients with chronic obstructive pulmonary disease (COPD) who have been symptomatic for at least 2 years and meet specific inclusion criteria, such as having moderate to severe COPD and a history of cigarette smoking. The study also outlines various exclusion criteria, such as recent respiratory tract infections, use of systemic corticosteroids, and presence of other lung diseases.",
    "This sample is a phase 2 clinical trial for patients with advanced or metastatic liver cancer, testing the effectiveness of bevacizumab (avastin) and erlotinib (tarceva) as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with squamous cell carcinoma of the head and neck, testing the effectiveness of erlotinib and temsirolimus as treatment options for platinum-refractory or platinum-ineligible patients. The eligibility criteria include specific disease characteristics, previous treatment history, and certain health parameters.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the effectiveness of gemcitabine/carboplatin and iniparib drugs, with specific eligibility criteria including prior chemotherapy regimens, ER/PR/HER-2 status, organ function, and exclusion criteria such as prior treatment with certain drugs and major medical conditions.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the effectiveness of alogliptin and voglibose drugs compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of essential tremor using sodium oxybate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with schizophrenia, testing the effectiveness of the drug ly2140023 compared to placebo and standard of care, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with relapsed or refractory diffuse large B-cell lymphoma, testing the efficacy of the drugs syb l-0501 and rituximab, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with colorectal cancer who have failed previous therapy, and it involves the drugs vandetanib and folfiri. The eligibility criteria include histologically confirmed colorectal cancer and progression on or following treatment for metastatic colorectal cancer.",
    "This sample is a phase 2 clinical trial for the drug zd6474 in patients with lung cancer who have failed previous chemotherapy regimens, and it includes detailed inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the effectiveness of albiglutide or exenatide in combination with diet and exercise therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of moderate to severe vasomotor symptoms in postmenopausal women, using drugs such as mk-6913 and 17-\u03b2 estradiol, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for Huntington disease, testing the drugs acr16 10 mg, acr16 22.5 mg, and acr16 45 mg, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for the treatment of multicentric Castleman's disease using siltuximab, placebo, and best supportive care, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer resistant to chemotherapy, testing the drug E7070, with specific eligibility criteria including prior chemotherapies, measurable lesions, age, performance status, renal and liver function, and written informed consent.",
    "This sample is a phase 1/phase 2 trial testing the drugs obatoclax mesylate and topotecan hydrochloride on patients with recurrent small cell lung cancer and unspecified adult solid tumors, with specific eligibility criteria including prior chemotherapy and stable brain metastases.",
    "This sample is a phase 2 clinical trial for previously untreated BCR-ABL-positive acute lymphoblastic leukemia (ALL) patients aged 15-64 years, testing the effectiveness of a combination of drugs including imatinib, cyclophosphamide, daunorubicin, vincristine, prednisolone, methotrexate, cytarabine, and dexamethasone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced or metastatic colorectal cancer, testing the drug simvastatin. Eligibility criteria include a diagnosis of colorectal cancer, progressive disease in the past 3 months, and failure of prior regimens. Other criteria include WHO performance status, organ function, and no history of toxicity during statin use. Prior therapy restrictions include no prior EGFR-targeting agents and no concurrent use of verapamil or amiodarone.",
    "This sample is a phase 2 clinical trial for high-risk indolent or intermediate B-cell lymphoma, testing the effectiveness of cyclophosphamide, doxorubicin hydrochloride, prednisone, and vincristine sulfate as treatment options, with specific eligibility criteria for patients.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the drug docetaxel, with eligibility criteria including histologically confirmed infiltrating carcinoma of the breast, clinically measurable disease, and specific patient characteristics such as age, sex, and performance status.",
    "This sample is a phase 2 clinical trial for patients with extrahepatic bile duct cancer or liver cancer, testing the drug fluorouracil, with specific eligibility criteria including no distant metastases, no tumor encasement of portal vein or hepatic artery, and various patient characteristics such as age, performance status, and hematopoietic and hepatic conditions.",
    "This sample is a phase 2 trial for patients with hepatocellular carcinoma (HCC) that is locally advanced or metastatic, testing the efficacy of vandetanib and best supportive care as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with advanced non-small cell lung cancer (NSCLC) that have progressed after at least 2 prior chemotherapy regimens. The study will test the effectiveness of sorafenib compared to a placebo in treating the disease. The eligibility criteria include specific disease confirmation, blood count requirements, liver function limits, prior therapy recovery, and other medical conditions that would preclude study participation.",
    "This sample is a phase 2 clinical trial for patients with newly diagnosed acute myeloid leukemia (AML) who are at least 61 years old. The trial will test the effectiveness of sorafenib, a drug used to treat cancer, compared to a placebo. The inclusion criteria include having a certain percentage of leukemic blasts in the bone marrow and providing informed consent. The exclusion criteria include having certain medical conditions, such as cardiac disease or impaired renal function, and having concurrent malignancies other than AML.",
    "This sample is a phase 2 clinical trial for osteoarthritis, testing the effectiveness of naproxen, ce-224535, and placebo in healthy adults aged 18 to 75 with knee OA, while excluding individuals with other joint diseases or who are pregnant or lactating.",
    "This phase 2 trial aims to evaluate the efficacy of preladenant, l-dopa, and other Parkinson's disease treatments in participants with moderate to severe idiopathic Parkinson's disease, with specific inclusion and exclusion criteria, and the study will exclude participants with drug-induced or atypical parkinsonism, cognitive impairment, major depression, unstable medical conditions, excessive alcohol consumption, breastfeeding, allergies to study drug, and other clinically significant conditions or situations.",
    "This phase 2 trial aims to evaluate the efficacy of rm-131, a drug for treating diabetic gastroparesis, compared to a placebo, in patients with diabetes mellitus and symptoms suggestive of gastroparesis, as well as abnormal gastric emptying and stable concomitant medications.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus or impaired glucose tolerance, testing the efficacy of canakinumab 150 mg compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for non-small-cell lung carcinoma, testing the drugs cisplatinum and docetaxel, with eligibility criteria including confirmed NSCLC, specific laboratory and lung function requirements, and exclusion criteria such as prior chemotherapy or surgery for NSCLC.",
    "This sample is a phase 2 trial for patients with chronic myelogenous leukemia (CML) who are currently on imatinib therapy. The study aims to evaluate the effectiveness of gleevec (imatinib) and valproic acid in treating CML patients who have shown a plateau in the effect of imatinib on the detected level of the bcr-abl transcript. The inclusion criteria include age, life expectancy, ECOG performance status, and hepatic and renal function. The exclusion criteria include pregnancy, concurrent chemotherapy or radiation therapy, severe medical problems, and hypersensitivity to valproic acid.",
    "This sample is a phase 2/phase 3 trial for the treatment of type 2 diabetes mellitus using alogliptin and pioglitazone, with eligibility criteria including completion of a previous study, understanding and compliance with protocol requirements, and exclusion criteria related to hepatic impairment, renal impairment, and cardiac failure.",
    "This sample is a phase 2 trial for patients with metastatic adenocarcinoma of the prostate, testing the efficacy of carboplatin, rad 001, and prednisone as treatment options, with specific eligibility criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with schizophrenia, testing the effectiveness of lurasidone and haloperidol compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of type 2 diabetes mellitus, testing the drugs placebo, tak-875, sitagliptin, and combinations of tak-875 and sitagliptin, with eligibility criteria including a historical diagnosis of type 2 diabetes, specific BMI and HbA1c levels, and stable use of metformin.",
    "This sample is a phase 2 trial for breast cancer patients with HER2 overexpressing tumors, testing the effectiveness of lapatinib, trastuzumab, and endocrine drugs, with specific eligibility criteria including tumor size, age, and absence of brain or leptomeningeal disease.",
    "This sample is a phase 2 clinical trial that aims to evaluate the effectiveness of leuprolide acetate depot and matched placebo in patients with Hodgkin disease, non-Hodgkin lymphoma, multiple myeloma, or mantle cell lymphoma who are eligible for hematopoietic stem cell transplant, and meet specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for HIV-positive patients who have been taking anti-HIV therapy and have a viral load between 500 and 10,000 copies/ml. The study will test the effectiveness of abacavir sulfate in reducing viral load.",
    "This sample is a phase 1/phase 2 trial for patients with lymphoma and non-Hodgkin's lymphoma, testing the drug pci-24781, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial that focuses on patients with anemia, leukemia, lymphoma, and other related diseases, and it investigates the use of darbepoetin alfa and epoetin alfa drugs to treat these conditions. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 1/phase 2 trial for patients with leukemia, specifically acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or acute leukemia of ambiguous lineage. The study aims to evaluate the efficacy of drugs such as clofarabine, cytarabine, and methotrexate in patients who have relapsed or are refractory to prior induction therapy. Eligibility criteria include specific disease characteristics, performance status, kidney and liver function, and prior therapy history.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the effectiveness of capecitabine, oxaliplatin, and trastuzumab as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial testing the effectiveness of [s,s]-reboxetine + pregabalin and pregabalin in treating pain that persists for more than 3 months after the healing of shingles skin rash, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C, genotype 1, testing the drugs copegus, pegasys, and ro4588161, with inclusion criteria including adult patients aged 18-65 with compensated liver disease, and exclusion criteria including infection with any HCV genotype other than genotype 1 and previous treatment for CHC.",
    "This sample is a phase 2 clinical trial for relapsing-remitting multiple sclerosis, testing the effectiveness of a placebo drug on subjects who meet specific eligibility criteria, including confirmed diagnosis of MS, baseline EDSS between 0.0 and 5.0, and evidence of relapse or gadolinium-enhancing lesions on MRI.",
    "This sample is a phase 2 clinical trial for patients with squamous cell carcinoma of the head and neck, testing the effectiveness of cyclophosphamide, indomethacin, zinc, and omeprazole as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with superficial bladder cancer, testing the effectiveness of gemcitabine as a chemotherapy drug, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of major depressive disorder, testing the drugs cp-316,311, placebo, and sertraline, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for major depressive disorder, testing the effectiveness of a vasopressin v1b receptor antagonist (ssr149415) compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for Parkinson's disease patients who have end-of-dose deterioration despite optimal levodopa therapy, and it will test the efficacy of the drug bia 9-1067 compared to placebo and levodopa/carbidopa or levodopa/benzerazide.",
    "This sample is a phase 1/phase 2 trial for patients with non-resectable or metastatic pancreatic cancer, testing the effectiveness of everolimus, cetuximab, irinotecan, capecitabine, and oxaliplatin as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for the treatment of schizophrenia, testing the drugs sb-773812 and olanzapine, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2/phase 3 trial for patients with Parkinson's disease, testing the efficacy of three different doses of the drug CEP-1347 in improving symptoms, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial studying the effectiveness of mf59 adjuvant and placebo in preventing cytomegalovirus infections in mothers who have delivered a newborn infant within the previous 12 months, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced non-small cell lung cancer, testing the drug erlotinib (Tarceva) as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for psoriasis, testing the drugs cromoglicate and placebo, with eligibility criteria including a clinical diagnosis of stable plaque psoriasis, specific disease severity and treatment area requirements, and exclusion criteria related to previous treatments and other skin disorders.",
    "This sample is a phase 2 trial for patients with acute heart failure, testing the drug acipimox. The inclusion criteria include NYHA class III-IV and ejection fraction <35, while the exclusion criteria include age <18 or >85, allergies, renal failure, and other conditions.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndromes and acute myelogenous leukemia, testing the drug lenalidomide as a treatment option. The eligibility criteria include specific disease characteristics, previous cancer therapy discontinuation, and certain laboratory test results.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) that are ineligible for surgery, testing the drug erlotinib hydrochloride. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with advanced stages IIB/III/IV cutaneous T-cell lymphoma, testing the drug aminocamptothecin. Eligible patients must have measurable or evaluable disease, meet certain patient criteria, and have not received certain prior therapies.",
    "This sample is a phase 2 trial for patients with ErbB2- (HER2/neu-) overexpressing invasive breast cancer, testing the efficacy of trastuzumab, paclitaxel, fec75, and lapatinib as preoperative chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with stable coronary artery disease (CAD), testing the drug A-002. The inclusion criteria include being \u226518 years old, having stable CAD, and being able to comply with the protocol requirements. The exclusion criteria include recent hospitalization for acute coronary syndrome or ST-segment elevation acute myocardial infarction, chronic inflammatory disease, recent cancer treatment, severe liver or renal impairment, uncontrolled diabetes, and pregnancy.",
    "This sample is a phase 2 clinical trial for patients diagnosed with myeloproliferative neoplasms (MPN) using the drug itacitinib, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the effectiveness of docetaxel plus doxercalciferol and docetaxel plus placebo in treating the disease, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with Parkinson's disease and peripheral edema, testing the drug domperidone to treat leg edema caused by pramipexole or ropinirole treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the drug \"a3309\" in patients with constipation, specifically chronic constipation, and the eligibility criteria include meeting protocol specified criteria for constipation and having no clinically relevant findings for physical exam, ECG, laboratory tests, and colonoscopy.",
    "This sample is a phase 2 trial for asthma, testing the effectiveness of mometasone, montelukast, and placebo as comparators, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with extensive stage small cell lung cancer or recurrent small cell lung cancer, testing the efficacy of topotecan hydrochloride and 7-hydroxystaurosporine as a second-line treatment option. The eligibility criteria include specific disease characteristics, prior treatment history, and certain health parameters.",
    "This sample is a phase 2 trial for patients with transitional cell carcinoma, testing the drug paclitaxel, with specific eligibility criteria including prior chemotherapy, ECOG performance status, and organ function requirements.",
    "This sample is a phase 2 clinical trial for patients with recurrent lung cancer, testing the efficacy of erlotinib as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This phase 2 trial is investigating the efficacy of custirsen sodium and docetaxel in treating patients with metastatic or locally advanced breast cancer that is not curable with standard therapy, and who have no known CNS metastases, with specific eligibility criteria including measurable disease and certain patient characteristics.",
    "This sample is a phase 2 clinical trial testing the effectiveness of lisinopril, losartan potassium, benazepril hydrochloride, and ramipril, all blood pressure medications, in patients with hypertension and solid tumor malignancy, who are not on active chemotherapy or radiation therapy.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the drug ly2189265 and a placebo, with inclusion criteria including specific diabetes medication usage, HbA1c levels, blood pressure, weight stability, BMI, and willingness to wear a blood pressure monitoring device, and exclusion criteria including recent heart-related events, certain medications, specific medical conditions, and history of certain diseases.",
    "This sample is a phase 2 trial for patients with newly diagnosed metastatic renal cell carcinoma, testing the drugs zd6126 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for rheumatoid arthritis, testing the drugs ask8007 and placebo, with inclusion criteria including meeting the ARA 1987 revised criteria for RA classification and being treated with MTX, LEF, or SS2 for at least 4 months prior to baseline.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer (NSCLC) patients, testing the efficacy of vinorelbine, cisplatin, bevacizumab, docetaxel, and gemcitabine as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with metastatic renal cell carcinoma, testing the drug su011248 capsule, and the eligibility criteria include having histologically proven renal cell carcinoma with clear cell histology and excluding any previous cellular therapy or systemic molecular-targeting therapy for RCC.",
    "This sample is a phase 2 trial for patients with HER2-positive metastatic breast cancer who are resistant to trastuzumab, and it aims to evaluate the efficacy of ridaforolimus in combination with trastuzumab as a treatment option.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the efficacy of capecitabine and mitomycin c as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced stage IIIb or stage IV nonsquamous non-small cell lung cancer, testing the effectiveness of two drug combinations (paclitaxel + carboplatin + bevacizumab and carboplatin + paclitaxel + bevacizumab + pf-3512676) in treating the disease. The eligibility criteria include specific disease stage, performance status, and measurable disease, while exclusion criteria include certain types of lung cancer, CNS metastasis, and prior systemic treatment for NSCLC.",
    "This sample is a phase 2 clinical trial for patients with stage III ovarian, fallopian tube, or primary peritoneal carcinoma, testing the effectiveness of cisplatin, liposomal doxorubicin, and paclitaxel as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 trial for lymphoma patients, testing the effectiveness of various drugs including campath-1h, g-csf, gm-csf, bcnu, stem cell transplant, preparative regimen for allogenic stem cell transplantation, cytarabine, etoposide, melphalan, campath, fludarabine, and cyclophosphamide, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial for patients with male breast cancer, stage IIIB, stage IIIC, or stage IV breast cancer, testing the drugs vorinostat and paclitaxel, with specific eligibility criteria including disease stage, performance status, blood counts, liver and kidney function, and exclusion criteria such as recent chemotherapy or radiotherapy, and allergies to study drugs or similar compounds.",
    "This sample is a phase 2 trial for eosinophilic esophagitis, testing the efficacy of low dose budesonide tablet, high dose budesonide tablet, high dose budesonide suspension, and placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for various types of leukemia, myelodysplastic syndrome, lymphoma, and paroxysmal nocturnal hemoglobinuria, where eligible participants will receive systematic chemotherapy and antibodies. The inclusion criteria include specific diagnoses and disease statuses, age range, suitable donor availability, and certain health parameters. Exclusion criteria include allergies, lactation, pregnancy, and active central nervous system leukemia.",
    "This sample is a phase 2 clinical trial for small cell lung cancer, testing the drugs irinotecan, carboplatin, and sunitinib, with eligibility criteria including confirmed diagnosis, measurable disease, specific performance status, adequate bone marrow and organ function, resolution of prior therapy effects, and informed consent.",
    "This sample is a phase 1/phase 2 trial that focuses on patients with various diseases such as graft versus host disease, leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. The trial involves the use of drugs like busulfan, cyclophosphamide, methotrexate, and tacrolimus, and has specific eligibility criteria for patients and donors.",
    "This sample is a phase 2 clinical trial for patients with colorectal cancer, testing the drugs folfiri, ro5083945, and cetuximab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic hepatitis B, testing the efficacy of tenofovir df and emtricitabine/tenofovir df drugs in treating the disease, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with stage IV malignant melanoma, testing the drug everolimus. The eligibility criteria include having measurable disease, specific hematopoietic and hepatic levels, and no concurrent chemotherapy or immunosuppressive therapy.",
    "This sample is a phase 2 trial for the drug etelcalcetide in patients with secondary hyperparathyroidism, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is investigating the effectiveness of anastrozole and goserelin acetate in treating patients with recurrent or metastatic breast cancer, with specific eligibility criteria including confirmed breast cancer, hormone receptor-positive disease, and stable brain metastases.",
    "This sample is a phase 2 trial testing the drugs etanercept and placebo on oncology patients with stomatitis, who are enrolled in PBSCT/BMT protocols, to assess the inflammatory response and drug-related adverse events.",
    "This sample is a phase 2 trial for patients with rheumatoid arthritis, testing the drugs nnc 0151-0000-0000 and placebo, with specific inclusion and exclusion criteria.",
    "This phase 2 trial aims to evaluate the efficacy of adl5859, duloxetine, and placebo in treating peripheral neuropathy and neuropathic pain in patients with diabetes mellitus, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for eosinophilic esophagitis, testing the effectiveness of budesonide plus prevacid and placebo plus prevacid as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C virus infection who have had unsuccessful HCV treatment, and the drug being tested is cts-1027. The inclusion criteria include liver impairment, specific blood test results, and willingness to use contraception. The exclusion criteria include severe liver disease, hepatocellular carcinoma, HIV infection, and prior or concomitant drug therapy for HCV.",
    "This sample is a phase 2 clinical trial for patients with symptomatic multiple myeloma, testing the effectiveness of bendamustine, velcade, and dexamethasone as a treatment option. The eligibility criteria include specific disease criteria, prior treatment history, laboratory test results, and other medical conditions.",
    "This sample is a phase 2 clinical trial for asthma, testing the drugs bi671800, placebo, and montelukast, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 clinical trial aims to evaluate the efficacy of thalomid, lenalidomide, clarithromycin, and dexamethasone in treating newly diagnosed multiple myeloma patients with poor prognostic factors, while ensuring they meet specific eligibility criteria such as age, disease stage, and laboratory parameters.",
    "This sample is a phase 2 clinical trial for patients with metastatic melanoma, testing the combination of everolimus and imatinib as a treatment option. The eligibility criteria include having measurable disease, prior treatment limitations, specific organ and marrow function requirements, and the use of contraception during the study. Exclusion criteria include receiving other investigational agents or prior treatment with an mTOR inhibitor, known brain metastases, uncontrolled intercurrent illness, pregnancy or breastfeeding, and HIV-positive status.",
    "This sample is a phase 2 clinical trial for patients with dementia of the Alzheimer type, testing the drug trx0014 and a placebo, with inclusion criteria including a clinical diagnosis of Alzheimer's disease and mild to moderate dementia, and exclusion criteria including sensitivity to trx0014, use of other anti-dementia drugs, and significant impairment of renal, hepatic, or hematological function.",
    "This sample is a phase 2 trial testing the drug dabigatran etexilate for patients with atrial fibrillation and stroke, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with chronic myelogenous leukemia and acute lymphoblastic leukemia (philadelphia chromosome positive), testing the drug nilotinib. The eligibility criteria include being diagnosed with Ph+ ALL who are relapsed or refractory to standard therapy, or being diagnosed with CML in blast crisis or accelerated phase or chronic phase who are resistant or intolerant to imatinib. Exclusion criteria include significant or serious uncontrolled cardiovascular disease, impairment of gastrointestinal function, pregnancy or breastfeeding, and other concurrent severe medical conditions.",
    "This sample is a phase 2/phase 3 trial for Parkinson's disease, testing the efficacy of tozadenant (syn115) at different doses, along with levodopa and placebo, in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for postmenopausal women with breast cancer and bone diseases, testing the eligibility criteria for adjuvant therapy with aromatase inhibitors and the use of vitamin D as a drug.",
    "This sample is a phase 2 trial for amyotrophic lateral sclerosis (ALS) patients, testing the drug thalidomide, with specific inclusion and exclusion criteria related to disease diagnosis, duration, and ALSFRS-R score.",
    "This sample is a phase 1/phase 2 clinical trial for patients with symptomatic multiple myeloma, where the drug being tested is busulfan, and the eligibility criteria include age, renal function, pulmonary function, cardiac function, and myeloma markers.",
    "This sample is a phase 2 trial testing the drug rituximab for previously untreated symptomatic classical C-GVHD, a condition that occurs after allogeneic stem cell transplant, and the eligibility criteria include having at least 3 sites of organ involvement or individual organ score of at least 2, being 18 years or older, having an ECOG performance status of 0-2, and being accessible for treatment and follow-up.",
    "This phase 2 trial aims to evaluate the effectiveness of the drug afn-12520000 in treating various skin and subcutaneous tissue bacterial infections, wound infections, cutaneous abscesses, burn infections, and cellulitis, with specific eligibility criteria for patients to be included in the study.",
    "This phase 2 trial is testing the drug rad001 (everolimus) in patients with systemic mastocytosis, with specific eligibility criteria including age, liver function, and exclusion of certain medical conditions and medications.",
    "This sample is a phase 2 clinical trial for cystic fibrosis patients with the G551D mutation, testing the efficacy of ivacaftor and placebo, with inclusion criteria including a minimum weight of 40 kg, confirmed diagnosis of CF and G551D mutation, and a minimum FEV1 of 40% of predicted normal.",
    "This sample is a phase 2/phase 3 trial for patients with low-grade B-cell lymphoma, testing the effectiveness of rituximab in combination with standard chop or bi-weekly chop chemotherapy, with specific eligibility criteria including age, disease stage, and prior treatment history.",
    "This sample is a phase 2 clinical trial for patients with intermittent claudication, testing the drugs ataciguat, placebo, and cilostazol, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed or refractory multiple myeloma, testing the efficacy of bortezomib and sorafenib as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with castration-resistant prostate cancer, testing the drugs rad001 and bicalutamide, with specific inclusion and exclusion criteria outlined in the protocol.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the combination of gk activator and metformin as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of pulmonary hypertension using the drug tadalafil, with specific eligibility criteria including biopsy proven sarcoidosis, certain pulmonary pressure measurements, lung function tests, and stable sarcoidosis treatment regimen.",
    "This sample is a phase 2 trial testing the drug nnc126-0083 and placebo in subjects with growth hormone disorder and adult growth hormone deficiency, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic pancreatic cancer, testing the effectiveness of gemcitabine and lapatinib as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with stage IV breast cancer, testing the effectiveness of gemcitabine as a treatment option, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with relapsed/refractory multiple myeloma, testing the effectiveness of bortezomib, dexamethasone, and doxorubicin hcl liposome as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for individuals with velo-cardio-facial syndrome and psychosis, testing the effectiveness of metyrosine and placebo in treating symptoms, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with prostatic neoplasms, testing the drugs cetuximab and docetaxel, with eligibility criteria including histologic proof of prostatic adenocarcinoma, negative bone scan and MRI, and adequate bone marrow, hepatic, and renal function.",
    "This phase 2 trial is testing the drug pivanex in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), who meet specific eligibility criteria.",
    "In this phase 2 trial, the drug tasocitinib plus methotrexate, tofacitinib plus placebo methotrexate, and placebo tofacitinib plus methotrexate will be tested on adult patients with moderate to severe early rheumatoid arthritis who are methotrexate and biologic disease modifying antirheumatic drug naive.",
    "This sample is a phase 2 clinical trial for patients with neoplastic meningitis and lymphoma, testing the effectiveness of cytarabine liposome injection as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for HIV infection, testing the efficacy of ritonavir and fosamprenavir as part of an antiretroviral therapy regimen, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with Parkinson's Disease, testing the effectiveness of afq056 with l-dopa and placebo in reducing OFF time and dyskinesias.",
    "This sample is a phase 2 clinical trial for patients with metastatic uveal melanoma, testing the drug temozolomide, and includes eligibility criteria such as measurable disease, performance status, and various laboratory values.",
    "This sample is a phase 2 clinical trial for patients with Parkinson's disease experiencing end-of-dose motor fluctuations, testing the efficacy of different doses and formulations of levodopa/DDCI, including Stalevo, in reducing off time and improving motor symptoms.",
    "This sample is a phase 2 trial for the drug sapropterin dihydrochloride in patients with intermittent claudication, a symptom of peripheral artery disease (PAD), and it includes eligibility criteria such as age, diagnosis criteria, and medication restrictions.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the drug laquinimod, and includes eligibility criteria such as a minimum 3-month diagnosis of Crohn's disease and moderate to severe symptoms as determined by the CDAI score.",
    "This sample is a phase 2 trial testing the drug fg-4592 in patients with dialysis and anemia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for individuals with HIV infection who have prior resistance to NNRTIs, and it aims to evaluate the efficacy of the drug TMC125 in combination with other antiretroviral therapies.",
    "This sample is a phase 2 trial for patients with congestive heart failure (CHF) who remain fluid overloaded despite standard treatment, and the drug being tested is extraneal.",
    "This sample is a phase 1/phase 2 trial for the drug rituximab in patients with rheumatoid arthritis, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 2 clinical trial for patients with gastric cancer, testing the effectiveness of capecitabine and oxaliplatin as treatment options, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 2 clinical trial for the treatment of benign prostatic hyperplasia (BPH) using the drugs tadalafil and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with malignant melanoma or melanoma, testing the drug depsipeptide, and includes eligibility criteria such as stage of disease, cardiac health, age, and prior treatments.",
    "This sample is a phase 2 clinical trial for pediatric subjects with refractory partial onset seizures, testing the effectiveness of levetiracetam as an antiepileptic drug, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with unresectable AJCC Stage III/IV malignant melanoma, testing the drug cyclophosphamide, with eligibility criteria including age \u226518, histologic diagnosis of melanoma, measurable disease, and specific laboratory values within certain ranges.",
    "The sample is a phase 1/phase 2 trial that aims to test the effectiveness of lapatinib, carboplatin, and paclitaxel in treating relapsed ovarian, primary peritoneal, fallopian tube carcinoma patients, as well as stage IV metastatic breast cancer patients who have failed previous chemotherapies.",
    "This sample is a phase 2 trial for the treatment of restless legs syndrome, testing the drugs aplindore and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for esophageal cancer patients, testing the drug paclitaxel, with inclusion criteria including measurable disease, previous chemotherapy regime, age 20 or older, and ECOG PS of 0-1, and exclusion criteria including previous therapy with Taxanes.",
    "This sample is a phase 2 clinical trial for patients with mesothelioma, testing the effectiveness of pemetrexed and cisplatin as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial testing the drugs akb-6548 and placebo on patients with anemia and kidney disease, with specific eligibility criteria including age, kidney function, hemoglobin levels, and iron levels.",
    "This sample is a phase 2 trial for the treatment of painful diabetic neuropathy, testing the drugs grt3938y and placebo, with inclusion criteria including symmetrical painful diabetic peripheral neuropathy and exclusion criteria including hypersensitivity to opioids and acetaminophen, confounding painful conditions, and significant vascular disease.",
    "This sample is a phase 2 clinical trial for patients with breast cancer, testing the drug docetaxel. The eligibility criteria include having histologically confirmed breast cancer with distant metastatic disease, measurable disease, and specific patient characteristics such as age, sex, and performance status.",
    "This sample is a phase 1/phase 2 trial testing the drugs ino-8875 and placebo for the treatment of ocular hypertension and glaucoma, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drug glycopyrronium bromide. The inclusion criteria include age 40-75, a clinical diagnosis of moderate to severe COPD, and a demonstrated response to ipratropium. The exclusion criteria include pregnancy, recent hospitalization for airway disease, and history of lung volume reduction surgery or chest/lung irradiation.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the drug fulvestrant. The inclusion criteria include having confirmed adenocarcinoma of the prostate, receiving LHRH agonists, and having a rise in PSA despite anti-androgen withdrawal. The exclusion criteria include concomitant hormonal therapy other than an LHRH and history of hypersensitivity to fulvestrant.",
    "This sample is a phase 2 trial testing the drug dasatinib in patients with stage III unresectable or stage IV melanoma, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) testing the effectiveness of carboplatin, cediranib maleate, and gemcitabine hydrochloride as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with metastatic prostate adenocarcinoma that is unresponsive to hormone therapy and mitoxantrone-based chemotherapy. The study will test the effectiveness of estramustine, docetaxel, and carboplatin as treatment options. The eligibility criteria include having a histological diagnosis of prostate adenocarcinoma, metastatic disease, and specific progression criteria.",
    "This sample is a phase 2 trial for psoriasis patients, testing the drug cc10004, and the eligibility criteria include having severe plaque type psoriasis, meeting specific clinical laboratory criteria, and being a candidate for photo/systemic therapy.",
    "This sample is a phase 2 trial for patients with essential tremor, testing the effectiveness of the drug t2000 in treating the condition, with specific inclusion and exclusion criteria provided.",
    "This sample is a phase 2 clinical trial for patients with HCV infection who have previously been treated with interferon therapy, and it will test the efficacy of the drugs gs-9450 and gs-9450 placebo in achieving a sustained viral response. The eligibility criteria include age, BMI, liver function, and previous treatment history, while the exclusion criteria include pregnancy, liver disease, autoimmune disease, and recent use of certain medications.",
    "This sample is a phase 2 clinical trial for patients with advanced ovarian epithelial or primary peritoneal cancer, testing the efficacy of cisplatin, alvocidib, and cisplatin/flavopiridol as treatment options, with specific eligibility criteria and restrictions on prior treatments.",
    "This sample is a phase 2 clinical trial for patients with relapsed or progressive multiple myeloma. The study aims to evaluate the efficacy and safety of melphalan, velcade, thalidomide, and dexamethasone as treatment options. The inclusion criteria include having measurable disease, specific performance status, platelet count, ANC, renal and hepatic function, and signed informed consent. Exclusion criteria include recent chemotherapy or radiotherapy, significant neurotoxicity, hepatic dysfunction, heart failure, recent myocardial infarction, uncontrolled infection, history of ventricular cardiac arrhythmias, poorly controlled hypertension or diabetes, and pregnancy or breastfeeding.",
    "This sample is a phase 2 trial for patients with stage I-III invasive breast cancer, testing the combination of vorinostat and tamoxifen as neoadjuvant treatment before surgery, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the effectiveness of cdb-2914 (ulipristal acetate) and placebo in women aged 18-35 for contraception, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for anal cancer, testing the drugs cisplatin, fluorouracil, and mitomycin c, with eligibility criteria including histologically confirmed squamous cell anal carcinoma and specific tumor characteristics.",
    "This sample is a phase 2 clinical trial for patients with gastrointestinal stromal tumors, testing the effectiveness of imatinib mesylate (gleevec) as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the treatment of depressive disorder using the drugs gsk372475 and paroxetine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial testing the drug azd2423 and placebo for patients with neuropathic pain due to painful diabetic polyneuropathy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drugs ns1209 and lidocaine for the treatment of neuropathic pain and allodynia after a peripheral nerve injury, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is testing the effectiveness of xp21279 and carbidopa, sinemet, and placebos in treating Parkinson's disease patients with predictable motor fluctuations, who are currently on stable QID or 5 times daily regimens of Sinemet or carbidopa-levodopa.",
    "This sample is a phase 2 clinical trial for patients with clinical stage I, II, or III operable invasive mammary carcinoma, specifically targeting HER2-positive and ER-positive/PR-positive breast cancer. The trial aims to evaluate the efficacy of lapatinib ditosylate and letrozole as neoadjuvant therapy prior to surgical treatment.",
    "In this sample, the phase of the trial is phase 2 and the disease being studied is diabetes mellitus. The icd-10 codes associated with the disease include P70.2, O24.92, Z83.3, E10.65, E10.9, E11.65, and E11.9. The drugs being tested are rosuvastatin and atorvastatin, and the eligibility criteria include hyperlipidemia, urinary protein, and diabetes. Exclusion criteria include previous rosuvastatin treatment within 6 months, statin intolerance, and severe hypertension.",
    "This sample is a phase 2 trial for peripheral T-cell lymphoma, testing the drugs ontak and chop chemotherapy, with specific eligibility criteria including prior treatment and measurable disease sites.",
    "This sample is a phase 2 clinical trial for patients with recurrent uterine sarcoma and uterine leiomyosarcoma, testing the effectiveness of sunitinib malate as a treatment option. The eligibility criteria include specific disease characteristics, prior treatment history, and various health parameters.",
    "This sample is a phase 1/phase 2 trial for patients with hepatocellular carcinoma (HCC) who are not eligible for curative therapy, testing the drug denspm for its effectiveness in treating HCC. The eligibility criteria include having histologically proven HCC or meeting specific criteria if biopsy is not possible, having measurable disease, and meeting certain laboratory values. The exclusion criteria include recent localized therapy or systemic therapy for HCC, receiving another investigational therapy, having unstable serious medical conditions, and having certain contraindications.",
    "This sample is a phase 2 clinical trial for patients with advanced hepatocellular carcinoma, testing the drug apatinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastatic or non-resectable soft tissue sarcoma, testing the effectiveness of adriamycin and trofosfamide as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with diffuse large B-cell lymphoma (DLBCL) who have relapsed or are refractory to combination chemotherapy. The study will test the effectiveness of lenalidomide, gemcitabine, oxaliplatin, rituximab, and etoposide in treating DLBCL. The inclusion criteria include histologically proven DLBCL, measurable disease, and an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. Exclusion criteria include other lymphoma histologies, history of malignancies other than DLBCL, eligibility for autologous stem cell transplant, and neuropathy grade 4.",
    "This sample is a phase 2 clinical trial for bladder cancer, testing the effectiveness of cisplatin, doxorubicin hydrochloride, methotrexate, and vinblastine as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 clinical trial for patients with acute myeloid leukemia, myelodysplastic syndrome, and chronic myeloid leukemia, testing the effectiveness of drugs such as clofarabine, busulfan, fludarabine, thymoglobulin, and filgrastim, with specific eligibility criteria including age, donor compatibility, performance status, and various health parameters.",
    "This sample is a phase 2 clinical trial for patients with metastatic/unresectable melanoma, testing the effectiveness of the drug vorinostat, a histone deacetylase inhibitor, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of aclidinium 200 \u03bcg / formoterol 12 \u03bcg, placebo, formoterol 12 \u03bcg, and aclidinium 200 \u03bcg in improving lung function and symptoms. The inclusion criteria include age between 40 and 80 years old, clinical diagnosis of stable moderate to severe COPD, smoking history of at least 10 pack-years, and specific lung function measurements. The exclusion criteria include asthma, recent COPD exacerbation or respiratory infection, and certain cardiovascular and ophthalmic conditions.",
    "This phase 2 trial is testing the drugs prochymal\u2122 and placebo on subjects with moderate or severe chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for hypertension, testing the drugs mk0736, mk0916, and placebo, with inclusion criteria based on blood pressure levels and exclusion criteria including pre-menopausal women and patients taking more than two blood pressure lowering medications.",
    "This sample is a phase 2 trial for patients with inoperable stage IIIA and selected IIIB non-small cell lung cancer (NSCLC), testing the efficacy of carboplatin and pemetrexed disodium as treatment options, with specific eligibility criteria including histologically or cytologically documented NSCLC, measurable disease, ECOG performance status 0-1, negative PET scan for distant metastasis, and various laboratory value requirements.",
    "This sample is a phase 2 clinical trial for patients with esophageal cancer, testing the effectiveness of cisplatin and irinotecan hydrochloride as treatment options, with specific eligibility criteria including disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the drugs uk-432,097 and placebo. The inclusion criteria include a diagnosis of COPD, a smoking history of at least 10 pack-years, and stable disease for at least 1 month prior to screening. Exclusion criteria include more than 2 exacerbations of COPD in the preceding year and a history of respiratory failure or significant disease instability.",
    "This sample is a phase 2 trial testing the drugs zd6126, placebo, 5-fluorouracil, leucovorin, and oxaliplatin on patients with metastatic colorectal carcinoma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for chronic myelogenous leukemia (CML) patients who have not received previous treatment. The study will evaluate the effectiveness of nilotinib and pegylated interferon 2a in combination as a treatment option. The inclusion criteria include performance status, duration of CML diagnosis, and various organic and blood function requirements. Exclusion criteria include prior TKI or interferon treatment, certain medical conditions, and recent surgeries or investigational treatments.",
    "This phase 2 trial is testing the effectiveness of g-csf plus plerixafor in patients with non-Hodgkin's lymphoma or multiple myeloma who are eligible for autologous transplantation, and have not had more than 3 prior regimens of chemotherapy.",
    "This sample is a phase 2 trial for the treatment of psoriasis vulgaris involving the face and intertriginous areas, using calcipotriol plus hydrocortisone (leo 80190) as a topical treatment. The inclusion criteria include specific disease severity and treatment area requirements, while the exclusion criteria include restrictions on previous treatments and certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) who have progressed while receiving treatment with a tyrosine kinase inhibitor targeting the EGFR pathway. The trial will test the efficacy of cetuximab, a monoclonal antibody, in treating the disease. The inclusion criteria include pathologically confirmed stage IIIB or IV recurrent or progressive NSCLC, measurable disease, suitable tissue sample for EGFR mutational analysis, and ECOG Performance Status 0-2. The exclusion criteria include pregnancy or breastfeeding, active concurrent malignancy, uncontrolled cardiac disease, uncontrolled seizure disorder or active neurological disease, prior severe infusion reactions to a monoclonal antibody, prior chemotherapy regimen within 21 days prior to study entry, and any concurrent chemotherapy or other investigational agents.",
    "This phase 2 trial aims to evaluate the efficacy of arry-371797, p38 inhibitor, oxycodone hydrochloride (hcl) extended release (er), and placebo in reducing moderate to severe pain in patients with osteoarthritis of the knee, who have been on nonsteroidal anti-inflammatory drugs (NSAIDs) and have discontinued opioids prior to the study.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast adenocarcinoma, testing the effectiveness of vinorelbine and bevacizumab in combination as a chemotherapy regimen. The eligibility criteria include previous chemotherapy treatment, measurable disease, specific liver and kidney function, and no brain metastases without prior radiation therapy.",
    "This sample is a phase 2 trial for patients with lung cancer, pulmonary complications, and radiation fibrosis, testing the drug captopril in combination with radiotherapy, with specific eligibility criteria including disease stage, performance status, and various health parameters.",
    "This sample is a phase 2 trial for insomnia, testing the efficacy of the drug \"zaleplon ap formulation\" compared to a placebo capsule, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial aims to evaluate the efficacy of amg 223, a drug, in patients with end stage renal disease, chronic kidney disease, hyperphosphatemic kidney disease, and other related diseases, who meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for HIV infections, testing the effectiveness of various drugs including emtricitabine/tenofovir disoproxil fumarate and tenofovir 1% vaginal gel, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with Crohn's disease or ulcerative colitis and mild to moderate anemia, testing the effectiveness of iron supplement and vitamin E in treating these conditions.",
    "This sample is a phase 2/phase 3 trial testing the use of gabapentin in patients undergoing elective surgery for open unilateral inguinal herniorraphy, with specific inclusion and exclusion criteria. The diseases being studied include pain, analgesia, and inguinal hernia.",
    "This sample is a phase 2 clinical trial for the treatment of irritable bowel syndrome (IBS) with the drug eluxadoline. The study includes specific inclusion and exclusion criteria for patient eligibility, such as a diagnosis of IBS with a subtype of diarrhea and exclusion of patients with other GI disorders.",
    "This phase 2 trial is testing the effectiveness of clofarabine, idarubicin, and cytarabine in treating acute myeloid leukemia patients who are chemotherapy-na\u00efve and meet specific eligibility criteria.",
    "This sample is a phase 2 trial for patients with incurable metastatic renal cell carcinoma who have progressed on or within 6 months of stopping VEGF-targeted therapy. The study will evaluate the efficacy of everolimus and gdc-0980 as potential treatments for this disease.",
    "This sample is a phase 2 trial for previously untreated stage III, IV, or bulky stage II diffuse large B-cell non-Hodgkin's lymphoma patients, testing the efficacy of cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone as treatment options, with specific eligibility criteria and required diagnostic tests.",
    "This sample is a phase 2 trial for patients with locally advanced or metastatic pancreatic cancer who have progressed after standard first-line therapy, and it will test the efficacy of bortezomib and panobinostat as potential treatments.",
    "This sample is a phase 2 trial for patients with atherogenic dyslipidaemia and abdominal obesity, testing the effectiveness of the drug gft505 80mg compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with lymphoblastic lymphoma or acute lymphoblastic leukemia, testing the effectiveness of various drugs including cytarabine, decitabine, and doxorubicin hydrochloride, among others, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastatic or recurrent renal cell carcinoma, testing the drugs cediranib and cediranib placebo, with inclusion and exclusion criteria related to previous anti-cancer therapy, diabetes, and high blood pressure.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the effectiveness of the drug krp-104 in combination with metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug rp5063 and aripiprazole against a placebo for patients with acute schizophrenia or schizoaffective disorder, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for psoriasis, testing the drug placebo, with specific inclusion and exclusion criteria for each part of the trial.",
    "This sample is a phase 2 clinical trial for patients with recurrent and/or metastatic head and neck squamous cell carcinoma, testing the drug SU011248 for palliative treatment. The eligibility criteria include confirmation of recurrence, measurable lesions, failed or relapsing after first-line chemotherapy, and normal organ function.",
    "This sample is a phase 2 trial that investigates the effects of Lovaza, an omega-3 fatty acid supplement, on patients with cardiovascular disease and bleeding disorders, who meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of aclidinium bromide and formoterol as treatments, along with a placebo, and includes eligibility criteria such as age, smoking history, and lung function measurements.",
    "This sample is a clinical trial for patients with prostate neoplasms, testing the drugs abiraterone acetate and prednisone/prednisolone or dexamethasone in phases 1 and 2, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with acute lymphoblastic leukemia (ALL) or acute mixed lineage leukemia, testing the effectiveness of various drugs including cytarabine, daunorubicin hydrochloride, etoposide, imatinib mesylate, leucovorin calcium, methotrexate, prednisolone, therapeutic hydrocortisone, and vincristine sulfate, with specific eligibility criteria for patients to participate in the study.",
    "This phase 2 trial is investigating the use of minocycline in patients with multiple sclerosis and optic neuritis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial for colorectal cancer, testing the drugs cediranib, bevacizumab, 5-fluorouracil, leucovorin, and oxaliplatin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with unresectable stage IV melanoma, testing the drug temozolomide, with specific eligibility criteria including disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 2 clinical trial for patients with epithelial ovarian cancer, testing the combination of mk-1775 and carboplatin as a treatment option. The eligibility criteria include having a proven p53 mutated pathway, measurable disease or elevated CA-125 levels, and having received previous platinum therapy.",
    "This sample is a phase 2 clinical trial for patients with endometrial cancer, testing the effectiveness of carboplatin, cisplatin, and paclitaxel as treatment options, with specific eligibility criteria for patient inclusion.",
    "This sample is a phase 2 trial for patients with acute lymphoblastic leukemia, testing the drug dasatinib. The inclusion criteria include being Ph+ and/or BCR/ABL+ ALL, age \u226518 years old, and no prior treatment with anti-leukemic drugs except for steroids. The exclusion criteria include impaired cardiac function, gastrointestinal diseases that may affect drug absorption, and use of therapeutic warfarin.",
    "This sample is a phase 1/phase 2 trial for patients with esophageal adenocarcinoma and gastric adenocarcinoma, testing the effectiveness of panitumumab, epirubicin, oxaliplatin, and xeloda as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) who are surgical candidates, testing the effectiveness of dasatinib, a targeted therapy drug, in combination with surgery. The eligibility criteria include specific tumor size and absence of nodal metastases, as well as various organ function requirements. Exclusion criteria include previous dasatinib therapy, cardiac symptoms, and certain medications that may interact with dasatinib.",
    "This sample is a phase 2 clinical trial for patients with head and neck cancer, testing the drug tas-106. The inclusion criteria include age, confirmed diagnosis, prior treatment, and measurable disease, while exclusion criteria include brain involvement, peripheral neuropathy, and history of another malignancy.",
    "This sample is a phase 2 trial for patients with pancreatic cancer, testing the effectiveness of fluorouracil, gemcitabine hydrochloride, and oxaliplatin as treatment options. The eligibility criteria include specific disease characteristics, performance status, blood counts, liver and kidney function, and exclusion of certain medical conditions. Prior chemotherapy or radiotherapy for pancreatic cancer is not allowed, and concurrent major surgical procedures are not anticipated. Concurrent use of certain medications and investigational agents is also not allowed.",
    "This sample is a phase 2 clinical trial for lapatinib and capecitabine in patients with metastatic breast cancer, with specific eligibility criteria including documented progressive advanced or metastatic breast cancer, prior treatment with taxane and anthracycline regimens, and ErbB2 overexpression.",
    "This phase 2 trial is testing the drug eribulin mesylate for patients with locally advanced or metastatic pancreatic cancer who have received prior gemcitabine-based therapy, and have certain eligibility criteria including measurable disease, age over 18, and adequate organ function.",
    "This sample is a phase 2 clinical trial for the treatment of postherpetic neuralgia, a persistent neuropathic pain condition, using the drugs xpf-002 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with potentially resectable esophageal cancer, testing the effectiveness of carboplatin, celecoxib, and paclitaxel as treatment options, with specific eligibility criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung carcinoma, testing the drug rad001, and has specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for ambulant female patients with metastatic breast cancer who have been previously treated with an anthracycline and a taxane. The study aims to evaluate the efficacy and safety of the drug e7070 in this patient population. The inclusion criteria include histologically or cytologically confirmed breast cancer with at least one measurable metastatic lesion, prior treatment with an anthracycline and a taxane, and a Karnofsky performance status of >= 70%. The exclusion criteria include previous extensive chemotherapy regimens, untreated brain metastases, and certain laboratory abnormalities.",
    "This sample is a phase 2 clinical trial for patients with recurrent or persistent ovarian or peritoneal cancer, testing the drug pemetrexed. The inclusion criteria include histologically confirmed disease, measurable disease, and prior platinum-based chemotherapy, while exclusion criteria include prior therapy with pemetrexed and history of other invasive malignancies.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer who have undergone radical prostatectomy, and it aims to evaluate the effectiveness of bicalutamide, docetaxel, flutamide, and lhrh agonist drugs in preventing lymph node or distant metastases.",
    "This sample is a phase 2 clinical trial for osteoporosis, testing the drugs placebo and dp001 on postmenopausal females with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for rheumatoid arthritis, testing the drugs ccx-354-c and placebo, with eligibility criteria including active RA, specific joint counts, and stable doses of methotrexate and other medications.",
    "This sample is a phase 1/phase 2 trial for the treatment of chronic hepatitis C, using the drugs daclatasvir and placebo, with key inclusion criteria including being chronically infected with hepatitis C virus genotype 1 and having a BMI of 18 to 35 kg/m\u00b2.",
    "This sample is a phase 2 clinical trial for chronic obstructive pulmonary disease (COPD) patients, testing the efficacy of drugs rv568 and placebo in improving lung function, with specific inclusion and exclusion criteria for participant eligibility.",
    "This sample is a phase 2 trial for the treatment of pulmonary hypertension using riociguat, sildenafil, and placebo, with specific eligibility criteria including age, disease classification, and pulmonary function.",
    "This phase 2 trial is testing the drug rdea806 in HIV-infected male subjects who have not received antiretroviral therapy before, and the eligibility criteria include having a documented chronic HIV-1 infection, a plasma viral load above 5000 HIV-1 RNA copies/ml, and no primary mutation in the reverse transcriptase gene associated with resistance to RT inhibitors.",
    "This sample is a phase 2 clinical trial for patients with recurrent ovarian carcinoma, fallopian tube carcinoma, and primary peritoneal carcinoma, testing the effectiveness of paclitaxel albumin-stabilized nanoparticle formulation as a second-line treatment option. The eligibility criteria include prior platinum-based chemotherapy, platinum and paclitaxel resistance, and specific medical and health conditions.",
    "This sample is a phase 2 clinical trial for patients with recurrent non-small cell lung cancer, testing the drug cediranib maleate, and includes eligibility criteria such as prior platinum-based chemotherapy, specific blood counts, and normal organ function.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic or recurrent gastric cancer, testing the drugs taxol and campt, topotesin, with eligibility criteria including prior treatment for advanced disease, measurable lesions, specific hematologic values, and normal ECG.",
    "This sample is a phase 1/phase 2 trial for essential tremor, testing the drugs levetiracetam and placebo, with inclusion criteria including a history of tremor for 5 or more years and no other neurological problems, and exclusion criteria including prior stroke or other neurological disease, psychiatric problems, history of renal disease, and pregnancy.",
    "This sample is a phase 2 trial for advanced, surgically unresectable colorectal cancer (CRC) patients, testing the efficacy of bevacizumab, capecitabine, and oxaliplatin as a chemotherapy regimen, with specific eligibility criteria and exclusion criteria.",
    "This phase 2 trial is testing the efficacy of imatinib mesylate and paclitaxel in treating non-small cell lung cancer patients aged 70 or older, with specific inclusion and exclusion criteria related to disease stage, hepatic and renal function, performance status, and reproductive potential.",
    "This sample is a phase 2 clinical trial for patients with metastatic prostate cancer, evaluating the effectiveness of tandutinib, a tyrosine kinase inhibitor, in combination with a prior taxane-based regimen. The eligibility criteria include having bone metastases, castrate level of testosterone, evidence of progressive disease, and adequate organ function.",
    "This sample is a phase 1/phase 2 trial for myeloma patients, testing the drugs trisenox, velcade, melphalan, and vitamin C, with eligibility criteria including primary refractory disease, age up to 75 years, Zubrod performance status of <2, and negative Beta hCG test in women with childbearing potential.",
    "This sample is a phase 2 trial for HIV-infected, therapy-naive subjects, testing the drugs GW873140 and Kaletra (lopinavir/ritonavir) for their effectiveness in treating HIV infection.",
    "This sample is a phase 2 trial for patients with epilepsy, testing the effectiveness of e2007 (perampanel) compared to placebo, with specific inclusion and exclusion criteria for enrollment.",
    "This sample is a phase 2 clinical trial for patients with mild asthma, testing the drug SB010 and placebo, with inclusion criteria including age, diagnosis, lung function, skin prick test, and consent, and exclusion criteria including other diseases, pulmonary conditions, concomitant treatments, and allergies.",
    "This sample is a phase 2 trial for heart failure patients, testing the effectiveness of the drug jnj-39588146 at different doses, along with a placebo, and the eligibility criteria include a diagnosis of heart failure and specific exclusion criteria related to heart health.",
    "This sample is a phase 2 trial for endometriosis, testing the drugs placebo, tak-385, and leuprorelin acetate, with eligibility criteria including completion of a previous study and exclusion criteria related to adverse events and efficacy of the study drug.",
    "This sample is a phase 2 trial for HIV infection, testing the effectiveness of raltegravir film-coated tablet, raltegravir chewable tablet, and other anti-retroviral therapy drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial for patients with chronic idiopathic constipation, testing the drug plecanatide. The inclusion criteria include meeting the modified Rome III criteria for constipation, having less than 3 complete spontaneous bowel movements per week, and willingness to discontinue certain medications. The exclusion criteria include having loose or watery stool, having Irritable Bowel Syndrome, and having certain gastrointestinal conditions or surgeries.",
    "This sample is a phase 2 clinical trial testing the effectiveness of nitazoxanide and placebo in treating influenza, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with metastatic, hormone-receptor positive breast cancer, testing the effectiveness of naltrexone, a drug used to treat opioid addiction, in combination with other therapies.",
    "This sample is a phase 2 trial for the treatment of generalized anxiety disorder (GAD) using the drugs eszopiclone and placebo, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 2 trial for patients with colorectal cancer and metastatic cancer, testing the effectiveness of fluorouracil, leucovorin calcium, and oxaliplatin in combination, with specific eligibility criteria and exclusion criteria for patients.",
    "This sample is a phase 1/phase 2 trial for primary erythromelalgia and inherited erythromelalgia, testing the drugs xpf-002 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with relatively stable, moderate to severe chronic obstructive pulmonary disease (COPD). The study aims to evaluate the effectiveness of tiotropium, salmeterol, fluticasone, ciclesonide low, ciclesonide high, and placebo in treating COPD symptoms. The inclusion criteria include being 40 years or older, current or ex-smokers with a smoking history of more than 10 pack years. Exclusion criteria include other significant diseases, medications that can influence the study results, hypersensitivity to the study medication, and unstable COPD.",
    "This phase 2 trial is investigating the use of thalidomide in patients with recurrent or persistent endometrial carcinoma who have received prior chemotherapy, and have measurable lesions outside the area of prior radiotherapy.",
    "This sample is a phase 2 trial for sickle cell disease, testing the effects of nitric oxide and oxygen on pain relief, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for chronic hepatitis C, testing the drugs psi-7977, daclatasvir, and ribavirin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of bevacizumab and erlotinib in combination therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with stage IV pancreatic cancer, testing the combination of sorafenib tosylate and gemcitabine hydrochloride as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the drug peficitinib and placebo in patients with moderate to severe plaque psoriasis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic or locally recurrent clear-cell Renal Cell Carcinoma, testing the efficacy of the drugs gw786034 and placebo, with specific eligibility criteria including prior therapy and adequate organ function.",
    "This sample is a phase 2 trial for patients with pulmonary arterial hypertension (PAH) who have not responded well to current PAH drugs. The study will test the effectiveness of nilotinib and placebo in improving symptoms and functional class in these patients.",
    "This sample is a phase 2 trial for HIV prevention, testing the effectiveness of tenofovir gel and placebo in sexually active individuals aged 18-40, who are HIV negative and agree to use non-barrier contraception.",
    "This sample is a phase 2 trial for obesity, testing the drugs placebo, diazoxide, and metformin + diazoxide, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with platinum-sensitive recurrence of epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer, testing the effectiveness of carboplatin and pemetrexed as treatment options. The eligibility criteria include specific disease diagnoses, measurable lesions, previous platinum-containing regimen, certain blood counts, liver function, and recovery from previous therapy.",
    "This sample is a phase 2 clinical trial for infertility treatment, focusing on female patients who require ICSI treatment. The study will evaluate the effectiveness of FSH-GEX\u2122 and Gonal-F\u00ae drugs in patients who meet specific inclusion criteria, while excluding those with certain medical conditions or contraindications.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the efficacy of cetuximab +/- dexamethasone as a treatment option. The inclusion criteria include having measurable disease, refractory or relapsed disease, and a life expectancy of more than 12 weeks. The exclusion criteria include prior allogeneic transplantation, severe cardiovascular disease, HIV infection, and insufficient bone marrow reserve.",
    "This sample is a phase 2 clinical trial for the treatment of seasonal allergic rhinitis, testing the drugs rv568 and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 trial for colorectal cancer patients, testing the effectiveness of various drugs including capecitabine, irinotecan, and oxaliplatin, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with ovarian, fallopian tube, or primary peritoneal cavity cancer, testing the effectiveness of gemcitabine hydrochloride and topotecan hydrochloride as treatment options. The eligibility criteria include specific disease characteristics and patient characteristics such as age, performance status, and hematopoietic, hepatic, and renal function. Prior concurrent therapy is also specified.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic unresectable pancreatic adenocarcinoma, testing the combination of arq 197 and gemcitabine as a potential treatment option. The eligibility criteria include age, disease confirmation, performance status, contraception use, and various laboratory values.",
    "This sample is a phase 2 trial for patients with metastatic melanoma and skin cancer, testing the effectiveness of cyclophosphamide and fludarabine phosphate in combination with other eligibility criteria such as age, disease status, and serology.",
    "This sample is a phase 2 clinical trial for patients with stage III or IV squamous cell carcinoma of the oral cavity, oropharynx, larynx, hypopharynx, or nasopharynx, testing the efficacy of fosaprepitant dimeglumine, cisplatin, palonosetron hydrochloride, and dexamethasone in combination with radiation therapy.",
    "This sample is a phase 2 clinical trial for the drug certolizumab pegol in treating moderate to severe chronic plaque psoriasis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial for rheumatoid arthritis, testing the effectiveness of prednisone in combination with methotrexate for patients who are inadequate responders to TNF-alpha antagonists or methotrexate alone. The eligibility criteria include age 18-80, specific disease criteria, adequate renal function, negative pregnancy test, and stable corticosteroid dose. Exclusion criteria include other inflammatory arthritis, abnormal blood counts, liver abnormalities, positive viral serology, recent treatment with TNF-alpha antagonists or investigational agents, and history of severe allergic reactions or infections.",
    "This sample is a phase 2 clinical trial for patients with large granular lymphocytic leukemia (LGL leukemia), testing the effectiveness of cyclosporine as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the drug azd6765, testing its effectiveness in treating depression in patients who have not responded well to other antidepressants. The inclusion criteria include a diagnosis of depression and inadequate response to previous antidepressant treatment, while the exclusion criteria include other psychiatric disorders, pregnancy or lactation, and current diagnosis of cancer.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic adenocarcinoma of the pancreas, testing the effectiveness of gemcitabine and etoposide as treatment options. The eligibility criteria include specific hematologic and chemical parameters, as well as a signed informed consent. Previous chemotherapy, concurrent radiation therapy, and other active neoplasms are among the exclusion criteria. The disease diagnostic criteria and staging are based on histologic or cytologic diagnosis using standard pathologic criteria and AJCC staging.",
    "This sample is a phase 2 clinical trial for patients with liver cancer, testing the drugs epirubicin hydrochloride and thalidomide, with eligibility criteria including diagnosis of hepatocellular carcinoma, measurable disease, and specific patient characteristics such as age, performance status, and laboratory values.",
    "This sample is a phase 1/phase 2 trial for patients aged 0-18 with relapsed or residual juvenile myelomonocytic leukemia (JMML) after allogeneic HCT, testing the efficacy of drugs such as cyclosporine, cytarabine, and methotrexate, among others, with specific eligibility criteria including organ function and written informed consent.",
    "This sample is a phase 2 clinical trial for schizophrenia, testing the drugs \"merck l-830982\" and \"placebo\" on male participants aged 18-50 who meet diagnostic criteria for schizophrenia or schizoaffective disorder and are clinically stable on their current medication dose for at least 3 months.",
    "This sample is a phase 2 clinical trial for bladder cancer patients, testing the effectiveness of gemcitabine and cisplatin as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with metastatic clear cell renal cell carcinoma, recurrent renal cell cancer, or stage IV renal cell cancer, testing the drug sorafenib tosylate, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with urothelial carcinoma, testing the effectiveness of docetaxel and asa404 as a second-line chemotherapy regimen, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with mantle cell lymphoma, testing the effectiveness of fludarabine, mitoxantrone, and rituximab as a treatment option, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with chronic myelogenous leukemia (CML) who have not responded to interferon therapy, and it is testing the effectiveness of imatinib mesylate as a treatment option.",
    "This sample is a phase 1/phase 2 trial for urinary incontinence, testing the drugs uish001 and matching placebo, with inclusion criteria being moderate to severe urge, stress, or mixed urinary incontinence, and exclusion criteria including medical history of migraines, neurologic problems, swallowing disorder, stroke, severe depression, heart failure, peripheral edema, moderate to severe asthma, chronic obstructive pulmonary disease (COPD), certain restricted medications, and any other condition that would interfere with the subject's safety.",
    "This sample is a phase 2 trial for patients with locally advanced pancreatic cancer, testing the effectiveness of cisplatin, fluorouracil, and gemcitabine hydrochloride as preoperative treatment. Eligible patients must have histologically confirmed adenocarcinoma of the pancreas, measurable disease, and meet certain criteria for age, performance status, hematopoietic, hepatic, renal, and other factors. Prior concurrent therapies are not specified.",
    "This sample is a phase 2 clinical trial for patients with urothelial carcinoma of the bladder or urethra, testing the effectiveness of gemcitabine hydrochloride and cisplatin as treatment options. The eligibility criteria include specific disease stages, performance status, blood counts, and renal function. Exclusion criteria include recent intravesicular therapy, allergies to study drugs, and certain medical conditions.",
    "This sample is a phase 2 trial for osteoarthritis, testing the drugs cg100649 and celecoxib, with eligibility criteria including confirmed OA diagnosis, pain duration, normal blood pressure, and exclusion criteria such as use of certain medications and history of certain diseases.",
    "This sample is a phase 2 trial for rheumatoid arthritis, testing the drugs glpg0634 and placebo, with eligibility criteria including active RA symptoms, stable methotrexate use, and negative pregnancy test for female subjects.",
    "This sample is a phase 2 trial testing a combination of drugs including cyclophosphamide, cytarabine, and dexamethasone for the treatment of Burkitt's leukemia or Burkitt's or Burkitt-like lymphoma, with specific eligibility criteria including age, hepatic and renal function, HIV status, and prior therapy restrictions.",
    "This sample is a phase 2 trial for obesity, testing the effectiveness of the drug \"naltrexone sr 32 mg/bupropion sr 360 mg/day\" compared to a placebo, with eligibility criteria including BMI between 27 and 40 kg/m\u00b2, normal laboratory values, and non-smoking status.",
    "This phase 2 trial is investigating the use of 131-i-tm-601 and 131i-tm601 drugs in patients with malignant glioma, glioblastoma multiforme, anaplastic astrocytoma, oligo-astrocytoma, and gliosarcoma, who have experienced progression or recurrence following radiotherapy, and are candidates for resection of the recurrent tumor. The study aims to evaluate the safety and efficacy of the drugs in these patients.",
    "This sample is a phase 2/phase 3 trial for early Parkinson's disease, testing the drugs SPM 962 and placebo, with inclusion criteria including a diagnosis of Parkinson's disease, age between 30 and 80, Hoehn & Yahr stage 1-3, and a total UPDRS Part 2 and 3 score over 10, and exclusion criteria including previous participation in a trial with SPM 962, L-dopa treatment for over 6 months, psychiatric symptoms, orthostatic hypotension, history of epilepsy or serious cardiac disorder/arrhythmia, and various other criteria.",
    "This sample is a phase 2 trial for rheumatoid arthritis, testing the drugs crx-102, prednisolone, dipyridamole, and placebo, with eligibility criteria including having RA, swollen and tender joints, and being on a stable dose of DMARD(s) for at least 6 weeks prior to screening.",
    "This sample is a phase 2 clinical trial for patients with progressive thyroid cancer, testing the effectiveness of the drug sunitinib in treating the disease. The eligibility criteria include having confirmed thyroid cancer, measurable disease, and not having received more than one previous systemic treatment for cancer.",
    "This phase 2 trial aims to evaluate the efficacy of a combination of mometasone furoate nasal spray (MFNS) and oxymetazoline nasal spray (OXY) compared to MFNS alone, OXY alone, and placebo in patients with seasonal allergic rhinitis (SAR), with inclusion criteria including a documented history of SAR, positive skin-prick test response to seasonal allergens, and general good health, while exclusion criteria include asthma requiring corticosteroids, nasal structural abnormalities, and other clinically significant diseases.",
    "This sample is a phase 2 trial for primary effusion lymphoma (PEL) involving a body cavity, testing the effectiveness of a combination of drugs including bortezomib, cyclophosphamide, and doxorubicin hydrochloride, among others, in patients with previously treated or untreated disease. The eligibility criteria include age 18 and over, specific performance status, hematopoietic, hepatic, renal, cardiovascular, and neurologic requirements, as well as restrictions on pregnancy, other malignancies, infections, bleeding risks, and prior therapies.",
    "This sample is a phase 2 clinical trial for Parkinson's disease, testing the drugs istradefylline and placebo, with eligibility criteria including specific disease stage, medication requirements, and exclusion criteria such as neurosurgical treatment and pregnancy.",
    "This sample is a phase 2 trial for female patients with primary HER2-negative operable breast cancer, testing the combination of bevacizumab, docetaxel, and standard chemotherapy as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a clinical trial study that focuses on phase 1/phase 2 trials for patients with advanced non-hematologic malignancy, specifically melanoma, brain and central nervous system tumors, and solid tumors. The study aims to evaluate the effectiveness of drugs such as ps-341 (velcade) and temozolomide in treating these diseases, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the treatment of acromegaly, a pituitary disorder, using the drugs octreotide and dg3173, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for the treatment of chronic hepatitis C infection using the drugs idn-6556 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of chronic obstructive pulmonary disease (COPD) using drugs such as gw856553, placebo, and seretide, with specific eligibility criteria including age, smoking history, lung function, and exclusion criteria such as other medical conditions and medication use.",
    "This sample is a phase 2 trial for diabetic neuropathic pain, testing the drugs bvt.115959 and placebo, with inclusion criteria including a diagnosis of type 1 or 2 diabetes mellitus and documented painful, symmetrical, sensorimotor polyneuropathy for at least 6 months, and exclusion criteria including female patients who are fertile and of child-bearing potential, and clinically significant or unstable hepatic, respiratory, renal, hematologic, cardiovascular or peripheral vascular disease.",
    "This sample is a phase 2 clinical trial for asthma patients, testing the effectiveness of various drugs including fp/sal 250/50mcg bid and montelukast 10mg qd (pm), with specific eligibility criteria such as age, smoking history, asthma diagnosis, and lung function.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the drug dvd-r. The eligibility criteria include having a diagnosis of multiple myeloma, measurable disease, and certain laboratory test results within specific ranges.",
    "This sample is a phase 2 clinical trial for infertility, focusing on infertile men aged 35 to 55 who have difficulty timing relations to their partner's ovulation. The study will test the effectiveness of omega 3 fats and folic acid in improving fertility, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) that is not amenable to curative therapy. The study aims to evaluate the efficacy of cetuximab and pemetrexed as treatment options. The inclusion criteria include a diagnosis of locally advanced or metastatic NSCLC, previous treatment with platinum-containing or taxane-containing chemotherapy, and no more than two prior systemic anti-cancer therapies. The exclusion criteria include prior treatment with pemetrexed, prior therapy targeting the EGF pathway, active or uncontrolled infection, and pregnancy or breastfeeding.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the effectiveness of 4-aminosalicylic acid and paser placebo granules in patients aged 18-65 with confirmed diagnosis and specific criteria, while excluding certain medications and conditions.",
    "This sample is a phase 2 clinical trial for patients with advanced hepatocellular carcinoma, testing the efficacy of the drugs tac-101 and placebo in combination with transarterial chemoembolization (TACE) procedure, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with unresectable hepatocellular carcinoma, testing the drug sunitinib (su011248) as a potential treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for relapsed breast cancer patients who have previously received trastuzumab-containing therapy, and it aims to evaluate the efficacy of lapatinib, capecitabine, docetaxel, and nab-paclitaxel in treating the disease. The eligibility criteria include confirmation of breast cancer, presence of measurable lesions, documented amplification of the ErbB2 gene or overexpression of the ErbB2 protein, and a baseline cardiac ejection fraction of \u00b350%.",
    "This sample is a phase 2 trial for patients with advanced non-small cell lung cancer, testing the drug gw572016 (lapatinib) and evaluating eligibility criteria such as histological confirmation, prior systemic therapy, tumor tissue availability, measurable lesions, performance status, organ function, and screening assessments.",
    "This sample is a phase 1/phase 2 clinical trial for patients with recurrent non-small cell lung cancer, recurrent prostate cancer, stage III prostate cancer, stage IIIB non-small cell lung cancer, stage IV non-small cell lung cancer, stage IV prostate cancer, or unspecified adult solid tumor. The trial will test the drug docetaxel and has specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with esophageal or gastric cancer, testing the drugs matuzumab, epirubicin, cisplatin, and capecitabine, with specific eligibility criteria including histological confirmation, metastatic disease, EGFR expression, ECOG PS 0-1, and measurable lesions.",
    "This sample is a phase 1/phase 2 trial for patients with hepatocellular carcinoma, testing the combination of temsirolimus and sorafenib as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with rheumatoid arthritis, testing the effectiveness of a placebo drug in combination with methotrexate and a biologic tumor necrosis factor-alpha (TNF\u03b1) inhibitor therapy. The study has specific inclusion and exclusion criteria, and the primary disease being studied is rheumatoid arthritis.",
    "This sample is a phase 2 clinical trial for patients with glioblastoma multiforme, testing the drugs talampanel, temozolomide, and adjuvant temozolomide for eligibility criteria including age, confirmed diagnosis, no prior therapies, stable corticosteroid regimen, and a Karnofsky performance score of at least 60%.",
    "This sample is a phase 2 clinical trial for multiple sclerosis (MS) patients, testing the effectiveness of the drug act-128800 at different doses compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 trial for asthma, testing the drugs qax576 and placebo, with inclusion criteria including a history of asthma attacks and taking inhaled corticosteroids, and exclusion criteria including women of child-bearing potential and previous use of monoclonal antibodies.",
    "This sample is a phase 2 trial for patients with non-small cell lung cancer and efficacy as diseases, with icd-10 codes C78.00, C78.01, C78.02, D14.30, D14.31, D14.32, and C34.2. The drugs being tested are cisplatin, dexamethasone, vitamin b12, folic acid, and cisplatin, gemcitabine. The eligibility criteria include chemotherapy-naive patients with specific histological or cytological confirmation, measurable lesions, Eastern Cooperative Oncology Group performance status of 0 or 1, and adequate organ function.",
    "This sample is a phase 2 clinical trial for patients with locally recurrent or metastatic HER2-positive breast cancer, testing the efficacy of eribulin mesylate as a treatment option. The eligibility criteria include age 18 or older, histologically proven adenocarcinoma of the breast, measurable lesions, HER2 positivity, specific performance status, and adequate organ function. Exclusion criteria include prior chemotherapy for HER2 breast cancer, certain prior malignancies, and specific medical conditions.",
    "This phase 2 trial aims to evaluate the efficacy of IV bisphosphonate in patients with bone metastases in hormone-refractory prostate cancer, advanced breast cancer, or advanced cancer/multiple myeloma, who are currently receiving IV bisphosphonates and meet specific inclusion criteria, while excluding those with brain metastases, prior administration of AMG 162, impending fracture in weight-bearing bones, and pregnancy/breastfeeding.",
    "This sample is a phase 2 clinical trial for patients with acute myeloid leukemia (AML) who have relapsed or refractory disease after standard induction therapy. The study aims to evaluate the efficacy and safety of clofarabine as a potential treatment option. The inclusion criteria include a diagnosis of AML, age above 40 years, adequate renal and hepatic functions, eligibility for intensive chemotherapy, and signed informed consent. Exclusion criteria include prior allogeneic hematopoietic cell transplantation (HCT), refractoriness to platelet support, and concurrent severe diseases or infections.",
    "This sample is a phase 1/phase 2 trial for metastatic colorectal cancer, testing the drugs pimasertib, placebo, and folfiri, with eligibility criteria including confirmed K-Ras mutated colon/rectum cancer and disease progression after first-line treatment with oxaliplatin and fluoropyrimidines based chemotherapy.",
    "This sample is a phase 2 clinical trial for schizophrenia, testing the drugs amg 747 and placebo. The inclusion criteria include a diagnosis of schizophrenia, specific scores on symptom scales, and stable antipsychotic therapy. The exclusion criteria include other mental disorders, substance abuse, and planned changes to nicotine use.",
    "This sample is a phase 2 trial for patients with refractory multiple myeloma, testing the drug sorafenib tosylate, with specific eligibility criteria including disease status, previous treatments, performance status, and various medical conditions.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory acute lymphoblastic leukemia, testing the effectiveness of lenalidomide as a treatment option, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with unresectable stage IV melanoma, testing the efficacy of carboplatin and paclitaxel albumin-stabilized nanoparticle formulation as treatment options, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 trial for locally advanced pancreatic ductal adenocarcinoma, testing the effectiveness of bevacizumab, 5-fluorouracil, oxaliplatin, and gemcitabine as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for the drug gsk1292263 and its matching placebo, along with sitagliptin, in patients with type 2 diabetes mellitus. The eligibility criteria include age, BMI, diabetes diagnosis, metformin therapy, glucose and HbA1c levels, and various medical conditions. Exclusion criteria include certain medical conditions, drug/alcohol use, pregnancy/lactation, renal disease, ECG abnormalities, and previous insulin use.",
    "This sample is a phase 1/phase 2 clinical trial that aims to investigate the effectiveness of losartan, zileuton, n-acetylcysteine, pravastatin, and erythromycin in treating hermansky-pudlak syndrome, pulmonary fibrosis, oculocutaneous albinism, platelet storage pool deficiency, and metabolic disease, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung carcinoma, testing the effectiveness of the drugs zd6474, paclitaxel, and carboplatin in treating the disease, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with myelodysplastic syndromes (MDS) and deletion 5q(31), testing the effectiveness of lenalidomide as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 clinical trial for patients with acute myeloid leukemia, myelodysplastic syndrome, or multiple myeloma, testing the drug chr-2797 (tosedostat), an aminopeptidase inhibitor, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of arthritis, specifically gouty arthritis, using the drug dexamethasone. The inclusion criteria include a VAS pain scale score over 50 and an acute gout flare for no longer than 3 days, while the exclusion criteria include recent treatment with anti-TNF medication, recent use of anti-inflammatory medication for acute gout, pregnancy or breastfeeding, high infection risk, severe allergies, history or risk of tuberculosis, and active infection.",
    "This sample is a phase 2 clinical trial for bladder cancer, testing the drugs gemcitabine, cisplatin, and gefitinib, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for systemic sclerosis, testing the drugs sar100842 and placebo, with eligibility criteria including meeting ACR criteria, having diffuse cutaneous involvement, and a Modified Rodnan Skin Score \u2265 15.",
    "This sample is a phase 2 clinical trial for kidney transplantation, testing the drugs cyclosporine and cp-690,550, with inclusion criteria of being a first-time kidney transplant recipient between the ages of 18 and 70 years, and exclusion criteria of having any non-kidney transplant.",
    "This phase 2 trial is investigating the use of bortezomib, a drug used to treat multiple myeloma, in patients with various types of advanced liver and bile duct cancers who are not eligible for surgery, and have not received more than 2 prior chemotherapy regimens.",
    "This phase 2 trial is testing the drug enzastaurin in patients with Waldenstrom's macroglobulinemia or multiple myeloma who have been previously treated with up to 5 therapies, and have specific eligibility criteria including certain laboratory values and expected survival of greater than 12 weeks.",
    "This sample study is a phase 1/phase 2 trial testing the safety and efficacy of a placebo in healthy individuals aged 18-40 years for the prevention of influenza, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the treatment of acquired immunodeficiency syndrome (AIDS) and HIV infections, testing the efficacy of drugs such as d/c/f/taf, drv, cobi, and ftc/tdf, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the combination of capecitabine and oxaliplatin as a treatment option. The eligibility criteria include preserved organ function, good performance status, no more than one prior therapy, and no active brain metastasis. Exclusion criteria include no prior use of capecitabine or oxaliplatin and no concurrent therapy.",
    "This sample is a phase 2 clinical trial for the treatment of diabetic neuropathic pain, testing the drugs abt-894 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial aims to evaluate the efficacy of lapatinib ditosylate and tamoxifen citrate in patients with estrogen receptor positive, progesterone receptor positive, or recurrent breast carcinoma, as well as stage IIIB, IIIC, or IV breast cancer, who have failed hormonal manipulation with tamoxifen.",
    "This sample is a phase 2 clinical trial for chronic kidney disease, testing the effectiveness of lanthanum carbonate and placebo in patients with specific eligibility criteria, including age, kidney function, and vitamin D levels, while excluding those with certain conditions or allergies.",
    "This sample is a phase 2 clinical trial for patients with ankylosing spondylitis, testing the effectiveness of abatacept, a drug used to treat rheumatoid arthritis, in reducing disease activity. The eligibility criteria include age range, disease severity, and previous treatment history. Exclusion criteria include certain health conditions, medications, and lab findings.",
    "This phase 2 trial is testing the effectiveness of bevacizumab + erlotinib hydrochloride and gemcitabine hydrochloride + cisplatin or carboplatin in treating patients with non-squamous non-small cell lung cancer (NSCLC) who have measurable disease and meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with myeloma, testing the effectiveness of topotecan, cyclophosphamide, and melphalan as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 clinical trial for patients with persistent asthma, testing the effectiveness of various drugs including dupilumab and fluticasone/salmeterol combination therapy, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial aims to evaluate the efficacy of the drug mk-8777 compared to a placebo in treating major depressive disorder in female patients who are anti-depressant na\u00efve and have a score of at least 9 but not more than 20 on the Quick Inventory of Depression Symptomatology - Clinician Rated (QIDS-C).",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung carcinoma or lung neoplasms, testing the drug HKI-272, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with advanced pancreatic cancer, testing the combination of RAD001 and erlotinib as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 clinical trial for adult patients with various types of brain tumors, testing the effectiveness of sorafenib tosylate, erlotinib hydrochloride, tipifarnib, and temsirolimus as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 trial for patients with metastatic melanoma, testing the drugs sorafenib and pegylated interferon \u03b1-2b, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for cystic fibrosis patients, testing the efficacy of reduced glutathione sodium salt compared to normal saline as a treatment, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with gemcitabine-refractory metastatic pancreatic adenocarcinoma, testing the drug CO-1.01, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial that aims to evaluate the effectiveness of lo-ovral oral contraceptive pills and placebo in treating women with aplastic anemia, menorrhagia, and amenorrhea, who are aged 12-55 years, have a uterus and at least one functioning ovary, and do not desire pregnancy. The study also includes eligibility criteria and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with coronary artery disease, testing the drugs e5555 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for attention deficit hyperactivity disorder (ADHD) using drugs such as tc-5619-238 and placebo, with specific inclusion and exclusion criteria for participants.",
    "In this sample, a phase 2 trial is being conducted to test the effectiveness of mucinex and placebo in treating acute respiratory infection, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for the treatment of amyotrophic lateral sclerosis (ALS) using the drug KNS-760704, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with persistent asthma, testing the efficacy of different doses of las100977 and salbutamol inhalers, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 trial for breast cancer patients, testing the effectiveness of doxorubicin, cyclophosphamide, paclitaxel, and bevacizumab as preoperative treatment, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 2 trial is testing the effectiveness of anastrozole and gefitinib in postmenopausal women with histologically confirmed breast cancer, specifically those with metastatic or locally recurrent disease, locally advanced disease in elderly patients, or bone metastases only, who have failed prior tamoxifen therapy and have estrogen receptor and/or progesterone receptor positive status.",
    "This phase 2 trial aims to evaluate the effectiveness of levetiracetam and placebo in treating levodopa-induced dyskinesia in patients with Parkinson's disease, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 2 trial for smoking cessation, testing the drugs EVT 302, placebo, and nicotine replacement therapy (NRT), with eligibility criteria including age, BMI, smoking habits, previous experience of craving, and liver function test results.",
    "This sample is a phase 1/phase 2 trial for the treatment of diffuse systemic sclerosis, using the drugs abatacept and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with multiple sclerosis, testing the effectiveness of memantine and placebo drugs on severe cognitive impairment, with specific inclusion and exclusion criteria.",
    "In this phase 2 trial, the drug irinotecan is being tested for its effectiveness in treating patients with colorectal neoplasms and metastases who have not received prior chemotherapy or curative local therapy, and meet certain eligibility criteria.",
    "This sample is a phase 2 clinical trial for the treatment of schizophrenia, testing the drugs azd2624, olanzapine, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of the drugs bea 2180 br and tiotropium in improving lung function, with specific eligibility criteria including age, smoking history, and spirometric criteria.",
    "This sample is a phase 2 clinical trial for patients with non-Hodgkin lymphoma, testing the effectiveness of intravenous vitamin C as a treatment option for those who have failed previous therapies and have no other standard therapeutic options available. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory follicular lymphoma, testing the effectiveness of bortezomib and rituximab as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for acute myeloid leukemia (AML) patients who have declined intensive chemotherapy, and it will test the effectiveness of lintuzumab (sgn-33), low dose cytarabine, and placebo as treatment options. The eligibility criteria include having at least 20% blasts in blood or marrow, a minimum of 50% leukemic blasts expressing CD33, an ECOG performance status score of 0 to 2, and a white blood cell count less than 30,000/\u00b5L.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer and carcinoma, testing the drugs pemetrexed and cisplatin, with specific eligibility criteria including tumor accessibility, cancer stage, and prior treatment history.",
    "This sample is a phase 2 clinical trial for patients with esophageal cancer, testing the drug gefitinib. The inclusion criteria include a histologically documented diagnosis of esophageal cancer, age between 70-85 years, and a performance status of 0 to 2. The exclusion criteria include evidence of tracheoesophageal fistula or prior systemic chemotherapy or radiation therapy for esophageal cancer.",
    "This sample is a phase 2 trial for patients with metastatic or unresectable locally recurrent clear cell renal carcinoma, testing the effectiveness of bevacizumab and rad001 drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for HIV-infected females with central fat accumulation, testing the efficacy of raltegravir, an antiretroviral drug, in combination with specific nucleoside analogues for reducing HIV RNA levels and central fat accumulation.",
    "This phase 2 trial aims to evaluate the efficacy of indacaterol/glycopyrrolate, indacaterol, glycopyrrolate, and placebo in treating moderate to severe stable Chronic Obstructive Pulmonary Disease (COPD) in adults aged \u226540 years with a smoking history of at least 10 pack years, based on specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial that aims to evaluate the effectiveness of methylphenidate hydrochloride, galantamine, and placebo capsules in treating cognitive symptoms in individuals with posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI). The eligibility criteria include having a DSM-IV diagnosis of chronic PTSD and/or a history of TBI, clinically significant cognitive complaints, and being interested in receiving treatment for cognitive symptoms.",
    "This sample is a phase 2 clinical trial for rheumatoid arthritis, testing the effectiveness of the drug glpg0259 oral capsule compared to a placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory lymphoid malignancies, multiple myeloma, or other transplant eligible diagnoses, testing the efficacy of bendamustine hydrochloride, dexamethasone, and etoposide as a treatment option.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma who are refractory or relapsed from prior bortezomib-containing regimens, and it aims to evaluate the efficacy of the drug pxd101 (belinostat) in treating the disease.",
    "This sample is a phase 2 clinical trial for patients with malignant ascites, testing the drug bevacizumab to determine its effectiveness in treating persistent or symptomatic ascites caused by various types of tumors. The study has specific inclusion and exclusion criteria, and patients must meet certain eligibility requirements to participate.",
    "This sample is a phase 2 trial for patients with congestive heart failure, testing the effectiveness of lixivaptan and placebo in reducing symptoms of volume overload, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for the treatment of irritable bowel syndrome constipation predominant, using the drugs rose-010 and placebo, with eligibility criteria including a previous diagnosis of IBS, constipation predominant type IBS, and exclusion criteria such as pregnancy, breastfeeding, and certain medications.",
    "This sample is a phase 1/phase 2 trial for the treatment of type 1 diabetes using etanercept and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of arthritis, rheumatoid using drugs such as placebo, baricitinib, and methotrexate, with eligibility criteria including a diagnosis of adult-onset RA, active RA symptoms, and regular use of MTX.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of paclitaxel and carboplatin as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C, testing the efficacy of anti-CD3 monoclonal antibody and sodium chloride placebo drugs, with eligibility criteria including age, previous treatment failure, HCV RNA levels, liver disease criteria, and exclusion criteria such as recent surgery, organ transplants, and autoimmune diseases.",
    "This sample is a phase 2 clinical trial for patients with Parkinson's disease, testing the effectiveness of g-csf and placebo drugs on symptoms such as wearing OFF and dyskinesia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for female patients with HER2-positive breast cancer, testing the effectiveness of capecitabine and trastuzumab in patients with metastatic or recurrent disease after previous treatment with Herceptin and taxanes. The eligibility criteria include age, histological confirmation, measurable lesions, performance status, and exclusion criteria such as uncontrolled CNS metastases and pregnancy.",
    "This sample is a phase 2 clinical trial for the treatment of schizophrenia using the drugs pf-02545920, placebo, and risperidone, with eligibility criteria including a diagnosis of schizophrenia with acute exacerbation of illness and exclusion criteria such as clinically significant uncontrolled medical illness and comorbid psychiatric disorders.",
    "This sample is a phase 2 clinical trial for patients with invasive breast cancer, testing the drug everolimus, and includes eligibility criteria such as measurable disease, planned surgical resection, and specific laboratory values.",
    "This sample is a phase 2 clinical trial for patients with advanced prostate cancer, testing the effectiveness of dasatinib in reducing PSA levels in patients with metastatic disease and castrate levels of testosterone.",
    "This sample is a phase 2 trial for the treatment of soft tissue infections using daptomycin and vancomycin, with specific inclusion and exclusion criteria, such as the presence of clinical signs and symptoms associated with the infection and a minimum creatinine clearance requirement.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes, testing the effectiveness of the drugs ipragliflozin and metformin compared to a placebo, with eligibility criteria including specific HbA1c values, no current anti-diabetic medication, stable diet and exercise program, and exclusion criteria such as type 1 diabetes, insulin therapy, and significant cardiovascular disease.",
    "This sample is a phase 2 trial for patients with non-small cell lung cancer, testing the effectiveness of erlotinib, bevacizumab, gemcitabine, and cisplatin as treatment options, with specific eligibility criteria including tumor stage, histological tumor types, previous chemotherapy, and various laboratory parameters.",
    "This sample is a phase 2 clinical trial testing the drugs amifostine trihydrate, carboplatin, cisplatin, and paclitaxel for the treatment of locoregionally advanced undifferentiated nasopharyngeal cancer, with specific eligibility criteria for patients.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the drug everolimus (rad001) to determine its effectiveness in treating the disease. The eligibility criteria include age \u2265 18 years old, documented disease progression within 6 months of previous chemotherapy, and a World Health Organization performance status of 0, 1, or 2. Exclusion criteria include current or recent use of anti-cancer agents, hypersensitivity to everolimus or other rapamycins, and untreated central nervous system metastases.",
    "This sample is a phase 1/phase 2 trial for head and neck cancer patients, testing the effectiveness of carboplatin, cisplatin, docetaxel, fluorouracil, and lapatinib ditosylate as treatment options, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 trial testing the drug trv120027 and placebo in patients with heart failure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with low or intermediate-1 risk myelodysplastic syndromes, who require regular blood transfusions and have high levels of endogenous epoetin alfa. The drug being tested is everolimus, and the eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 2 trial for patients with moderate or severe asthma, testing the effectiveness of drugs such as chf 5188 pmdi, budesonide extrafine pmdi, and seretide(r) evohaler(r), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the drug \"pd 0200390\" in patients with primary insomnia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung carcinoma, testing the effectiveness of paclitaxel poliglumex and carboplatin as chemotherapy drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients who have failed first-line chemotherapy and are scheduled for second-line therapy with Tarceva. The study will test the efficacy of doxycycline and erlotinib (Tarceva) as treatment options.",
    "This sample is a phase 1/phase 2 trial testing the drugs amg 655 and doxorubicin for the treatment of locally advanced or metastatic, unresectable soft tissue sarcoma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with relapsed and/or metastatic squamous cell carcinoma of the head and neck. The drug being tested is cetuximab, and the eligibility criteria include age, disease confirmation, life expectancy, clinical examination, and various blood and liver function requirements. There are also exclusion criteria, such as age, specific types of cancer, inability to follow the treatment schedule, and pregnancy/nursing.",
    "This sample is a phase 2 trial for dry eye disease, testing loteprednol etabonate ophthalmic suspension and its vehicle, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with renal cell cancer, testing the effectiveness of fludarabine, melphalan, and cyclophosphamide in combination with allogeneic stem cell transplantation as a treatment option. The eligibility criteria include having metastatic RCC with predominant conventional cell type, prior nephrectomy, and at least one prior treatment for metastatic RCC.",
    "This sample is a phase 2 trial for the treatment of postherpetic neuralgia, with the drugs atx08-001 and placebo being tested, and includes eligibility criteria such as age, diagnosis duration, pain severity, and exclusion criteria such as other sources of pain, alcohol/drug abuse, and certain medical conditions.",
    "This sample is a phase 2 trial for patients with heart failure and renal impairment, testing the drugs rolofylline and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of the drugs nva237 100 \u00b5g and nva237 200 \u00b5g compared to a placebo in improving lung function. The eligibility criteria include age, smoking history, and specific lung function measurements.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of fluorouracil, irinotecan hydrochloride, leucovorin calcium, and oxaliplatin as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This phase 2 trial is investigating the effectiveness of gefitinib, a drug used to treat esophageal cancer, in patients with resectable, localized disease, and no known distant metastases. Eligible patients must have histologically confirmed squamous cell or adenocarcinoma of the thoracic esophagus and meet various criteria related to performance status, organ function, and other clinical factors.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the drugs tu-100 and matching placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with recurrent glioblastoma or gliosarcoma, testing the effectiveness of the drug pd 0332991 in combination with radiation therapy and temozolomide chemotherapy.",
    "This sample is a phase 1/phase 2 clinical trial for patients with prostate cancer, testing the drug odm-201. The eligibility criteria include having confirmed adenocarcinoma of the prostate, ongoing androgen deprivation therapy, progressive metastatic disease, and adequate bone marrow, hepatic, and renal function.",
    "This sample is a phase 2 clinical trial for cystic fibrosis, testing the use of l-arginine as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the drug jnj16269110 and metformin, with eligibility criteria including a history of type 2 diabetes, stable metformin treatment, specific BMI and HbA1c ranges, and exclusion criteria such as other types of diabetes, intolerance to certain medications, and certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of docetaxel and bortezomib as treatment options, with specific eligibility criteria including disease stage, prior treatment history, and certain laboratory values.",
    "This sample is a phase 2 clinical trial for rheumatoid arthritis (RA) patients, testing the efficacy of the drug mk-8457 in combination with methotrexate, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with paranoid schizophrenia, testing the drugs mk0249 and placebo, with inclusion criteria including stable living arrangement, good health, specific PANSS and CGI-S scores, and exclusion criteria including certain medications, liver disease, and recent alcohol or drug dependence.",
    "This sample is a phase 2 trial for patients with hepatocellular carcinoma (HCC) who are not suitable for liver transplantation or resection, and it will test the effectiveness of bevacizumab in treating HCC. The inclusion criteria include patients with confirmed HCC, Child-Pugh Stage A or B, and written informed consent. The exclusion criteria include extrahepatic tumor spread, complete portal vein thrombosis, and prior TACE or TAE.",
    "This sample is a phase 2 trial for patients with ventilator-associated pneumonia, respiratory infection, and tracheobronchitis, testing the effectiveness of aerosolized vancomycin or gentamicin as a treatment option. The inclusion criteria include being on mechanical ventilation for more than 3 days, being over 18 years old with a survival expectancy of more than 14 days, and having more than 2 ccs of tracheal secretions every 4 hours. Exclusion criteria include drug allergies and pregnancy.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic or locally recurrent colorectal cancer, testing the drugs zd1839 and oxaliplatin in patients who have failed prior therapy with fluorouracil, leucovorin calcium, and irinotecan. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with recurrent ovarian or peritoneal cancer, testing the effectiveness of the drugs Abraxane and Bevacizumab, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer stage IV patients, testing the effectiveness of iniparib, gemcitabine, and cisplatin as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic thyroid cancer, testing the drug amg 706. The eligibility criteria include confirmed diagnosis, measurable disease, and evidence of disease progression.",
    "This sample is a phase 2 clinical trial that aims to test the effectiveness of atomoxetine, a drug used to treat attention deficit disorder with hyperactivity, in individuals with cocaine-related disorders who also meet the criteria for cocaine dependence and adult ADHD.",
    "This phase 2 trial is testing the effectiveness of gnrh (leuprolide), testosterone gel, and docetaxel in treating prostate cancer patients who meet specific inclusion criteria, while excluding patients with certain conditions or who are taking prohibited medications.",
    "This sample is a phase 2 trial testing the drug su011248 for the treatment of metastatic colorectal cancer in patients who have failed previous cancer therapies, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung cancer, testing the efficacy of apatinib and placebo drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with colorectal cancer or familial adenomatous polyposis, testing the effectiveness of celecoxib and eflornithine drugs, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with overactive bladder and urinary incontinence, testing the drugs elb245 and tolterodine, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 trial testing the drug riociguat (bay63-2521) versus placebo in patients with symptomatic pulmonary hypertension due to left ventricular diastolic dysfunction, with the exclusion of other types of pulmonary hypertension.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the effectiveness of docetaxel and prednisone as treatment options, with specific eligibility and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed and/or relapsed/refractory multiple myeloma, testing the drugs cci-779 and bortezomib, with specific inclusion and exclusion criteria outlined in the protocol.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the effectiveness of lixisenatide, liraglutide, and metformin in controlling blood sugar levels, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for allergic rhinoconjunctivitis, testing the effectiveness of a placebo drug on patients who meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 trial for individuals with Type 1 Diabetes Mellitus, testing the drugs viaject\u00ae25, viaject\u00ae7, and insulin lispro, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with stage III-IVB head and neck cancer, testing the effectiveness of docetaxel, cisplatin, and cetuximab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with colorectal cancer and metastatic cancer, testing the drugs capecitabine and oxaliplatin, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 2 clinical trial for patients with bipolar disorder, testing the drug memantine hcl, and the eligibility criteria include a diagnosis of bipolar I disorder and currently experiencing a manic or mixed episode.",
    "This sample is a phase 2 trial for patients with leukemia, testing the effectiveness of cyclophosphamide, methotrexate, and prednisone as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 trial for hormone refractory prostate cancer, testing the drugs docetaxel and trovax, with eligibility criteria including histologically confirmed adenocarcinoma of the prostate, progressive disease following androgen deprivation, and adequate bone marrow function.",
    "This sample is a phase 2 clinical trial for patients with metastatic or recurrent breast cancer, testing the drug enzastaurin hydrochloride. The inclusion criteria include prior therapy with an anthracycline and a taxane, absence of HER2-positive tumors, and measurable disease. The exclusion criteria include more than 2 chemotherapy regimens, brain cancer from breast cancer, pregnancy or breastfeeding, inability to swallow tablets, and serious heart conditions.",
    "This sample is a phase 2 trial for patients with inadequately controlled type 2 diabetes, testing the drug roflumilast, with specific inclusion and exclusion criteria, including baseline HbA1c levels and BMI range.",
    "This sample is a phase 2 trial for patients with metastatic melanoma or skin cancer, testing the effectiveness of cyclophosphamide and fludarabine in combination with autologous tumor infiltrating lymphocytes (TIL) for treatment. The eligibility criteria include measurable metastatic melanoma with available TIL, age between 18 and 70, Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, and various serology, hematology, and chemistry requirements.",
    "This sample is a phase 2 clinical trial for patients with amyotrophic lateral sclerosis (ALS), testing the drug thalidomide, and includes eligibility criteria such as age, diagnosis, vital capacity, and previous treatment with riluzole.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the drugs placebo and ly2599506, and includes eligibility criteria such as having a hemoglobin A1c value between 7.0% and 10.0%.",
    "This sample is a phase 2 clinical trial for non-Hodgkin's lymphoma, testing the effectiveness of cyclophosphamide, mitoxantrone, vincristine, prednisone, and rituximab in patients over 70 years old with specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for metastatic breast cancer patients, testing the effectiveness of multiple drugs including bevacizumab, docetaxel, and gemcitabine, with eligibility criteria including stable brain metastases and adequate organ function.",
    "This sample is a phase 2 clinical trial for patients with multiple sclerosis, testing the drug biib041 (pr fampridine) to evaluate its effectiveness in improving walking ability. The study has specific inclusion and exclusion criteria, and patients must meet certain requirements such as having a diagnosis of MS, EDSS score of 4 to 7, and not having certain medical conditions or taking specific medications.",
    "This sample is a phase 2 clinical trial for patients with glioblastoma multiforme, testing the drug tln-4601, and includes eligibility criteria such as prior treatment, age, organ function, and exclusion criteria such as life expectancy, HIV history, and hypersensitivity to certain substances.",
    "This sample is a phase 2 trial testing the effectiveness of sch 619734 and placebo in reducing nausea and vomiting in patients receiving cisplatin-based chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of schizophrenia, testing the drugs amg 747 and placebo. The eligibility criteria include a diagnosis of schizophrenia, specific scores on symptom scales, stable antipsychotic therapy, and informed consent. Exclusion criteria include other mental disorders, substance abuse or dependence, and plans to modify nicotine use.",
    "This sample is a phase 2/phase 3 trial investigating the use of high dose multivitamin in patients with chronic kidney disease, cardiovascular disease, and death as the diseases of interest. The eligibility criteria include age range, previous kidney transplant, minimum creatinine clearance, and willingness to stop certain supplements. Exclusion criteria include pregnancy, certain medical conditions, recent cardiac events or surgeries, and other factors that may affect study participation.",
    "This sample is a phase 2 clinical trial for rheumatoid arthritis, testing the drugs cp-690,550 and placebo, with inclusion criteria based on meeting the ACR classification criteria and having active disease, and exclusion criteria related to recent infections and vaccine history.",
    "This sample is a phase 2 clinical trial for patients with uterine neoplasms, testing the effectiveness of carboplatin, cisplatin, and paclitaxel in treating the disease. The eligibility criteria include specific staging, absence of metastases, and adequate organ function.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the combination of carboplatin and bevacizumab as treatment. The eligibility criteria include specific disease characteristics, organ function requirements, and exclusion of prior therapy with platinum agents or VEGF inhibitors.",
    "In this sample, the phase of the trial is phase 2 and the disease being studied is Huntington's disease. The drug being tested is dimebon, and the eligibility criteria include having clinical features of HD with a confirmatory family history or genetic confirmation, and being able to take medication orally. Exclusion criteria include unstable medical illness and pregnancy or lactation in females.",
    "This sample is a phase 2 clinical trial for patients with schizophrenia, testing the effectiveness of olanzapine-raim and placebo drugs. The inclusion criteria include meeting diagnostic criteria for schizophrenia, being an inpatient, and having specific PANSS-EC scores. Exclusion criteria include a history of diabetes mellitus and recent treatment with antipsychotics or benzodiazepines.",
    "This sample is a phase 2 clinical trial testing the drug Iressa (gefitinib) for patients with brain metastases from non-small cell lung cancer, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drugs zalutumumab and cisplatin on patients with locoregionally advanced squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx or larynx, excluding those who have had prior treatment with radiotherapy or chemotherapy in the head and neck area, or prior treatment with similar drugs.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndrome or chronic myelomonocytic leukemia, testing the drug decitabine as a potential treatment option for those who have failed therapy with azacytidine.",
    "This sample is a phase 2 trial for patients with prostate cancer, testing the drug sandostatin, and includes eligibility criteria such as confirmed adenocarcinoma, biochemical disease progression, and specific medical conditions that exclude patients from participating in the trial.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small-cell lung carcinoma, testing the drug pt-523 for injection as a potential treatment option. The eligibility criteria include age \u2265 18 years, confirmed NSCLC stage III or IV, or recurrent disease, failed previous chemotherapy regimens, and adequate organ function.",
    "This phase 2 trial aims to evaluate the efficacy of tp-434, ertapenem, and placebo in treating complicated intra-abdominal infection, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with recurrent ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, testing the effectiveness of cyclophosphamide and fludarabine phosphate as salvage chemotherapy regimens, with specific eligibility criteria including measurable disease, prior treatment failure, and availability of a related HLA-haploidentical natural killer cell donor.",
    "This sample is a phase 2 trial for trauma patients, testing the effectiveness of propranolol and propranolol er in reducing pain scores for patients with fractures, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of multiple sclerosis using duloxetine and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial testing the drug Torisel in subjects with advanced adenocarcinoma and neoplasms, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for chronic hepatitis C, testing the drugs celgosivir and peginterferon alfa 2b + ribavirin, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for patients with pancreatic cancer, testing the effectiveness of gemcitabine, erlotinib, and sorafenib as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic colorectal cancer, testing the effectiveness of irinotecan, avastin, and erbitux as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for locally advanced or metastatic breast cancer, testing the effectiveness of gemcitabine, carboplatin, and trastuzumab as treatment options, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with recurrent malignant gliomas, testing the drug panobinostat. The eligibility criteria include having no more than three prior therapies, a KPS score of at least 60, and meeting various laboratory and medical condition requirements.",
    "This phase 2 trial is investigating the efficacy of mk-0873 and usual care in treating patients with lung diseases, specifically chronic obstructive pulmonary disease (COPD), and the eligibility criteria include age range, lung function tests, and exclusion of severe medical conditions, continuous oxygen therapy, cardiac arrhythmias, other lung diseases, and history of colitis.",
    "This sample is a phase 2 trial for smoking cessation, testing the drugs evt 302, placebo, evt 302 plus open label nicotine replacement, and placebo plus open label nicotine replacement, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for patients with heart failure, testing the drug cxl-1020 and its various doses, along with a placebo, to evaluate its efficacy and safety in improving left ventricular ejection fraction and reducing heart failure symptoms.",
    "This sample is a phase 2 trial for patients with asthma, testing the efficacy of tiotropium bromide at different doses, with specific inclusion and exclusion criteria.",
    "This phase 2 trial aims to evaluate the efficacy of warfarin and placebo in treating pulmonary hypertension in patients with sickle cell anemia or sickle cell beta zero thalassemia, who have evidence of persistent elevation of pulmonary artery systolic pressure but no evidence of moderate or severe diastolic dysfunction.",
    "This sample is a phase 1/phase 2 clinical trial for adult patients with various types of brain tumors, including glioblastoma and meningioma, using erlotinib hydrochloride as the drug, with specific eligibility criteria and required medical tests.",
    "This sample is a phase 2 clinical trial for HIV infections, testing the effectiveness of the drugs mk0639 and indinavir sulfate compared to nelfinavir mesylate, with a treatment duration of 48 weeks. The eligibility criteria include being at least 18 years old, HIV positive, and having no active heart disease. Exclusion criteria include pregnancy or breastfeeding, unwillingness to use birth control, recent use of investigational drugs or vaccines, and substance abuse.",
    "This sample is a phase 2 clinical trial that aims to evaluate the effectiveness of gemcitabine hydrochloride, carboplatin, and dexamethasone in treating various types of relapsed or refractory lymphoid malignancies, including B-cell, T-cell, and Hodgkin's Disease. The study includes patients with measurable disease, specific performance status, and certain laboratory values, while excluding patients with HIV, active hepatitis B virus infection, or other medical conditions that would contraindicate aggressive chemotherapy.",
    "This sample is a phase 2 clinical trial for patients with small cell lung cancer, testing the drug pemetrexed, and includes eligibility criteria such as prior chemotherapy regimens and completion of radiation therapy.",
    "This sample is a phase 2 clinical trial for patients with non-squamous non-small cell lung cancer, testing the effectiveness of erlotinib and gemcitabine as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with recurrent or stage III non-small cell lung cancer, testing the drugs bortezomib, paclitaxel, and carboplatin, with eligibility criteria including specific disease stage, performance status, blood counts, liver and kidney function, heart health, lung function, and exclusion of other severe diseases or infections.",
    "This sample is a phase 2 clinical trial for patients with inoperable, locally advanced, or metastatic colorectal cancer, testing the combination of s-1 and bevacizumab as a treatment option, with specific eligibility criteria including age, disease stage, previous treatment, and organ function requirements.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the drugs lenalidomide and bortezomib, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1/phase 2 trial for the treatment of age-related macular degeneration and choroidal neovascularization using the drugs ibi-20089 and lucentis, with specific eligibility criteria for subjects aged 55 and older.",
    "This sample is a phase 2 clinical trial for patients with small cell lung cancer (SCLC) and it will test the effectiveness of cisplatin, gleevec\u2122, and irinotecan as potential treatments. The eligibility criteria include specific disease characteristics, performance status, hematopoietic, hepatic, renal, and cardiovascular conditions, as well as prior concurrent therapies.",
    "This sample is a phase 2 clinical trial for ovarian cancer patients who have received no more than 3 previous platinum-containing treatments and have been progression-free for at least 6 months. The study will test the effectiveness of olaparib, paclitaxel, and carboplatin in treating serous ovarian cancer.",
    "This sample is a phase 2 clinical trial for participants with refractory or relapsed acute myelogenous leukemia (AML) or untreated AML, testing the drug ly2090314, with specific eligibility criteria including organ function, performance status, previous therapies, and contraceptive precautions.",
    "This sample is a phase 2 clinical trial for ulcerative colitis, testing the drugs hmpl-004 low dose, placebo, and hmpl-004 high dose, with inclusion criteria of having active confirmed mild to moderate ulcerative colitis and exclusion criteria of being diagnosed with Crohn's Disease.",
    "This sample is a phase 2 clinical trial for patients with metastatic prostate cancer, testing the effectiveness of the drugs mitoxantrone, prednisone, and sorafenib, with specific eligibility criteria for patient inclusion.",
    "This sample is a phase 2 trial for patients with predominantly clear cell renal cancer, testing the drug rad001, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with recurrent epithelial ovarian or primary peritoneal carcinoma, testing the drug Abraxane, with specific eligibility criteria including disease stage, prior treatment, blood counts, and blood chemistry levels.",
    "This sample is a phase 2 clinical trial for patients with soft tissue sarcoma, testing the drug glufosfamide as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This study is testing the effectiveness of d-methadone and placebo in treating chronic pain in patients with various types of cancer, with specific inclusion and exclusion criteria for each phase of the trial.",
    "This sample is a phase 2 trial for rheumatoid arthritis (RA) patients who have failed nonbiologic DMARD treatment, and it aims to evaluate the efficacy of the drug vx-509 compared to placebo in reducing disease symptoms.",
    "This sample is a phase 2 clinical trial for pancreatic cancer, testing the drugs rp101 and gemcitabine, with specific eligibility criteria for subjects to be included or excluded from the study.",
    "This sample is a phase 2 clinical trial for prostate cancer patients who have been treated with Zoladex and bicalutamide, and are experiencing rising PSA levels. The trial aims to test the effectiveness of escalating doses of casodex in these patients.",
    "This sample is a phase 2 trial for participants hospitalized with acute coronary syndrome (ACS) who are anticipated to undergo percutaneous coronary intervention (PCI). The study compares the effectiveness of prasugrel, clopidogrel, and placebo in preventing bleeding and other adverse events in these participants.",
    "This sample is a phase 2 trial testing the drugs imatinib mesylate and paclitaxel for the treatment of various stages of non-small cell lung cancer, with specific eligibility criteria including histologic diagnosis, measurable disease, and certain laboratory values, while excluding patients with brain metastasis, prior chemotherapy, or other significant malignancies.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C virus (HCV) genotype 1 infection, testing the efficacy of drugs such as bms-791325, placebo, peg-interferon alfa-2a, and ribavirin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the drug nitazoxanide, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for lupus nephritis, testing the drugs cnto 136 and placebo, with inclusion criteria including a diagnosis of SLE and persistently active nephritis, and exclusion criteria including recent cyclophosphamide use and high serum creatinine levels.",
    "This sample is a phase 2 clinical trial for patients with advanced or metastatic colorectal cancer who have failed prior treatment with a fluoropyrimidine in combination with either irinotecan or oxaliplatin. The study will test the drug epothilone d to evaluate its effectiveness in treating the disease.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndromes, testing the effectiveness of azacitidine, erythropoietin, and azacitidine (monotherapy) in treating anemia in patients with MDS.",
    "This sample is a phase 2 trial for patients with prostate cancer, testing the drug azacitidine for injectable suspension. The eligibility criteria include confirmed diagnosis of prostate cancer, PSA progression, Karnofsky Performance Status >70, specific lab values, and agreement to use birth control. The exclusion criteria include no evidence of PSA progression, prior chemotherapy or treatment with Vidaza, hypersensitivity to Vidaza, certain heart conditions, concurrent immunotherapy or bisphosphonate therapy, recent treatment with radiation therapy or other agents, CNS involvement, uncontrolled medical or psychiatric illness, and positive for HIV, hepatitis B, or hepatitis C.",
    "This sample is a phase 2 clinical trial for patients with primary malignant glioma, specifically glioblastoma multiforme, gliosarcoma, anaplastic astrocytoma, or anaplastic oligodendroglioma, who are either chemotherapy na\u00efve or non-na\u00efve and scheduled to receive Irinotecan/Bevacizumab chemotherapy. The eligibility criteria include age >18 years, specific lab values within normal limits, Karnofsky >60%, and signed consent form approved by the Institutional Review Board. The exclusion criteria include previous participation in any clinical trial involving palonosetron, ongoing vomiting from any organic etiology, and co-medication that may interfere with study results.",
    "This sample is a phase 2 clinical trial for patients with renal failure who have received a kidney transplant. The study aims to evaluate the safety and efficacy of lcp tacro (tacrolimus) and Prograf as maintenance immunosuppression therapy. The inclusion criteria include patients aged 18-65 who have stable doses of tacrolimus and meet certain health requirements. The exclusion criteria include patients with certain medical conditions, those receiving other investigational agents, and those with a history of malignancy.",
    "This sample is a phase 2 clinical trial for patients with myelodysplastic syndromes, blood disease, and bone marrow disease, testing the effectiveness of vorinostat in treating these conditions, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for non-small-cell lung cancer, testing the drugs pemetrexed, cisplatin, and carboplatin, with specific eligibility criteria for patients to be included or excluded from the study.",
    "This sample is a phase 2 clinical trial for patients with metastatic prostate cancer who have failed initial hormonal therapy and have disease progression after at least one chemotherapy regimen. The drug being tested is docetaxel, and the eligibility criteria include specific disease characteristics and patient characteristics.",
    "This sample is a phase 2 trial for chronic hepatitis B, testing the drugs lb80380 and entecavir, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug sorafenib for the treatment of soft tissue sarcoma, specifically angiosarcoma, cutaneous or visceral, malignant hemangiosarcoma, malignant hemangiopericytoma, grade 3-4 leiomyosarcoma, and grade 3-4 liposarcoma. The study includes eligibility criteria such as measurable disease, specific hematopoietic, hepatic, renal, and cardiovascular requirements, and excludes patients with brain metastases or prior sorafenib use.",
    "This sample is a phase 2 trial for patients with early recurrent prostate cancer who have undergone prior curative treatment, testing the drug fulvestrant, and includes eligibility criteria related to disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 2 clinical trial for non-small-cell lung carcinoma, testing the effectiveness of pemetrexed, cisplatin, and cixutumumab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for esophageal cancer, testing the combination of ppx with cisplatin and radiation as a treatment option. The eligibility criteria include specific pathology confirmation, absence of distant organ metastases, and certain blood count and organ function requirements. The study excludes patients with active or uncontrolled infection, other medical conditions that would interfere with the protocol therapy, and concurrent use of non-indicated chemotherapy or investigational agents.",
    "This sample is a phase 1/phase 2 clinical trial for castrate-resistant prostate cancer, testing the drugs bez235, prednisone, and abiraterone acetate, with eligibility criteria including confirmed adenocarcinoma of the prostate, radiographic evidence of disease, castrate levels of testosterone, and adequate bone marrow and organ function.",
    "This sample is a phase 2 clinical trial for patients with relapsed non-Hodgkin's or Hodgkin's lymphoma, testing the effectiveness of a combination of drugs including pentostatin, cyclosporin, mycophenolate mofetil, and methotrexate, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 1/phase 2 trial for patients with renal cell carcinoma (RCC) that tests the effectiveness of ril-21 alone or in combination with sorafenib as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the drug capecitabine, and includes eligibility criteria related to disease progression, prior treatments, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 2 clinical trial for patients with chronic lymphocytic leukemia, testing the effectiveness of chlorambucil and r-etodolac + chlorambucil as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 1/phase 2 clinical trial for metastatic pancreatic cancer, testing the efficacy of ipi-926 plus gemcitabine and placebo plus gemcitabine as treatments, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with prostate cancer, testing the drug dexamethasone. The eligibility criteria include a history of androgen-independent prostate cancer, rising PSA levels, and specific patient characteristics such as ECOG status and ANC count. Prior concurrent therapy requirements are also outlined.",
    "This sample is a phase 2 trial for patients with cognitive impairment and schizophrenia, testing the drugs eltoprazine and placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with multiple myeloma, testing the drug simvastatin, and includes eligibility criteria such as stable or progressive disease, age \u2265 18 years, and performance status < 3.",
    "This sample is a phase 2 clinical trial for age-related macular degeneration, testing the effectiveness of fluocinolone acetonide/medidur injections in patients who have not shown improvement with Lucentis injections, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for HIV-1 infection, testing the drugs cenicriviroc and truvada in treatment-na\u00efve patients with specific eligibility criteria, such as BMI, viral load, and CD4 count.",
    "This sample is a phase 1/phase 2 trial for patients with malignant pleural mesothelioma, testing the effectiveness of chemotherapy as a treatment option. The eligibility criteria include age > 18 years, no previous chemotherapy, and adequate organ function.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of a combination treatment with clarithromycin, lenalidomide, and dexamethasone. The eligibility criteria include specific disease stage, measurable disease markers, age, performance status, and various laboratory values. Exclusion criteria include certain medical conditions, prior therapy for multiple myeloma, and hypersensitivity to the drugs being used.",
    "This phase 2 trial is testing the drug plerixafor in patients with multiple myeloma or non-Hodgkin's lymphoma who are in remission and eligible for autologous transplant, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for dry eye syndrome, testing the effectiveness of chitosan-n-acetylcysteine eye drops compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for metastatic breast cancer patients who have received anthracycline chemotherapy and are eligible based on certain criteria, with gemcitabine and paclitaxel as the drugs being tested.",
    "This sample is a phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection in children, using the drugs lexiva (gw433908) and ritonavir, with specific eligibility criteria including age, HIV-1 RNA levels, and prior antiretroviral therapy.",
    "This sample is a phase 2 trial testing the drug azacitidine for the treatment of chronic myeloproliferative disorders and secondary myelofibrosis, with specific eligibility criteria including confirmed myelofibrosis, symptomatic disease, absence of t(9;22) translocation, and certain patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) testing the effectiveness of gemcitabine hcl and pemetrexed disodium drugs, with specific eligibility criteria including disease stage, measurable lesions, absence of brain metastases, and various patient characteristics.",
    "This sample is a phase 2 trial for patients with chronic kidney disease and diabetic nephropathy, testing the efficacy of atrasentan (low dose group, high dose group, and placebo group) in combination with anti-hyperglycemic medication and ACEi/ARB treatment. The inclusion criteria include specific requirements for diabetes treatment, kidney function, urinary albumin levels, serum albumin, BNP, blood pressure, HbA1c, and serum potassium. The exclusion criteria include restrictions on edema, loop diuretic use, heart failure, and specific medication combinations.",
    "This sample is a phase 2 clinical trial for patients with nasopharyngeal carcinoma, testing the effectiveness of cetuximab in combination with radiotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with prostate cancer, testing the effectiveness of androgen ablation, cabazitaxel, salvage therapy, and neoadjuvant treatment in combination with chemohormonal therapy, with eligibility criteria including specific PSA levels, biopsy results, and prior radiation therapy.",
    "This phase 2 trial aims to evaluate the efficacy of moxifloxacin and diphenhydramine in treating advanced or metastatic malignant solid tumors that have not responded to standard therapy or for which no standard therapy is available.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs MSDC-0160 and placebo, with inclusion criteria including a diagnosis of probable Alzheimer's disease based on NIA-AA criteria and MMSE scores of 20 or greater, and exclusion criteria including significant neurological/psychiatric diseases other than AD, history of heart failure, and ALT and/or AST levels that are twice the upper limit of normal.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes, testing the effectiveness of insulin NPH and ex1000 in combination with oral antidiabetic drugs (OADs) for glycemic control. The inclusion criteria include having type 2 diabetes for at least 12 months, current NPH treatment for at least 3 months, BMI less than or equal to 40 kg/m2, HbA1c less than or equal to 9.5%, and FPG less than or equal to 12 mmol/L. The exclusion criteria include treatment with GLP-1 mimetics or DPP-4 inhibitors, more than 1 IU/kg NPH insulin daily, hypoglycemia unawareness or recurrent major hypoglycemia, known or suspected allergy to trial products, recent receipt of any investigational drug, and any other condition that may interfere with trial participation or evaluation of results.",
    "This sample is a phase 1/phase 2 clinical trial for multiple myeloma patients who have had one to three prior regimens and did not respond or relapsed. The study will test the drugs kw-2478 and bortezomib, and the eligibility criteria include confirmed diagnosis, informed consent, performance status, life expectancy, M protein levels, and adequate hematologic, liver, and renal function.",
    "This sample is a phase 2 clinical trial for patients with osteoarthritis of the knee, testing the effectiveness of different drugs (fx006 10 mg, fx006 40 mg, fx006 60 mg, tca ir 40) based on eligibility criteria such as age, BMI, and exclusion criteria such as certain medical conditions and recent surgeries.",
    "This sample is a phase 2 trial for patients with primary central nervous system lymphoma, testing the effectiveness of rituximab, methotrexate, and cytarabine as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes and obesity, testing the drugs placebo and incb013739, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic pancreatic cancer, testing the effectiveness of gemcitabine, placebo, erlotinib, and apricoxib as potential treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for liver transplantation patients, testing the drug fk778, with inclusion criteria including age, negative pregnancy test, and being a recipient of a primary whole cadaveric liver transplant, and exclusion criteria including previous organ transplants, HIV positive status, and certain medical conditions.",
    "This sample is a phase 2/phase 3 trial for pancreatic cancer, testing the drug rubitecan, with inclusion criteria including non-resectable adenocarcinoma of the pancreas and exclusion criteria including active infections and scheduled surgery within 8 weeks.",
    "This phase 2 trial is testing the effectiveness of celecoxib and doxorubicin hydrochloride in treating patients with metastatic prostate cancer who have osteoblastic metastases and have shown progressive disease after response to prior induction chemotherapy.",
    "This sample is a phase 2 trial for patients with chronic lymphocytic leukemia (CLL) and includes the drug bendamustine as a potential treatment option, with specific eligibility criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with cholangiocarcinoma, hepatobiliary neoplasm, liver cancer, bile duct cancer, or cancer of the gallbladder. The trial will test the effectiveness of gemcitabine, cisplatin, carboplatin, capecitabine, and 5fu in treating these diseases. The eligibility criteria include specific diagnostic criteria, tumor size limitations, and liver function requirements.",
    "This sample is a phase 2 trial for postmenopausal osteoporosis, testing the drugs alendronate, denosumab, and placebo, with key inclusion criteria being postmenopausal, ambulatory women between 50 and 70 years old with low bone mineral density, and key exclusion criteria being subjects currently receiving medication affecting bone metabolism or having an underlying condition affecting their ability to take alendronate or receive denosumab.",
    "This sample is a phase 2/phase 3 trial for patients with multiple myeloma, testing the drugs tanespimycin and bortezomib, and includes eligibility criteria such as prior treatment regimens, no prior use of certain inhibitors, and no known infections.",
    "This sample is a phase 2 trial testing the use of botulinum toxin and saline in patients with severe cognitive impairment and paratonia, specifically those with Alzheimer's disease, vascular dementia, or frontotemporal dementia, and a paratonic rigidity in an arm(s) interfering in the provision of care. The study aims to determine the effectiveness of these drugs in improving the condition.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the drug gw685698/gw642444. The eligibility criteria include being a male subject or a non-child bearing potential female between 40-80 years old, having a clinical history of COPD, and having a current or previous history of \u2265 10 pack-years of cigarette smoking.",
    "This sample is a phase 2 trial for liver transplantation, testing the effectiveness of different drug combinations (mmf + tacrolimus, sotrastaurin + tacrolimus) along with standard care medications, on recipients meeting specific inclusion criteria such as being 18 years or older, having a primary de novo orthotopic liver transplant, and being HCV-negative, while excluding those with prior transplants, high MELD-score, or HCC beyond Milan criteria.",
    "This sample is a phase 2 trial testing the drug pf-00489791 and placebo in patients with mild to moderate hypertension, with inclusion criteria including age between 18 and 70 years and exclusion criteria including diabetes and significant cardiovascular events within the last 12 months.",
    "This sample is a phase 2/phase 3 trial for amyotrophic lateral sclerosis (ALS) testing the drugs memantine (ebixa), riluzole, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the drug darinaparsin in patients with hepatocellular carcinoma, with specific eligibility criteria and exclusion criteria listed.",
    "This sample is a phase 2 clinical trial for patients with colorectal cancer, testing the effectiveness of a combination of drugs including bevacizumab, capecitabine, 5-fluorouracil, and leucovorin, in pre-operative combined chemo-radiotherapy. The eligibility criteria include age, confirmed rectal cancer, measurable lesions, and performance status, while exclusion criteria include prior radiotherapy or chemotherapy for rectal cancer, brain metastases, and certain medications.",
    "In this phase 2 trial, the drug combination of gemcitabine, docetaxel, cisplatin, and etoposide will be tested for the treatment of non-small cell lung cancer, with specific eligibility criteria including no prior chemotherapy or radiation therapy and no prior malignancy.",
    "This sample is a phase 1/phase 2 clinical trial for patients with unresectable hepatocellular carcinoma (HCC), testing the drug sorafenib. The eligibility criteria include having measurable disease, adequate organ function, and suitable hepatic arterial anatomy for treatment with SIR-Spheres. Exclusion criteria include previous radiation therapy to the liver, liver failure, and certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with urinary bladder neoplasms, testing the drug tamoxifen as a systemic therapy regimen for those who have already received 1-2 regimens and have the cancer spread to other parts of the body, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with relapsed/refractory marginal zone B-cell lymphoma, testing the drug everolimus. The eligibility criteria include having a histologically proven diagnosis of the disease, measurable or evaluable disease, and a life expectancy of at least 3 months.",
    "This sample is a phase 2 clinical trial for patients with metastatic or unresectable gastric or esophageal adenocarcinoma, testing the efficacy of docetaxel, cisplatin, fluorouracil, bevacizumab, and leucovorin as a treatment option. The eligibility criteria include specific disease classifications, radiographic evaluation, prior treatment history, and various health parameters.",
    "This sample is a phase 2 trial for patients with relapsed follicular B-cell lymphoma, testing the drugs sargramostim and rituximab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with histologically confirmed GIST who have imatinib resistance, and it aims to evaluate the efficacy of ptk787/zk222584 in treating metastatic disease.",
    "This sample is a phase 2 trial for patients with follicular lymphoma, testing the effectiveness of rituximab, fludarabine, and mitoxantrone as a second-line chemotherapy treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 2 trial is testing the effectiveness of irinotecan hydrochloride and temozolomide in treating adult patients with recurrent or refractory glioblastoma or gliosarcoma, with specific eligibility criteria including histological confirmation of the disease, prior treatment with temozolomide, and radiographic evidence of tumor progression.",
    "This sample is a phase 2 trial for patients with follicular lymphoma, testing the efficacy of rituximab + bendamustine as a treatment option, with specific eligibility criteria including age, disease stage, and various hematological and organ function requirements.",
    "This sample is a phase 2 clinical trial for rheumatoid arthritis patients who have had an insufficient response to methotrexate treatment, and it will test the effectiveness of diacerein compared to a placebo.",
    "This sample is a phase 2/phase 3 trial that focuses on patients with various neuroendocrine tumors, including gastrointestinal carcinoid tumor, islet cell tumor, lung cancer, neoplastic syndrome, and neuroendocrine tumor. The trial will evaluate the effectiveness of 5-fluorouracil, leucovorin, and oxaliplatin as treatment options, and it includes eligibility criteria related to disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 2 trial testing the drugs bta798 and placebo on subjects with asthma and presumptive human rhinovirus infection, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients diagnosed with chronic hepatitis C, testing the effectiveness of taribavirin and ribavirin as potential treatments, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 trial for patients with chronic myeloid leukemia, testing the effectiveness of reduced intensity conditioning, busulfan, and fludarabine as a treatment option, with specific eligibility criteria including age, consent, organ function, and disease status.",
    "This sample is a phase 2 clinical trial for patients with follicular NHL, testing the effectiveness of bevacizumab and rituximab in treating the disease, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic breast cancer who are not eligible for surgery or radiotherapy with curative intent, and it aims to evaluate the efficacy of edotecarin as a treatment option.",
    "This sample is a phase 2/phase 3 trial that focuses on diabetic patients aged 55 and above with diseases such as diabetes, myocardial infarction, and cardiovascular disease. The study aims to test the effectiveness of natural source vitamin E 400iu/day as a treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with transitional cell carcinoma, testing the drug vinflunine as a second-line treatment option after cisplatin and gemcitabine, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic adenocarcinoma of the prostate, testing the drug ixabepilone, and includes eligibility criteria such as evidence of disease progression and specific laboratory values.",
    "This sample is a phase 2 trial studying the effectiveness of vigabatrin and placebo in treating alcoholism and cocaine dependence, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with myelofibrosis, testing the drug obatoclax mesylate (gx15-070ms), and includes inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with myeloid leukemia, testing the drugs filgrastim and pegfilgrastim, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for kidney transplantation, testing the drugs alemtuzumab, sirolimus, tacrolimus, and methylprednisolone (or equivalent), among others, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with renal clear cell carcinoma, testing the efficacy of gemcitabine, capecitabine, and sorafenib as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 2 trial is testing the drugs clofarabine and cytarabine in patients with refractory or relapsed acute lymphoblastic leukemia (ALL) who have evidence of ALL in bone marrow or peripheral blood, and meet specific patient eligibility criteria.",
    "This phase 2 trial is testing the drug SU11248 in patients with metastatic breast cancer who have received taxane-based chemotherapy and meet specific eligibility criteria.",
    "This sample is a phase 2 trial for patients with inoperable stage III or IV melanoma, testing the drug imatinib mesylate, with eligibility criteria including specific disease types, tumor tissue availability, and various health parameters.",
    "This sample is a phase 2 clinical trial for ulcerative colitis, testing the drugs telotristat etiprate and placebo, with inclusion criteria including a diagnosis of ulcerative colitis, disease extension, and willingness to remain on a stable dose of 5-aminosalicylic acid (5-ASA)/mesalamine therapy.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the effectiveness of the drug combination AC (adriamycin and cyclophosphamide) followed by paclitaxel, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with malignant glioma, glioblastoma, or gliosarcoma, testing the effectiveness of bevacizumab, temozolomide, and topotecan as treatment options, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is testing the drug romidepsin in patients with stage IIa or IIIa multiple myeloma who have progressive disease and have had 1-4 prior lines of therapy, with various eligibility criteria including specific laboratory values and performance status.",
    "This sample is a phase 2 trial for patients with neuropathy caused by ARTs, testing the effectiveness of dimiracetam and a sugar pill as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced non-small cell lung cancer (NSCLC) using carboplatin, chemoprotection, and paclitaxel as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 trial for patients with recurrent mantle cell lymphoma, testing the drug temsirolimus, with specific eligibility criteria including histological confirmation of MCL, measurable disease, and certain laboratory values within normal limits.",
    "This sample is a phase 2 trial for geographic atrophy, a form of age-related macular degeneration, testing the drugs fcfd4514s and sham, with inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with Ewing's sarcoma or primitive neuroectodermal tumor (PNET) that has recurred or not responded to prior therapy. The drug being tested is cytarabine, and the eligibility criteria include specific disease characteristics and patient characteristics.",
    "This sample is a phase 2 trial for asthma and airway inflammation, testing the effectiveness of various drugs including mometasone furoate/formoterol and placebo, with eligibility criteria including documented asthma diagnosis, persistent allergic asthma, and specific laboratory test results.",
    "This sample is a phase 2 clinical trial for patients with squamous cell cancer of the head and neck, testing the drug cetuximab. The eligibility criteria include having a confirmed recurrence or second primary tumor in the head and neck, previous radiation therapy, and specific blood counts within normal range. Patients must not have distant metastases or completely resected recurrence with negative margins, and should not have other concurrent invasive malignancies or certain medical illnesses. Pregnant and nursing women are excluded, as well as those who have previously been treated with cetuximab.",
    "This sample is a phase 1/phase 2 trial for women with Her-2 positive and ER-negative or ER-low breast cancer, testing the effectiveness of trastuzumab (herceptin\u00ae) in preventing metastasis, with specific eligibility criteria including no prior treatment with chemotherapy, hormonal therapy, or trastuzumab.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the effectiveness of 5-fluorouracil, capecitabine, cyclophosphamide, docetaxel, and epirubicin in treating T2-3, N0-1, M0 breast adenocarcinoma.",
    "This sample is a phase 2 clinical trial for breast cancer patients with bone metastasis, testing the drugs rad001 and placebo, and includes eligibility criteria such as histologically confirmed invasive adenocarcinoma of the breast and postmenopausal hormone receptor positive patients who have received an aromatase inhibitor.",
    "This sample is a phase 2 clinical trial for patients with refractory metastatic colorectal cancer, testing the drug lbh589, and includes eligibility criteria such as age, disease status, previous treatments, and laboratory values.",
    "This sample is a phase 2 clinical trial for hepatocellular carcinoma, testing the drugs bevacizumab and erlotinib, with eligibility criteria including confirmed diagnosis of hepatocellular carcinoma, elevated AFP levels, and adequate organ functions.",
    "This sample is a phase 2 trial testing the drug \"sch 530348\" on patients with arterial obstructive diseases and coronary disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the efficacy of oral sufentanil and placebo in patients undergoing major upper or lower abdominal surgery, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with metastatic renal cell carcinoma who have previously received or are currently receiving sunitinib malate. The study aims to evaluate the efficacy of Panzem\u00ae NCD in combination with sunitinib malate in treating the disease. The eligibility criteria include having measurable disease, normal organ and marrow function, and adequate cardiac function. The exclusion criteria include active brain metastases, gastrointestinal abnormalities, and uncontrolled intercurrent illness.",
    "This sample is a phase 2 clinical trial for patients with relapsed or chemotherapy-resistant low-grade CD20+ B cell non-Hodgkin lymphoma, testing the effectiveness of bexxar (tositumomab) and potassium iodide (KI) as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic, androgen-independent prostate cancer, testing the drug perifosine, with eligibility criteria including documented disease progression and specific patient characteristics.",
    "This sample is a phase 2 trial for the drug NGX267 in patients diagnosed with primary or secondary Sj\u00f6gren's syndrome, with inclusion and exclusion criteria specified, and the drug being tested for its effectiveness in treating dry mouth symptoms.",
    "This sample is a phase 2 clinical trial for multiple sclerosis, testing the drugs cdp323 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with unresectable stage III or stage IV melanoma, testing the drug STA-9090 as a tyrosine kinase inhibitor, with eligibility criteria including specific disease characteristics, performance status, laboratory values, and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic bladder cancer, transitional cell cancer of the renal pelvis and ureter, and urethral cancer. The drug being tested is depsipeptide, and the eligibility criteria include having measurable disease, disease progression or recurrence after prior chemotherapy, and meeting certain patient characteristics such as performance status and organ function.",
    "This sample is a phase 2 trial for essential hypertension, testing the drugs act-280778, placebo, and amlodipine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for the treatment of major depressive disorder in children and adolescents using the drug duloxetine, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for idiopathic pulmonary fibrosis (IPF) patients aged 50 or older, testing the drug cc-930, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the drug ph-797804 and placebo in patients with moderate to severe chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for cystic fibrosis patients, testing the drugs oligog cf-5/20 and saline, with eligibility criteria including a confirmed diagnosis of cystic fibrosis, positive microbiological finding of Pseudomonas aeruginosa, and FEV1 between 35%-80% of predicted normal value.",
    "This sample is a phase 1/phase 2 trial for patients with stage IV pancreatic cancer, testing the combination of erlotinib hydrochloride and gemcitabine hydrochloride as a treatment option. The eligibility criteria include specific disease stage, performance status, blood counts, liver and kidney function, and exclusion of other medical conditions.",
    "This sample is a phase 2 clinical trial for age-related macular degeneration (AMD) using the drugs ot-551 and a vehicle placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 trial testing the use of Lamictal in the treatment of post-herpetic neuralgia, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients diagnosed with type 2 diabetes mellitus, testing the effectiveness of exenatide (ly2148568) and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with glioblastoma multiforme, testing the drug everolimus, and includes specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 2 trial aims to evaluate the efficacy of 20mg daily citalopram compared to placebo in individuals with Huntington's disease who have mild executive dysfunction, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with osteoarthritis of the knee, testing the effectiveness of pennsaid gel and vehicle as pain therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial that aims to evaluate the effectiveness of ati-5923 and coumadin (warfarin) in patients with various cardiovascular diseases, including atrial fibrillation, atrial flutter, venous thromboembolic disease, myocardial infarction, and cardiomyopathy, who require chronic anticoagulation. The eligibility criteria include specific indications for warfarin anticoagulation, age greater than 18, and willingness to comply with the study protocol. The exclusion criteria include contraindications to anticoagulation, active bleeding, concomitant use of other anticoagulant or antiplatelet agents, and certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with liver cancer, testing the drug octreotide acetate. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with advanced breast cancer, testing the combination of trastuzumab and letrozole as a treatment option, with specific eligibility criteria including HER-2 amplification and prior treatment with a nonsteroidal aromatase inhibitor.",
    "This sample is a phase 2 clinical trial for glaucoma, testing the efficacy of ar-12286 and latanoprost ophthalmic solutions in reducing intraocular pressure, with specific inclusion and exclusion criteria for participants.",
    "This sample is a clinical trial for patients with leukemia, specifically those with chronic myelogenous leukemia (CML) who are resistant or intolerant to imatinib. The trial is divided into two phases (phase I and phase II) and aims to evaluate the effectiveness of the drug radotinib in treating CML patients. The eligibility criteria include age, performance status, laboratory values, and previous treatments. Exclusion criteria include certain medical conditions, recent surgeries, and pregnancy.",
    "This sample is a phase 2/phase 3 trial for patients with chronic lymphocytic leukemia, testing the effectiveness of bendamustine and fludarabine drugs in refractory or relapsed situations after first-line treatment. The inclusion criteria include confirmed chronic B-cell leukemia, specific disease stages, and negative pregnancy test or adequate contraception. Exclusion criteria include certain types of leukemia, previous treatment with fludarabine or bendamustine, and certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with metastatic or locally recurrent prostate cancer that is not curable with standard therapy. The drug being tested is sunitinib (su011248), and the eligibility criteria include prior treatment with docetaxel chemotherapy and no evidence of disease progression.",
    "This sample is a phase 2 clinical trial for patients with Parkinson's disease, testing the drugs adx48621 and placebo. The inclusion criteria include having idiopathic PD, experiencing moderately disabling dyskinesia, and having a certain mAIMS score. The exclusion criteria include recent surgical treatment for PD, unstable co-existing psychiatric disease, significant medical conditions, and pregnancy or breastfeeding.",
    "This sample is a phase 2 clinical trial for the drug tivozanib in the treatment of renal cell carcinoma, with specific eligibility criteria and exclusion criteria listed.",
    "This sample is a phase 2 clinical trial for patients with adenocarcinoma of the prostate and prostate cancer, testing the effectiveness of celecoxib and placebo in combination with planned prostatectomy. The eligibility criteria include age, performance status, hemoglobin levels, creatinine levels, and signed informed consent.",
    "This sample is a phase 2 trial for non-squamous non-small cell lung cancer, testing the effectiveness of standard chemotherapy and bevacizumab (Avastin) in patients who meet the inclusion/exclusion criteria of MO19390.",
    "This sample is a phase 2 clinical trial for non-Hodgkin's lymphoma, testing the drugs rituxan and 1018 iss, with specific eligibility criteria for participants.",
    "This sample is a phase 1/phase 2 trial for patients with recurrent glioblastoma multiforme, glioma, astrocytoma, or brain tumor, testing the efficacy of the drug combination itv depocyt + temozolomide, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with recurrent or refractory small cell lung cancer, testing the drug SNS-595, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug laromustine for patients with fludarabine refractory or relapsed chronic lymphocytic leukemia (CLL), Richter syndrome, or other refractory lymphoproliferative diseases. Eligible patients must have an ECOG performance status of 0-2, creatinine \u2264 2.0 mg/dL, AST and ALT \u2264 3 times ULN, and meet other criteria.",
    "This phase 2 trial aims to evaluate the effectiveness of atorvastatin in reducing LDL cholesterol levels in adult patients with venous thromboembolism and hypercholesterolemia who have completed at least 6 months of oral anticoagulant treatment.",
    "This sample is a phase 2 clinical trial for non-small-cell lung cancer, testing the drugs pemetrexed and gemcitabine, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 trial for HIV-infected individuals with measurable HIV Neurocognitive Impairment (HNCI) who are considering initiating or changing their HAART regimens. The study aims to evaluate the safety and efficacy of FDA-approved antiretroviral therapy in improving neurocognitive function, with eligibility criteria including confirmed HIV infection, age 18 or older, and willingness to undergo lumbar punctures. Exclusion criteria include presence of serious illness, neurologic disorders other than HIV causing neurocognitive impairment, and active psychiatric disorders or substance use.",
    "This sample is a phase 2/phase 3 trial for pediatric renal allograft recipients with biopsy proven acute rejection episodes, testing the use of rituximab for transplant rejection. The eligibility criteria include a decline in renal function, adequate liver function, negative pregnancy test, and agreement to use birth control. Exclusion criteria include recent treatment with investigational agents, previous treatment with rituximab, history of severe allergic reactions, HIV or hepatitis B/C, recurrent infections, ongoing use of high dose steroids, and various other contraindications.",
    "This sample is a phase 2 clinical trial for patients with gastric cancer, testing the drug irofulven. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drug bapineuzumab, and includes eligibility criteria such as age, diagnosis, cognitive score, and brain imaging requirements.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the efficacy of 250mg rilapladib and placebo drugs on patients who meet specific inclusion criteria, such as having a clinical diagnosis of possible Alzheimer's disease, stable dosing of Alzheimer's disease therapy, and specific cognitive test scores.",
    "This sample is a phase 2 clinical trial for asthma patients, testing the drug ff/gsk573719, and the eligibility criteria include being an outpatient, having a diagnosis of asthma, and meeting certain lung function requirements.",
    "This sample is a phase 2 clinical trial for patients with esophageal neoplasms, testing the effectiveness of oxaliplatin, cisplatin, and 5-fluorouracil (5-fu) in treating unresectable or metastatic disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the effectiveness of ondansetron, olanzapine, and placebo in treating alcohol dependence, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic melanoma, testing the drug raf265. The inclusion criteria include confirmed diagnosis of melanoma, measurable disease, ECOG performance status of 0 or 1, and no concurrent anticancer or investigational therapy for at least 4 weeks prior to enrollment. The exclusion criteria include significant cardiac disease or other significant medical/psychiatric disease, history of primary central nervous system tumor or brain metastases, history of melena, hematemesis, or hemoptysis within the last 3 months, and previous therapy with certain molecularly targeted agents.",
    "This sample is a phase 2 clinical trial for patients with rheumatoid arthritis, testing the drug ly2127399 against a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of bortezomib, dexamethasone, thalidomide, and cyclophosphamide as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for women with signs and symptoms of myocardial ischemia, testing the effectiveness of ranolazine and placebo in the absence of obstructive coronary artery disease, with inclusion criteria including abnormal stress testing and \u226510% myocardial ischemia by CMR perfusion, and exclusion criteria including contraindications to ranolazine and drugs that inhibit CYP3A, pregnancy or breastfeeding, and a life expectancy less than 6 months.",
    "This sample is a phase 2 trial for patients with recurrent childhood acute lymphoblastic leukemia, testing the drugs methotrexate and mercaptopurine, with specific eligibility criteria including diagnosis, relapse status, performance status, and various medical conditions.",
    "This sample is a phase 2 clinical trial for bladder cancer, testing the drugs cisplatin and fluorouracil in patients with specific disease characteristics and patient eligibility criteria.",
    "This sample is a phase 2 trial for the drug zgn-440 in patients with Prader-Willi Syndrome and obesity, with specific inclusion and exclusion criteria, including a stable body weight requirement and restrictions on the use of weight loss agents and narcotics.",
    "This sample is a phase 2 clinical trial for patients with chronic lymphocytic leukemia (CLL), testing the drugs fludarabine and campath, with eligibility criteria including a diagnosis of CLL and advanced or progressive disease with at least 2 active clinical signs.",
    "This sample is a phase 2 trial for rheumatoid arthritis patients who have failed previous treatments, and it is testing the efficacy of canakinumab compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with recurrent, locally advanced, or metastatic breast cancer, testing the drugs dasatinib and dasatinib 100 mg, with eligibility criteria including prior chemotherapy with an anthracycline and/or a taxane, expression of ER/PR receptor and/or overexpression of Her2/neu, and availability of paraffin-embedded tissue block.",
    "This sample is a phase 1/phase 2 trial testing the drug Proellex on healthy adult females with conditions such as excessive menstrual bleeding, menstrual pain, uterine fibroids, and endometriosis, who meet certain eligibility criteria.",
    "This sample is a phase 2 trial for cystic fibrosis patients, testing the drug biaxin (clarithromycin), with inclusion criteria including a diagnosis of CF and an FEV1 of 30% predicted at the time of screening.",
    "This sample is a phase 2 trial for patients with gastric carcinoma or gastroesophageal junction carcinoma, testing the effectiveness of oxaliplatin, capecitabine, and celecoxib as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the effectiveness of 1.5 mg or 2.0 mg cjc-1134-pc compared to a placebo, with specific eligibility criteria including BMI, stable diabetes, lifestyle, metformin dose, and HbA1c levels.",
    "This sample is a phase 2 trial for patients with lymphoma, specifically B-cell lymphoma, and the drug being tested is idarubicin. The eligibility criteria include having a histological or cytological diagnosis of non-Hodgkin's lymphoma, previous treatment with high-dose methotrexate, and adequate organ function.",
    "This sample is a phase 2 clinical trial for rheumatoid arthritis, testing the drugs rob 803 and placebo in patients who meet specific inclusion criteria, such as having a diagnosis of RA, active disease, and taking methotrexate.",
    "This sample is a phase 2 clinical trial for patients with undifferentiated arthritis, testing the effectiveness of abatacept and placebo in treating the disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for insulin-na\u00efve type 2 diabetes subjects, testing the efficacy of various drugs including insulin degludec/insulin aspart and metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for breast cancer patients with tumors overexpressing HER2neu, testing the efficacy of the drugs myocet, taxotere, and herceptin, with various eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with uterine or soft tissue leiomyosarcoma, testing the effectiveness of docetaxel and gemcitabine hydrochloride as second-line treatment for metastatic or unresectable disease, with specific eligibility criteria including prior anthracycline-based chemotherapy and certain patient characteristics.",
    "This sample is a phase 2 trial for patients with CD20+ diffuse large B-cell lymphoma, testing the effectiveness of the drugs r-chop14 induction regimen and r-acvbp14 induction regimen, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with hypercholesterolemia, testing the efficacy of gemcabene, atorvastatin, and placebo in reducing LDL-C levels, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) who have demonstrated progressive disease after first-line chemotherapy. The study aims to evaluate the efficacy and safety of the drugs pemetrexed and matuzumab in this patient population. The inclusion criteria include specific age, diagnosis, disease stage, prior treatment, and organ function requirements, while the exclusion criteria include certain medical conditions and prior treatments.",
    "This sample is a phase 2 trial for the treatment of schizophrenia, testing the drugs gsk239512 and placebo, with inclusion criteria including a clinical diagnosis of schizophrenia and exclusion criteria including a significant homicidal or suicidal risk or evidence of previous risk.",
    "This phase 2 trial is investigating the use of sulindac, a nonsteroidal anti-inflammatory drug, in current or former smokers with precancerous conditions or stage I non-small cell lung cancer, who meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with small cell lung cancer (SCLC) who have relapsed after first-line chemotherapy. The study aims to evaluate the efficacy and safety of topotecan and vorinostat as treatment options. The inclusion criteria include a histologically or cytologically proven diagnosis of SCLC, measurable lesions according to RECIST criteria, and adequate cardiac, hepatic, renal, and bone marrow function. Exclusion criteria include prior treatment with an HDAC inhibitor, symptomatic and/or unstable pre-existing brain metastases, and severe or uncontrolled medical diseases. Pregnant or breastfeeding women are also excluded from the study.",
    "This sample is a phase 1/phase 2 trial for patients with unresectable pancreatic cancer, testing the effectiveness of oxaliplatin, 5fu, and folfox 6 as chemotherapy drugs, with specific eligibility criteria for patients to be included in the study.",
    "This sample is a phase 2 trial for Huntington's disease, testing the effectiveness of creatine monohydrate and placebo in individuals who are expansion positive or at risk for HD and not clinically diagnosed, with additional inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for previously untreated acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) patients over 60 years old, testing the effectiveness of clofarabine and ara-c drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with primary breast cancer, testing the efficacy of lapatinib and lapatinib-placebo drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial studying the effectiveness of selumetinib and selumetinib sulfate in treating various types of ovarian and peritoneal carcinomas, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for the drug oglemilast and placebo in patients with chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with advanced prostate cancer, testing the drug fulvestrant, and includes eligibility criteria related to disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 2 trial for patients with nonsquamous non-small cell neoplasm of lung, non-small cell lung cancer metastatic, or non-small cell lung cancer stage iiib, testing the drug pemetrexed, with specific eligibility criteria including prior platinum-based doublet therapy and a Performance Status of 0 or 1.",
    "This sample is a phase 2 trial for osteoporosis, testing the drugs teriparatide, placebo, and different doses of ba058, with eligibility criteria including low bone mineral density and good general health.",
    "This sample is a phase 2 trial for patients with locally advanced or metastatic gastro-oesophageal junction cancer or gastric cancer, testing the efficacy of azd4547 and paclitaxel as treatment options, with specific inclusion and exclusion criteria outlined.",
    "In this phase 2 trial, the drug anamorelin hcl and placebo will be tested on patients with stage IIIB or IV non-small-cell lung carcinoma who are eligible for treatment with paclitaxel and carboplatin +/- bevacizumab, with the aim of evaluating its effectiveness in treating the disease.",
    "This sample is a phase 2 clinical trial for major depressive disorder, testing the drug mecamylamine, and includes inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 clinical trial for lung cancer patients with specific criteria, including having received one or two prior systemic therapies, and excludes patients with brain metastases or a history of stroke within 6 months. The study will test the drugs bevacizumab and bortezomib for their effectiveness in treating the disease.",
    "This sample is a phase 2 clinical trial for patients with recurrent non-small cell lung cancer, testing the drugs seliciclib and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients diagnosed with primary or mixed dementia, testing the effectiveness of megestrol acetate and placebo in treating weight loss and malnutrition.",
    "This sample is a phase 2 clinical trial for patients with metastatic or locally advanced inoperable breast cancer, who are progressing on treatment with tamoxifen. The study aims to evaluate the efficacy of tamoxifen and zarnestra in post-menopausal patients with hormone-sensitive breast cancer.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic non-small-cell lung carcinoma that has relapsed after chemotherapy. The study aims to evaluate the efficacy of dalotuzumab and erlotinib in treating the disease. The inclusion criteria include having had at least one chemotherapy regimen for recurrent or metastatic disease, being 18 years or older, and having a performance status of 0-2 on the ECOG scale. The exclusion criteria include recent chemotherapy or biological therapy, not having recovered from previous therapy, and participation in another clinical study.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs abt-288, donepezil, and placebo, with inclusion criteria including a diagnosis of probable AD, postmenopausal or surgically sterile females, and an identified caregiver, and exclusion criteria including current or recent use of AD or dementia medications, history of drug or alcohol abuse, and intolerance or adverse reaction to donepezil.",
    "This sample is a phase 2 clinical trial for the treatment of bladder cancer using the drugs sorafenib and placebo, with eligibility criteria including histologically proven urothelial carcinoma, locally advanced or metastatic disease, and specific hematologic, renal, hepatic, and coagulation-physiological functions.",
    "This sample is a phase 2 trial for patients with depression and excessive daytime sleepiness, testing the effectiveness of mirtazapine treatment, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is investigating the efficacy of ogx-427 and prednisone in treating castration resistant prostate cancer patients who have metastatic disease and show progression of the disease, with specific eligibility criteria including age, performance status, histological diagnosis, and prior therapy.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C, testing the effectiveness of drugs such as bms-790052 and pegylated-interferon alfa-2a, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with leukemia, specifically acute lymphoblastic leukemia and blastic phase chronic myelogenous leukemia, who are not eligible for bone marrow transplant. The study will test the effectiveness of arsenic trioxide as a treatment option.",
    "This sample is a phase 2 clinical trial for patients scheduled to undergo unilateral inguinal hernia repair, testing the drugs sky0402 and bupivacaine hcl for postoperative pain control.",
    "This sample is a phase 2 trial for obesity, testing the drugs nasal placebo, placebo capsule, pyy3-36, and sibutramine, with inclusion criteria including BMI 30-43 kg/m2 and good health, and exclusion criteria including previous surgical treatment for obesity and serious medical or psychiatric conditions.",
    "This sample is a phase 2/phase 3 trial for patients with intermediate- or high-grade malignant soft tissue sarcoma, testing the effectiveness of the drugs doxorubicin hydrochloride and trabectedin, with eligibility criteria including previously untreated disease, confirmed disease progression, and specific patient characteristics.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs evp-6124 and placebo, with inclusion criteria including subjects with probable Alzheimer's disease and specific cognitive scores, and exclusion criteria including prior participation in an amyloid vaccination clinical study and history of stroke within 18 months of screening.",
    "This sample is a phase 2 clinical trial for patients with b-cell chronic lymphocytic leukemia, testing the effectiveness of fludarabine phosphate and alemtuzumab as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic or locally unresectable clear cell renal carcinoma, testing the drug lbh589. The eligibility criteria include documented disease progression or intolerance to previous treatments, measurable disease, and specific laboratory values.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the efficacy of cediranib maleate and irinotecan hydrochloride as a second-line treatment option, with specific eligibility criteria including prior treatment history and certain patient characteristics.",
    "This sample is a phase 2 trial for patients with castration-resistant prostate cancer, testing the drug testosterone, with specific eligibility criteria including a history of response to castration therapy and evidence of progressive disease.",
    "This sample is a phase 2 clinical trial for patients with inoperable locally advanced or metastatic squamous cell carcinoma of the head and neck. The study will test the effectiveness of oxaliplatin and 5-fu drugs in treating the disease. The eligibility criteria include age, tumor size, performance status, blood counts, and liver function.",
    "This sample is a phase 2 clinical trial for the treatment of atherosclerosis using the drug losmapimod 7.5 mg compared to a placebo, with eligibility criteria including age, body weight, previous cardiovascular events, peripheral vascular disease, and certain medical conditions.",
    "This sample is a phase 2 trial for painful diabetic neuropathy, testing the effectiveness of clonidine topical gel (arc-4558) and placebo gel in patients with Type 1 or Type 2 diabetes mellitus and chronic pain in the lower extremities.",
    "This sample is a phase 2 trial for the treatment of type 1 diabetes mellitus using sirolimus, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced melanoma, testing the drug ipilimumab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with asthma, testing the effectiveness of tiotropium as an add-on therapy for moderate persistent asthma patients who are symptomatic despite their current maintenance treatment with medium doses of ICS.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of glycopyrrolate inhalation solution and placebo in improving lung function, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for lung cancer patients, testing the drugs ipilimumab, placebo, paclitaxel, and carboplatin, with eligibility criteria including confirmed lung cancer, measurable tumor lesion, and an Eastern Cooperative Oncology Group performance status of \u22641.",
    "This sample is a phase 2 clinical trial for patients with recurrent, persistent, or newly diagnosed metastatic squamous cell carcinoma of the head and neck. The study will test the effectiveness of gemcitabine and paclitaxel as treatment options. Eligibility criteria include age 18 and over, Zubrod performance status of 0-1, and no serious organ dysfunction or comorbid conditions that would preclude study treatment.",
    "This sample is a phase 2 clinical trial testing the drugs vanoxerine and placebo for the treatment of symptomatic atrial fibrillation and atrial flutter, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients aged 70 or older with locally advanced or metastatic gastric cancer, testing the effectiveness of irinotecan associated with fluorouracil and leucovorin as a palliative chemotherapy treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with refractory metastatic melanoma, testing the efficacy of dmf5 melanoma reactive til, cyclophosphamide, fludarabine, and aldesleukin as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced non-small cell lung carcinoma (NSCLC), testing the efficacy of the topotecan/docetaxel combination and docetaxel as second-line chemotherapy options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with relapsed or refractory Hodgkin's disease or lymphoma, testing the drug alemtuzumab (Campath-1H) as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with schizophrenia, testing the drugs bl - 1020, placebo, and risperidone, with eligibility criteria including a confirmed diagnosis of schizophrenia, acute exacerbation of psychosis, and willingness to comply with study procedures.",
    "This sample is a phase 2 clinical trial for patients with recurrent non-small cell lung cancer, stage IIIB non-small cell lung cancer, or stage IV non-small cell lung cancer. The trial will test the effectiveness of erlotinib hydrochloride and celecoxib as treatment options. The eligibility criteria include specific disease stage, prior chemotherapy regimens, measurable lesions, performance status, blood counts, organ function, and absence of certain medical conditions or medications.",
    "This sample is a phase 2 trial for patients with osteoarthritis in the knee and hip, testing the drugs cg100649 and silicified microcrystalline cellulose + talc, with specific eligibility criteria including age, BMI, blood pressure, OA confirmation, chronic pain duration, and medication usage.",
    "This sample is a phase 2 clinical trial that aims to evaluate the effectiveness of pentostatin, a drug, in treating various diseases including leukemia, lymphoma, Hodgkin's disease, hematologic neoplasms, multiple myeloma, and renal cell carcinoma. The eligibility criteria include specific diagnoses and age requirements, and the exclusion criteria include certain medical conditions and eligibility for other treatments.",
    "This sample is a phase 2 trial for the treatment of hypercholesterolemia, testing the drugs etc-1002 and placebo, with specific inclusion and exclusion criteria related to statin intolerance and lipid levels.",
    "This sample is a phase 2 clinical trial for patients with metastatic melanoma and skin neoplasms, testing the drug imatinib mesylate (sti571) to determine its effectiveness in treating the disease. The eligibility criteria include specific biopsy results, measurable indicator metastasis, and normal organ and marrow function.",
    "This sample is a phase 2 clinical trial for patients with castrate-resistant prostate cancer, testing the drug itraconazole, and includes eligibility criteria such as age, disease progression, and hormone levels.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndrome (MDS), testing the effectiveness of arsenic trioxide as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with stage III or IV squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx, testing the effectiveness of erlotinib hydrochloride and cisplatin as treatment options.",
    "This sample is a phase 2 trial for the treatment of hepatitis C virus (HCV) infection using the drugs abt-450, abt-267, ribavirin, and ritonavir. The eligibility criteria include having a chronic HCV infection, specific laboratory values, and not being pregnant or having certain medical conditions.",
    "This sample is a phase 2 trial for attention deficit hyperactivity disorder (ADHD) using the drug atomoxetine, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with acute coronary syndrome, testing the drugs placebo and cer-001, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of diabetic neuropathic pain, with the drugs abt-639, placebo, and lidocaine being tested, and specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial testing the drug mecamylamine hydrochloride (inversine) on patients with major depressive disorder, who are on SSRI monotherapy and have depression scores on HDRS-17 item scale of 12 or higher. The study has inclusion and exclusion criteria, and the drug's eligibility is based on the patient's history and blood pressure.",
    "This sample is a phase 1/phase 2 trial for Parkinson's disease, testing the efficacy of levodopa and carbidopa solution for sc administration compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with persistent atrial fibrillation, testing the effectiveness of eplerenone and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with rheumatoid arthritis, testing the effectiveness of infliximab and placebo drugs, with specific eligibility criteria including disease duration, joint symptoms, laboratory tests, and medication history.",
    "This sample is a phase 1/phase 2 trial investigating the use of bevacizumab, ag-013726, and ag-013736 (axitinib) in patients with locally advanced or metastatic colorectal cancer (CRC) who have not received prior systemic therapy. The inclusion criteria include having measurable disease by RECIST and controlled hypertension, while the exclusion criteria include prior treatment with anti-angiogenesis agents and prior irradiation of bone marrow.",
    "This sample is a phase 2 clinical trial for the treatment of postherpetic neuralgia and pain using the drugs ngx-1998 and placebo liquid, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for smoking cessation, testing the drug nicotine, with inclusion criteria including current cigarette smokers who smoke their first cigarette more than 30 minutes after waking up, and exclusion criteria including intolerance or hypersensitivity to nicotine, recent myocardial infarction or cerebrovascular accident, and use of any nicotine replacement therapy or other treatment for smoking cessation within one month of screening visit.",
    "This sample is a phase 1/phase 2 clinical trial for patients with refractory advanced solid tumors or metastatic/advanced ovarian carcinoma, colorectal cancer, or head and neck squamous cell cancer. The trial will test the efficacy of the drugs ji-101 and everolimus in treating these diseases. The eligibility criteria include age, tumor measurement, organ and marrow function, blood pressure, thyroid and cardiac function, pregnancy status, and informed consent. Exclusion criteria include brain metastases, gastrointestinal conditions, recent surgery or therapy, bleeding disorders, pregnancy or breastfeeding, allergies to the investigational products, drug or alcohol abuse, viral infections, cardiac or gastrointestinal abnormalities, and use of certain medications.",
    "This sample is a phase 2 clinical trial for patients with small cell lung cancer (SCLC) previously treated with at least one therapeutic regimen, including doxorubicin. The study aims to evaluate the efficacy and safety of the drugs ngr-htnf and doxorubicin in treating SCLC, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 2 trial is testing the efficacy of Nuvigil\u00ae and placebo in patients with malignant glioma, specifically supratentorial WHO grade 3 anaplastic glioma or grade 4 glioblastoma, who require external beam radiation therapy (EBRT) and concurrent temozolomide (TMZ). The study includes eligibility criteria such as age, renal and liver function, bone marrow function, Karnofsky Performance Status, and recovery from neurosurgery. Exclusion criteria include pre-existing traumatic brain injury, dementing illness, neurological deficits, prior treatment with EBRT or stereotactic radiosurgery, and history of certain cardiac conditions. Patients must agree to use birth control and avoid alcohol consumption during therapy.",
    "This sample is a phase 2 trial for liver cirrhosis patients, testing the drugs conivaptan and placebo, with inclusion criteria including euvolemia or hypervolemia secondary to cirrhosis and clinical evidence of portal hypertension, and exclusion criteria including volume depletion or dehydration and history of bleeding from esophageal varices within three months before the study.",
    "This sample is a phase 2 trial for children with hypertension, testing the efficacy and safety of perindopril as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients with HER2-positive tumors, testing the efficacy of trastuzumab (herceptin) in combination with chemotherapy, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial for the treatment of type 2 diabetes mellitus using alogliptin and voglibose drugs, with eligibility criteria including completion of a phase 2 dose-ranging study and exclusion criteria related to hepatic and renal impairment.",
    "This sample is a phase 2 trial for patients with myelodysplasia and leukemia, testing the effectiveness of chemotherapy as a treatment option, with specific eligibility criteria and required laboratory values.",
    "This sample is a phase 2 clinical trial for amyotrophic lateral sclerosis (ALS) patients, testing the drugs ck-2017357, placebo, and riluzole 50 mg, with inclusion criteria including a diagnosis of ALS, grip strength requirements, ability to swallow tablets, and current use of riluzole, while exclusion criteria include life expectancy less than 3 months, prior treatment with CK-2017357, and use of non-invasive positive pressure ventilation.",
    "This sample is a phase 2 trial for patients with estrogen receptor-positive breast cancer, testing the drugs anastrozole and pazopanib hydrochloride, with eligibility criteria including specific disease stages, performance status, and various laboratory values.",
    "This sample is a phase 2 clinical trial for patients with uncontrolled epilepsy, specifically primary generalized tonic-clonic seizures, and idiopathic generalized epilepsy. The drug being tested is lacosamide, and the eligibility criteria include having a diagnosis of uncontrolled epilepsy, recent PGTC seizures, and a stable dose regimen of 1 to 3 antiepileptic drugs.",
    "This sample is a phase 2 trial for the treatment of type 2 diabetes mellitus using the drugs tc-6987 and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1/phase 2 clinical trial for sickle cell disease, testing the drugs eptifibatide and placebo, with inclusion criteria including age between 18 and 55 years, confirmed diagnosis of sickle cell anemia or sickle beta zero thalassemia, and normal baseline coagulation profile, and exclusion criteria including baseline hemoglobin < 6.0 gm/dl, history of major gastrointestinal bleeding or bleeding diathesis, and ongoing episode of acute chest syndrome.",
    "This sample is a phase 2 clinical trial for pancreatic cancer patients, testing the efficacy of gemcitabine hydrochloride and serine proteinase inhibitor wx-671 drugs, with specific eligibility criteria for patients, including disease characteristics and patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung carcinoma, testing the neoadjuvant therapy with cisplatin plus docetaxel as a treatment option. The eligibility criteria include specific disease characteristics, medical fitness for surgery, absence of prior chemotherapy or radiation, and acceptable hematologic and chemistry parameters.",
    "This sample is a phase 2 clinical trial for patients with hypercholesterolemia, testing the effectiveness of drugs such as mk-6213 and atorvastatin calcium, along with placebos, in reducing cholesterol levels. The eligibility criteria include age range, stable weight, and exclusion of certain diseases and conditions.",
    "This sample is a phase 2 clinical trial for patients with myelodysplastic syndromes (MDS) and thrombocytopenia, testing the efficacy of a placebo drug. The eligibility criteria include specific diagnostic criteria for MDS, age restrictions, performance status, liver and kidney function requirements, and exclusion criteria such as previous treatments for MDS or other related disorders.",
    "This sample is a phase 2 trial for the treatment of overactive bladder, testing the drugs agn-214868 and agn-214868 placebo, with eligibility criteria including symptoms of overactive bladder and inadequate response to anticholinergics.",
    "This sample is a phase 2 clinical trial testing the drug bkm120 on patients with various advanced solid tumors, including lung cancer, breast cancer, colorectal cancer, and cholangiocarcinoma, who have not responded to standard treatment or refuse it, and have specific PIK3CA mutations.",
    "This sample is a phase 2 clinical trial for hematologic diseases, testing the use of G-CSF and GM-CSF drugs in allogeneic peripheral blood stem cell transplantation, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic prostate cancer, testing the drug sunitinib. The eligibility criteria include having stage IV disease, prior chemotherapy with docetaxel, and an ECOG Performance Status of 0-2. Exclusion criteria include prior treatment with Sutent, concurrent immunotherapy, and significant bleeding in the previous 4 weeks.",
    "This sample is a phase 2 clinical trial for patients with metastatic or locally recurrent colorectal cancer, testing the effectiveness of fluorouracil, irinotecan hydrochloride, leucovorin calcium, and oxaliplatin as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung cancer, testing the effectiveness of gemcitabine and uft as chemotherapy drugs, with specific eligibility criteria including age, performance status, and adequate organ function.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the efficacy of ipragliflozin and metformin in improving glycemic control, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for hypercholesterolemia, testing the effectiveness of atorvastatin and aegr-733 in various doses, along with a placebo, in reducing LDL cholesterol levels in men and women between the ages of 18 and 70 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of docetaxel, cisplatin, and sti571 drugs, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with head and neck cancer, testing the effectiveness of lapatinib oral tablets, radiotherapy, and cisplatin chemotherapy as primary treatment. The eligibility criteria include confirmed diagnosis of SCCHN, ErbB1 over-expression, specific disease stages, and adequate organ function.",
    "This sample is a phase 2 clinical trial for patients with stage IIIB or IV non-small cell lung cancer, testing the drug pemetrexed disodium, and includes eligibility criteria such as previous chemotherapy treatment, specific disease characteristics, and various patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with head and neck squamous cell cancer, testing the effectiveness of imatinib mesylate and docetaxel as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the treatment of head and neck cancer using the drugs panitumumab and cisplatin, with specific eligibility criteria for patients with locally advanced disease.",
    "This sample is a phase 2 clinical trial for patients with newly diagnosed active multiple myeloma, testing the effectiveness of a combination of drugs including bortezomib, cisplatin, cyclophosphamide, dexamethasone, doxorubicin hydrochloride, etoposide, lenalidomide, melphalan, and thalidomide, with specific eligibility criteria for patients' disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 2 clinical trial testing the effectiveness of different oral contraceptives, including estetrol and estradiol valerate, dienogest, in women with regular menstrual cycles and good physical and mental health, but excluding those with certain medical conditions or who are breastfeeding or planning to become pregnant.",
    "This sample is a phase 2 clinical trial for patients with primary peritoneal cavity cancer or recurrent ovarian epithelial cancer, testing the drug lapatinib ditosylate, and includes eligibility criteria such as measurable disease, prior platinum-based chemotherapy, and specific laboratory values.",
    "This sample is a phase 2 clinical trial testing the combination of lapatinib and capecitabine in patients with untreated, newly diagnosed, advanced metastatic or unresectable gastric cancer, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with follicular lymphoma, testing the effectiveness of the drugs velcade, bendamustine, and rituximab, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for schizophrenia, testing the effectiveness of lurasidone and placebo drugs on patients who meet the DSM-IV criteria for schizophrenia and agree to a minimum 31-day hospitalization.",
    "This sample is a phase 2 trial for type 1 diabetes, testing the effectiveness of mycophenolate mofeteil (mmf) and daclizumab (dzb) compared to placebo control, with specific eligibility criteria including age, C-peptide levels, and autoantibodies.",
    "This sample is a phase 2 clinical trial for patients with stage IIIA, IIIB, or IV non-small cell lung cancer, testing the combination of celecoxib and docetaxel as a treatment option. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for autism spectrum disorder (ASD) and related disorders, testing the drug memantine hydrochloride (HCL) in children aged 6-12 who meet the DSM-IV-TR diagnostic criteria for autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS). The study aims to evaluate the safety and efficacy of memantine HCL in this population.",
    "This sample is a phase 2 clinical trial for female patients with stage IV breast cancer and overexpression of ErbB2, testing the effectiveness of vinorelbine, lapatinib, and capecitabine as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial investigating the use of moxaverine in patients with macular degeneration, glaucoma, and regional blood flow issues, with specific eligibility criteria for each disease group.",
    "This sample is a phase 2 clinical trial testing the drug dasatinib in patients with advanced breast cancer, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug combination of g-csf and plerixafor in patients with non-Hodgkin lymphoma and multiple myeloma, with specific eligibility criteria for inclusion and exclusion.",
    "This phase 2 trial is testing the drug tivantinib in participants with triple-negative breast cancer who have received prior chemotherapy, and the eligibility criteria include having measurable disease, recent evidence of progressive disease, and being hormone-receptor poor and HER2-negative.",
    "This sample is a phase 2 trial testing the drugs avp-923 and placebo for the treatment of central neuropathic pain in patients with multiple sclerosis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with stage IV breast cancer, testing the effectiveness of gemcitabine, paclitaxel, carboplatin, and cisplatin as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with moderate-severe chronic obstructive pulmonary disease (COPD), testing the drug UK-500,001, with inclusion criteria including a smoking history of at least 10 pack-years and exclusion criteria including any significant co-morbid disease and use of any maintenance therapy except short acting bronchodilators.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC), testing the drugs rad001 and docetaxel. The eligibility criteria include confirmed NSCLC, ECOG Performance Status of 0, 1, or 2, adequate bone marrow, renal and hepatic function, completed prior therapy at least 3 weeks prior to registration, and being at least 18 years of age. Exclusion criteria include chronic treatment with systemic steroids, uncontrolled brain or leptomeningeal metastases, HIV seropositivity, gastrointestinal impairment, bleeding diathesis, hypersensitivity to everolimus or sirolimus, pregnancy or breastfeeding, and various other medical conditions.",
    "This sample is a phase 2 trial for patients with glaucoma or ocular hypertension, testing the effectiveness of bimatoprost 0.01% and 0.03% ophthalmic solutions, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the effectiveness of the drugs imatinib and docetaxel, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for the drug BL-1020 in patients with schizophrenia, with specific inclusion and exclusion criteria for participation in the study.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the drug bi 10773 against placebos of different doses, with inclusion criteria including specific HbA1c levels and exclusion criteria such as uncontrolled hyperglycemia and impaired renal function.",
    "This sample is a phase 2 trial for metastatic breast cancer, testing the drug sagopilone (bay86-5302, zk 219477), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with breast cancer, testing the drugs docetaxel and doxorubicin hydrochloride. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for the drug azd9668 and placebo in patients with chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with estrogen receptor positive tumor and breast cancer, testing the effectiveness of eribulin mesylate and capecitabine as adjuvant therapy, with specific eligibility criteria including receptor status, performance status, renal and liver function, and exclusion criteria such as stage III and IV invasive breast cancer, prior chemotherapy, and pre-existing neuropathy.",
    "This sample is a phase 2 clinical trial for patients with unresectable squamous cell carcinoma of the head and neck, testing the effectiveness of carboplatin, cisplatin, docetaxel, and fluorouracil as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This phase 2 trial aims to evaluate the effectiveness of Avastin (bevacizumab) and gemcitabine in treating pancreatic neoplasms, with specific eligibility criteria including histologic proof of adenocarcinoma, potentially resectable disease, and adequate renal and hepatic function.",
    "This sample is a phase 2 clinical trial for patients with relapsed or progressed multiple myeloma, testing the combination therapy of lenalidomide and rituximab, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer, testing the drugs cisplatin, gemzar, docetaxel, and alimta, with eligibility criteria including a microscopic diagnosis of NSCLC stages IIIB and IV, no prior chemotherapy treatment for lung cancer, and adequate laboratory values.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the drugs gefitinib and docetaxel, with specific inclusion and exclusion criteria related to prior treatments and timing of adjuvant treatment.",
    "This sample is a phase 2 clinical trial for patients with recurrent or metastatic head and neck squamous carcinoma or nasopharyngeal carcinoma, testing the effectiveness of the drugs e10a, cisplatin, and paclitaxel, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs mk0249 and a placebo, with specific inclusion and exclusion criteria for patients, such as age, disease severity, and medication history.",
    "This sample is a phase 2 clinical trial for adult acute myeloid leukemia (AML) patients with del (5q) abnormality, testing the effectiveness of lenalidomide as a treatment option.",
    "This sample is a phase 2 clinical trial for patients with acute myeloid leukemia (AML) who have received previous treatment and have residual disease. The study aims to evaluate the efficacy and safety of elacytarabine plus idarubicin as a treatment option. The inclusion criteria include confirmed diagnosis of AML, specific laboratory values, and patients' ability to comply with the study requirements. Exclusion criteria include allergies to certain medications, history of significant toxicities from previous chemotherapy, and uncontrolled intercurrent illnesses.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of panitumumab and folfiri drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the use of desogestrel/ethinyl estradiol and ethinyl estradiol in premenopausal women for contraception, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with incurable breast cancer, testing the effectiveness of fulvestrant and sorafenib tosylate drugs in postmenopausal patients who have previously been treated with a third-generation aromatase inhibitor and have a HER2/neu-negative tumor.",
    "This sample is a phase 2 trial for patients with pancreatic cancer, testing the drugs erlotinib and gemcitabine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the effectiveness of the CMF regimen, cyclophosphamide, fluorouracil, and methotrexate, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for the drug MK-6096 and placebo in patients with painful diabetic neuropathy, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the treatment of sarcoma in infants and children, using a combination of cyclophosphamide, etoposide, ifosfamide, and vincristine sulfate, with specific eligibility criteria including age, performance status, life expectancy, hematopoietic, hepatic, and renal function, and no prior or concurrent chemotherapy or radiotherapy.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer (NSCLC) patients with measurable disease, testing the drug sta 9090, and includes inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with recurrent and/or metastatic head and neck cancer, testing the drug gsk1363089 (foretinib) to evaluate its effectiveness and safety. The eligibility criteria include having measurable disease, being at least 18 years old, and having an Eastern Cooperative Oncology Group (ECOG) performance status of 1 or less.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the drug syr-472 and a placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the drug temozolomide for the treatment of Acute Myeloid Leukemia in patients over 60 years old who are unfit for conventional chemotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug azd4017 and placebo in patients with raised intraocular pressure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with submassive pulmonary embolism, testing the effectiveness of drotrecogin alfa (activated), enoxaparin, and placebo drugs, with specific eligibility criteria based on symptoms and timing of onset.",
    "This sample is a phase 2/phase 3 trial for the treatment of schizophrenia, focusing on the cognitive effects on schizophrenic patients. The trial will test the drugs cyp-1020 and risperidone, and the eligibility criteria include specific age range, duration of symptoms, severity of symptoms, and previous response to antipsychotic treatment.",
    "This sample is a phase 2 clinical trial for endometriosis, testing the drugs placebo, tak-385, and leuprorelin acetate, with eligibility criteria including premenopausal women with dysmenorrhea and pelvic pain associated with endometriosis, diagnosed by laparotomy, laparoscopy, or MRI confirmation of chocolate cyst of the ovary.",
    "This sample is a phase 2 trial for patients with atrial fibrillation, testing the drug ati-5923, and includes inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 trial for patients with lymphoma, testing the effectiveness of cyclophosphamide, doxorubicin, prednisone, and vincristine as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with leukemia, specifically acute myeloid leukemia, who are in their first relapse after receiving induction chemotherapy. The study aims to evaluate the effectiveness of gemcitabine hydrochloride and mitoxantrone hydrochloride as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 2 clinical trial for patients with breast cancer, testing the effectiveness of capecitabine as a treatment option. The eligibility criteria include specific requirements for age, performance status, laboratory results, and exclusion criteria such as distant metastasis, previous radiation treatment, and hypersensitivity to capecitabine.",
    "This sample is a phase 2 clinical trial for patients with acute myocardial infarction and ST elevation, testing the effectiveness of nitric oxide and placebo drugs in combination with percutaneous coronary intervention.",
    "This sample is a phase 2 clinical trial for endometriosis pain, testing the drugs elagolix and placebo, with inclusion criteria including age, pelvic pain, recent diagnosis of endometriosis, regular menstrual cycle, and BMI range, and exclusion criteria including recent use of certain medications, recent surgery, uterine fibroids, and unstable medical condition or chronic disease.",
    "This sample is a phase 2 clinical trial for patients with recurrent, metastatic, or unresectable gastroesophageal or gastric adenocarcinoma. The trial will test the effectiveness of the drugs folfox and bevacizumab in treating the disease, and includes eligibility criteria such as specific disease types, previous treatment history, laboratory parameters, and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the effectiveness of pegylated liposomal doxorubicin and docetaxel as second-line chemotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for asthma, testing the drugs rosiglitazone, theophylline, beclomethasone, and inhaled beclomethasone and oral theophylline, with inclusion criteria including a clinical diagnosis of mild or moderate persistent asthma and a history of asthma for at least 6 months, and exclusion criteria including asthma exacerbation within four weeks of screening and type 1 or type 2 diabetes mellitus.",
    "This sample is a phase 2 trial for the drug sb-705498 in patients with irritable colon, characterized by faecal urgency and rectal hyperalgesia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for breast cancer patients, testing the drug letrozole, an aromatase inhibitor, with specific eligibility criteria including ER and/or PgR positive tumors, postmenopausal status, and adequate organ function.",
    "This sample is a phase 2 trial for patients with psoriasis, testing the effectiveness of cyclosporine as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with prostate cancer and bone metastases, testing the drugs zd4054 at different doses, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for pregnant women with documented HIV-1 infection, assessing the use of kaletra (lopinavir/ritonavir) and kaletra (lopinavir/ritonavir) + combivir (zidovudine/lamivudine) to prevent mother-to-child transmission of HIV. The inclusion criteria include being assessed between 20 and 24 months of pregnancy, having a CD4 count above or equal to 350 per mm3, and a viral load under 30,000 copies per ml.",
    "This sample is a phase 2 clinical trial for patients with advanced, inoperable stage IV melanoma, testing the effectiveness of bevacizumab (Avastin) and fotemustine in treating the disease. The eligibility criteria include having measurable and/or evaluable sites of metastases, while exclusion criteria include prior chemotherapy and/or immunotherapy for metastatic disease, prior malignancies within the past 5 years (except non-melanoma skin cancer or in situ cancer of cervix), clinically significant cardiovascular disease, and ongoing treatment with certain medications.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients, testing the efficacy of suramin, docetaxel, and carboplatin compared to a placebo, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for locally advanced/inflammatory adenocarcinoma of the breast, testing the effectiveness of gemcitabine, epirubicin, and albumin-bound paclitaxel as chemotherapy drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer, testing the drug erlotinib hcl, and includes eligibility criteria such as confirmed NSCLC, previous chemotherapy treatment, specific performance status, age, recovery from prior treatment effects, ability to comply with study procedures, and availability of tumor tissue for testing.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the effectiveness of gemcitabine and docetaxel drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung carcinoma, testing the drug celecoxib, and includes specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 trial testing the drugs gwp42003 and gwp42004, along with a placebo, on patients with dyslipidemias and type 2 diabetes who meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with progressive breast cancer, testing the effectiveness of anastrozole (arimidex) and goserelin (zoladex) in premenopausal women with specific eligibility criteria, such as confirmed breast cancer, positive hormone receptor determination, and certain blood test results, while excluding patients with active infections, prior treatment with certain medications, and other conditions.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the efficacy of capecitabine and fulvestrant as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with migraine headache, testing the drugs placebo and LY2300559, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the effectiveness of intravenous immunoglobulin as a treatment option, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for metastatic breast cancer, testing the efficacy of different drug combinations including ixabepilone, capecitabine, and docetaxel, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with emphysema, testing the drugs placebo and rar gamma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of psoriasis vulgaris using calcipotriol plus betamethasone dipropionate (leo 80185) gel, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer, testing the effectiveness of docetaxel, gemcitabine, and bevacizumab as treatment options, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for participants with type 2 diabetes mellitus, testing the efficacy of insulin glargine /lixisenatide fixed ratio combination, insulin glargine, and metformin in controlling blood glucose levels, with specific inclusion and exclusion criteria for participant eligibility.",
    "This sample is a phase 2 trial for patients with advanced lung cancer who have previously been treated with erlotinib hydrochloride or gefitinib and have developed acquired resistance. The drug being tested is dasatinib, and the eligibility criteria include specific disease characteristics and patient characteristics.",
    "This sample is a phase 2 trial for the treatment of macular degeneration using the drug pazopanib, with specific eligibility criteria including age, visual acuity, and exclusion criteria such as other eye diseases and prior treatments.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of capecitabine, gefitinib, and oxaliplatin as treatment options, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 2 trial for osteoarthritis, testing the drugs sd-6010 and placebo, with inclusion criteria including age, BMI, and previous diagnosis of knee OA, and exclusion criteria including other rheumatic diseases and confounding conditions in the study knee.",
    "This sample is a phase 2 clinical trial for patients with metastatic adenocarcinoma of the pancreas, testing the drug saracatinib, and includes eligibility criteria such as prior chemotherapy, performance status, blood counts, liver function, and exclusion criteria such as brain metastases, cardiac dysfunction, and uncontrolled concurrent illness.",
    "This sample is a phase 1/phase 2 trial for previously untreated patients with histologically confirmed DLBCL, testing the efficacy of bortezomib, cyclophosphamide, doxorubicin, vincristine, prednisolone, and lenograstim in patients aged 70 or less with advanced stage disease, normal liver function, and measurable disease. The study has specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with locally advanced, unresectable or metastatic pancreatic carcinoma, testing the drug erlotinib as a potential treatment option. The eligibility criteria include specific disease requirements, previous therapy limitations, age restrictions, organ and marrow function requirements, and precautions regarding drug interactions and pregnancy.",
    "This sample is a clinical trial for phase 1/phase 2 participants with non-small cell lung cancer, malignant mesothelioma, or advanced/metastatic solid tumors, testing the combination of pemetrexed, cisplatin, and LY2603618 as a first-line palliative treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with liver cancer, testing the effectiveness of capecitabine and oxaliplatin as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with recurrent extensive stage small cell lung cancer, testing the drug topotecan hydrochloride, with specific eligibility criteria including measurable disease, prior response to first-line therapy, and eligibility for high-dose chemotherapy.",
    "This sample is a phase 2 trial for the treatment of overactive bladder using liposome encapsulated botulinum toxin A and normal saline instillation, with specific eligibility criteria including age, symptoms, previous treatment, and exclusion criteria such as cardiopulmonary disease and urinary tract infections.",
    "This sample is a phase 2 clinical trial for endometrial cancer patients, testing the effectiveness of cisplatin, doxorubicin hydrochloride, and paclitaxel as treatment options, with specific eligibility criteria including disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with unresected primary colon cancer and radiographically confirmed metastatic colon cancer, testing the effectiveness of fluorouracil, leucovorin, and oxaliplatin as treatment options.",
    "This sample is a phase 2 clinical trial for patients with angioimmunoblastic T-cell lymphoma, testing the effectiveness of cyclosporine as a treatment option. The inclusion criteria include a diagnosis of the specific lymphoma, measurable disease parameters, and previous treatment failure, while the exclusion criteria include prior use of cyclosporine, active infections, and certain medical conditions.",
    "This sample is a phase 1/phase 2 trial for patients with prostatic neoplasms, testing the combination of samarium sm-153 lexidronam and docetaxel as a treatment option, with specific eligibility criteria including histological evidence of adenocarcinoma of the prostate, progressive castrate metastatic disease, and evidence of at least 3 bone metastases on bone scan.",
    "This sample is a phase 1/phase 2 trial that aims to evaluate the effectiveness of various drugs, such as regulatory T-cells and melphalan, in treating diseases like acute leukemia, chronic myelogenous leukemia, myelodysplastic syndrome, non-Hodgkin lymphoma, and chronic lymphocytic leukemia, among others, in patients who meet specific eligibility criteria.",
    "This sample is a phase 2 trial for rheumatoid arthritis, testing the drugs placebo and bms-817399, with eligibility criteria including a minimum duration of RA, specific joint counts, and previous treatment with Methotrexate.",
    "This sample is a phase 2 clinical trial for patients with liver cirrhosis and biliary disease, testing the drugs int-747, ursodeoxycholic acid (urso), and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with hyperuricemia and gout, testing the effectiveness of arhalofenate, febuxostat, and colchicine in reducing serum uric acid levels, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic breast neoplasms and metastases, neoplasm. The study will test the effectiveness of cyclophosphamide, doxorubicin hydrochloride, fludarabine phosphate, paclitaxel, and mesna in treating these diseases. The eligibility criteria include having a diagnosis of metastatic infiltrating carcinoma of the breast, a positive CEA stain, and meeting certain health requirements.",
    "This sample is a phase 2 clinical trial testing the effectiveness of aprepitant/ramosetron/dexamethasone in reducing chemotherapy-induced nausea and vomiting in patients with ovarian cancer. The eligibility criteria include being over 18 years old, receiving moderately emetogenic chemotherapy, having a Karnofsky score > 60, and a life expectancy > 4 months. Exclusion criteria include various medical conditions, recent use of nonapproved drugs, abnormal laboratory values, recent use of antiemetic drugs, benzodiazepines or opiates, and certain drug interactions.",
    "This sample is a phase 2 trial testing the drug radafaxine for the treatment of major depressive disorder, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with non-resectable colorectal cancer and liver metastases, testing the efficacy of cetuximab, cetuximab and folfiri, and cetuximab and folfox as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with multiple sclerosis, testing the efficacy of masitinib in slowing down the progression of the disease.",
    "This sample is a phase 2 clinical trial for patients with gastroesophageal reflux disease (GERD), testing the effectiveness of rabeprazole 20 mg in reducing heartburn symptoms. The inclusion criteria include patients aged 18 to 65 with a minimum three-month history of GERD symptoms and at least 4 days of heartburn per week. Exclusion criteria include patients with significant abnormalities in various body systems, pregnancy or lactation, allergy to proton pump inhibitors, and history of certain gastrointestinal conditions.",
    "This sample is a phase 2 clinical trial for patients with recurrent or metastatic esophageal cancer, testing the effectiveness of sunitinib malate and paclitaxel as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with decompensated chronic congestive heart failure, testing the drugs placebo and cinaciguat (bay58-2667) to determine their effectiveness in improving symptoms and hemodynamic parameters.",
    "This sample is a phase 2 clinical trial for lupus nephritis, testing the drugs laquinimod, mycophenolate mofetil, prednisolone/prednisone, and placebo, with inclusion criteria including subjects diagnosed with SLE and a histological diagnosis of proliferative or membranous lupus nephritis, and exclusion criteria including severe renal impairment, clinically significant or unstable medical or surgical condition, pregnancy or nursing, and lack of acceptable birth control method.",
    "This sample is a phase 2 clinical trial for patients with non-metastatic, unresectable pancreatic adenocarcinoma, testing the effectiveness of fluorouracil and gemcitabine hydrochloride as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for breast cancer patients with specific eligibility criteria, testing the effectiveness of bevacizumab and tac in comparison to a placebo and other drugs in the treatment of HER2-negative disease.",
    "This sample is a phase 2 clinical trial for patients with histologically confirmed rectal adenocarcinoma, involving the distal 12 cm of the rectum, with no evidence of distant metastases. The study will test the effectiveness of capecitabine and oxaliplatin as treatment options.",
    "This sample is a phase 2 trial for gout patients, testing the effectiveness of drugs such as allopurinol and bcx4208, with eligibility criteria including age, diagnosis of gout, and willingness to take prophylaxis for gout flares.",
    "This sample is a phase 2 clinical trial for patients with kidney cancer, testing the drug triapine. The eligibility criteria include having locally recurrent or metastatic disease, being measurable by clinical or radiological means, and meeting certain patient characteristics such as age, performance status, and normal organ function.",
    "This sample is a phase 2 clinical trial for patients with metastatic advanced colorectal cancer, testing the drug cabazitaxel. The eligibility criteria include having confirmed cancer, being in progression after standard treatment, and having a life expectancy of more than three months.",
    "This sample is a phase 2 trial testing the use of aripiprazole, an antipsychotic drug, for the treatment of autism in adolescents aged 12 to 18 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the drug azd4818 and placebo in patients with chronic obstructive pulmonary disease (COPD). The inclusion criteria include a clinical diagnosis of COPD, a smoking history of at least 10 pack-years, and lung function within a specific range. The exclusion criteria include active tuberculosis, other respiratory tract disorders, and certain cardiac conditions.",
    "This sample is a phase 2 clinical trial for patients with scleroderma, testing the effectiveness of imatinib mesylate in treating severe cutaneous or systemic scleroderma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients diagnosed with non-small cell lung cancer, testing the drugs pemetrexed and cisplatin in different phases, with specific eligibility criteria including age, disease diagnosis, and required blood, liver, lung, and kidney function.",
    "This sample is a phase 2 clinical trial for allergic rhinitis, testing the efficacy of cetirizine dihydrochloride and placebo in patients with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic or locally recurrent liver cancer, testing the drug pemetrexed. The inclusion criteria include a diagnosis of liver cancer, measurable disease, and no prior therapy with pemetrexed, while the exclusion criteria include prior therapy with pemetrexed and a history of other invasive malignancies.",
    "This sample is a phase 2 trial for the treatment of chronic hepatitis C infection with a combination of drugs including abt-450, abt-072, abt-333, ritonavir, peginterferon alpha-2a, and ribavirin, and includes eligibility criteria such as HCV genotype 1 infection, liver biopsy within 3 years, and negative screen for drugs and alcohol.",
    "This sample is a phase 2 clinical trial for prostate cancer, testing the drugs enzastaurin, placebo, docetaxel, and prednisone, with inclusion and exclusion criteria specified.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the drug bevacizumab, and includes eligibility criteria such as age range and prior therapy history.",
    "This sample is a phase 2 clinical trial for patients with potentially resectable pancreatic cancer, testing the effectiveness of gemcitabine, tarceva, and oxaliplatin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with advanced renal cell carcinoma, testing the drug sunitinib malate. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial that aims to investigate the effectiveness of lithium carbonate, placebo, and citalopram in treating major depressive disorder, dysthymia, depression not otherwise specified, and borderline personality disorder, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for narcolepsy, testing the drugs adx-n05 and placebo, with inclusion and exclusion criteria specified.",
    "This sample is a phase 2 trial for the treatment of postherpetic neuralgia, testing the drugs ph-797804 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with pancreatic cancer, testing the drugs pertuzumab and erlotinib. The eligibility criteria include having histologically-confirmed pancreatic adenocarcinoma, measurable lesions, prior therapy with gemcitabine, specific laboratory values, and an echocardiogram or MUGA scan demonstrating LVEF >= 50%. There are also exclusion criteria, such as prior therapy with EGFR-targeted agents and certain medical conditions.",
    "This sample is a phase 2 trial for patients with idiopathic pulmonary fibrosis (IPF) and pulmonary hypertension (PH), testing the drug treprostinil sodium for inhalation. The eligibility criteria include specific diagnostic criteria for IPF and PH, age range, and exclusion criteria such as other medical conditions or drug exposures associated with pulmonary fibrosis or pulmonary arterial hypertension.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the effectiveness of liposomal doxorubicin and docetaxel as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of chronic hepatitis C, testing the drugs gs-5885, tegobuvir, gs-9451, ribavirin tablet, and gs-5885, with specific eligibility criteria for subjects to be included or excluded from the trial.",
    "This sample is a phase 2/phase 3 trial for attention deficit hyperactivity disorder (ADHD) using oros methylphenidate and placebo as drugs, with inclusion criteria including meeting DSM-IV-Text Revision criteria for ADHD and experiencing at least moderate impairment, and exclusion criteria including current or lifetime history of psychosis and substance dependence within 3 months of screening.",
    "This sample is a phase 2 trial for patients with non-small cell lung cancer, testing the effectiveness of vandetanib induction, docetaxel, carboplatin, and placebo as treatments, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with prostate neoplasms, testing the drugs abiraterone acetate and glucocorticoid, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with acute diverticulitis, testing the effectiveness of mesalamine, probiotic, placebo, and antibiotic for diverticulitis in treating the disease. The eligibility criteria include a clinical diagnosis of acute diverticulitis and specific requirements for female patients.",
    "This sample is a phase 2 trial for breast cancer patients with HER2+ status, using a combination of taxotere, cytoxan, and herceptin drugs, with specific eligibility criteria including tumor size, lymph node involvement, cardiac function, and previous chemotherapy history.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the drug nab-paclitaxel, with specific eligibility criteria including relapse within 12 months after completing chemotherapy and previous treatment with a solvent-based taxane.",
    "This sample is a phase 2 clinical trial for patients with moderate-to-severe osteoarthritis of the knee, testing the effectiveness of lidoderm (lidocaine 5% patch) compared to a placebo patch in reducing pain.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the effectiveness of the drugs cyclo-z and placebo in controlling blood glucose levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with relapsing-remitting multiple sclerosis (MS), testing the effectiveness of ocrelizumab and avonex compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with estrogen and/or progesterone receptor-positive breast cancer, testing the efficacy of erlotinib hydrochloride and letrozole as treatment options, with specific eligibility criteria and requirements for patients' medical history and condition.",
    "This sample is a phase 2 clinical trial for patients with unresectable or metastatic renal cell cancer, testing the effectiveness of the drugs bibf 1120 and sunitinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with pleural mesothelioma, testing the drugs cisplatin, sodium thiosulfate, and alimta, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for psoriasis, testing the effectiveness of different concentrations of ph-10 (rose bengal) as a treatment option, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the effectiveness of ezetimibe and simvastatin in reducing cholesterol levels in patients with stable antidiabetic treatment, specific cholesterol levels, and other eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with diabetic nephropathy, testing the efficacy of pyridoxamine dihydrochloride and placebo in combination with ACE-I or ARB medications, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drugs \"bibw 2948 bs\" and \"placebo\" on patients with chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with small cell lung cancer, testing the drugs carboplatin and irinotecan, with eligibility criteria including measurable disease, specific patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with newly diagnosed glioblastoma multiforme, testing the drug axitinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with recurrent or stage IV melanoma, testing the drug tipifarnib, with specific eligibility criteria including no history of brain metastases and no allergies to azoles or compounds structurally similar to R115777.",
    "This sample is a phase 2 clinical trial for ovarian cancer, peritoneal cancer, fallopian tube cancer, stage 3 cancer, and stage 4 cancer. The trial will test the effectiveness of bevacizumab, carboplatin, and paclitaxel in patients who meet specific inclusion criteria and do not have certain exclusion criteria such as unstable heart conditions, high blood pressure, vascular disorders, and bleeding problems.",
    "This sample is a phase 1/phase 2 clinical trial for non-Hodgkin's lymphoma, testing the drugs bortezomib, chop, and rituximab, with specific eligibility criteria including histologically confirmed diagnosis, no prior anti-cancer therapy, CD20 antigen expression, measurable disease, and certain blood counts, while excluding CNS involvement, HIV disease, pregnancy or nursing, recent major surgery, and known peripheral neuropathy.",
    "This sample is a phase 2 trial for patients with mycosis fungoides, testing the effectiveness of 0.04% mechlorethamine gel in achieving a complete response after completing a previous study phase.",
    "This sample is a phase 2 clinical trial for patients with metastatic or unresectable non-small cell lung cancer (NSCLC), testing the effectiveness of carboplatin, gefitinib, and paclitaxel as treatment options. The eligibility criteria include age 65 and over, ECOG performance status of 0-2, and various medical conditions that must be controlled.",
    "This sample is a phase 2 clinical trial for irritable bowel syndrome (IBS) using the drugs asimadoline and placebo, with inclusion criteria including a diagnosis of IBS and willingness to comply with daily telephone diary entry.",
    "This sample is a phase 2 trial testing the drug leuprolide acetate in post-menarche females under 40 years old with hematopoietic stem cell transplantation candidacy and specific hormonal levels, to evaluate its effectiveness in treating amenorrhea, premature ovarian failure, and ovarian function insufficiency.",
    "This sample is a phase 2 clinical trial for patients with nasopharyngeal neoplasms, testing the drug pemetrexed (alimta) as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "The sample is a phase 2/phase 3 clinical trial for atopic dermatitis, testing the drug fexofenadine/allegra (m016455), with inclusion criteria of patients aged 6 months through 11 years and exclusion criteria related to itching scores and specific affected areas.",
    "This sample is a phase 2 clinical trial for patients with diffuse large B-cell non-Hodgkin's lymphoma, testing the effectiveness of a combination of drugs including carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, ifosfamide, prednisone, and vincristine, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for kidney transplantation, testing the drug fk778, with inclusion criteria including being a recipient of a primary or retransplanted cadaveric or non-HLA-identical living donor kidney, and exclusion criteria including receiving an organ transplant other than kidney or receiving a kidney transplant from a cadaveric donor aged 60 or older.",
    "This sample is a phase 2 clinical trial for rheumatoid arthritis, testing the effectiveness of natalizumab compared to a placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 clinical trial for patients with metastatic non-small-cell lung cancer, testing the drug ly573636-sodium, and includes specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with unresectable, locally advanced or metastatic gastric adenocarcinoma, testing the effectiveness of the drug combination dos (docetaxel, oxaliplatin and s-1) in treating the disease. The eligibility criteria include age between 18 to 70 years old, ECOG performance status \u22642, and adequate bone marrow, kidney, and liver function.",
    "This sample is a phase 2 clinical trial for patients with acute myeloid leukemia (AML) in first relapse after prior complete response, testing the drugs cytarabine and gemtuzumab ozogamicin, with eligibility criteria including histologically confirmed AML, CD33 positivity, and specific patient characteristics such as age, performance status, and hematopoietic parameters.",
    "This sample is a phase 1/phase 2 trial for allergic asthma, testing the drugs qge031, omalizumab, and placebo, with inclusion criteria including positive skin prick test, airway hyperresponsiveness, and early asthmatic response, and exclusion criteria including pregnancy, smoking, and poorly controlled asthma.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) who are eligible for curative surgical resection. The trial aims to evaluate the effectiveness of gemcitabine and cisplatin as treatment options. The inclusion criteria include histologically or cytologically confirmed diagnosis of NSCLC, node positive stage II or stage IIIA disease, and tumor amenable to surgical resection. The exclusion criteria include prior tumor therapy, concurrent administration of other tumor therapies, serious concomitant disorders, presence of uncontrolled active infection, and stage IIIb or IV disease.",
    "This sample is a phase 2 trial for HIV-1 infection, testing the drug bms-986001 along with other antiretroviral drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer, testing the drugs amg 951 (rhapo2l/trail), bevacizumab, carboplatin, and paclitaxel, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for bladder cancer patients, testing the effectiveness of cisplatin, gemcitabine hydrochloride, and sorafenib tosylate as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This phase 2 clinical trial is testing the drug belinostat for the treatment of advanced malignant mesothelioma, including epithelial, sarcomatoid, and mixed subtypes, in patients who have received only 1 prior systemic chemotherapy regimen for advanced mesothelioma and have unresectable disease.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the effectiveness of gemcitabine and cisplatin chemotherapy drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for atherosclerosis, testing the effectiveness of sb480848 tablets as a lipid-lowering therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of psoriasis using the drugs placebo and baricitinib, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for the treatment of ocular hypertension and open angle glaucoma using ar-13324 ophthalmic solution at different concentrations, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with recurrent or metastatic breast cancer, testing the effectiveness of gemcitabine and oxaliplatin as a chemotherapy regimen. The eligibility criteria include specific disease diagnosis, prior chemotherapy history, age, performance status, blood counts, liver and kidney function, and absence of certain toxicities. Prior treatment with gemcitabine or oxaliplatin and severe peripheral neuropathy are exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of cisplatin and pemetrexed disodium as treatment options, with specific eligibility criteria and patient characteristics outlined.",
    "This sample is a phase 2 trial for patients with stage IV colorectal cancer and p185 HER2 overexpression, testing the drug irinotecan hydrochloride, with specific eligibility criteria including performance status, blood counts, liver and kidney function, heart health, and prior treatments.",
    "This sample is a phase 2 clinical trial testing the drug tygacil for the treatment of various bacterial infections, including intra-abdominal infection, pneumonia, and skin diseases. The trial includes patients aged 8 to 11 years who require hospitalization and IV antibiotic therapy for at least 5 days. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer who have previously failed irinotecan and oxaliplatin containing regimens, and it will test the efficacy of irinotecan hydrochloride and placebo as treatment options.",
    "This sample is a phase 2 clinical trial for patients with estrogen or progesterone receptor positive stage IIIb/IV non-small cell lung cancer, testing the combination of fulvestrant and erlotinib as a potential treatment option. The eligibility criteria include stable disease on erlotinib monotherapy for at least 2 months, age 18 or older, ECOG Performance Status \u22642, adequate organ function, and postmenopausal status in female patients. Exclusion criteria include pregnancy or breastfeeding, receiving other investigational drugs or anti-cancer agents, hormone replacement therapy, uncontrolled infection, and hypersensitivity to active or inactive excipients of fulvestrant.",
    "This sample is a phase 2 clinical trial for sickle cell disease, testing the use of ketamine for acute pain management in children and adults with sickle cell disease who have a history of vasoocclusive pain episodes.",
    "This sample is a phase 2 clinical trial for patients with melanoma, testing the effectiveness of cisplatin as a treatment option. The eligibility criteria include specific requirements for the patient's medical condition, laboratory values, and previous treatments.",
    "This sample is a phase 2 trial for patients with recurrent adult diffuse large cell lymphoma, recurrent grade 1-3 follicular lymphoma, or recurrent mantle cell lymphoma, testing the drug bortezomib, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for breast cancer patients with HER2/neu-positive disease, testing the effectiveness of cyclophosphamide, doxorubicin hydrochloride, lapatinib ditosylate, and paclitaxel as treatment options, with specific eligibility criteria for patients.",
    "This sample is a phase 2 clinical trial for patients with advanced non-small cell lung cancer, testing the drug S-1 as a second-line therapy option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial that includes patients with various diseases such as leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes, and it involves the use of drugs like cyclophosphamide and fludarabine phosphate. The eligibility criteria include specific disease criteria, organ function requirements, and age restrictions.",
    "This sample is a phase 2 trial for lung cancer patients, testing the drug kos-862, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for prostate cancer patients, testing the drugs exisulind, luteinizing hormone-releasing hormone (LHRH) agonist, and antiandrogen, with specific eligibility criteria including histologically or cytologically documented prostate cancer and a performance status score of 0 or 1.",
    "This sample is a phase 2 trial for patients with idiopathic pulmonary fibrosis (IPF) and severe pulmonary arterial hypertension (PAH), testing the effectiveness of treprostinil therapy in improving their condition.",
    "This sample is a phase 2 trial for patients with metastatic renal cell carcinoma who are refractory to sorafenib or sunitinib therapy, and the drug being tested is RAD001 (everolimus).",
    "This sample is a phase 2 clinical trial for bipolar disorder, testing the effectiveness of cariprazine and placebo in patients aged 18 to 65 who meet the DSM-IV criteria for bipolar I disorder, acute manic or mixed episode, and have specific Young Mania Rating Scale (YMRS) scores.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of exenatide and placebo in combination with other medications, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastatic renal cell carcinoma, testing the drug erlotinib hydrochloride, and includes eligibility criteria such as histological confirmation of the disease, availability of tumor tissue for molecular studies, and specific laboratory values.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic breast cancer, testing the effectiveness of paclitaxel albumin nanoparticle and sorafenib drugs, with eligibility criteria including HER2-negative status, measurable disease, and specific liver, renal, and bone marrow function requirements.",
    "This sample is a phase 2 clinical trial for the treatment of gastroparesis in patients with type 1 or type 2 diabetes mellitus, using drugs such as placebo, 10mg tzp-102, and 20mg tzp-102, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with chronic myelogenous leukemia (CML) who have shown resistance to Gleevec. The trial will test the effectiveness of nexavar (sorafenib) in treating CML patients with specific criteria, such as having a WBC count above 20 x 109/L and an anticipated survival of at least 16 weeks.",
    "This sample is a phase 2/phase 3 trial for type 1 diabetes, testing the drugs anakinra and saline, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with incurable squamous cell carcinoma of the head and neck, testing the drug paclitaxel. Eligibility criteria include specific disease characteristics, age, performance status, hematopoietic and hepatic function, and prior therapy history.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndromes (MDS) who are not eligible for bone marrow or stem cell transplantation therapy. The study will test the effectiveness of 5-azacytidine, valproic acid, and atra in treating MDS patients with a high risk of acute myeloid leukemia (AML) transformation.",
    "This sample is a phase 2 trial for patients with relapsed or refractory renal cell carcinoma, testing the drug gw786034, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for cystic fibrosis patients, testing the efficacy of mannitol, mannitol + pulmozyme, and dornase alpha in improving lung function, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of various drugs including olodaterol and tiotropium bromide, with specific eligibility criteria including spirometric criteria and smoking history.",
    "This sample is a phase 2 clinical trial for patients with relapsing multiple sclerosis (RMS) who have been treated with teriflunomide or interferon-\u03b2-1. The study aims to evaluate the safety and efficacy of influenza vaccination in these patients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with Stage IIIB or IV HER2-positive metastatic breast cancer, testing the drug bibw 2992, and includes eligibility criteria such as previous treatment, age, performance score, and disease status.",
    "This sample is a phase 2 clinical trial for patients with stage III - IVB head and neck cancer, testing the effectiveness of oxaliplatin and pemetrexed disodium drugs, with specific eligibility criteria including age, performance score, bone marrow and renal function, and the need for contraception and medication compliance.",
    "This sample is a phase 2 trial for patients with type 1 diabetes, testing the effectiveness of insulin degludec and insulin glargine in maintaining HbA1c levels between 7-11%, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the use of g-csf and saline in patients preparing for in vitro fertilization and embryo transfer with endometrial growth of less than 7 mm, unresponsive to standard treatment, and excluding patients with sickle cell disease, renal insufficiency, upper respiratory infection or pneumonia, chronic neutropenia, and known past or present malignancy.",
    "This sample is a phase 2 clinical trial for breast cancer patients with HER2 overexpression and ER positivity, testing the efficacy of iressa and tamoxifen as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for hepatocellular carcinoma, testing the drug patupilone, and includes eligibility criteria for patients with previously un-irradiated measurable lesions.",
    "This sample is a phase 2 clinical trial for patients with active rheumatoid arthritis, testing the effectiveness of the drugs ch-1504 and methotrexate (mtx) in reducing symptoms and improving joint health. The eligibility criteria include specific age range, diagnosis of rheumatoid arthritis, and certain blood test values. Patients with previous methotrexate therapy, previous therapy with biologic agents, or certain medical conditions are excluded from the study.",
    "This sample is a phase 2 clinical trial for patients with schizophrenia, testing the drug RO4917838 along with standard antipsychotic therapy and a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with lymphoma, specifically DLBCL, testing the combination of rituximab and gemcitabine as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of various drugs including tiotropium and placebos administered via HandiHaler devices, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for breast cancer patients, testing the efficacy of bevacizumab in combination with other drugs, with specific eligibility criteria including age, disease stage, blood count, kidney and liver function, and cardiac health.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndromes (MDS) who have low or int-1 IPSS scores, are transfusion dependent, and have resistance or loss of response to previous treatment with Epoetin alpha/beta or Darbepoetin. The study will test the effectiveness of lenalidomide and epoetin beta as potential treatments for MDS.",
    "This sample is a phase 2 trial for postmenopausal Asian women with osteoporosis, testing the effectiveness of lasofoxifene and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for atopic dermatitis, testing the drugs leo 29102 and elidel\u00ae on patients between 18 and 65 years old with mild to moderate atopic dermatitis on the trunk and limbs, involving 3% to 10% of the body surface area, and meeting specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of the drugs pt001 mdi, tiotropium bromide, and pt001 placebo mdi, with inclusion criteria including age, clinical history of COPD, and lung function measurements, and exclusion criteria including pregnancy, asthma, and other medical conditions.",
    "This sample is a phase 2 trial for the treatment of HCV infection using drugs such as gs-9256, gs-9190, ribavirin, and peginterferon alfa-2a, with specific eligibility criteria including age, BMI, HCV genotype, liver condition, and other health factors.",
    "This sample is a phase 1/phase 2 trial for patients with cardiovascular diseases, specifically idiopathic cardiomyopathy, and heart failure. The study aims to evaluate the use of allopurinol and dobutamine as potential treatments, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with HTLV-1-associated adult T-cell leukemia/lymphoma (ATLL), testing the effectiveness of a combination of drugs including etoposide, cyclophosphamide, doxorubicin hydrochloride, lamivudine, prednisone, vincristine sulfate, and zidovudine, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 clinical trial for the treatment of posttraumatic stress disorder (PTSD) using 3,4-methylenedioxymethamphetamine (MDMA) and lactose (placebo) drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer, testing the drugs erlotinib, placebo, gemcitabine, cisplatin, and carboplatin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for liver cancer patients, testing the drug sunitinib malate, with specific eligibility criteria for disease characteristics and patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic colorectal cancer, testing the effectiveness of a combination therapy including irinotecan, capecitabine, cetuximab, and oxaliplatin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with depression, testing the effectiveness of duloxetine and placebo matching with bms-820836 in treating Major Depressive Disorder, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with relapsed Diffuse Large B-cell Lymphoma (DLBCL), testing the effectiveness of the drugs mk0683, vorinostat, and suberoylanilide hydroxamic acid (saha) over a 6-month treatment period. The inclusion criteria include being 18 years or older, having stable disease for at least 3 months on previous treatment, and not having received any other therapies for at least 4 weeks prior to the study. The exclusion criteria include previous treatment with similar investigational agents and having failed more than 3 prior treatment regimens.",
    "This sample is a phase 2 clinical trial for patients with advanced ovarian cancer, testing the drugs azd0530, carboplatin, and paclitaxel, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial investigating the use of IVIG and rituximab in kidney transplant patients with anti-HLA antibodies, with the goal of inhibiting cytotoxic antibody activity and monitoring anti-HLA antibody levels.",
    "This sample is a phase 2 clinical trial for the treatment of multiple myeloma using lenalidomide and dexamethasone, with specific eligibility criteria including age, disease status, and performance status.",
    "This phase 2 trial aims to evaluate the effects of pomegranate polyphenol extract (POMx) on adult subjects with cardiomyopathy and heart failure, who have been on stable doses of HF evidence-based therapies for at least 3 months, and have a GFR <60 cc/hr for at least 3 months.",
    "This sample is a phase 2 trial for patients with Waldenstrom Macroglobulinemia, testing the efficacy of the drug combination DT PACE + Rituxan in treating advanced and symptomatic disease, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with myelodysplastic syndrome (MDS) who are transfusion dependent or have low hemoglobin levels, and it aims to evaluate the effectiveness of panhematin in treating the disease.",
    "This sample is a phase 2 trial for the drug rabeprazole sodium in children aged 12 to 16 years with symptomatic gastroesophageal reflux disease (GERD) or suspected/proven GERD, who have been treated with or are currently receiving proton pump inhibitors (PPIs), histamine receptor (H2) blockers, or antacids. The study aims to assess the safety and efficacy of the drug in this population.",
    "This sample is a phase 2 clinical trial for advanced non-small cell lung cancer, testing the effectiveness of cetuximab and gemcitabine as treatment options, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 2 trial for age-related macular degeneration, testing the effectiveness of avastin and preservative-free triamcinolone acetonide in patients with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for atopic dermatitis, testing the efficacy of 10% imcooh cream compared to placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for the treatment of influenza, testing the drugs peramivir and oseltamivir, with eligibility criteria including age, presence of fever and respiratory symptoms, and the need for hospitalization for supportive care.",
    "This sample is a phase 2 clinical trial for patients with recurrent or stage I-III prostate cancer, testing the drug cilengitide, with specific eligibility criteria including PSA-only progression and normal organ function.",
    "This phase 2 trial aims to evaluate the efficacy of nitazoxanide, placebo, and ribavirin in treating chronic hepatitis C genotype 1 patients, while excluding those with previous interferon-based treatment, liver disease, certain infections, psychiatric disorders, and other specific conditions.",
    "This sample is a phase 2 clinical trial for patients with breast cancer, specifically targeting HER2 positive disease, testing the drug su011248/trastuzumab, and including eligibility criteria such as unresectable or metastatic disease and prior treatment with trastuzumab or lapatinib.",
    "This sample is a phase 2 trial for patients with metastatic renal cell carcinoma, testing the efficacy of nexavar (sorafenib, bay43-9006) compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of benign prostatic hyperplasia (BPH) using the drugs ly500307 and placebo, with specific eligibility criteria including history of BPH, prostate volume, urinary flow rate, PSA levels, and exclusion criteria such as previous BPH treatments and cardiovascular disease.",
    "This sample is a phase 2 clinical trial testing the drugs bevacizumab, carboplatin, and gemcitabine for the treatment of myeloproliferative disorder, urothelial carcinoma, and cancer, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with pulmonary fibrosis, testing the effectiveness of pirfenidone compared to a placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndromes who have failed 5-azacytidine treatment, and it aims to evaluate the efficacy of clofarabine as a salvage therapy. The inclusion criteria include patients who have received at least six cycles of 5-azacytidine and have either shown no response or experienced disease relapse, as well as patients whose MDS has progressed while on 5-azacytidine. The exclusion criteria include prior clofarabine therapy, pregnancy, and concurrent chemotherapy or immunotherapy.",
    "This sample is a phase 2 trial for patients with pancreatic cancer who have failed first-line gemcitabine therapy, and it includes the drugs azd6244 and capecitabine as potential treatments. The inclusion criteria require confirmation of pancreatic cancer, while the exclusion criteria exclude patients who have previously received therapy with EGFR inhibitors, MEK inhibitors, or capecitabine, as well as those with recent surgery or severe conditions.",
    "This sample is a phase 2 trial for ocular hypertension and open angle glaucoma, testing the drugs syl040012 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial is investigating the efficacy of amg 386, sorafenib, and amg 386 placebo iv in treating advanced renal cell carcinoma, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with squamous cell carcinoma of the head and neck, testing the effectiveness of cisplatin and docetaxel drugs in combination with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 clinical trial for patients with stage IV or unresectable stage III non-ocular malignant melanoma, testing the drugs cp-4055 and sorafenib (nexavar) to determine their effectiveness in treating the disease. The eligibility criteria include having measurable disease, a performance status of 0-1, and being 18 years or older. Exclusion criteria include known brain metastases, ocular malignant melanoma, and prior treatment with cp-4055 and/or sorafenib.",
    "This sample is a phase 1/phase 2 trial for non-Hodgkin's lymphoma, specifically diffuse large B-cell lymphoma and mantle cell lymphoma, using vincristine sulfate liposome injection plus rituximab as the drug combination, with specific eligibility criteria for patients to be included or excluded from the study.",
    "This sample is a phase 2 clinical trial for patients with b-cell chronic lymphocytic leukemia, recurrent small lymphocytic lymphoma, or refractory chronic lymphocytic leukemia, testing the drug sunitinib malate, with specific eligibility criteria including disease progression, chemotherapy requirement, and various medical conditions.",
    "This sample is a phase 2 clinical trial for patients with non-squamous non-small cell lung cancer, testing the effectiveness of the drugs megf0444a, bevacizumab, carboplatin, paclitaxel, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for acute myocardial infarction, testing the efficacy of mesenchymal stem cell therapy compared to a control group, with specific inclusion and exclusion criteria for patient enrollment.",
    "This sample is a phase 2 trial for patients with fibromyalgia, sleep issues, and chronic pain, testing the drugs eplivanserin and placebo, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is testing the effectiveness of carboplatin and abi-007 in treating locally recurrent or metastatic HER-2-negative breast cancer patients who are unable to receive trastuzumab, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial testing the drugs \"nnc 0142-0000-0002\" and \"placebo\" on subjects with Crohn's disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of chronic Hepatitis C, testing the drugs sofosbuvir, rbv, and peg, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for lung cancer patients, testing the drug erlotinib (tarceva), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the drug bortezomib. The inclusion criteria include being in partial response or better after high dose chemotherapy and autologous stem cell transplantation, fulfilling defined laboratory requirements, and meeting certain contraception requirements. The exclusion criteria include receiving another antimyeloma or experimental therapy following transplantation, having grade 2 or greater peripheral neuropathy, having uncontrolled or severe cardiovascular disease, and having any conditions that would compromise well-being or study completion.",
    "This sample is a phase 1/phase 2 clinical trial for patients with liver carcinoma, testing the drugs ave1642, sorafenib, and erlotinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of opioid-induced constipation, testing the drugs rdc-1036 (alks 37) and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for HIV infections, testing the efficacy of indinavir, lamivudine, and ritonavir in patients who have failed two antiretroviral regimens and have specific eligibility criteria.",
    "This sample is a phase 2 trial for endometriosis, testing the drug dienogest (Visanne, Bay86-5258) in female adolescents with dysmenorrhea and pelvic pain, who have either suspected endometriosis or ultrasound findings suggestive of endometriosis, and have not previously used hormonal agents.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the drugs amg 827 and placebo, with inclusion criteria including a diagnosis of Crohn's disease and evidence of active inflammation, and exclusion criteria including short bowel syndrome and recent bowel surgery.",
    "This sample is a phase 2 trial for irritable bowel syndrome (IBS) using the drug milnacipran and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with metastatic or locally advanced gastric cancer or adenocarcinoma of the esophagogastric junction. The trial will test the effectiveness of docetaxel, 5-fluorouracil, oxaliplatin, and folinic acid as treatment options. The eligibility criteria include no prior chemotherapy in the metastatic state and adequate blood and biochemistry parameters.",
    "This sample is a phase 2 trial for patients with hepatitis B virus (HBV) who have previously received entecavir or lamivudine. The study aims to evaluate the response of participants who were virologic nonresponders, partial virologic responders, or complete responders who relapsed. The inclusion criteria include age of 16 years and older, while the exclusion criteria include HIV coinfection and receiving nephrotoxic or hepatotoxic agents.",
    "This sample is a phase 2 clinical trial for patients with paroxysmal atrial fibrillation, testing the drugs bms-914392 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with newly diagnosed acute myeloid leukemia (AML) who are eligible for intensive induction chemotherapy with the drugs clofarabine, cytarabine, and idarubicin. The eligibility criteria include specific genetic mutations and laboratory values, as well as requirements for informed consent and contraception for female patients.",
    "This sample is a phase 2 clinical trial for colorectal cancer, testing the combination therapies of sol (s-1, leucovorin, and oxaliplatin) and mfolfox6 (5-fu, l-lv, and oxaliplatin), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-squamous cell Stage IVA Wet or Stage IVB lung cancer, testing the effectiveness of pazopanib and pemetrexed as a treatment option. The eligibility criteria include having completed 4 to 6 cycles of chemotherapy with specific drugs and having measurable disease. There are also exclusion criteria, such as a history of other malignancies, gastrointestinal abnormalities, and cardiovascular conditions.",
    "This sample is a phase 2 trial for the treatment of hypercholesterolemia using the drugs gemcabene and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for various types of leukemia, lymphoma, myelodysplastic syndromes, and multiple myeloma, where the drug being tested is amd3100, and the eligibility criteria include age restrictions, HLA-matched sibling donors, and various health requirements.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma and plasma cell leukemia, testing the drug fludarabine/busulfan x 4 days as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of schizophrenia, testing the drugs jnj-40411813 and antipsychotic medication, along with a placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial is investigating the use of erlotinib hydrochloride, an EGFR antagonist, in patients with intraductal papillary mucinous neoplasm of the pancreas, recurrent pancreatic cancer, or various stages of pancreatic cancer, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) who have had progressive disease after prior gemcitabine-containing chemotherapy. The study aims to evaluate the efficacy of gemcitabine hydrochloride and triapine as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of the drug bi 1744 cl plus tiotropium bromide in improving lung function, with specific eligibility criteria including age, smoking history, and spirometric criteria.",
    "This sample is a phase 2 trial for the treatment of hyperlipidemia, testing the drugs placebo, mbx-8025, and atorvastatin, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 2 clinical trial for patients with advanced, surgically unresectable colon or rectum cancer who have failed a first-line metastatic regimen, testing the effectiveness of cetuximab and irinotecan as a second-line therapy. The eligibility criteria include consent to participate, measurable disease, histologic confirmation of adenocarcinoma, Eastern Cooperative Oncology Group performance status of 0, 1, or 2, estimated life expectancy of at least 12 weeks, and adequate organ function. Exclusion criteria include prior therapy with irinotecan or cetuximab, systemic therapy within 28 days of study treatment, candidates for surgical resection, histology other than adenocarcinoma, serious concomitant medical conditions, central nervous system metastases, pulmonary fibrosis or interstitial pneumonitis, and other contraindications or high-risk conditions.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of 5-fluorouracil, bevacizumab, leucovorin, and irinotecan as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 trial studying the use of tacrolimus (advagraf, prograf) in heart, lung, and pancreas transplantation patients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing multiple drugs including pt003, pt001, pt005, and tiotropium inhalation powder, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 trial for patients with advanced mesothelioma of the pleura, testing the effectiveness of pemetrexed disodium, gemcitabine hydrochloride, and carboplatin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with primary mediastinal (thymic) large B-cell lymphoma, testing the efficacy of the epoch regimen, cyclophosphamide, doxorubicin hydrochloride, etoposide, prednisone, and vincristine sulfate as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma and plasma cell neoplasm, testing the drug dexamethasone acetate, with eligibility criteria including specific disease characteristics and patient characteristics.",
    "This phase 2 trial is investigating the drug ci-1040 in patients with metastatic or inoperable non-small cell lung, breast, or colon cancer, or duct cell carcinoma of the exocrine pancreas, who meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for breast cancer patients aged 55 to 80, testing the drug bn83495, with specific eligibility criteria including tumor size, hormone receptor status, and menopausal status.",
    "This sample is a phase 2 clinical trial for patients with squamous cell cancer of the head and neck, testing the effectiveness of the drugs pemetrexed and gemcitabine in combination, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with metastatic pancreatic cancer, testing the effectiveness of gemcitabine as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial investigating the use of lovaza\u00ae and a placebo in patients with acute myocardial infarction, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the effectiveness of the drug epirubicin, with specific eligibility criteria including age, tumor size, ER-negative status, and availability of tumor samples for evaluation of biological markers.",
    "This sample is a phase 1/phase 2 trial for patients with multiple myeloma, testing the drugs depsipeptide, bortezomib, and dexamethasone. The eligibility criteria include having previously been diagnosed with multiple myeloma, being between the ages of 18 and 75, having measurable disease, and meeting certain laboratory values.",
    "This sample is a phase 2 clinical trial for irritable bowel syndrome (IBS) with constipation (IBS-C), testing the drugs tc-6499 and placebo in men and women of specific age ranges and BMI, with the goal of evaluating their effectiveness in treating IBS-C symptoms.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the effectiveness of sorafenib and bevacizumab drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for atopic dermatitis, testing the drugs sun13834 and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the drug alvocidib. The eligibility criteria include specific patient characteristics and restrictions on prior and concurrent therapies.",
    "This sample is a phase 2/phase 3 trial for patients with relapsed ovarian, fallopian tube, or primary peritoneal cancer, testing the effectiveness of paclitaxel, saracatinib, and a matched placebo as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs sb-742457, placebo, and donepezil, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients, testing the effectiveness of bevacizumab and platinum-based chemotherapy as first-line treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with hematological malignancies, testing the drugs darbepoetin alpha (aranesp) and iron saccharate (venofer) to improve iron stores and marrow recovery post-transplant, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with asthma, testing the drug revamilast against a placebo, with inclusion criteria including a documented diagnosis of asthma and a Forced Expiratory Volume in One Second (FEV1) between 50% and 80% of the predicted value, and exclusion criteria including pregnant or lactating women and patients with relevant lung diseases causing impairment in lung function.",
    "This sample is a phase 2 clinical trial for premenopausal women with locally advanced or metastatic breast cancer, testing the combination of anastrozole and goserelin as endocrine treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for women with metastatic or locally advanced breast cancer and HER2 overexpression, testing the effectiveness of trastuzumab, paclitaxel, and myocet as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for chronic heart failure patients, testing the effectiveness of drugs including placebo, rhnrg-1 dose 1, and rhnrg-1 dose 2, with eligibility criteria including age > 18, NYHA classification of II or III, stable HF medication regime, LVEF < 35%, and other specific requirements.",
    "This sample is a phase 2 trial for patients with recurrent or metastatic melanoma, testing the effectiveness of sorafenib tosylate as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for HIV-1 infected individuals, testing the effectiveness of etravirine (tmc125) and an optimized background regimen (obr) in reducing viral load, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for ovarian cancer, peritoneal neoplasms, and fallopian tube neoplasms, testing the drugs paclitaxel and carboplatin, with eligibility criteria including histologic diagnosis, EGFR status, performance status, and various organ function requirements.",
    "This sample is a phase 2 clinical trial for the treatment of osteoporosis in postmenopausal women, testing the drug ly2541546 against a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drug sam-531, with inclusion criteria including a diagnosis of probable Alzheimer's disease and age between 50 and 90, and exclusion criteria including significant neurological disease and current major depressive disorder.",
    "This sample is a phase 2 trial for major depressive disorder, testing the effectiveness of ziprasidone and placebo as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with recurrent or metastatic squamous cell carcinoma of head and neck, testing the effectiveness of pemetrexed, cetuximab, and cisplatin as systemic therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for ovarian and endometrial cancer patients, testing the drugs vintafolide and ertafolide, with specific eligibility criteria for each part of the trial.",
    "This sample is a phase 2 clinical trial for patients with non-metastatic infiltrating carcinoma of the breast and HER-2 amplification, testing the effectiveness of trastuzumab in combination with eligibility criteria including normal LVEF, adequate bone marrow, renal and liver function, and signed informed consent.",
    "This sample is a phase 2 trial for lung cancer patients, testing the effectiveness of drugs such as tarceva, paclitaxel, and carboplatin, with specific eligibility criteria including pathologic documentation of NSCLC, measurable disease, and Zubrod performance status of 0 or 1.",
    "This phase 2 trial is testing the effectiveness of irinotecan, cisplatin, and celecoxib in treating patients with unresectable or metastatic esophageal cancer, and the eligibility criteria include having measurable disease, a Zubrod performance status of 0-2, and adequate renal and hepatic function.",
    "This sample is a phase 2 trial for amyotrophic lateral sclerosis (ALS) patients, testing the efficacy of CK-2017357 and riluzole in improving grip strength and lung function, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer (NSCLC) patients who have progressed after one prior chemotherapy regimen. The study aims to evaluate the efficacy of enzastaurin, pemetrexed, and placebo in treating the disease. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 2 clinical trial for patients with metastatic or unresectable Kras and Braf wild-type biliary tract adenocarcinoma or gallbladder adenocarcinoma. The study aims to evaluate the efficacy of panitumumab, oxaliplatin, and gemcitabine as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with esophageal cancer, testing the effectiveness of oncogel (paclitaxel gel), cisplatin, and 5-fu in combination with chemoradiation therapy and esophagectomy as a treatment plan. The eligibility criteria include specific disease stage, medical ability to tolerate surgery, and various health parameters.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of canagliflozin and sitagliptin compared to a placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of major depressive disorder, testing the drugs sep-225289, venlafaxine, and placebo, with specific inclusion and exclusion criteria for participants.",
    "In this sample, the phase 2 trial is focused on dry eye disease, with the icd-10 codes indicating specific subtypes of the disease. The study will test the effectiveness of ecabet ophthalmic solution compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic prostate cancer, testing the drug abt-751. The eligibility criteria include prior hormonal therapy, prior treatment with docetaxel, and specific hematologic, renal, and hepatic function requirements.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the drug lixisenatide (ave0010) in combination with metformin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of lenalidomide, pioglitazone, dexamethasone, and treosulfan as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for opioid-induced constipation, testing the drugs placebo, adl5945 0.1 mg, and adl5945 0.25 mg, with eligibility criteria including age, body weight, BMI, opioid dose, and specific symptoms of constipation.",
    "This sample is a phase 2 clinical trial for adults with untreated acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS), testing the effectiveness of tosedostat, cytarabine, and decitabine as potential treatments, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for endometrial cancer patients, testing the drug letrozole, and includes eligibility criteria such as histologically proven adenocarcinoma, hormone receptor positivity, postmenopausal status, measurable disease, and adequate organ function.",
    "This sample is a phase 2 trial for patients with colorectal cancer who have failed prior irinotecan- or oxaliplatin-containing regimens, and it involves the use of drugs such as bevacizumab, folfiri, and ag-013736. The inclusion criteria include histologically documented colorectal cancer, while the exclusion criteria include prior treatment with more than one regimen in the first-line metastatic setting and prior irradiation of more than 25% of bone marrow.",
    "This sample is a phase 2 clinical trial for gastroesophageal reflux disease (GERD) testing the drugs spd557 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2/phase 3 clinical trial for patients with locally advanced head and neck cancer, testing the effectiveness of two drug combinations (docetaxel, cisplatin, 5-fluorouracil (5-fu), radiotherapy and cisplatin, 5-fluorouracil (5-fu), radiotherapy) in combination with eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2/phase 3 trial for patients with head and neck cancer and squamous cell carcinoma, testing the drug erlotinib. The inclusion criteria include having metastatic, recurrent, or persistent cancer, while the exclusion criteria include not having received prior chemotherapy for the disease and not having undergone chemotherapy or radiotherapy within 4 weeks prior to the study.",
    "This sample is a phase 2 clinical trial for patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma, testing the drug dasatinib, with specific eligibility criteria including prior platinum-based chemotherapy and various medical parameters.",
    "This sample is a phase 2 trial for patients with hematologic malignancies, including leukemia, lymphoma, and myeloma, who have residual disease after chemotherapy and are unlikely to achieve remission with additional chemoradiotherapy. The treatment includes cyclophosphamide, tacrolimus, and mycophenolate mofetil, and the eligibility criteria include organ function requirements, performance status, and the availability of related donors.",
    "This sample is a phase 2 clinical trial for patients with mycosis fungoides, testing the drug mechlorethamine-mch (nitrogen mustard) as a treatment option, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is testing the drug perifosine for patients with Waldenstrom's macroglobulinemia, a rare type of blood cancer, who have relapsed or refractory disease and meet specific eligibility criteria.",
    "This sample is a phase 2 trial for mesothelioma patients who have previously been treated with one course of chemotherapy, and are now being tested with vinorelbine and vandetanib drugs. The inclusion criteria include being diagnosed with mesothelioma, no previous treatment with vinorelbine, and no serious heart problems in the last 3 months. The exclusion criteria include serious abnormal laboratory values, severe or uncontrolled disease, pregnancy or breastfeeding, other cancers in the last 5 years, major surgery or radiation therapy within 4 weeks prior to starting study therapy, and receipt of any investigational agents within 30 days prior to commencing study treatment.",
    "This sample is a phase 2 clinical trial for allergic rhinitis, testing the drugs oc000459 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial is investigating the efficacy of docetaxel and prednisone in patients with hormone-resistant prostate cancer, prostate adenocarcinoma, recurrent prostate carcinoma, or stage IV prostate cancer, who have metastatic disease and castrate-resistant disease, and meet specific eligibility criteria.",
    "This sample is a phase 2 trial for the drug biib014 and placebo in patients with Parkinson's disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with myelodysplastic syndromes (MDS) and thrombocytopenia, testing the effectiveness of azacitidine and decitabine compared to a placebo in treating the disease. The eligibility criteria include a diagnosis of MDS, specific risk categories, and exclusion criteria such as prior exposure to hypomethylating agents and history of leukemia or aplastic anemia.",
    "This phase 2 trial aims to evaluate the efficacy and safety of bol-303259-x and timolol maleate in subjects with ocular hypertension and open angle glaucoma, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for chronic insomnia, testing the drugs ramelteon and placebo, with inclusion criteria including a clinical diagnosis of Alzheimer's disease, post-menopausal females, and a Mini-Mental State Examination score of 8 to 28, while exclusion criteria include history of drug abuse, significant stroke or vascular dementia, and severe renal dysfunction or disease.",
    "This sample is a phase 2 clinical trial for major depressive disorder (MDD) using the drugs prx-00023 and placebo, with key inclusion criteria being a diagnosis of MDD and key exclusion criteria including pregnancy, recent electroconvulsive therapy, and certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with advanced gynecological malignancies, testing the combination of pazopanib, carboplatin, and paclitaxel as a treatment option. The eligibility criteria include specific disease types, performance status, and organ function requirements.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs t-817ma and placebo in patients who are already receiving Donepezil, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for asthmatic patients with reversible airway obstruction, testing the drugs azd3199, formoterol, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed multiple myeloma, testing the drug cep-18770, and includes eligibility criteria such as previous treatment history, disease measurements, organ function, and contraception requirements.",
    "This sample is a phase 1/phase 2 trial for patients with progressive hormone-refractory prostate cancer, testing the drugs docetaxel, prednisone, and su011248, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with Parkinson's disease, testing the efficacy of drugs such as Comtan\u00ae, Nebicapone, Levodopa/DDCI, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic gastric or esophageal adenocarcinoma, testing the drug Jevtana. The eligibility criteria include prior chemotherapy, measurable disease, specific blood counts, liver function, neuropathy grade, and performance status, among others.",
    "This sample is a phase 2 trial for patients with asthma, testing the effectiveness of zileuton and placebo drugs. The eligibility criteria include age, diagnosis of asthma, lung function measurements, and exclusion criteria such as hypersensitivity to zileuton and recent respiratory infections.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the efficacy of multiple drugs (ta-7284-low, ta-7284-low-middle, ta-7284-high-middle, ta-7284-high, and placebo) based on specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-Hodgkin's lymphoma and cancer, testing the effectiveness of drugs such as vincristine, vp-16, rituximab, dexamethasone, and levofloxacin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug pirfenidone in patients with diabetes mellitus and diabetic nephropathy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with squamous cell cancer and cancer of the head and neck, testing the effectiveness of gefitinib, cisplatin, and 5-fluorouracil as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with mycosis fungoides/S\u00e9zary syndrome, testing the drug lenalidomide, with eligibility criteria including prior treatment failure and specific patient characteristics.",
    "This sample is a phase 1/phase 2 trial for patients with colorectal cancer, testing the effectiveness of bevacizumab, oxaliplatin, and capecitabine as chemotherapy drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with previously untreated follicular lymphoma, testing the drug lenalidomide, and includes eligibility criteria such as specific disease stages, CD20 antigen expression confirmation, and exclusion criteria for certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with esophageal neoplasms or esophageal diseases, testing the effectiveness of erlotinib and avastin in combination with eligibility criteria including prior chemotherapy treatment, age greater than 18, and adequate hepatic and renal function.",
    "This sample is a phase 1/phase 2 trial for graft failure, testing the drugs fludarabine, campath 1h, and fk506, with eligibility criteria including a diagnosis of engraftment failure, availability of a healthy donor, and age between birth and 65.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drug elnd005 compared to a placebo control, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with stage III-IVB head and neck cancer, testing the drug bevacizumab (Avastin) as a treatment option. The eligibility criteria include having measurable disease, no prior chemotherapy or radiotherapy for head and neck cancer, and an ECOG performance status of 0-1.",
    "This sample is a phase 2 clinical trial for patients with recurrent or refractory ovarian, primary peritoneal, or fallopian tube carcinoma, testing the drug mifepristone as a treatment option.",
    "This sample is a phase 2 trial for patients with follicular non-Hodgkin's lymphoma, testing the effectiveness of the drugs bortezomib, cyclophosphamide, prednisone, and vincristine sulfate, with eligibility criteria including specific disease characteristics and patient characteristics.",
    "In this phase 2 trial, the drug gs-5806 and a placebo are being tested for the treatment of respiratory syncytial virus infections, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 clinical trial for patients with acute lymphoblastic leukemia (ALL) who have received prior induction regimens and have relapsed or refractory disease. The study will test the drug clofarabine to evaluate its effectiveness in treating ALL patients.",
    "This sample is a phase 2 trial for adults with attention deficit disorder with hyperactivity, testing the drugs atomoxetine and buspirone, with inclusion criteria being adults with ADHD and exclusion criteria being other Axis I Psychiatric Disorders.",
    "This sample is a phase 2 trial for the treatment of type 2 diabetes using bezafibrate + diflunisal and bezafibrate + placebo, with specific eligibility criteria including age, duration of diabetes, HgbA1C levels, FPG levels, BMI, and previous treatment with metformin.",
    "This sample is a phase 2 clinical trial for participants diagnosed with schizophrenia, testing the drugs jnj-37822681, olanzapine, and placebo, with eligibility criteria including specific diagnostic criteria, PANSS scores, and BMI requirements.",
    "This sample is a phase 2 trial for patients with type II diabetes mellitus, testing the drugs azd1656, placebo, and glipizide, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for the treatment of impetigo, a skin infection, using experimental topical gel (cd07223) and a placebo comparator. The eligibility criteria include age requirements, specific lesion characteristics, and exclusion of other skin diseases or infections.",
    "This sample is a phase 2 clinical trial for patients with advanced, inoperable gastric adenocarcinoma, testing the efficacy of docetaxel and capecitabine as a chemotherapy regimen, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for the treatment of Friedreich ataxia using resveratrol, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced or recurrent endometrial cancer, testing the drug xl147 (sar245408) to determine its effectiveness in treating the disease. The eligibility criteria include having received one platinum-based chemotherapy regimen for endometrial cancer, being at least 18 years old, having an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, and having at least one measurable lesion.",
    "This sample is a phase 2 clinical trial for advanced renal cell carcinoma, testing the drugs temsirolimus (cci-779) in subjects of Japanese, Chinese, or Korean ethnicity, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with von Hippel-Lindau syndrome, renal cell carcinoma, and hemangioblastoma, testing the drug su011248, also known as sunitinib malate, with specific eligibility criteria including genetic confirmation of VHL disease, measurable VHL-related lesions, and normal organ and marrow function.",
    "This sample is a phase 2 clinical trial for patients with myelodysplastic syndrome, acute myeloid leukemia, chronic myeloid leukemia, and other related diseases, testing the efficacy of a wt1 peptide vaccine as a treatment option. The eligibility criteria include specific diagnoses, age range, HLA-A0201 positivity, and exclusion criteria such as HIV positivity and low bone marrow reserves.",
    "This sample is a phase 2 trial for patients with gastroesophageal reflux disease (GERD), testing the drug azd3355 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for pancreatic cancer, testing the drugs cisplatin and gemcitabine hydrochloride, with eligibility criteria including locally resectable disease, no metastasis, and specific patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with active rheumatoid arthritis, testing the efficacy of maraviroc and its placebo in combination with methotrexate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with chronic kidney disease and diabetic nephropathy, testing the drugs atrasentan and placebo, with specific eligibility criteria including age, diabetes treatment, medication use, laboratory values, and exclusion criteria related to edema, pulmonary conditions, and orthostatic hypotension.",
    "This sample is a phase 2 trial for the treatment of rhinitis, testing the drugs sb-705498, fp, and placebo, with eligibility criteria including a diagnosis of AR, positive skin prick test and RAST for seasonal pollen, and specific age and weight requirements.",
    "This sample is a phase 2 clinical trial for patients with metastatic or locally advanced unresectable breast cancer, testing the effectiveness of anastrozole and gefitinib as a treatment option for patients who have progressive disease after more than 2 months of aromatase inhibitor therapy.",
    "This phase 2 trial is investigating the effectiveness of capecitabine and imatinib mesylate in treating breast cancer patients with stage IV measurable disease who have experienced disease progression after prior chemotherapy regimens, and meet various eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with myeloma, testing the effectiveness of dasatinib, melphalan, and prednisone as a treatment regimen, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of gemcitabine, docetaxel, and cetuximab as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial that aims to evaluate the effectiveness of sertraline, placebo, and gabapentin in treating cocaine dependence and depressive symptoms in individuals aged 18-65 who meet specific inclusion criteria, such as having a history of cocaine use and meeting DSM-IV criteria for cocaine dependence.",
    "This sample is a phase 2 clinical trial for patients with chronic lymphocytic leukemia (CLL), testing the effectiveness of cyclophosphamide, fludarabine, alemtuzumab, and rituximab as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with metastatic prostate cancer, testing the drug docetaxel. The inclusion criteria include confirmed MAIPC, progressive disease, and chemotherapy-naive patients, while exclusion criteria include serious medical illness and history of cardiac disease.",
    "This sample is a phase 2 clinical trial for patients with ovarian neoplasms, testing the effectiveness of bevacizumab and erlotinib drugs in combination with eligibility criteria including prior therapy relapse, elevated CA-125 or measurable disease, and adequate hepatic and renal function.",
    "This sample is a phase 2 clinical trial for bladder cancer patients, testing the effectiveness of gemcitabine, carboplatin, and sorafenib as treatment options, with specific eligibility criteria including histologic documentation of diagnosis, unresectable or metastatic disease, and adequate bone marrow, liver, and renal function.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung carcinoma, testing the effectiveness of vinorelbine, gemcitabine, and cisplatin in combination with high dose palliative radiation therapy for locoregional control.",
    "This sample is a phase 2 trial for the treatment of bronchiolitis using fluticasone propionate, targeting patients who are at least 18 years old and have undergone allogeneic hematopoietic stem cell transplantation. The inclusion criteria include new onset airflow obstruction and a total lung capacity of over 85%, while exclusion criteria include active pulmonary infection and hypersensitivity to corticosteroids.",
    "This sample is a phase 2 clinical trial for patients with refractory or recurrent metastatic breast cancer, testing the drug perillyl alcohol. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial that aims to evaluate the effectiveness of beclomethasone dipropionate, tacrolimus, and methotrexate in preventing acute graft-versus-host disease (GVHD) in patients undergoing allogeneic hematopoietic stem cell transplantation (HCT) with a myeloablative pre-transplant conditioning regimen. The study includes patients who meet specific inclusion criteria and excludes those who have received cord blood transplant, T cell depletion, or certain medications within a specified timeframe, among other criteria.",
    "This sample is a phase 2 clinical trial for patients with anaplastic or poorly differentiated variant thyroid cancer, testing the drug fosbretabulin disodium, and includes eligibility criteria such as age, performance status, and various medical conditions.",
    "This sample is a phase 2 clinical trial for lung cancer patients, testing the drugs cisplatin and gemcitabine hydrochloride, with eligibility criteria including specific disease characteristics and patient characteristics.",
    "This sample is a phase 2 trial for the drug vx-702 in patients with rheumatoid arthritis, where the inclusion criteria include being 18 to 75 years old, having active RA, and taking MTX for at least 6 months, while the exclusion criteria include planned major surgery and recent corticosteroid injections.",
    "This sample is a phase 2 trial for patients undergoing coronary artery bypass graft surgery, testing the drugs mdco-2010 and placebo, with specific inclusion and exclusion criteria.",
    "This study is a phase 2/phase 3 trial investigating the effectiveness of various combinations of valsartan, amlodipine, and placebo in treating patients with essential hypertension, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of the drugs bortezomib, melphalan, and prednisone, with specific eligibility criteria including histologically confirmed multiple myeloma, no prior therapy, normal organ and marrow function, and a life expectancy greater than 3 months.",
    "This sample is a phase 2 trial for patients with lymphoma and non-Hodgkin lymphoma, testing the drugs rituximab and velcade, with specific eligibility criteria including prior chemotherapy and a measurable disease, among others.",
    "In this sample, the phase 2 trial is focused on patients with metastatic, progressive hormone refractory prostate cancer, and the drugs being tested are cp-751,871, docetaxel, and prednisone. The inclusion criteria include a diagnosis of the specified cancer and adequate bone marrow, liver, and kidney function, while the exclusion criteria include previous chemotherapy treatment.",
    "This sample is a phase 2 clinical trial for patients with relapsed or resistant multiple myeloma, testing the drug pomalidomide, with specific eligibility criteria including prior lenalidomide therapy, adequate hematopoietic and renal function, and no significant peripheral neuropathy.",
    "This sample is a phase 1/phase 2 trial for patients with ovarian cancer, peritoneal cancer, fallopian tube cancer, or bowel obstruction, testing the effectiveness of cisplatin and paclitaxel drugs in treating malignant bowel obstruction. The eligibility criteria include specific symptoms, CT findings, non-surgical candidacy, and adequate hematological, renal, and hepatic function. There are also exclusion criteria, such as pregnancy, previous chemotherapy, and certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with chronic hepatitis C virus, testing the drugs ldv/sof and rbv, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of acute heart failure using the drugs cinaciguat (bay58-2667) and placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 clinical trial for patients with acute heart failure, testing the drugs rlx030 and placebo. The inclusion criteria include patients hospitalized or requiring admission for acute heart failure within the previous 48 hours, with a pulmonary wedge pressure of 18 mmHg or higher. The exclusion criteria include systolic blood pressure below 115 mmHg, significant valvular diseases or arrhythmias, recent acute coronary syndrome, treatment with mechanical support, and impaired renal or hepatic function.",
    "This sample is a phase 2 clinical trial for the treatment of irritable bowel syndrome (IBS) with the drugs \"250 mg lx1033 tablets\" and \"placebo tablet\". The eligibility criteria include having IBS-D symptoms, experiencing frequent diarrhea, and having a high level of abdominal pain.",
    "This sample is a phase 2 trial for patients with stomach neoplasm or neoplasm metastasis, testing the effectiveness of docetaxel and capecitabine as palliative chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with malignant glioma, glioblastoma multiforme, and gliosarcoma, testing the effectiveness of the drug gliadel/avastin/cpt-11 in combination with eligibility criteria for patient selection.",
    "This sample is a phase 2 trial for patients with non-small cell lung cancer (NSCLC) who have received one prior platinum-based chemotherapy regimen. The study aims to evaluate the efficacy and safety of the drugs pivanex and docetaxel in treating recurrent or progressive NSCLC. The inclusion criteria include histologically confirmed NSCLC, measurable or non-measurable disease, adequate renal and liver function, and an ECOG performance status of 0, 1, or 2. Exclusion criteria include receipt of more than one chemotherapy regimen for NSCLC, second malignancy within the last 5 years, and pregnancy or lactation.",
    "This sample is a phase 2 clinical trial for patients with invasive breast cancer, testing the effectiveness of lapatinib oral tablets and paclitaxel infusion as treatment options. The study includes eligibility criteria such as confirmed ER+ and/or PR+ status, documented amplification of ErbB2, and measurable lesions according to RECIST criteria. The study also outlines exclusion criteria, baseline laboratory values, and organ function requirements.",
    "This sample is a phase 2 clinical trial for postmenopausal women with non-small cell lung cancer, testing the efficacy of fulvestrant, anastrozole, bevacizumab, and best supportive care as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients aged 8-19 with newly diagnosed cancer, who are chemotherapy naive and scheduled to receive moderately or highly emetogenic chemotherapy. The study aims to evaluate the effectiveness of decadron\u00ae, benadryl\u00ae, ativan\u00ae, and ondansetron hydrochloride in preventing nausea and vomiting.",
    "This sample is a phase 2 trial for patients with recurrent or stage IV prostate cancer, testing the drug vorinostat, and includes eligibility criteria such as PSA progression, ECOG performance status, and normal organ function.",
    "This phase 2 trial is testing the effectiveness of cisplatin and pemetrexed disodium in treating patients with resectable stage IB or II non-small cell lung cancer, who have no evidence of metastatic disease and meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for the treatment of dry eye syndromes using different concentrations of opc-12759 and a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 2 trial is investigating the efficacy of rosiglitazone xr (extended release) oral tablets versus placebo in patients with mild to moderate Alzheimer's disease, with specific inclusion and exclusion criteria, including the requirement of a permanent caregiver for enrollment.",
    "This sample is a phase 2 trial for advanced and metastatic breast cancer patients who have not responded to previous hormonal treatments, and the drug being tested is fulvestrant. The inclusion criteria include postmenopausal women requiring hormonal treatment, while the exclusion criteria include previous treatment with multiple regimens of systemic anticancer therapy or endocrine therapy for advanced breast cancer.",
    "This sample is a phase 2 trial for patients with follicular lymphoma, testing the effectiveness of rituximab as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for HIV infections, testing the efficacy of tipranavir capsules and ritonavir capsules in HIV-infected patients who are TPV na\u00efve and have not received a PI based regimen within 6 months of enrollment.",
    "This sample is a phase 2 clinical trial for ovarian cancer, fallopian tube neoplasms, and peritoneal neoplasm, testing the drugs enzastaurin, carboplatin, paclitaxel, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial testing the effectiveness of sublingual methadone in managing pain due to cancer or its treatment, with specific eligibility criteria for patients who can participate in the trial.",
    "This sample is a phase 2 trial testing the drug azilsartan for patients with mild to moderate essential hypertension, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for rheumatoid arthritis (RA) patients who have active disease despite treatment with methotrexate (MTX). The study will test the efficacy of atacicept, a drug, in reducing the symptoms of RA. The inclusion criteria include having RA for at least 6 months, specific joint and inflammation markers, and being on MTX treatment. Exclusion criteria include previous or concurrent treatment with other RA drugs, participation in other clinical trials, and certain medical conditions.",
    "This sample is a phase 2 trial for patients with coronary artery disease (CAD) who are eligible for percutaneous coronary intervention (PCI) with one stent. The study aims to evaluate the safety and efficacy of the drugs m118 and unfractionated heparin in this patient population. The inclusion and exclusion criteria are provided, along with a substudy that requires blood specimens.",
    "This sample is a phase 2 clinical trial for patients with squamous cell carcinoma of the head and neck region, testing the drug oxaliplatin as an adjuvant therapy following surgical resection, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for multiple sclerosis patients who have been on stable therapy with Copaxone, Rebif, Betaseron, or Avonex for at least six months, and aims to test the effectiveness of polyphenon e in treating the disease.",
    "This sample is a phase 2 trial for patients aged 1 to 21 with myelodysplastic syndromes (MDS), testing the drug amifostine trihydrate, and includes eligibility criteria such as confirmed MDS diagnosis, specific MDS subtypes, no treatment-induced MDS, and normal hematopoietic, hepatic, renal, and other health parameters.",
    "This sample is a phase 2 clinical trial for small cell lung cancer, testing the effectiveness of bevacizumab, chemotherapy, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for major depressive disorder, testing the drugs alks 5461 and placebo, with inclusion criteria including a diagnosis of MDD and inadequate response to previous treatment, and exclusion criteria including certain psychiatric disorders and hypersensitivity to buprenorphine or opioid antagonists.",
    "This sample is a phase 2 trial for patients with mantle cell lymphoma, testing the effectiveness of carmustine, cytarabine, etoposide, and melphalan as part of a transplant procedure, with specific eligibility criteria for patients and donors.",
    "This sample is a phase 2 trial for patients with recurrent or progressive locally advanced or metastatic breast cancer, testing the effectiveness of dasatinib in combination with chemotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic myeloproliferative disorders and secondary myelofibrosis, testing the drug dacogen. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for participants with type 2 diabetes mellitus, testing the effectiveness of lixisenatide, liraglutide, insulin glargine, and metformin in managing blood glucose levels, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with stable coronary artery disease or unstable angina, testing the use of argatroban and heparin as anticoagulant medications prior to percutaneous coronary angioplasty or stent insertion.",
    "This sample is a phase 2 clinical trial for Parkinson's disease, testing the drugs placebo and tozadenant, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with high-risk/limited stage III or IV squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx. The drug being tested is cisplatin, and the eligibility criteria include specific disease characteristics and patient characteristics such as age, blood counts, liver and kidney function, and absence of other malignancies.",
    "This sample is a phase 2 trial for patients with pancreatic cancer and ductal adenocarcinoma, testing the drugs PCI-27483 and gemcitabine, with specific eligibility criteria including age, weight, disease diagnosis, measurable disease, surgical history, performance status, coagulation function, and willingness to participate.",
    "This sample is a phase 2 trial for attention-deficit/hyperactivity disorder (ADHD) using drugs such as abt-894, atomoxetine, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for prostate cancer, testing the drug polyphenon e (egcg) in patients scheduled for prostatectomy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with colorectal neoplasms, testing the effectiveness of bevacizumab, oxaliplatin, capecitabine, and irinotecan as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory classical Hodgkin lymphoma, testing the drug PLX3397, with eligibility criteria including confirmation of the disease, previous treatment history, radiographically measurable disease, and adequate hematologic, hepatic, and renal function.",
    "This sample is a phase 2 trial for rectal cancer patients, testing the drugs avastin and capecitabine, with eligibility criteria including specific disease stage, tumor location, and various health parameters.",
    "This sample is a phase 2 trial for patients with coronary artery disease, testing the drugs cangrelor and prasugrel, with eligibility criteria including age, previous myocardial infarction or revascularization, and treatment with aspirin.",
    "This sample is a phase 2 clinical trial for the drug GSK256066 and placebo in patients with chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 2 trial for patients with non-small cell lung cancer (NSCLC) and metastatic cancer, testing the effectiveness of chemotherapy and porfimer sodium in patients who have received or are currently receiving front-line chemotherapy. The eligibility criteria include histologically confirmed NSCLC with pleural spread, resectable primary tumor, medical fitness for surgery, and no prior treatment for NSCLC except pleurodesis or front-line chemotherapy.",
    "This sample is a phase 2 clinical trial for patients with schizophrenia, testing the efficacy of the drugs aqw051 and placebo in treating the disease, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial aims to evaluate the efficacy of vinorelbine, capecitabine, and trastuzumab in treating HER2 positive breast cancer patients with non-operable locally advanced or metastatic disease who have previously been treated with trastuzumab and taxanes.",
    "This sample is a phase 2 clinical trial for the treatment of lower urinary tract symptoms using the drug tamsulosin, with specific inclusion and exclusion criteria for male participants.",
    "This sample is a phase 2 clinical trial for chronic obstructive pulmonary disease (COPD) patients, testing the drugs mk633 and a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with gastrointestinal stromal tumors (GIST), testing the effectiveness of imatinib mesylate as a treatment option. The inclusion criteria include patients aged 18-80 with a diagnosis of GIST, while the exclusion criteria include the presence of metastatic disease and the use of other antineoplastic treatments.",
    "This sample is a clinical trial study for prostate cancer patients in different phases, testing drugs such as arn-509 and abiraterone, with specific eligibility criteria for each phase.",
    "This sample is a phase 2 clinical trial for patients with diffuse large B-cell lymphoma, testing the effectiveness of a combination of cyclophosphamide, doxorubicin hydrochloride, prednisone, and vincristine sulfate as treatment, with specific eligibility criteria including disease stage, CD20+ B-cell phenotype, and absence of certain conditions or infections.",
    "This sample is a phase 2 clinical trial for patients with various types of acute myeloid leukemia and myelodysplastic syndrome, testing the effectiveness of azacitidine and entinostat as treatment options.",
    "This sample is a phase 2 trial for patients with locally advanced/metastatic non-small cell lung cancer, testing the efficacy of erlotinib, sunitinib, and placebo as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) and brain metastasis, testing the efficacy of temozolomide and radiotherapy as treatment. The inclusion criteria include prior histologic confirmation of NSCLC, presence of measurable disease in the brain, and certain blood count and organ function requirements. The exclusion criteria include recent chemotherapy or radiation therapy, recent surgery, and certain medical conditions.",
    "This sample is a phase 2 trial for patients with chronic Genotype 1 Hepatitis C infection, testing the effectiveness of vaniprevir, pegylated-interferon, ribavirin, and placebo as comparators, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the efficacy of metformin and placebo drugs, with specific eligibility criteria including age, BMI, HbA1c levels, kidney function, fasting glucose levels, stable body weight, and other medical conditions, while excluding individuals with certain medical conditions, allergies, substance abuse, recent surgeries, and those on specific medications.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed or refractory B- or T-cell non-Hodgkin's lymphoma, testing the effectiveness of bortezomib and gemcitabine hydrochloride as treatment options.",
    "This sample is a phase 2 clinical trial for patients with cervical intraepithelial neoplasia grade 1 (CIN 1) and human papillomavirus (HPV) infection, testing the efficacy of a placebo drug, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for psoriasis vulgaris, testing the effectiveness of ct327 at different concentrations and a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for rheumatoid arthritis, testing the efficacy of methotrexate, rituximab, corticosteroids, and placebo in patients who have failed treatment with other disease-modifying anti-rheumatic drugs or biologics.",
    "This sample is a phase 2 clinical trial for non-Hodgkin's lymphoma, testing the effectiveness of a combination of doxorubicin, rituxan, cyclophosphamide, vincristine, and prednisone as a treatment option, with specific eligibility criteria for participants.",
    "This sample is a phase 2 trial for patients with Waldenstrom macroglobulinemia, testing the effectiveness of thalidomide, lenalidomide, and rituximab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis (NASH) using the drugs asp9831 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial investigating the use of urea 40% cream, fluocinonide 0.05% cream, tazarotene 0.1% cream, and bland emollient cream in patients receiving sorafenib for hand-foot skin reaction and rash, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for menopausal and female climacteric states, testing the drugs gsk232802 and premarin against a placebo, with eligibility criteria including postmenopausal women aged 40 to 65 years old, a minimum average frequency of seven daily moderate to extremely severe hot flashes or episodes of night sweats, and a BMI within the range 19 to 35 kg/m2.",
    "This sample is a phase 2 clinical trial for the drug nbi-98854 in patients with neuroleptic-induced tardive dyskinesia, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial testing the drug foretinib (formerly gsk1363089 or xl880) on patients with metastatic renal cell carcinoma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for men with clinically localized prostate cancer, testing the effectiveness of different drug combinations (goserelin with dutasteride, goserelin with bicalutamide and dutasteride, and goserelin with bicalutamide and dutasteride and ketoconazole) based on specific eligibility criteria, including clinical stage, PSA level, Gleason score, and surgical resectability.",
    "This sample is a phase 1/phase 2 trial for non-small-cell lung carcinoma patients who have progressed after prior chemotherapy or chemoradiotherapy, and it will test the efficacy of entinostat, sndx-275, and erlotinib as potential treatments.",
    "This sample is a phase 2 clinical trial for patients with hepatocellular carcinoma and various other bile duct cancers, testing the effectiveness of cisplatin, erlotinib, and gemcitabine as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory Hodgkin's lymphoma, testing the drug resminostat (4sc-201) to evaluate its effectiveness in treating the disease. The eligibility criteria include having measurable anatomical disease, an ECOG Performance Score of 0, 1, or 2, and not having received previous treatment with an HDAC inhibitor or undergone allogeneic hematopoietic stem cell transplantation.",
    "This sample is a phase 2 clinical trial for patients with metastatic or unresectable clear cell renal carcinoma, testing the efficacy of decitabine and interferon alfa-2b as treatment options.",
    "This sample is a phase 2 clinical trial for patients with metastatic ocular melanoma, testing the drug imatinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients, testing the effectiveness of bevacizumab, oxaliplatin, and pemetrexed drugs, with specific eligibility criteria including histologically documented Stage IIIB/IV non-squamous cell NSCLC and an ECOG Performance Status of 0 or 1.",
    "This phase 2 trial is testing the drugs jnj-40411813 and placebo for the treatment of major depressive disorder, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for breast cancer patients who are HER2 negative, with eligibility criteria including no prior chemotherapy regimen, ECOG performance status \u2264 1, and estimated life expectancy > 12 weeks. The study will test the drugs ym155 and docetaxel.",
    "This sample is a phase 2 clinical trial for breast cancer patients who meet specific eligibility criteria, including having had surgical removal of the tumor, expressing estrogen and/or progesterone receptors, and having undergone chemotherapy with cyclophosphamide. The drug being tested in this trial is anastrozole.",
    "This sample is a phase 2 trial for the drug bi 10773 in patients with type 1 diabetes, with specific inclusion and exclusion criteria, aiming to assess its efficacy in controlling blood glucose levels.",
    "This sample is a phase 2 trial for postmenopausal women with metastatic breast cancer, testing the efficacy of anastrozole, exemestane, letrozole, and sorafenib tosylate as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with paranoid schizophrenia and schizophrenia, testing the drugs mk0557 and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2/phase 3 trial for patients with unresectable advanced gastric carcinoma and recurrent gastric carcinoma, testing the efficacy of tegafur/gimeracil/oteracil potassium (s-1) and krestin (psk) in combination as a treatment option. The eligibility criteria include age, prior treatment history, organ function, performance status, and written informed consent. There are also exclusion criteria, such as certain medical conditions and medications, that would make patients ineligible for the study.",
    "This sample is a phase 2 clinical trial for asthma patients, testing the drugs mn-221 and placebo, with eligibility criteria including a diagnosis of asthma, specific lung function requirements, and restrictions on medication use.",
    "This sample is a phase 2 trial for the treatment of ovarian hyperstimulation syndrome using the drug norprolac, and it includes eligibility criteria for participants.",
    "This sample is a phase 2 trial for age-related macular degeneration, testing the effectiveness of drugs such as ranibizumab and pf-04523655 in treating the disease, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the drug degarelix. The inclusion criteria include histologically proven prostate cancer, rising serum PSA levels, and an ECOG P.S. score of 0 to 2. The exclusion criteria include previous or present endocrine treatment for prostate cancer and being a candidate for curative therapy within 12 months.",
    "This sample is a phase 2 clinical trial for patients with chronic lymphocytic leukemia (CLL) who meet specific inclusion criteria, and the drug being tested is lenalidomide.",
    "This sample is a phase 2 trial for patients with ocular hypertension or open-angle glaucoma, testing the efficacy of ar-12286 ophthalmic solution 0.7%, ar-12286 ophthalmic solution 0.5%, and timolol maleate ophthalmic solution 0.5% in reducing intraocular pressure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer, testing the combination of abt-751 and carboplatin as a potential treatment option. The eligibility criteria include age, confirmed diagnosis, measurable lesions, advanced stage of disease, and adequate hematologic, renal, and hepatic function. The exclusion criteria include other malignancies, untreated CNS metastasis, concurrent anti-cancer therapy or radiotherapy, and allergies to carboplatin or sulfa.",
    "This sample is a phase 2 trial for patients with Waldenstrom macroglobulinemia, testing the effectiveness of a combination of drugs including bortezomib, carmustine, cisplatin, cyclophosphamide, cytarabine, dexamethasone, doxorubicin hydrochloride, etoposide, melphalan, and thalidomide, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 2 clinical trial for patients with Waldenstrom's macroglobulinemia, testing the drugs cc-5103 (lenalidomide) and rituximab. The eligibility criteria include specific diagnostic criteria, age requirements, previous treatment discontinuation, and various health parameters.",
    "This sample is a phase 2 trial for patients with clear cell renal cell carcinoma, recurrent renal cell cancer, or stage IV renal cell cancer, testing the drug tandutinib. The eligibility criteria include having received prior FDA approved therapy for metastatic renal cell carcinoma and having measurable disease.",
    "This sample is a phase 2 clinical trial for chronic constipation, testing the drug ati-7505, with specific inclusion and exclusion criteria, such as age, negative colonoscopy, and refraining from certain medications.",
    "This sample is a phase 2 trial testing the drugs agn201781 and placebo for the treatment of postherpetic neuralgia or post-traumatic peripheral neuralgia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for prostate cancer patients who have experienced progression following prostatectomy or radiation therapy, and it aims to evaluate the effectiveness of celecoxib, a non-steroidal anti-inflammatory drug, in slowing down the progression of the disease.",
    "This sample is a phase 2 trial investigating the use of epinephrine and metoprolol in patients over 18 years old who experience in-hospital cardiac arrest, specifically ventricular fibrillation or tachycardia. The study aims to determine the effectiveness of these drugs in treating these conditions.",
    "This sample is a phase 2 trial for the drug np001 in patients with amyotrophic lateral sclerosis (ALS), with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of lenalidomide, melphalan, and dexamethasone as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of a combination of drugs including erlotinib, fluorouracil, leucovorin, oxaliplatin, and irinotecan, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma and plasma cell neoplasm, testing the effectiveness of bortezomib, cyclophosphamide, dexamethasone, and thalidomide as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 clinical trial for ovarian cancer, testing the drug ispinesib, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer who have not responded to hormone therapy, and it aims to evaluate the effectiveness of pemetrexed in treating the disease. The eligibility criteria include specific requirements for disease progression, prior treatments, and hormone levels.",
    "This sample is a phase 2 clinical trial for patients with stage III/B or IV squamous NSCLC, testing the drug dasatinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the drug las100977 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with Type 2 diabetes, testing the drugs placebo and agi-1067, with eligibility criteria including a minimum HbA1c level of \u22657.5% and stable antidiabetic medication usage.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the drug temozolomide, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for cancer patients, testing the effectiveness of interferon alfa-2a as a cancer vaccine, with specific eligibility criteria and exclusion criteria.",
    "This phase 2 trial is investigating the effectiveness of cisplatin and fluorouracil in treating patients with newly diagnosed pancreatic cancer, who meet specific eligibility criteria.",
    "This sample is a phase 2/phase 3 trial testing the use of propranolol, a drug, in children under 10 with recurrent respiratory papillomatosis, a disease, who have undergone at least 4 surgical interventions in the past year. The study has specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the drug bi 10773, with inclusion criteria including HbA1c levels, age, BMI, and antihypertensive treatment stability. Exclusion criteria include acute coronary syndrome, uncontrolled hyperglycemia, liver disease, impaired renal function, and history of cancer or bariatric surgery.",
    "This sample is a phase 2 clinical trial for lung cancer patients, testing the effectiveness of celecoxib, docetaxel, and pemetrexed disodium as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for small cell lung cancer (SCLC) patients with extensive disease, testing the drugs amrubicin and topotecan. The eligibility criteria include a histological or cytological diagnosis of SCLC, response to first-line platinum-based chemotherapy, and measurable disease defined by RECIST criteria.",
    "This sample is a phase 2 clinical trial for patients with breast cancer and brain metastases, testing the effectiveness of sunitinib and capecitabine as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of carfilzomib, cyclophosphamide, and dexamethasone as a treatment. The eligibility criteria include age, consent, disease diagnosis, measurable disease, performance status, and specific laboratory values. Exclusion criteria include certain medical conditions and allergies.",
    "This sample is a phase 2 trial for patients with Bipolar I Disorder experiencing a major depressive episode, testing the effectiveness of armodafinil and placebo as adjunctive treatment to lithium, olanzapine, or valproic acid.",
    "This sample is a phase 2 trial for patients who have undergone allogeneic transplant within the past year and are experiencing their first episode of viral respiratory tract infection after transplant. The study aims to test the effectiveness of drugs such as prednisone, azithromycin, montelukast, and symbicort in treating respiratory tract infections in this population.",
    "This sample is a phase 2 trial for patients with hepatocellular carcinoma, testing the combination of sorafenib and capecitabine as a treatment option. The eligibility criteria include specific requirements for bone marrow, renal, and hepatic function, as well as exclusion criteria such as prior systemic therapy and uncontrolled ascites.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the drug plerixafor for autologous transplantation eligibility, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with osteoarthritis of the knee, testing the drugs fx006 and tca ir, with specific eligibility criteria including age, diagnosis confirmation, pain score, BMI, and restrictions on medication use.",
    "This sample is a phase 2 clinical trial for patients with small cell lung cancer, testing the effectiveness of irinotecan, carboplatin, and bevacizumab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the treatment of dry eye syndromes, testing the efficacy of three different ophthalmic suspensions (placebo, 1% opc-12759, and 2% opc-12759) on patients who meet specific inclusion criteria, such as having a subjective complaint of dry eye for at least 20 months and moderate to severe ocular discomfort and corneal-conjunctival damage.",
    "This sample is a phase 2 clinical trial for patients with ovarian, fallopian tube, or primary peritoneal cancer, testing the effectiveness of the drugs doxorubicin hcl liposome, bevacizumab, and carboplatin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for hormone refractory prostate cancer, testing the drug docetaxel, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1/phase 2 clinical trial for patients with urinary bladder neoplasms, testing the drug lenalidomide, with specific eligibility criteria including age, performance status, disease type, and organ function requirements.",
    "This sample is a phase 2 trial for HIV infections, testing the effectiveness of valproic acid and HAART in patients with specific eligibility criteria and excluding those with certain conditions or medications.",
    "This sample is a phase 2 clinical trial for the treatment of irritable bowel syndrome with constipation using linaclotide acetate and a matching placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with prostatic neoplasms, testing the drugs abiraterone acetate, abiraterone acetate mtd, and dexamethasone, with eligibility criteria including documented adenocarcinoma of the prostate, refractory or resistant to hormone therapy, and evidence of progressive prostate cancer.",
    "This phase 2 trial aims to evaluate the efficacy of dalteparin and gemcitabine hydrochloride in treating patients with metastatic or locally advanced adenocarcinoma of the pancreas, while also assessing their eligibility criteria and excluding patients with certain medical conditions or prior treatments.",
    "This sample is a phase 2 clinical trial for patients with advanced kidney cancer, testing the effectiveness of carboplatin and paclitaxel as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 trial for patients with recurring or metastatic Pancreatic Adenocarcinoma, testing the effectiveness of gemcitabine and etanercept as potential treatments.",
    "This sample is a phase 2 trial for patients with active rheumatoid arthritis who have had an inadequate response to methotrexate, and the drugs being tested include placebo and cp-690,550.",
    "This sample is a phase 1/phase 2 clinical trial for patients with ovarian cancer, testing the drugs sorafenib and topotecan, with specific eligibility criteria for enrollment.",
    "This sample is a phase 2 trial testing the effectiveness of 1% tenofovir gel in preventing HIV infections and treating chronic hepatitis B, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for the treatment of fibromyalgia using the drug nabilone, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for participants with human immunodeficiency virus type 1, testing the effectiveness of etravirine, nucleotide reverse transcriptase inhibitors, protease inhibitors, and enfuvirtide in treating the disease, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for the drug ibodutant in patients with irritable bowel syndrome with diarrhea, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with acute myeloid leukemia (AML) who are ineligible for intensive chemotherapy, and the drug being tested is decitabine. The inclusion criteria include a recent diagnosis of AML or transformed from myelodysplastic syndrome (MDS), while the exclusion criteria include previous treatment for AML, previous use of Vidaza, and recent use of other investigational agents.",
    "This phase 2 clinical trial is testing the effectiveness of the drug brivanib versus placebo in patients with advanced non-small cell lung cancer, transitional cell carcinoma, soft tissue sarcoma, gastric/esophageal adenocarcinoma, and pancreatic cancer including ampulla of vater tumors, who have no approved effective therapy or are intolerable to such therapy.",
    "This phase 2 trial is investigating the efficacy of brostallicin and cisplatin in treating patients with triple-negative breast cancer, with specific eligibility criteria including histologically confirmed adenocarcinoma of the breast, triple-negative breast cancer defined by HER2-, ER-, and PgR-, and a maximum of 4 prior chemotherapy regimens in the metastatic setting.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer, testing the effectiveness of induction chemotherapy as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with hormone refractory prostate cancer, testing the effectiveness of docetaxel and gemcitabine drugs, with specific eligibility criteria including histologically verified adenocarcinoma of the prostate, stage IV disease, and satisfactory hepatic and renal function.",
    "This sample is a phase 2 trial testing the drug mipomersen and placebo in patients with metabolic diseases, hyperlipidemias, metabolic disorder, hypercholesterolemia, dyslipidemias, and lipid metabolism disorders, who have a diagnosis of statin intolerance, coronary artery disease (CAD), and hypercholesterolemia, and have had stable weight for more than 6 weeks.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory multiple myeloma, testing the drug dexamethasone as a treatment option. The eligibility criteria include having failed at least 2 prior lines of therapy and measurable secretory disease.",
    "This sample is a phase 2 trial for the treatment of rheumatoid arthritis using the drugs adalimumab, cp-690-550, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the efficacy of asp1585 and sevelamer hydrochloride, along with a placebo, in treating hyperphosphatemia in patients with chronic kidney disease who are on hemodialysis. The trial has specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drug tideglusib and placebo in patients aged 50 to 85 with a MMSE score of 14 to 26, who are currently on stable doses of approved Acetylcholinesterase-Inhibitors and/or Memantine. The study has specific inclusion and exclusion criteria, including no significant psychiatric or medical diseases, no chronic liver disease, no chronic daily intake of excluded medications, and no enrollment in another investigational drug study within 3 months before the baseline visit.",
    "This sample is a phase 2 clinical trial for patients with aggressive non-Hodgkin's lymphoma who have shown progression after prior chemotherapy, and it involves the drugs gemcitabine, cisplatin, and dexamethasone. The eligibility criteria include specific histological diagnoses, performance status, and measurable disease.",
    "This sample is a phase 1/phase 2 trial testing the drugs docetaxel and oxaliplatin on patients with esophageal neoplasms and stomach neoplasms, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for breast cancer and non-small-cell lung carcinoma, testing the drugs SCH 727965, capecitabine, and erlotinib, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer who have undergone complete resection and will receive adjuvant chemotherapy with carboplatin and docetaxel. The eligibility criteria include specific disease characteristics and patient characteristics, and exclude patients with severe hypersensitivity to docetaxel or polysorbate 80 and those with peripheral neuropathy \u2265 grade 2.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory acute lymphocytic leukemia, testing the effectiveness of cytarabine, fludarabine phosphate, and idarubicin as treatment options. Eligibility criteria include specific disease characteristics, age, performance status, and absence of certain medical conditions.",
    "This sample is a phase 2 trial for patients with prostate cancer, testing the drugs nilutamide and dasatinib, with eligibility criteria including confirmed diagnosis of adenocarcinoma of the prostate, evidence of disease progression on androgen deprivation therapy, and adequate organ and marrow function.",
    "This sample is a phase 2 trial testing the drug etc-1002 and placebo in patients with hyperlipidemia and type 2 diabetes, with specific inclusion criteria including a minimum 6 month history of diabetes, fasting C-peptide \u2265 0.8 ng/mL, HbA1C of 7-10%, fasting glucose from 140-270 mg/dL, BMI from 25-35 kg/m2, and LDL-C \u2265 100 mg/dL.",
    "This sample is a phase 2 clinical trial for opioid-induced constipation, testing the effectiveness of the drugs placebo and naldemedine in subjects aged 18 years or older with non-malignant chronic pain and < 3 spontaneous bowel movements a week.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of the drug ly2189265 compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for Friedreich's ataxia, testing the drug epoetin alfa, and includes eligibility criteria such as a molecular diagnosis of FA and age between 18 and 50 years.",
    "This sample is a phase 2/phase 3 trial for kidney transplantation, testing the effectiveness of rituximab and placebo in renal transplant recipients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for esophagus cancer, testing the drugs oxaliplatin, docetaxel, and capecitabine, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial for multiple myeloma, testing the drugs lenalidomide, bortezomib, dexamethasone, and doxil, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with migraine, testing the effectiveness of lasmiditan and placebo in treating migraine attacks, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the drug pex168 or placebo, with inclusion criteria including a diagnosis of type 2 diabetes, stable metformin monotherapy, specific HbA1c levels, age range, and BMI range, and exclusion criteria including positive skin test for PEX168, use of certain medications, history of severe hypoglycemia or other medical conditions, and significant laboratory abnormalities.",
    "This sample is a phase 2 trial for patients with advanced soft tissue sarcoma, testing the drug perifosine, and includes eligibility criteria such as measurable disease, specific blood counts, liver and kidney function, and performance status.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the combination of capecitabine, celecoxib, and methotrexate as a treatment option. The eligibility criteria include age between 18 and 80, previous treatment limited to FOLFIRI+ bevacizumab, and persistent remission or stable disease from previous treatment.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the drugs hmpl-004 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the drug cp-866,087 and placebo on healthy pre-menopausal women with primary female sexual arousal disorder, and the study includes specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for rheumatoid arthritis (RA) patients in the Czech Republic, testing the efficacy of the drug nnc109-0012 compared to a placebo, with inclusion criteria including a diagnosis of RA, active RA, and stable methotrexate treatment, and exclusion criteria including allergies to trial products and BMI outside the range of 18.5 to 35.0 kg/m^2.",
    "This sample is a phase 2 clinical trial for the treatment of chronic hepatitis C infection using a combination of drugs including abt-267, abt-450, abt-333, ritonavir, and ribavirin, with specific inclusion and exclusion criteria for enrollment.",
    "This sample is a phase 2 clinical trial for HIV-1 infection, testing the drug bevirimat. The inclusion criteria include having documentation of HIV-1 infection, a CD4+ lymphocyte count of at least 100 cells/mm3, and a screening plasma HIV-1 RNA value of less than 400 copies/mL. The exclusion criteria include having any acute illness within 14 days prior to study entry, presence of any AIDS-related opportunistic infection, and inability to comply with the dosing schedule and protocol evaluations.",
    "This sample is a phase 2 clinical trial for patients with stage IV breast cancer who have confirmed adenocarcinoma and overexpression of the HER-2 gene. The study will test the effectiveness of albumin-bound paclitaxel, carboplatin, and herceptin\u00ae in treating the disease.",
    "This sample is a phase 2 clinical trial for patients with acute myeloid leukemia (AML) testing the combination of amonafide and cytarabine as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "In this sample, the phase of the trial is phase 2 and the disease being studied is cancer. The icd-10 codes associated with the disease are C05.2, C10.0, C16.0, C16.4, C17.0, C17.1, and C17.2. The drugs being tested are cediranib and cediranib 30 - 90 mg. The eligibility criteria include a clinical diagnosis of advanced solid tumor and the ability to eat a high fat breakfast. Exclusion criteria include poorly controlled high blood pressure and a history of significant gastrointestinal problems.",
    "This sample is a phase 2 clinical trial for patients with recurrent melanoma or stage IV melanoma, testing the drug ixabepilone, with specific eligibility criteria including performance status, blood counts, organ function, and exclusion of certain medical conditions.",
    "This sample is a phase 2 trial for breast cancer patients, testing the drug vorinostat, with specific eligibility criteria including no prior hormonal therapy, stage I-III disease, and various health parameters, while excluding patients with certain conditions or taking specific medications.",
    "This phase 2 trial is investigating the efficacy of ixabepilone and cetuximab in treating metastatic pancreatic cancer patients who have not received prior chemotherapy, immunotherapy, or chemoradiotherapy, and have a Karnofsky performance status of 70-100.",
    "This sample is a phase 2 trial for hormone-refractory prostate cancer, testing the effectiveness of zoledronic acid tablets as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for allergic rhinitis, testing the drugs qax576 and placebo, with inclusion criteria of a history of allergic rhinitis and exclusion criteria including respiratory diseases other than mild intermittent asthma and a history of clinically significant drug allergy.",
    "This sample is a phase 2 clinical trial for patients with colorectal cancer, testing the combination of gm-ct-01 plus 5-fluorouracil as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with cutaneous T-cell lymphoma, testing the drug apo866, with specific inclusion and exclusion criteria.",
    "In this phase 2 trial, patients with chemotherapy naive non-small-cell lung carcinoma (NSCLC) stage III and IV will be treated with carboplatin, paclitaxel, and vinorelbine, while excluding those with New York Heart Association (NYHA) III or IV, brain metastases, and neurotoxicity Grade 2 or greater.",
    "This sample is a phase 2 clinical trial for previously untreated participants with CD20 positive B-cell chronic lymphocytic leukemia, testing the effectiveness of rituximab and chlorambucil as treatment options.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of a combination of drugs including fluorouracil, leucovorin, bevacizumab, capecitabine, and oxaliplatin, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 trial for obsessive-compulsive disorder (OCD) patients who have not responded to previous treatments, and it will test the effectiveness of paliperidone and placebo in reducing symptoms.",
    "This sample is a phase 2 trial for asthma patients aged 5-11 years, testing the effectiveness of the drug gw642444 compared to a placebo, with inclusion criteria including a diagnosis of asthma, controlled asthma symptoms, and a stable regimen of fluticasone propionate, and exclusion criteria including recent changes in asthma medication and presence of oral candidiasis.",
    "This sample is a phase 2 clinical trial testing the effectiveness of Sativex (low, medium, and high doses) in alleviating cancer-related pain in patients with advanced active cancer who are not fully relieved by their current opioid treatment.",
    "This sample is a phase 1/phase 2 trial for pancreatic cancer, testing the combination of hydroxychloroquine and gemcitabine as a treatment option. The eligibility criteria include biopsy-proven adenocarcinoma of the pancreas, specific staging requirements, normal organ function, and the ability to understand and sign a consent form. Exclusion criteria include prior chemotherapy or radiotherapy, evidence of metastasis, and allergies to the study drugs. Additionally, there are specific criteria related to pregnancy, HIV, porphyria, psoriasis, enzyme-inducing anti-epileptic medication, macular degeneration, and diabetic retinopathy.",
    "This sample is a phase 2 trial testing the drug \"ltx-109\" for the treatment of uncomplicated, Gram-positive skin infections, including mild eczema/dermatoses such as atopic dermatitis, in patients between the ages of 18 and 65.",
    "This sample is a phase 2 clinical trial for locally recurrent and metastatic breast cancer, testing the drugs amg 706 placebo, bevacizumab, amg 706, and paclitaxel, with specific eligibility criteria for participants.",
    "This sample is a phase 2 trial for endometriosis, testing the effectiveness of drugs such as elagolix and subcutaneous depot medroxyprogesterone acetate (DMPA-SC) compared to placebos, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial testing the effectiveness of bupropion sr, a drug used to treat nicotine dependence, in regular cigarette smokers aged 12-21 with a urine cotinine level greater than 100 ng/ml, while excluding participants with certain psychiatric diagnoses, substance abuse/dependence, pregnancy or lactation, seizure disorders, and other medical conditions.",
    "This sample is a phase 2 trial for individuals with sleep initiation and maintenance disorders, testing the drugs sb-649868 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastatic prostate cancer, testing the drug kos-862, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for psoriasis vulgaris, testing the effectiveness of various concentrations of e6201 and calcipotriene as topical treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for the drug \"jnj-37822681\" in patients with schizophrenia, with specific inclusion and exclusion criteria, such as a diagnosis of schizophrenia, a history of at least 12 months of schizophrenia, and a Positive and Negative Syndrome Scale score less than 70.",
    "This sample is a phase 2 clinical trial for patients with glioblastoma multiforme, testing the drug XL184. The eligibility criteria include having a confirmed diagnosis of Grade 4 astrocytic tumor, prior radiation and temozolomide therapy, and being in first or second relapse.",
    "This sample is a phase 2 clinical trial for metastatic colorectal cancer, testing the effectiveness of vismodegib, bevacizumab, modified folfox, and folfiri in combination, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for Huntington's disease, testing the drugs sen0014196 and placebo, with inclusion criteria including genetically confirmed HD, motor signs of HD, and clinical stages I to III. Exclusion criteria include prior use of certain HDAC inhibitors, significant medical illness, and abnormal ECG findings.",
    "This sample is a phase 2 clinical trial testing the drug clofarabine for the treatment of acute myelogenous leukemia (AML) in patients aged 60 years or older, with specific eligibility criteria including adverse prognostic factors and adequate renal and hepatic function.",
    "This sample is a phase 2 trial for the treatment of chronic hepatitis C, using telaprevir, ribavirin, and pegylated interferon alfa 2a, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2/phase 3 trial for patients with heart failure, congestive, using the drugs relaxin and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with coronary artery disease, testing the effectiveness of the drug e5555 (in different doses) compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic breast cancer, testing the effectiveness of gemcitabine hydrochloride and imatinib mesylate as a second-line chemotherapy regimen, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes, testing the efficacy of semaglutide and liraglutide in combination with metformin or diet and exercise, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with completely resected adenocarcinoma of the pancreas, testing the drug gemcitabine hydrochloride as a treatment option. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 trial for lupus nephritis, testing the drug nkt-01 in patients with active SLE nephritis who have received prior treatment with immunosuppressive drugs, and have certain eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for asthma patients, testing the effectiveness of various drugs including FP 100, gsk2190915 100, gsk2190915 300, montelukast, placebo, and fp/sal 100/50, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with advanced non-small cell lung cancer, testing the combination of carboplatin, hydroxychloroquine, and paclitaxel as a treatment option, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a clinical trial for patients with gastrointestinal cancer, testing the drugs everolimus and tivozanib in phase I/II, with specific eligibility criteria for enrollment.",
    "This sample is a phase 2 trial for the treatment of type 2 diabetes using different doses of pf-00734200, with inclusion criteria including a diagnosis of type 2 diabetes and Hb1AC levels between 7% and 11%, and exclusion criteria including a history of stroke or heart attack within one year, alcohol dependency or recent drug abuse, and evidence of diabetic complications with significant end-organ damage.",
    "This sample is a phase 2 clinical trial for patients with mild to moderate primary hypercholesterolemia, testing the drugs ave5530, placebo, and ezetimibe, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the drugs dasatinib and leuprolide acetate (lhrh analogue) to determine their effectiveness in treating the disease. The eligibility criteria include specific disease stage, predicted risk of recurrence-free survival, and willingness to undergo certain procedures.",
    "This sample is a phase 2 clinical trial for lung cancer patients, testing the effectiveness of cisplatin, etoposide, paclitaxel, and topotecan hydrochloride as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 clinical trial for patients with cervical carcinoma, testing the drug ixempra (ixabepilone) as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with metastatic pancreatic cancer, testing the combination of rx-0201 plus gemcitabine as a potential treatment option. The inclusion criteria include having written informed consent, being over 18 years old, having measurable lesions, a Karnofsky Performance Status of > 70, and a life expectancy of at least 6 months. The exclusion criteria include being unwilling or unable to provide informed consent, being treated with another investigational agent for pancreatic cancer, and having certain abnormal laboratory values.",
    "This sample is a phase 2 clinical trial for the drug gw679769, testing its effectiveness in treating major depressive disorder, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with metastatic renal cell carcinoma, testing the drug ispinesib, with specific eligibility criteria including prior therapy, performance status, and various medical parameters.",
    "This sample is a phase 1/phase 2 trial for patients with acute myeloid leukemia (AML) who have primary refractory AML or relapsed AML, and it involves the use of cytarabine and lovastatin as drugs. The eligibility criteria include having no prior remission, having a documented remission lasting >30 days, and not having received a high-dose cytarabine containing regimen within 3 months prior to registration.",
    "This sample is a phase 2 clinical trial for patients with schizophrenia, testing the effectiveness of the drug combination gwp42003 : gwp42004 (40:1) compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a clinical trial study that focuses on patients with recurrent or refractory malignant CNS tumors, including medulloblastoma, high grade glioma, and ependymoma, and it investigates the use of lapatinib ditosylate as a potential treatment option.",
    "This sample is a phase 2 trial for patients with unresectable liver metastases secondary to colorectal adenocarcinoma, testing the efficacy of the folfox regimen, fluorouracil, leucovorin calcium, and oxaliplatin in combination with radiofrequency interstitial ablation (RFA) or resection for treatment.",
    "This sample is a phase 1/phase 2 trial for Friedreich's ataxia, testing the drugs placebo and deferiprone, with inclusion criteria including a confirmed mutation in the frataxin gene and GAA repeats \u2265 400, and exclusion criteria including iron deficiency and previous use of deferiprone.",
    "This sample is a phase 2 trial for the treatment of hepatitis C, testing the drugs peg-intron, rebetol, and hcv 796, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with liver cancer (hepatocellular carcinoma) who are not candidates for surgical or radical therapies. The drug being tested is doxorubicin hydrochloride, and the eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with acute coronary syndrome, testing the efficacy of the drug \"e5555\" compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer and CNS disease, testing the drug zk219477, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 2 trial testing the drug pf-00489791 for the treatment of Raynaud's disease and peripheral vascular disease, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the drug indantadol, targeting patients with chronic cough, and the eligibility criteria include normal chest X-ray, normal lung function, and exclusion of patients with recent upper respiratory tract infection, pregnancy/breast-feeding, and current smokers or ex-smokers with <6 months abstinence or cumulative history of >10 pack years.",
    "In this sample, the phase 2 trial is testing the drug bosutinib for patients with chronic myeloid leukemia who are refractory to imatinib or have disease progression/relapse while on imatinib, and have undergone stem cell transplantation.",
    "This sample is a phase 2 clinical trial for patients with ovarian cancer, testing the combination of gleevec and paclitaxel as a treatment option. The eligibility criteria include age, histologically documented diagnosis, measurable disease, performance status, and adequate organ function. There are also exclusion criteria, such as recent anticancer treatment, cardiac problems, severe medical diseases, and certain medications that may interfere with gleevec.",
    "This sample is a phase 2 trial testing the drug ferric citrate for the treatment of hyperphosphatemia in patients with end-stage renal disease on hemodialysis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with metastatic colorectal cancer, testing the effectiveness of the drugs mitomycin c, capecitabine, and bevacizumab, with eligibility criteria including a histological diagnosis of colorectal cancer, measurable or non-measurable disease, and adequate bone marrow and hepatic function.",
    "This sample is a phase 2 trial for macular degeneration, testing the effectiveness of different types of verteporfin photodynamic therapy combined with bevacizumab, with the inclusion criteria being new wet AMD and no exclusion criteria specified.",
    "This sample is a phase 2 trial for asthma, testing the drugs mk0633 and placebo, with inclusion criteria including documented clinical history of chronic asthma symptoms and age range of 18-70 years, and exclusion criteria including history of kidney or chronic liver disease and recent history of heart problems.",
    "This sample is a phase 2 clinical trial for patients with colorectal cancer, testing the drug capecitabine. The eligibility criteria include confirmed colorectal cancer, measurable disease, age 70 and over, ECOG performance status 0-1, and various health requirements.",
    "This sample is a phase 1/phase 2 clinical trial for patients with primary Hepatocellular Carcinoma (HCC) using talaporfin sodium as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for rheumatoid arthritis, testing the effectiveness of a placebo drug in patients who meet specific inclusion criteria and do not meet certain exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed or resistant diffuse large B cell lymphoma, testing the effectiveness of azacytidine and vorinostat drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for osteoarthritis, testing the use of normal saline as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic melanoma, testing the drug temozolomide, and includes eligibility criteria such as histologically confirmed melanoma, stage IV disease, measurable disease, prior systemic therapy, and exclusion criteria such as life expectancy less than 4 months, known HIV positivity, and concurrent use of certain medications.",
    "This sample is a phase 2 clinical trial for patients with previously treated chronic lymphocytic leukemia (CLL), testing the effectiveness of cyclophosphamide, doxorubicin hydrochloride, prednisone, and vincristine sulfate in treating the disease. Eligibility criteria include specific disease characteristics and patient characteristics.",
    "This sample is a phase 2/phase 3 trial for patients with metastatic breast cancer and bone metastases, testing the effectiveness of zoledronic acid in improving outcomes. The eligibility criteria include having signed informed consent, being female and 18 years or older, having histologically confirmed invasive breast cancer with bone metastases, having an ECOG Performance Status of 0 to 2, and having a life expectancy of more than 3 months.",
    "This phase 2 trial is investigating the effectiveness of sorafenib tosylate and gemcitabine hydrochloride in treating locally advanced or metastatic adenocarcinoma of the pancreas, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 2 clinical trial for patients with recurrent or metastatic squamous cell carcinoma of the head and neck. The drug being tested is thalidomide, and the eligibility criteria include age 18 and over, specific performance status, and various medical requirements.",
    "This sample is a phase 2 clinical trial for mild to moderate Alzheimer's disease, testing the drugs azd1446 and placebo, with inclusion criteria including a history of progressive memory decline and treatment with donepezil, and exclusion criteria including allergies, other neurological diseases, and recent heart conditions.",
    "This sample is a phase 1/phase 2 trial for small cell lung cancer (SCLC) using the drugs pemetrexed and cisplatin, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the drug metformin, and includes eligibility criteria such as histologically confirmed cancer, age range, performance status, and normal organ function.",
    "This sample is a phase 2 clinical trial for patients with colorectal cancer, testing the effectiveness of capecitabine, fluorouracil, leucovorin calcium, and oxaliplatin in combination with radiotherapy for locally advanced or metastatic disease, with specific eligibility criteria for patients' disease characteristics and patient characteristics.",
    "This sample is a phase 2 trial for postmenopausal women with estrogen receptor and/or progesterone receptor positive invasive breast cancer, testing the efficacy of iressa in combination with arimidex and faslodex, with eligibility criteria including tumor size, organ function, and previous treatment history.",
    "This sample is a phase 2 trial testing the drug ag-013736 in patients with metastatic renal cell cancer, who are refractory to cytokine therapy and have undergone nephrectomy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with asthma, testing the drugs qaw039 and placebo, with inclusion criteria including a physician diagnosis of asthma, reversible airway obstruction, and a sputum eosinophil count \u2265 2% at screening. Exclusion criteria include use of other investigational drugs, history of hypersensitivity to study drugs, and recent lower respiratory tract infection.",
    "This sample is a phase 1/phase 2 trial for patients with lymphoma, specifically diffuse large cell B-cell NHL, who have failed prior systemic chemotherapy. The drug being tested is clofarabine, and the eligibility criteria include specific laboratory values, cardiac function, and understanding of the study. There are also exclusion criteria, such as previous treatment with clofarabine, history of T-cell lymphoma, and certain medical conditions.",
    "This sample is a phase 2 trial for patients with recurrent or stage IV melanoma, testing the drug 7-hydroxystaurosporine (UCN-01) to determine its efficacy and safety in treating the disease. The eligibility criteria include specific disease characteristics, prior treatment history, and various health parameters.",
    "This sample is a phase 2/phase 3 trial for rheumatoid arthritis patients, testing the effectiveness of rosuvastatin and placebo in reducing symptoms. The inclusion criteria include disease duration of over 5 years, positive RA latex serology or IgM RF ELISA, and specific joint counts and inflammatory markers. Patients on contraindicated medications will be excluded, as well as those with symptomatic vascular disease or contraindications to lipid-lowering therapy.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the drug LY2409021 and a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic breast cancer who have received prior chemotherapeutic regimens, and the drug being tested is E7389. The eligibility criteria include specific requirements for prior therapies, disease progression, measurable disease, and various health parameters.",
    "This sample is a phase 2 clinical trial for patients with metastatic melanoma, testing the effectiveness of chemotherapy with paclitaxel and carboplatin or temozolomide alone. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 2 trial for the treatment of idiopathic restless legs syndrome using the drug spm 962, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with histologically confirmed uterine carcinosarcoma, with eligibility criteria including stage III or IV disease, persistent or recurrent disease, and documented disease progression. The study will test the efficacy of carboplatin and paclitaxel as treatment options.",
    "The sample is a phase 2 clinical trial for patients with advanced non-small-cell lung cancer, testing the effectiveness of gefitinib, gemcitabine, and carboplatin as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with squamous cell carcinoma of the head and neck, testing the effectiveness of docetaxel, cisplatin, and 5-fu treatment followed by concomitant cisplatin, 5-fu, and radiotherapy, as well as concomitant cisplatin, 5-fu, and radiotherapy, as a treatment option. The eligibility criteria include specific tumor sites, stage of disease, previous treatment history, performance status, and various medical conditions.",
    "This sample is a phase 2 trial for the treatment of chronic obstructive pulmonary disease (COPD) using various drugs including placebo, td-4208, and ipratropium, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with newly diagnosed multiple myeloma, testing the drug thalidomide, and the eligibility criteria include age between 18 and 75 years old and measurable lesions.",
    "This sample is a phase 2 clinical trial for children with autism, Asperger's disorder, or pervasive developmental disorders, testing the drug DMSA for its effectiveness in reducing blood lead and/or blood mercury levels. The study has specific inclusion and exclusion criteria, and requires consent from legal guardians.",
    "This phase 2 trial is testing the effectiveness of lenalidomide and prednisone in treating patients with essential thrombocythemia, polycythemia vera, and primary myelofibrosis, who meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for the drug enzastaurin, targeting neoplasms and cancer, with specific eligibility criteria including previous participation in related studies, no other available therapy, measurable lesions, and certain pregnancy requirements.",
    "This sample is a phase 1/phase 2 trial for a vaccine enhancement patch targeting healthy adults, with inclusion criteria including age range and signed informed consent, and exclusion criteria including allergies to certain components, recent vaccinations, and comorbid conditions.",
    "This sample is a phase 2 clinical trial for patients with newly diagnosed primary invasive ductal breast adenocarcinoma, testing the drug cisplatin. The inclusion criteria include specific tumor stage and biomarker expression, while the exclusion criteria include no evidence of distant metastasis and certain medical conditions.",
    "This phase 2 trial is investigating the use of lovastatin in patients with breast cancer who have undergone lumpectomy and axillary nodal evaluation, and are planning to undergo radiotherapy, with specific eligibility criteria including negative surgical margins, no evidence of distant metastases, and no contraindication to an HMG-coA-reductase inhibitor.",
    "This sample is a phase 2 trial for chronic hepatitis B, testing the efficacy of drugs such as tenofovir disoproxil fumarate, emtricitabine/tenofovir disoproxil fumarate, and entecavir, with specific eligibility criteria including age, liver disease status, viral load, and negative serologies for HIV, HCV, and HDV.",
    "This phase 2 trial aims to evaluate the efficacy of vinorelbine oral formulation in patients with refractory breast, non-small cell lung, or prostate cancer who have previously received up to two chemotherapeutic regimens, and meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with colorectal cancer, testing the effectiveness of capecitabine, fluorouracil, leucovorin calcium, and oxaliplatin as combination chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with multiple myeloma and plasma cell neoplasm, testing the effectiveness of bortezomib, melphalan, and pegylated liposomal doxorubicin hydrochloride as treatment options, with specific eligibility criteria for patient selection.",
    "This phase 2 trial aims to investigate the effectiveness of baclofen and placebo in helping individuals who smoke at least 10 cigarettes per day for at least 6 months and are considering quitting smoking in the next 6 months, with various exclusion criteria such as certain medical conditions, alcohol or drug use disorders, and allergies to baclofen.",
    "This sample is a phase 2 trial for infants and children with confirmed HIV-1 infection, testing the effectiveness of saquinavir and ritonavir in combination with other antiretroviral drugs.",
    "This sample is a phase 2 clinical trial for patients with squamous cell carcinoma of the head and neck, testing the effectiveness of gemcitabine and oxaliplatin as treatment options, with specific eligibility criteria outlined.",
    "This sample is a phase 2 trial for patients with breast cancer, specifically recurrent or stage IV breast cancer, testing the effectiveness of paclitaxel and carboplatin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with stage IIIB or IV breast cancer, testing the drug ABT-751. The eligibility criteria include having recurrent tumor after or while on taxane therapy, being able to tolerate normal activities of daily living, and having adequate bone marrow, kidney, and liver function. Pregnant or breastfeeding individuals and those who have not received any anti-tumor therapy within 4 weeks of ABT-751 administration are excluded from the study.",
    "This sample is a phase 2 clinical trial for patients with metastatic or recurrent gastric cancer, testing the effectiveness of the drugs S-1 and LV, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with high-grade gliomas, testing the effectiveness of irinotecan hydrochloride as a treatment option. The eligibility criteria include having evidence of tumor progression, being over 18 years old, and having a Karnofsky performance status of at least 60.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic breast cancer, testing the effectiveness of lapatinib and everolimus as a treatment option. The eligibility criteria include specific disease characteristics, prior treatment history, and various health parameters.",
    "This sample is a phase 2 trial for patients with locally advanced or metastatic hereditary medullary thyroid carcinoma, testing the drug zd6474 (vandetanib) as a potential treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with hepatocellular carcinoma or liver cancer, testing the drugs bevacizumab (avastin) and erlotinib, with specific eligibility criteria including histologically confirmed carcinoma, measurable disease, and organ function requirements.",
    "This sample is a phase 2 trial for patients with acute myelogenous leukemia (AML) who have refractory or relapsed disease, and it involves the drugs cenersen, idarubicin, and cytarabine. The eligibility criteria include age greater than or equal to 18, certain laboratory values within normal limits, and the ability to comply with follow-up and management of toxicity.",
    "This sample is a phase 2 clinical trial that aims to evaluate the effectiveness of sirolimus and tacrolimus in stem cell transplantation for various diseases including acute myelogenous leukemia, graft versus host disease, acute lymphoblastic leukemia, chronic myelogenous leukemia, myelodysplastic syndromes, non-Hodgkin's lymphoma, and Hodgkin's disease. The eligibility criteria include specific disease stages, age range, performance status, and various health parameters.",
    "This sample is a phase 2 clinical trial for patients with relapsed or progressed esophageal and gastric adenocarcinoma, testing the drug sorafenib tosylate, with specific eligibility criteria including performance status, blood counts, liver function, and exclusion criteria such as cardiac disease, uncontrolled hypertension, and previous cancer.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndrome (MDS) and low or intermediate-1 risk IPSS. The study will test the effectiveness of lenalidomide and cyclosporine a in treating the disease, and includes eligibility criteria such as age, performance status, and laboratory test results.",
    "This sample is a phase 2 trial for hepatitis C, testing the drugs telaprevir, ribavirin, and pegylated interferon alfa 2a, with inclusion criteria requiring enrollment in specific control arms of previous studies.",
    "This sample is a phase 2 clinical trial for irritable bowel syndrome (IBS) patients, testing the drugs ast-120 and celphere\u00ae cp-305, with inclusion criteria including recurrent abdominal pain and exclusion criteria such as constipating IBS and major physical or psychiatric illness within the last six months.",
    "This sample is a phase 2 clinical trial for atopic dermatitis, testing the effectiveness of the drugs placebo and dupilumab in patients who have had an inadequate response to topical corticosteroids or calcineurin inhibitors.",
    "This sample is a phase 2 trial for postmenopausal women with newly diagnosed DCIS (breast carcinoma) and aims to evaluate the efficacy of tamoxifen and fulvestrant in treating the disease. The eligibility criteria include specific age groups, diagnostic requirements, and certain health parameters.",
    "This sample is a phase 2 clinical trial for patients with metastatic renal cell carcinoma, testing the effectiveness of sunitinib and bevacizumab drugs, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of the drugs panitumumab and cpt-11, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial for patients with end stage renal disease or renal transplant, testing the effectiveness of anti-thymocyte globulin, tol101, steroids, tacrolimus, and mycophenolate mofetil (mmf) as immunosuppressive medications, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for ovarian cancer, fallopian tube cancer, and peritoneal cancer, testing the effectiveness of bevacizumab, gemcitabine, and carboplatin as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 trial for the treatment of perianal high-grade squamous intraepithelial lesions (HSIL) in HIV-positive patients using cidofovir, with specific eligibility criteria and prior concurrent therapy requirements.",
    "This sample is a phase 2 trial for the treatment of chronic hepatitis C, testing the efficacy of pegylated interferon alfa-2a, placebo, and ribavirin in participants with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for asthma patients, testing the drug gw685698x, with eligibility criteria including age, gender, contraception use, asthma diagnosis, severity of disease, and current anti-asthma therapy.",
    "This sample is a phase 2 trial for patients with locally advanced or metastatic colorectal cancer who have received first-line therapy with FOLFOX or FOLFIRI plus bevacizumab, and it will test the efficacy of enzastaurin, placebo, leucovorin (lv), 5-fluorouracil (5-fu), and bevacizumab (bev) as treatment options.",
    "This sample is a phase 2 clinical trial for the treatment of postmenopausal osteoporosis using the drugs odanacatib and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with locally advanced, nonmetastatic pancreatic cancer, testing the effectiveness of capecitabine, oxaliplatin, and gemcitabine as treatment options, with specific eligibility criteria and patient characteristics outlined.",
    "This sample is a phase 2 clinical trial for rheumatoid arthritis, testing the drugs itacitinib and itacitinib placebo, with specific inclusion and exclusion criteria for subjects participating in the study.",
    "This sample is a phase 2 trial for patients with carcinoma of unknown primary site, testing the efficacy of paclitaxel, carboplatin, bevacizumab, and erlotinib as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 clinical trial for the treatment of influenza using nitazoxanide and placebo, with specific eligibility criteria including age, symptoms, confirmation of infection, and exclusion criteria such as severity of illness, high risk of complications, prior treatment with nitazoxanide, and other pre-existing chronic infections.",
    "This sample is a phase 2 trial for patients with asthma, testing the drugs qaw039, montelukast, and placebo. The eligibility criteria include a physician diagnosis of asthma, specific lung function values, and an Asthma Control Questionnaire score. Exclusion criteria include pregnancy, serious co-morbidities, and recent respiratory tract infections.",
    "This phase 2 trial aims to evaluate the effectiveness of the drug AEGR-733 in treating hyperlipidemia, with eligibility criteria including LDL-C levels between 100 and 190 mg/dL and hepatic fat under 6.2% per MRS, while excluding individuals with certain medical conditions and those who have been exposed to AEGR-733 in the past 12 months.",
    "This sample is a phase 2 trial for patients with schizophrenia, testing the efficacy of inhaled loxapine as a treatment for agitation, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with gastrointestinal stromal tumors (GIST), testing the effectiveness of perifosine and imatinib mesylate drugs in treating advanced GIST that has progressed on imatinib therapy.",
    "This sample is a phase 2 trial for the treatment of chronic obstructive pulmonary disease (COPD) using the drug gsk233705 at various doses, including a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with glioblastoma multiforme, testing the effectiveness of temozolomide and sorafenib as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for major depressive disorder, testing the effectiveness of tc-5214 + citalopram and placebo + citalopram as treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with non-small cell lung cancer, testing the effectiveness of carboplatin, erlotinib hydrochloride, and paclitaxel as combined modality therapy, with specific eligibility criteria for patients' disease characteristics and patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of bortezomib, placebo, and dexamethasone as treatments. The inclusion criteria include measurable secretory disease, disease progression after prior therapy, ECOG performance status score of 2 or less, and adequate bone marrow, liver, and renal function. The exclusion criteria include no prior treatment with bortezomib, not refractory to high-dose dexamethasone, not having grade 2 peripheral neuropathy, not having received an allogeneic bone marrow or peripheral blood stem cell transplant, and no prior or concomitant malignancy except for specific exceptions.",
    "This sample is a phase 2 trial for patients with prostate cancer that is unresponsive to hormone therapy, and it involves the drugs mitoxantrone and prednisone. The eligibility criteria include having radiographic evidence of metastatic prostate cancer, disease progression while receiving docetaxel, and a PSA level of at least 2 ng/mL.",
    "This sample is a phase 2/phase 3 trial testing the drug atorvastatin in patients with advanced cancers, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with small cell lung cancer, testing the drug sorafenib, with specific inclusion and exclusion criteria, and excluding certain therapies and medications.",
    "This sample is a phase 2 trial for patients with congestive heart failure (CHF) using the drug ditpa. The eligibility criteria include being a veteran, having moderately severe CHF, being 18 or older, and not having certain medical conditions or allergies.",
    "This sample is a phase 1/phase 2 clinical trial for patients with Malignant Pleural Mesothelioma (MPM), testing the effectiveness of carboplatin, bevacizumab, and pemetrexed as a treatment option. The eligibility criteria include specific disease diagnosis, measurable disease, performance status, renal and hepatic function, bone marrow function, and prior surgical procedures. Exclusion criteria include hypercalcemia, history of hemoptysis or thrombosis, ongoing unstable angina, congestive heart failure, recent surgical procedures, pregnancy or lactation, and inability to comply with study procedures. Adequate renal, hepatic, and bone marrow function are also required.",
    "This sample is a phase 2 trial for metastatic breast cancer, testing the efficacy of different drug combinations (ixabepilone + bevacizumab, paclitaxel + bevacizumab) in previously untreated patients, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with vision-threatening autoimmune uveitis, testing the drug apremilast as a potential treatment option for those who have failed to respond to prednisone and other systemic immunosuppressive medications.",
    "This sample is a phase 2 trial for patients with metastatic adenocarcinoma of the colon and/or rectum, testing the effectiveness of xelox, xeliri, and bevacizumab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 2 trial aims to evaluate the efficacy of vicriviroc and emtricitabine and tenofovir disoproxil fumarate in treating CCR5-tropic HIV infection, with specific eligibility criteria including a CD4 cell count of at least 100 cells/(cubic mm) and a minimum HIV RNA level of 2000 copies/mL.",
    "This sample is a phase 2 trial for patients with end stage renal disease and anemia, testing the drugs fg-4592 and epoetin alfa, with specific eligibility criteria including age, hemoglobin ranges, and previous epoetin alfa dose requirements.",
    "This sample is a phase 2 trial for essential hypertension, testing the effectiveness of various drugs including placebo, lercanidipine, and enalapril, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), testing the combination of panobinostat with rituximab as a potential treatment option. The eligibility criteria include having more than one line of prior chemotherapy and excluding patients currently receiving anticancer therapy or investigational agents, those with major surgery within the last 4 weeks, known leptomeningeal or brain metastases, HIV infection, uncontrolled infections, history of another malignancy (except for non-melanoma skin cancer or in situ cervical or breast cancer) unless disease-free for at least 3 years, hepatitis B or C positive, GI disease, pregnant or breastfeeding, and prior treatment with an HDAC inhibitor including valproic acid.",
    "This sample is a phase 2 clinical trial for the drug ataluren in patients with cystic fibrosis, testing its efficacy based on various inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for the drug ro5024048 in patients with chronic hepatitis C virus infection, genotype-1, who are treatment-naive or have previously been treated with interferon. The eligibility criteria include specific disease diagnosis, HCV RNA measurement, liver biopsy, and various health parameters.",
    "This sample is a phase 2 trial for patients with potentially resectable pancreatic cancer, testing the combination of gemcitabine and erlotinib as adjuvant therapy after surgery, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for painful bladder syndrome and interstitial cystitis, testing the drugs urg101 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with stage IV breast cancer, testing the effectiveness of capecitabine and cyclophosphamide as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with extensive stage or recurrent lung small cell carcinoma, testing the efficacy of carboplatin, cisplatin, etoposide, and sunitinib malate as treatment options, with specific eligibility criteria including histologically or cytologically documented small cell lung cancer, measurable disease, no prior chemotherapy for SCLC, completed radiation therapy, and specific performance status and cardiac health requirements.",
    "This sample is a phase 2 clinical trial for patients with pancreatic cancer, testing the drug triapine. The eligibility criteria include having unresectable, locally advanced, or metastatic disease, no prior chemotherapy except for gemcitabine-containing regimens, and meeting certain health requirements.",
    "This sample is a phase 2 clinical trial for pancreatic cancer patients who have failed prior chemotherapy, and it aims to evaluate the efficacy of the drug MKC-1 in treating the disease. The inclusion criteria include having confirmed pancreatic cancer, measurable disease, and specific laboratory results, while the exclusion criteria include pregnancy, central nervous system metastases, and certain medical conditions.",
    "This phase 2 trial is investigating the use of paclitaxel in patients with various types of non-small cell lung cancer, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, who have not received prior chemotherapy or biologic therapy for their lung cancer.",
    "This sample is a phase 2 trial for patients with non-Hodgkin's lymphoma, testing the drug lbh589, and includes eligibility criteria such as specific laboratory values, cardiac function requirements, and exclusion criteria for certain medical conditions and medications.",
    "This sample is a phase 2 clinical trial for patients with malignant mesothelioma, testing the combination of valproate plus doxorubicin as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for previously untreated CD20-positive diffuse large B-cell lymphoma, testing the effectiveness of obinutuzumab, cyclophosphamide, doxorubicin, prednisone, and vincristine as a treatment regimen. The eligibility criteria include specific disease stage, measurable lesions, performance status, and adequate hematologic function.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer and malignant pleural effusion, testing the effectiveness of paclitaxel, carboplatin, and irinotecan as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for obsessive-compulsive disorder (OCD) using the drug minocycline, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for the treatment of chronic obstructive pulmonary disease (COPD) using the drugs gsk573719 and tiotropium, with specific inclusion and exclusion criteria for subjects, including age, smoking history, lung function, and allergies.",
    "This sample is a phase 2 clinical trial for patients with locally recurrent or Stage IV breast cancer, testing the efficacy of eribulin, a chemotherapy drug, in patients who have received prior treatment with anthracyclines and taxanes. The eligibility criteria include specific disease characteristics, prior treatment history, and overall health status.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory B-cell non-Hodgkin lymphoma, testing the effectiveness of the drugs velcade and temsirolimus. The eligibility criteria include specific disease types, measurable tumor mass, previous treatment history, and certain laboratory values. Exclusions include recent therapy, stem cell transplant, and certain medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for advanced breast cancer and advanced malignant solid tumors, testing the drugs HKI-272 and paclitaxel, with specific inclusion and exclusion criteria for each part of the trial.",
    "This sample is a phase 2 clinical trial for patients with recurrent glioblastoma, testing the drug PLX3397, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with cutaneous t-cell lymphoma, testing the drug lbh589, an HDAC inhibitor, for those who have had disease progression or an inadequate response to previous HDAC inhibitor treatment.",
    "This sample is a phase 1/phase 2 trial for patients with multiple myeloma, testing the drugs doxil, melphalan, and bortezomib, with eligibility criteria including previous diagnosis of multiple myeloma, progressive disease, and specific patient characteristics.",
    "This sample is a phase 2 clinical trial for psoriasis, testing the drug navarixin 10 mg, with eligibility criteria including a BMI of 19 to 34, a diagnosis of psoriasis vulgaris, and specific requirements for target lesion size and severity.",
    "This sample is a phase 2 trial for contraception, testing the effectiveness of different levonorgestrel intrauterine systems (IUS) in women who are in need of contraception, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with sepsis and bacterial infections, testing the drugs placebo and biap, with specific eligibility criteria including age, infection, systemic inflammation, and acute renal failure.",
    "This sample is a phase 2 clinical trial for the treatment of dry eye, using the drugs de-089 ophthalmic solution and placebo ophthalmic solution, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for advanced and metastatic breast cancer patients, testing the effectiveness of fulvestrant in postmenopausal women who have not responded to previous hormonal treatments. The eligibility criteria include specific requirements for previous treatments and exclude patients with certain serious diseases or conditions.",
    "This sample is a phase 2 clinical trial that aims to test the drug nb32 in individuals with nicotine dependence, overweight, and obesity, who are motivated to quit smoking and concerned about weight gain after quitting. The study has specific inclusion and exclusion criteria, and participants must be 18 to 65 years old, have a BMI between 27 and 45kg/m2, and have smoked at least 10 cigarettes per day in the past year.",
    "This sample is a phase 2 clinical trial for patients with metastatic kidney cancer, testing the drug perifosine. The eligibility criteria include having documented progression on treatment with sunitinib or sorafenib, having at least one measurable lesion, normal organ and marrow function, ECOG performance status of 0 or 1, stable CNS metastases, and a life expectancy of at least 6 months. Exclusion criteria include not having recovered from adverse events from prior therapy, currently receiving sorafenib or sunitinib, known hypersensitivity to perifosine, pregnancy or breastfeeding, and unwillingness or inability to comply with the protocol.",
    "This sample is a phase 2/phase 3 trial for patients with recurrent follicular lymphoma, testing the efficacy of cyclophosphamide and rituximab, filgrastim, non-myeloablative conditioning regimen, rituximab maintenance therapy, and gvhd prophylaxis, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the drug firategrast in patients with multiple sclerosis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for lung cancer patients, testing the drug IPI-504, a known Hsp90 inhibitor, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for breast cancer patients, testing the drugs docetaxel and epirubicin hydrochloride, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for breast cancer patients with locally advanced or metastatic disease, testing the effectiveness of amg 479 or placebo administered with either exemestane or fulvestrant as endocrine therapy. The eligibility criteria include confirmation of hormone receptor positive disease status and disease progression while receiving prior endocrine therapy.",
    "This sample is a phase 2 trial for patients with metastatic renal cell carcinoma or renal cell carcinoma with sarcomatoid features, testing the effectiveness of doxorubicin, gemcitabine, g-csf, and neulasta as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This phase 2 trial aims to evaluate the efficacy of lapatinib and letrozole in postmenopausal patients with ER and/or PgR positive breast cancer, while excluding patients with stage IIIB, IIIC, or inflammatory breast cancer, stage IV breast cancer, contraindications to letrozole, prior treatment with chemotherapy, endocrine therapy or radiotherapy, and other specific criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer and brain metastases, testing the drug sunitinib, with specific inclusion and exclusion criteria related to brain lesions and prior treatments.",
    "This sample is a phase 1/phase 2 trial for patients with hematological malignancies who have undergone allogeneic stem cell transplantation, and it aims to evaluate the efficacy of rituximab in preventing chronic graft-versus-host disease (GVHD) following transplantation.",
    "This sample is a phase 2/phase 3 trial testing the effectiveness of trazodone and placebo in treating depression, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the effectiveness of empagliflozin (high and low doses) compared to placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for systemic lupus erythematosus (SLE) patients experiencing an active lupus flare in certain organ systems, testing the effectiveness of abatacept, placebo, and prednisone as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with poor prognosis acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), testing the drug ag-013736 (axitinib) as an anti-angiogenesis agent, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for tuberculosis and HIV infections, testing the effectiveness of nevirapine based therapy, efavirenz based therapy, and rifampicin (rmp) ethambutol (e) isoniazid (h) pyrazinamid (z) in patients with CD4 cell count < 250 cell/mm3 and who are na\u00efve of HAART. The study has specific inclusion and exclusion criteria, including age, TB treatment history, and pregnancy status.",
    "This sample is a phase 2 trial for the drug gw856553 in patients with rheumatoid arthritis, with specific eligibility criteria including a diagnosis of RA according to ACR criteria, DAS28 \u2265 4.2, and liver function tests within normal range.",
    "This sample is a phase 2 clinical trial for patients with melanoma, testing the drug vemurafenib. The eligibility criteria include age, histologic proof of melanoma, specific genetic mutations, stage of melanoma, measurable disease, performance status, ability to swallow pills, and adequate hematologic, hepatic, and renal function. Exclusion criteria include uveal melanoma, concurrent chemotherapy, immunotherapy, or radiotherapy, prior treatment with a RAF inhibitor, pregnancy or lactation, second active malignancy, and QTc interval > 500 msec.",
    "This sample is a phase 2 clinical trial for bladder cancer, testing the effectiveness of methotrexate, vinblastine, doxorubicin, cisplatin, and gemcitabine as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 1/phase 2 trial for patients with advanced non-small cell lung cancer, testing the drugs docetaxel and npi-2358 + docetaxel, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for relapsing-remitting multiple sclerosis, testing the effectiveness of interferon beta-1b group and interferon beta-1b/atorvastatin group drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with leukemia or myelodysplastic syndromes, testing the drug cytarabine. The eligibility criteria include specific disease characteristics, patient characteristics, and restrictions on prior and concurrent therapy.",
    "This sample is a phase 2 clinical trial for patients with diffuse large B-cell lymphoma, testing the effectiveness of dasatinib, an oral medication, as a treatment option for those who have relapsed or are refractory to previous therapy. The eligibility criteria include having measurable disease, a certain performance status score, and adequate organ function.",
    "This sample is a phase 2 clinical trial for patients with unresectable Stage III or Stage IV Malignant Melanoma, testing the drug zk-epo, with specific eligibility criteria including adequate organ function and exclusion criteria such as prior treatment with certain drugs or more than 2 previous chemotherapy regimens.",
    "This sample is a phase 2 clinical trial for non-alcoholic fatty liver disease, testing the drugs placebo and oltipraz, with inclusion criteria including patients over 18 with the disease, and exclusion criteria including certain liver disorders, previous medication use, and various other medical conditions.",
    "This sample is a phase 2 trial for breast cancer patients, testing the combination of letrozole and bevacizumab, with specific eligibility criteria including postmenopausal females with certain tumor characteristics and organ function, and excluding patients with certain medical conditions or prior treatments.",
    "This sample is a phase 2 trial for patients with refractory or relapsed CD22+ acute lymphoblastic leukemia, testing the efficacy of epratuzumab, fludarabine, cyclophosphamide, mesna, and interleukin-2 in combination with allogeneic hematopoietic stem cell transplant. The eligibility criteria include specific disease diagnosis, performance scale requirements, adequate organ function, negative pregnancy test, and specific donor requirements.",
    "This sample is a phase 2 trial for patients with stage IV pancreatic cancer, testing the drug capecitabine, and requiring specific disease characteristics and patient characteristics for eligibility.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the efficacy of taspoglutide and placebo as potential treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with lung cancer, testing the effectiveness of biricodar dicitrate, doxorubicin hydrochloride, and vincristine sulfate as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a clinical trial for patients with metastatic prostate cancer, testing the drug 2-deoxyglucose in both Phase I and Phase II, with specific eligibility criteria including disease progression, age, performance status, previous therapy, and various laboratory values.",
    "This sample is a phase 2 trial for the treatment of benign prostatic hyperplasia using normal saline, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for major depressive disorder, testing the drugs tasimelteon and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with advanced non-small cell lung cancer (NSCLC) who are not eligible for curative treatment or treatment with bevacizumab. The trial will test the effectiveness of carboplatin and paclitaxel albumin-stabilized nanoparticle formulation as a treatment option.",
    "This sample is a phase 2 trial investigating the use of multiple drugs, including tranexamic acid, for patients undergoing CABG surgery, with specific inclusion and exclusion criteria. The trial focuses on patients with bleeding disorders and requires written informed consent.",
    "This sample is a phase 2 trial testing the combination of irinotecan plus capecitabine in Asian patients with inoperable hepatocellular carcinoma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with chronic hepatitis C, testing the efficacy of nitazoxanide, ribavirin, and peginterferon-alfa-2a in combination therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for allergic rhinitis, testing the efficacy of house dust mites allergen extract tablets and placebo tablets, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with metastatic pancreatic adenocarcinoma, testing the efficacy of imexon in combination with gemcitabine compared to a placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for postmenopausal patients with newly diagnosed metastatic breast cancer, testing the drugs gefitinib and anastrozole, with specific inclusion and exclusion criteria.",
    "In this sample, the phase 2 trial is testing the effectiveness of daclatasvir, peginterferon alfa-2a, and ribavirin in treating chronic hepatitis C infection, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of neuropathic pain due to lumbosacral radiculopathy, with the drugs being placebo and gs856553, and the eligibility criteria including age, diagnosis, pain duration, and stable pain intensity.",
    "This sample is a phase 2 clinical trial for patients with cutaneous metastatic melanoma, testing the drug GSK2118436, a BRAF mutation-positive inhibitor, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for Hodgkin's disease, testing the drugs prednisone, vinblastine, doxorubicin, and gemcitabine, with specific eligibility criteria for patients aged 60 to 75 years.",
    "This sample is a phase 2 trial for patients with colon or colorectal cancer, testing the effectiveness of sir-spheres agent administration, cetuximab, and irinotecan as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for HIV infections, testing the efficacy of vicriviroc maleate and placebo in adult subjects with specific eligibility criteria, including prior therapy with antiretroviral agents and genotypically documented resistance mutations.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer that is progressive after androgen deprivation. The study will test the effectiveness of ketoconazole, lenalidomide, and therapeutic hydrocortisone as potential treatments for the disease.",
    "This sample is a phase 2 trial for patients with locally advanced or metastatic breast cancer, testing the drugs azd8931, anastrozole, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for sepsis, testing the effectiveness of simvastatin and an identical-appearing placebo in hospitalized patients, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic pancreatic cancer, testing the effectiveness of bevacizumab, gemcitabine, and oxaliplatin as treatment options, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial testing the drug cetuximab for the treatment of unresectable or metastatic esophageal or gastric adenocarcinoma, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with major depressive disorder, testing the drugs gw597599b and paroxetine, with inclusion criteria requiring patients to meet the diagnosis of MDD and exclusion criteria including patients with a primary diagnosis other than MDD, a history of schizophrenia or bipolar affective disorder, and patients receiving formal psychotherapy or cognitive/behavioral therapy concurrently or in the 12 weeks prior to screening visit.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the drugs ttp054 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with HER2 overexpressing metastatic breast cancer, testing the combination of rapamycin and trastuzumab as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for irritable bowel syndrome (IBS) with the drugs placebo and bms-562086, and the inclusion criteria include female subjects with D-IBS symptoms based on Rome II criteria and the Bowel Disease Questionnaire.",
    "This sample is a phase 2 trial for patients with lymphoma, specifically mycosis fungoides or Sezary syndrome, who have failed prior systemic therapy. The drug being tested is temozolomide, and the eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with previously untreated Grade I-II follicular B-cell non-Hodgkin's lymphoma, testing the drugs at-101 and rituximab, with eligibility criteria including specific disease stage, FLIPI score, performance status, hematological and hepatic/renal function.",
    "This sample is a phase 2 clinical trial for ovarian and endometrial cancer patients, testing the drug MKC-1. The eligibility criteria include having failed prior chemotherapy regimens, having measurable disease, and meeting certain laboratory result requirements. The exclusion criteria include recent administration of cancer therapy, significant bowel obstruction, and serious cardiac conditions.",
    "This sample is a phase 1/phase 2 trial for breast neoplasms, testing the drugs exemestane and sunitinib malate in postmenopausal patients with unresectable, locally recurrent, or metastatic disease, who are estrogen and/or progesterone receptor positive, and meet other eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with acute lymphoblastic leukemia (ALL), testing the effectiveness of a combination of drugs including cyclophosphamide, cytarabine, dexamethasone, and others, with specific eligibility criteria for patients and restrictions on prior and concurrent therapies.",
    "This sample is a phase 2 trial for pancreatic cancer patients, testing the drugs S-1 and gemcitabine hydrochloride, with specific eligibility criteria and exclusion criteria, including the prohibition of certain concomitant drugs.",
    "This sample is a phase 2 clinical trial for patients with supratentorial malignant primary gliomas, specifically glioblastoma multiforme and glioma, testing the effectiveness of thalidomide and cpt-11 drugs in combination therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with stage IIIB non-small cell lung cancer, testing the effectiveness of cisplatin and docetaxel as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and restrictions on prior concurrent therapy.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of various doses of the drug nva237 and a placebo in improving symptoms and lung function. The eligibility criteria include age, COPD diagnosis, smoking history, lung function measurements, and symptom severity.",
    "This sample is a phase 2 trial for patients aged 50 or older with subfoveal choroidal neovascularization (CNV) secondary to age-related maculopathy (AMD), testing the drug dexamethasone. The inclusion criteria include visual acuity between 20/40 and 20/400 in the study eye, while the exclusion criteria include recent intraocular surgery, glaucoma, cataract, high eye pressure, and uncontrolled systemic disease.",
    "This sample is a phase 2 trial for patients with non-small-cell lung carcinoma, testing the drug cetuximab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with myelodysplastic syndrome (MDS) using a combination of decitabine, arsenic trioxide, and ascorbic acid as treatment. The eligibility criteria include having an established diagnosis of MDS, specific performance status, and being transfusion dependent.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the drug pixantrone dimaleate. The eligibility criteria include prior treatment with anthracycline and/or taxane, measurable disease, specific laboratory values, and a performance status of 0, 1, or 2. Exclusion criteria include pregnancy, HER2 positive breast cancer, prior cumulative treatment with doxorubicin, and active brain metastasis.",
    "This sample is a phase 2 trial for adult acute myeloid leukemia patients, testing the effectiveness of busulfan, cytarabine, daunorubicin hydrochloride, decitabine, and etoposide as treatment options, with specific eligibility criteria for enrollment.",
    "This phase 2 trial aims to evaluate the efficacy of gemcitabine in treating patients with metastatic pancreatic cancer, with specific eligibility criteria including histologically or cytologically documented stage IV ductal adenocarcinoma of the pancreas, Eastern Cooperative Oncology Group (ECOG) performance status \u2264 2, and adequate hematologic, renal, and hepatic function.",
    "This sample is a phase 2 clinical trial for patients with squamous cell carcinoma of the head and neck, testing the drug everolimus 10mg daily, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with dermatofibrosarcoma protuberans (DFSP) or transformed fibrosarcomatous DFSP, testing the drug imatinib mesylate. The eligibility criteria include having measurable disease, submitting pathology materials for review, and meeting certain blood count and liver function requirements. Patients must not have had chemotherapy or investigational agents within 28 days prior to registration, and prior radiotherapy is allowed if certain conditions are met. Patients with known CNS metastases, pregnant or nursing women, and patients with other prior malignancies are not eligible.",
    "This sample is a phase 2 clinical trial for the treatment of major depressive disorder (MDD) using the drug rx-10100, with inclusion criteria including moderate to severe MDD and exclusion criteria such as pregnancy, psychotic disorders, anxiety disorders, and significant suicidality.",
    "This sample is a phase 2 clinical trial for breast cancer patients with specific criteria, including histologically confirmed adenocarcinoma, HER2 gene amplification, and normal cardiac function. The trial will test the effectiveness of nab-paclitaxel, bevacizumab, and trastuzumab as treatment options.",
    "This sample is a phase 2 clinical trial for patients with chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia who are resistant or intolerant to imatinib, and it is testing the drug dasatinib as a potential treatment option.",
    "This sample is a phase 2 clinical trial for the treatment of pulmonary arterial hypertension (PAH) using iloprost inhalation solution (Ventavis), with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the combination of eribulin mesylate and erlotinib as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with relapsed or refractory lymphoma, including follicular lymphoma, mantle cell lymphoma, and chronic lymphocytic leukemia. The study will test the effectiveness of the drugs bortezomib, cyclophosphamide, and dexamethasone in treating these diseases. The eligibility criteria include histological confirmation of the diseases, measurable disease, expected survival of more than 3 months, and specific laboratory values within normal ranges.",
    "This sample is a phase 2 clinical trial for breast cancer patients, testing the drug lovastatin, with specific eligibility criteria including genetic mutations, family history, and normal organ function.",
    "This sample is a phase 2 clinical trial for patients with ulcerative colitis, testing the drugs lt-02 and placebo. The eligibility criteria include having proven ulcerative colitis, active disease with bloody diarrhea, and an inadequate response to mesalazine treatment.",
    "This sample is a phase 2 clinical trial for breast cancer patients with specific criteria, including non-metastatic disease, HR negative and HER2 negative status, and clinical stage II and IIIa. The study will evaluate the efficacy of cetuximab and docetaxel as treatment options.",
    "This sample is a phase 2 trial for kidney transplantation patients, testing the drugs AEB071 and mycophenolic acid plus tacrolimus, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic melanoma and a BRAF V600E mutation, testing the drug RO5185426, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with advanced melanoma not responding to 1st line chemotherapy, testing the drug 852a, with inclusion criteria including measurable disease, ECOG performance status less than or equal to 2, and normal organ and bone marrow function, and exclusion criteria including stage IV disease previously progressed during interferon treatment, brain metastases, and concurrent malignancies.",
    "This sample is a phase 2 clinical trial that aims to evaluate the efficacy of reparixin continuous infusion and reparixin intermittent infusion in reducing the risk of delayed graft function (DGF) in patients undergoing renal transplantation from non-living donors with brain death. The study includes patients with end-stage renal disease (ESRD) who are at risk of developing DGF and are planned to receive induction with steroids and mycophenolate mofetil (MMF) or mycophenolic acid plus biological induction. The eligibility criteria and exclusion criteria are also provided.",
    "This sample is a phase 1/phase 2 trial for patients with mantle cell lymphoma, testing the effectiveness of temsirolimus and bendamustine drugs in patients who are not eligible for high dose chemotherapy with auto-SCT or allo-SCT. The eligibility criteria include age 18 or older, specific disease classification, previous treatment history, adequate bone marrow function, and measurable disease. Exclusion criteria include prior treatment with any m-TOR inhibitor, unstable or severe uncontrolled medical conditions, abnormal liver and renal function, previous malignancy, concurrent treatment with certain medications, pregnancy or breastfeeding, recent surgery or therapy with investigational agents, and other specific conditions.",
    "This sample is a phase 2 clinical trial for gastric cancer, testing the effectiveness of docetaxel, doxorubicin hydrochloride, fluorouracil, and hydroxyurea as treatment options, with specific eligibility criteria for patients.",
    "This sample is a phase 2 trial for major depression, testing the drugs du125530 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for patients with venous thrombosis, testing the drugs pd 0348292 and enoxaparin, with specific inclusion and exclusion criteria related to the patients' medical history.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the drug pemetrexed. The eligibility criteria include specific disease stage, weight loss, lung function, and consent requirements.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the effectiveness of sitagliptin, metformin, and placebo in managing blood glucose levels, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial is investigating the efficacy of carboplatin, paclitaxel, and cdp791 in treating male and female subjects with Stage IIIb or IV non-squamous non-small-cell lung cancer, who have an ECOG performance status of 0 or 1 and a life expectancy of at least three months.",
    "This sample is a phase 2 clinical trial that focuses on patients with various hematological diseases such as chronic myeloproliferative disorders, graft versus host disease, leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, and myelodysplastic syndromes. The trial aims to evaluate the effectiveness of cyclophosphamide, cyclosporine, and methylprednisolone in treating these diseases. The eligibility criteria include specific disease characteristics and patient characteristics such as age, performance status, and various health parameters.",
    "This sample is a phase 2 trial for patients with chronic lymphocytic leukemia, testing the drug mgcd0103, with specific inclusion and exclusion criteria, including prior treatment failure with fludarabine and Rituxan, age 18 or greater, ECOG performance status of 0 or 1, and specific laboratory requirements.",
    "This sample is a phase 2 clinical trial for patients with recurrent or metastatic renal cell carcinoma, testing the efficacy of tivozanib (av-951) compared to a placebo comparator, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the effectiveness of pioglitazone, a drug used to treat diabetes, in patients with major depressive disorder and metabolic syndrome. The eligibility criteria include being between the ages of 18 and 70, having a diagnosis of major depressive disorder, and meeting the criteria for metabolic syndrome.",
    "This sample is a phase 2 clinical trial for acute schizophrenia, testing the drug \"ir (immediate-release) quetiapine fumarate\" in patients aged 18 to 65, with specific inclusion and exclusion criteria.",
    "In this phase 2 trial, the drug fesoterodine fumarate is being tested for its effectiveness in treating overactive bladder symptoms, with the inclusion criteria being adult patients with OAB symptoms and the exclusion criteria including known hypersensitivity to the drug or any excipients, neurological diseases influencing bladder function, and complications of lower urinary tract pathology potentially responsible for urgency or incontinence.",
    "This sample is a phase 2 clinical trial for asthma patients, testing the effectiveness of fluticasone furoate and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with gastroesophageal reflux disease (GERD) who have not responded to previous treatment, and it aims to evaluate the effectiveness of the drugs ast-120 and celphere cp-305 in improving symptoms. The inclusion criteria include specific weight range, history of GERD symptoms, abnormal bilirubin level, normal esophageal pH value, and other factors. The exclusion criteria include concurrent GI or other pathology, cancer or chemotherapy treatment, history of upper GI surgery, and other factors.",
    "This sample is a phase 2 trial for glioblastoma multiforme, testing the drugs enzastaurin 500mg once daily and enzastaurin 250mg twice daily, with eligibility criteria including newly diagnosed GBM, unmethylated MGMT-promotor, and availability of tumor tissue specimens for analysis.",
    "This sample is a phase 2 clinical trial for patients with newly diagnosed, limited stage small cell lung cancer (SCLC). The study aims to evaluate the effectiveness of topotecan, an oral medication, in treating SCLC. The inclusion criteria include having no prior radiotherapy, being able to take oral medication, and having adequate bone marrow reserve and kidney/liver function. The exclusion criteria include extensive stage SCLC, pregnancy/lactation, recent use of investigational drugs, and severe medical problems unrelated to SCLC.",
    "This sample is a phase 2 clinical trial for previously untreated indolent nonfollicular non-Hodgkin's lymphoma, testing the effectiveness of rituximab in adult patients with active disease and at least 3 involved sites, with exclusion criteria including chronic lymphocytic leukemia, other malignancies within 3 years, systemic corticosteroid use, significant cardiovascular disease, central nervous system involvement, and hepatitis B or C virus infection, or HIV infection.",
    "This sample is a phase 2/phase 3 trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of drugs such as indacaterol, formoterol, and tiotropium, as well as placebos, in improving lung function. The study has specific inclusion and exclusion criteria, including age, smoking history, lung function measurements, and the absence of certain medical conditions.",
    "This phase 2 trial is testing the efficacy of cofactor, 5-fu, and leucovorin in treating surgically incurable, confirmed metastatic colon or rectal adenocarcinoma patients who meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 clinical trial for psoriasis, testing the effectiveness of hat1 topical solution and calcipotriol in patients with a psoriasis area and severity index (PASI) score between 3 and 12, who have not received systemic or topical immunosuppressive treatment within 4 weeks prior to enrollment.",
    "This sample is a phase 2 clinical trial for patients with refractory chronic lymphocytic leukemia, testing the drug sorafenib tosylate, and includes eligibility criteria such as specific disease stages, symptoms, and blood count levels.",
    "This sample is a phase 2 clinical trial for major depressive disorder, testing the drugs placebo, ro4917523 0.5 mg, and ro4917523 1.5 mg, with inclusion criteria including age, specific diagnosis, inadequate response to current treatment, and body mass index range, and exclusion criteria including current or previous use of certain treatments, history of bipolar disorder, and pregnancy or lactation.",
    "This sample is a phase 2/phase 3 trial for glaucoma patients requiring first-time filtering surgery, testing the drugs ranibizumab and mitomycin (mmc), with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for melanoma, testing the drugs intetumumab, dacarbazine, and placebo, with eligibility criteria including confirmed melanoma, specific stages of the disease, measurable disease or skin lesions, and prior chemotherapy history.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of fluorouracil, irinotecan hydrochloride, and leucovorin calcium as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for adult acute lymphoblastic leukemia in remission, testing the effectiveness of a combination of drugs including imatinib mesylate, methotrexate, vincristine sulfate, leucovorin calcium, tacrolimus, etoposide, cyclophosphamide, and cytarabine, with specific eligibility criteria for patients who have achieved remission following induction chemotherapy.",
    "This sample is a phase 2 trial for the drug pazopanib in patients with macular degeneration, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the drug \"gsk573719\" in patients with chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria, including age, smoking history, lung function, and medical history.",
    "This sample is a phase 2 clinical trial for osteoarthritis of the knee, testing the effectiveness of the drug grt6005 and a matching placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for the treatment of type 2 diabetes using the drug dio-902, with specific eligibility criteria including a diagnosis of type 2 diabetes for at least 6 months, stable metformin treatment, and specific HbA1C and C-peptide levels.",
    "This sample is a phase 2 trial for the treatment of hepatitis C, using the drugs sof, peg, and rbv, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with chronic lymphocytic leukemia (CLL) who have not received prior treatment. The study will test the effectiveness of the drug combination of ofatumumab and bendamustine in treating CLL. The eligibility criteria include age, diagnosis of CLL, need for chemotherapy, and specific health requirements.",
    "This sample is a phase 2 trial testing the effectiveness of interferon-alpha lozenges and placebo lozenges in patients with chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis. The inclusion criteria include a history of chronic cough and specific age and smoking history requirements. The exclusion criteria include ACE inhibitor use, GERD, and a history of lung cancer.",
    "This sample is a phase 2 trial for patients with intermediate or high grade locally advanced or metastatic soft tissue sarcoma, testing the effectiveness of Avastin and doxorubicin as treatment options, with specific eligibility criteria including normal renal and hepatic function, normal blood counts, and a performance status of 0-1 on the ECOG scale.",
    "This sample is a phase 2 clinical trial for patients with small cell lung cancer and carcinoma, small cell. The drug being tested is topotecan, and the eligibility criteria include having extensive lung cancer with progression after previous chemotherapy, measurable or evaluable disease, and adequate organ function.",
    "This sample is a phase 2 clinical trial for narcolepsy, testing the drugs adx-n05 and placebo, with inclusion criteria including a diagnosis of narcolepsy and good general health, and exclusion criteria including pregnancy, history of significant medical conditions or psychiatric disorders, and excessive caffeine or alcohol/drug use.",
    "This sample is a phase 2 trial for patients with epilepsy who have uncontrolled partial seizures, and it aims to test the effectiveness of the drug e2007 compared to a placebo in reducing the frequency of seizures.",
    "This sample is a phase 2 clinical trial for metastatic colorectal cancer, testing the drugs iressa (gefitinib), irinotecan, 5-fluorouracil, and leucovorin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with ovarian cancer, testing the effectiveness of aflibercept in platinum-resistant and topotecan- and/or liposomal doxorubicin-resistant disease, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with primary open angle glaucoma or ocular hypertension, testing the effectiveness of different doses of latanoprost in lowering intraocular pressure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with unresectable Stage III or IV malignant melanoma, testing the drugs ipilimumab+ placebo and ipilimumab+ budesonide, with inclusion criteria including a histologic or cytologic diagnosis of malignant melanoma and exclusion criteria including active, untreated central nervous system metastasis and autoimmune disease.",
    "This sample is a phase 2 clinical trial for adults with atopic dermatitis, testing the drugs e6005 and e6005 ointment (vehicle) to evaluate their effectiveness and safety in treating the disease.",
    "This sample is a phase 2 clinical trial for patients with stage III and IV head and neck cancer, testing the effectiveness of cetuximab, 5-fu, hydroxyurea, and cisplatin as treatment options. The eligibility criteria include age 18 or older, no prior chemotherapy or radiotherapy, and normal organ and marrow function.",
    "This sample is a phase 2 trial for patients with gastroesophageal reflux disease (GERD), testing the effectiveness of different doses of xp19986 sr3 and a placebo in reducing symptoms of heartburn and regurgitation.",
    "This sample is a phase 2 clinical trial for patients with severe, persistent asthma, testing the effectiveness of tiotropium and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the drug tralokinumab and placebo in patients with ulcerative colitis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of seasonal allergic rhinitis using budesonide and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for lung cancer patients, testing the effectiveness of filgrastim, pegfilgrastim, etoposide, and cisplatin as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of the drugs folfox-4+cetuximab and folfox-4 in combination, with specific eligibility criteria for enrollment.",
    "This sample is a phase 2 trial for patients with breast cancer, testing the drugs bevacizumab and doxorubicin hydrochloride liposome, and the eligibility criteria include confirmed breast cancer, measurable disease, and specific patient characteristics.",
    "This sample is a phase 2 trial testing the use of 5x5cm bupivacaine collagen sponges for postoperative pain management in patients undergoing unilateral inguinal or umbilical herniorrhaphy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for head and neck cancer, testing the effectiveness of bevacizumab, erlotinib, paclitaxel, and 5-fu drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with recurrent or refractory Hodgkin's lymphoma, testing the effectiveness of bortezomib and gemcitabine hydrochloride as treatment options, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for breast cancer patients with metastatic disease, testing the effectiveness of capecitabine and paclitaxel poliglumex as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-squamous cell non-small cell lung cancer, testing the effectiveness of pemetrexed disodium and sorafenib tosylate drugs, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer who have evidence of progressive metastatic disease and have received prior treatment with a taxane-based regimen. The drug being tested is panzem\u00ae ncd, and the eligibility criteria include specific requirements for PSA levels, prior hormonal therapy, and organ function.",
    "This sample is a phase 2 clinical trial for patients with various types of melanoma, testing the effectiveness of the drugs carboplatin, paclitaxel, and bortezomib, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with various lymphoid malignancies, including non-Hodgkin's lymphoma, Hodgkin's lymphoma, and multiple myeloma. The trial aims to evaluate the effectiveness of oncaspar, doxil, and decadron drugs in patients who have failed previous chemotherapy regimens. The eligibility criteria include specific disease types, prior treatment history, performance status, laboratory values, and signed informed consent. Exclusion criteria include recent chemotherapy or radiotherapy, active infections, psychiatric illness, pregnancy or breastfeeding, and certain prior treatments.",
    "This sample is a phase 2 clinical trial for patients with stage IV breast cancer, testing the efficacy of tesetaxel in combination with eligibility criteria including HER2 negative status, measurable disease, and prior chemotherapy and hormonal therapy.",
    "This sample is a phase 2 clinical trial for the drug panitumumab in patients with untreated locally advanced squamous cell carcinoma of the head and neck, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic hepatitis C, testing the efficacy of the drugs placebo and pf-04136309, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for multiple sclerosis (MS) patients, testing the efficacy of ofatumumab and placebo in patients with relapsing-remitting MS, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with myelodysplastic syndrome (MDS) using the drug decitabine, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial testing the drugs voraxaze (glucarpidase) and placebo on patients with solid tumors and hematologic malignancies who have delayed methotrexate clearance, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with coronary heart disease, testing the drugs placebo and dalcetrapib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for heart failure and heart decompensation, testing the drug cinaciguat (bay58-2667) against a placebo, with specific inclusion and exclusion criteria for enrollment.",
    "This sample is a phase 2 clinical trial for patients with stage IV or unresectable stage III malignant melanoma, testing the effectiveness of cyclophosphamide as a treatment option. The eligibility criteria include measurable disease, expression of NY-ESO-1 or LAGE-1, expected survival of at least 4 months, and specific laboratory parameters within certain ranges. There are also exclusion criteria, such as other serious illnesses, immunodeficiency, and recent chemotherapy or radiotherapy.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) using the drugs docetaxel and cisplatin, with eligibility criteria including age 18 or older, confirmed diagnosis of NSCLC, and no prior radiation therapy to currently involved tumor sites.",
    "This sample is a phase 2 clinical trial for bladder cancer patients who are candidates for cystectomy following chemotherapy, and the drugs being tested are abi-007, carboplatin, and gemcitabine. The inclusion criteria include specific tumor characteristics, performance status, and various blood and liver function levels, while the exclusion criteria include prior chemotherapy or radiotherapy, unresolved bacterial infection, and pregnancy or lactation.",
    "This sample is a phase 2 trial for patients with hepatitis C who are null responders to prior therapy with pegylated interferon and ribavirin. The study aims to evaluate the efficacy of cts-1027, pegylated interferon, ribavirin, and placebo in treating the disease. The eligibility criteria include specific HCV genotype, viral load, hemoglobin levels, and previous treatment adherence. Exclusion criteria include liver disease, ocular findings, HIV infection, pregnancy, renal impairment, alcohol abuse, psychiatric disease, and prior exposure to CTS-1027.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients who have undergone complete tumor resection, and it will test the effectiveness of pemetrexed, cisplatin, and carboplatin as treatment options.",
    "This sample is a phase 2 trial for the treatment of atherosclerosis using the drugs via-2291 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of benign prostatic hyperplasia (BPH) using the drug lonidamine, targeting male patients aged 65-80 (or 40-80 with vasectomy) with lower urinary tract symptoms (LUTS), prostate volume > 30 cc, Qmax < 15 mL/sec, IPSS > 12, and PSA > 1.0 ng/mL, while excluding patients with prior BPH treatment, prostate surgery, prostate cancer, active urinary tract infections, active cardiac/renal/hepatic disease, uncontrolled diabetes, systemic steroid usage, recent participation in an investigational drug study, or any other condition that could interfere with the study.",
    "This sample is a phase 2 trial for HIV infections and acquired immunodeficiency syndrome, testing the efficacy of various drugs including mk0518 monotherapy, mk0518 combination therapy, efavirenz, tenofovir, lamivudine, and placebo monotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for psoriasis, testing the drugs cc-10004 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with head and neck neoplasms and squamous cell carcinoma, testing the drugs bibw 2992 and cetuximab, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial testing the efficacy of activated recombinant human factor VII and placebo in patients with Dengue Haemorrhagic Fever, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for participants with moderate-to-severe chronic plaque psoriasis, testing the efficacy of a placebo drug, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with active rheumatoid arthritis, testing the efficacy of a placebo drug in combination with methotrexate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with mantle cell lymphoma, testing the drug bortezomib. The eligibility criteria include histologic documentation of the disease, extent of disease, prior treatment, age eligibility, and absence of certain medical conditions.",
    "This phase 2 trial is testing the effectiveness of siltuximab, placebo, and best supportive care in treating myelodysplastic syndrome (MDS) patients with symptomatic anemia who have received RBC transfusion and have adequate iron stores.",
    "This sample is a phase 2 trial for heart failure patients, testing the drugs placebo and omeacamtiv mecarbil, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastatic melanoma, testing the efficacy of bevacizumab, carboplatin, paclitaxel, and placebo as treatments, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the drug GW642444 in patients with chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria, and various assessments and measurements to determine eligibility and suitability for the study.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the drugs he3286 and placebo, with specific eligibility criteria including stable metformin use, fasting blood glucose levels, HbA1c levels, and BMI range.",
    "This sample is a phase 2 trial for patients with various types of lymphoma, testing the effectiveness of a combination of drugs including velcade, rituximab, cyclophosphamide, and decadron, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with leukemia, testing the drug clofarabine. The inclusion criteria include age, liver and kidney function, performance status, and absence of certain conditions. The exclusion criteria include concurrent treatments, severe concurrent diseases, infections, pregnancy or lactation, and significant concurrent diseases or psychiatric disorders.",
    "This sample is a phase 2 trial for patients with prostate cancer, testing the drug revlimid, and includes eligibility criteria such as documented prostate cancer, hormone refractory status, measurable disease, and adequate liver and bone marrow function.",
    "This study is testing the combination of f16il2 with doxorubicin in patients with advanced solid tumors and breast cancer, with specific eligibility criteria for each phase of the trial.",
    "This sample is a phase 2 trial for heart failure patients, testing the drugs gsk716155 and placebo, with inclusion criteria including chronic dilated cardiomyopathy and NYHA Class II/III heart failure, and exclusion criteria including active ischemia, history of drug/alcohol abuse, and known allergy to albiglutide or GLP-1 analogues.",
    "This sample is a phase 1/phase 2 clinical trial for patients with ER+ and/or PGR+ breast cancer that is refractory to a nonsteroidal aromatase inhibitor, testing the efficacy of xl147 (sar245408), xl765 (sar245409), and letrozole (femara) as potential treatments.",
    "This sample is a phase 1/phase 2 trial for type 1 diabetes, testing the drugs sitagliptin and insulin, with inclusion criteria including diabetes diagnosis, age at onset, disease duration, GADA positivity, and fasting C-peptide level, and exclusion criteria including insulin requirements, chronic infection, malignancy history, pregnancy, secondary diabetes, congestive heart failure, renal disease, and concurrent medical conditions.",
    "This sample is a phase 2 trial for HIV infections, testing the drugs tipranavir and ritonavir, with eligibility criteria including being treatment na\u00efve, having certain CD4 and viral load levels, and meeting various medical and lifestyle requirements.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs azd5423, budesonide, and placebo, with inclusion criteria including a clinical diagnosis of COPD, current maintenance therapy, and specific lung function measurements. Exclusion criteria include significant comorbidities, recent exacerbations, and participation in other clinical studies.",
    "This sample is a phase 2 trial for the treatment of hepatitis C using the drug \"ladr treatment\". The eligibility criteria include being an adult, having HCV RNA positive, and being a candidate for liver transplantation.",
    "This sample is a phase 2 trial for metastatic renal cell carcinoma, testing the drugs enzastaurin, sunitinib, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the drug docetaxel. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the combination of lapatinib and vinorelbine as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with psoriasis vulgaris, testing the drugs bt061 and placebo treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of atherosclerosis, testing the drugs sb-480848 and sb-480848 matching placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the drug vx-770 and placebo in patients with cystic fibrosis who have the G551D-CFTR mutation, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with stage I-III operable breast cancer, testing the drug capecitabine, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory diffuse large B-cell lymphoma, testing the drug fostamatinib. The inclusion criteria include age, previous treatment history, measurable disease, and performance status, while the exclusion criteria include recent treatment with certain drugs, unresolved toxicities, uncontrolled hypertension, evidence of tuberculosis, and inadequate bone marrow reserve.",
    "This sample is a phase 2/phase 3 trial for chronic kidney disease, testing the drug zemplar, with inclusion criteria of eGFR 15-59 ml/m2 and exclusion criteria of current vitamin D treatment.",
    "This sample is a phase 2 trial for patients with advanced cancer, testing the drug Remeron (mirtazapine) to improve appetite and weight loss in patients with cancer.",
    "This sample is a phase 2 trial for patients with lung cancer, testing the combination of gleevec and taxotere as a second-line treatment option, with specific eligibility criteria including prior chemotherapy treatment, documented recurrent/progressive disease, and certain laboratory values.",
    "This sample is a phase 2 clinical trial for patients with low-grade B-lymphocyte non-Hodgkin's lymphoma, testing the effectiveness of rituximab and bortezomib as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with rheumatoid arthritis (RA) who have failed at least 1 DMARD therapy. The study will test the effectiveness of the drug ph-797804 compared to a placebo in treating RA.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the drugs cjc-1134-pc and placebo, with eligibility criteria including BMI, stable diabetes, lifestyle, metformin dose, and HbA1c levels.",
    "This sample is a phase 2 clinical trial for patients with HER2 positive breast cancer, testing the effectiveness of lapatinib in combination with paclitaxel, fluorouracil, epidoxorubicin, and cyclophosphamide, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug aflibercept in patients with various types of metastatic colorectal cancer, with specific eligibility criteria including prior treatment history, disease measurements, and various laboratory values.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of the drugs bortezomib, dexamethasone, and thalidomide in treating relapsed or refractory disease. The eligibility criteria include having measurable disease, no evidence of POEMS syndrome, and meeting certain age, performance status, and laboratory requirements.",
    "This sample is a phase 2 trial for HIV-1 infected individuals, testing the efficacy of various drugs including gsk1265744, efavirenz, rilpivirine, placebo, and abacavir/lamivudine or tenofovir/emtricitabine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for chronic idiopathic constipation, testing the efficacy of sp-304 at different doses compared to a placebo, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 2/phase 3 trial for patients with type 2 diabetes mellitus, testing the effectiveness of alogliptin and pioglitazone in combination with pioglitazone alone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with recurrent non-small cell lung cancer, testing the efficacy of apricoxib/erlotinib and erlotinib/placebo as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic kidney cancer, testing the drug tanespimycin. The eligibility criteria include histologically confirmed renal cell carcinoma, measurable disease, specific age and performance status requirements, and various health parameters.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung cancer, testing the drugs pemetrexed and erlotinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the drug peficitinib in the treatment of arthritis, rheumatoid, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for patients with small cell lung cancer, testing the effectiveness of carboplatin and pemetrexed disodium as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for renal transplant patients who are receiving cyclosporine or tacrolimus. The study aims to evaluate the efficacy of belatacept, cyclosporine a, and tacrolimus in patients who have completed 1 year in the IM103-010ST study and remained on study treatment. The inclusion criteria include age 18 and older, 6-36 months post-transplant, and calculated GFR between 35 and 75mL/min/1.73 m\u00b2. The exclusion criteria include significant infection, acute rejection within 3 months, prior graft loss due to rejection, pregnancy, and positive crossmatch.",
    "This sample is a phase 2 clinical trial for patients with myelodysplastic syndromes, testing the drug obatoclax mesylate (gx15-070ms), and includes inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for the treatment of depression, testing the drugs \"evt 101\" and \"placebo\" on patients who have not responded to previous treatment regimens and have a score of 18 or higher on the Ham-D-17 scale.",
    "This sample is a phase 2 trial for heart failure patients with NYHA Classification III or IV, chronic kidney disease, and recent hospitalization for heart failure decompensation. The study will test the effectiveness of clp and placebo drugs in reducing fluid overload and improving patient outcomes.",
    "This sample is a phase 2 clinical trial for patients with rheumatoid arthritis, testing the drugs cp-690,550 and atorvastatin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with stage IV gastric cancer, testing the drug paclitaxel as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of various drugs including ep-101 via nebulizer, tiotropium bromide, and ipratropium bromide inhalation solution, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 trial for rheumatoid arthritis (RA) patients with active disease, testing the drugs nnc0114-0006 and placebo, and includes eligibility criteria such as a diagnosis of RA meeting specific criteria, concomitant treatment with methotrexate (MTX), and exclusion criteria such as BMI limits and history of severe systemic fungal infection.",
    "This sample is a phase 2 clinical trial for small cell lung cancer (SCLC) patients who are refractory to first-line platinum-based chemotherapy, testing the efficacy of the drug amrubicin. The eligibility criteria include having a histological or cytological diagnosis of SCLC, being at least 18 years old, having an ECOG Performance Status of 0, 1, or 2, and having measurable disease defined by RECIST criteria.",
    "This sample is a phase 2 trial for the drug ataluren in patients with Duchenne muscular dystrophy, with inclusion criteria including completion of a previous study, confirmed screening laboratory values, and willingness to comply with study procedures, and exclusion criteria including recent use of certain medications, hypersensitivity to study drug ingredients, and ongoing participation in other clinical trials.",
    "This sample is a phase 2 trial for kidney transplantation, testing the drug fk778, with inclusion criteria including end stage kidney disease and exclusion criteria including immunological high risk and previous organ transplants.",
    "This sample is a phase 2 trial for bronchiolitis, testing the drug mk-0476 (montelukast sodium) on patients with active bronchiolitis or a history of bronchiolitis and asthma-like symptoms.",
    "This sample is a phase 2 clinical trial for patients with squamous cell carcinoma of the head and neck, testing the drug gefitinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial that focuses on various diseases such as chronic myeloproliferative disorders, graft versus host disease, leukemia, multiple myeloma and plasma cell neoplasm, and myelodysplastic syndromes. The study involves the use of drugs like busulfan, cyclophosphamide, cyclosporine, leucovorin calcium, methotrexate, and methylprednisolone, and has specific eligibility criteria for patients.",
    "This sample is a phase 2 trial for the drug \"gsk561679\" in the treatment of major depressive disorder (MDD), with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 trial for patients with relapsed or chemotherapy/immunotherapy-resistant mantle cell lymphoma, testing the drug everolimus. The eligibility criteria include specific disease characteristics and patient characteristics, and exclude patients with certain medical conditions or prior treatments.",
    "This sample is a phase 2 clinical trial for patients with recurrent small cell lung cancer, testing the drug romidepsin. The eligibility criteria include having histologic or cytologic documentation of the disease, no more than 1 prior chemotherapy regimen, and measurable disease.",
    "This sample is a phase 2 trial testing the effectiveness of dexamethasone implant in treating pseudophakic cystoid macular edema and diabetic macular edema in diabetic patients who develop the condition after cataract surgery, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with bronchial asthma, testing the drugs ono-6950, placebo, and montelukast, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic renal cell cancer, testing the effectiveness of bevacizumab, interferon alfa-2a, and vinblastine as potential treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with adenocarcinoma of the lung, testing the effectiveness of carboplatin, paclitaxel, pemetrexed, and cisplatin as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for metastatic breast cancer patients, testing the drugs ixabepilone and ixabepilone, with eligibility criteria including measurable disease, HER2 negative status, prior chemotherapy, and specific laboratory values.",
    "This sample is a phase 1/phase 2 trial investigating the use of bumetanide, a diuretic, in term babies with neonatal seizures who have received standard anticonvulsive therapy and meet specific inclusion criteria, excluding those with certain medical conditions or who have received diuretics or other anticonvulsive medications.",
    "This sample is a phase 2 trial testing the drug doripenem for the treatment of nosocomial pneumonia and ventilator-associated pneumonia, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial testing the drug levonorgestrel for contraception, with specific inclusion and exclusion criteria, and various medical conditions and medications that would disqualify participants from the study.",
    "This sample is a phase 2 clinical trial for patients aged 18-65 with kidney diseases who have received a first renal transplant, testing the efficacy of voclosporin and tacrolimus as oral medications, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), testing the drug temozolomide, and includes eligibility criteria such as confirmed diagnosis, prior chemotherapy restrictions, and low MGMT expression.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the drug bortezomib. The inclusion criteria include having a first relapse after ASCT, symptomatic myeloma, and a certain number of CD34+ stem cells. The exclusion criteria include certain medical conditions and previous use of experimental drugs.",
    "This sample is a phase 2 trial for patients with colorectal adenocarcinoma who have progressed on previous chemotherapy, and it will test the effectiveness of bevacizumab and everolimus as treatment options. The eligibility criteria include having measurable or evaluable disease, normal organ and marrow function, and the ability to understand and sign a consent form. Exclusion criteria include recent radiation therapy or other investigational agents, CNS metastases, uncontrolled hypertension, and significant vascular disease.",
    "This sample is a phase 2 clinical trial for patients with glioblastoma multiforme, testing the drug sunitinib, and includes eligibility criteria such as tumor progression, organ function, and age range.",
    "This sample is a phase 2 clinical trial for patients with neuroendocrine tumors, testing the drugs rad001 and erlotinib, with specific eligibility criteria including measurable disease sites, histologic diagnosis, and various laboratory values within normal ranges.",
    "This sample is a phase 2 clinical trial for patients with inoperable differentiated thyroid cancer, testing the drug rosiglitazone maleate, and includes eligibility criteria such as failed prior therapy, elevated thyroglobulin levels, and specific patient characteristics.",
    "This sample is a phase 2 trial for patients with rheumatoid arthritis, testing the efficacy of fostamatinib disodium (r935788) and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with colorectal cancer and liver metastases, testing the efficacy of oxaliplatin, raltitrexed, and other intravenous chemotherapy drugs, with specific eligibility criteria including age, WHO status, life expectancy, and hepatic lesion size.",
    "This sample is a phase 2 trial for the treatment of schizophrenia, testing drugs such as pf-00217830 and aripiprazole, with inclusion criteria including a current diagnosis of schizophrenia and an increase in symptoms over the past 2-4 weeks.",
    "This sample is a phase 2 trial studying the effectiveness of capsaicin patch in treating Painful Postherpetic Neuralgia, with eligibility criteria including having a diagnosis of the condition, being in good health, and having unbroken skin over the painful area(s).",
    "This sample is a phase 2 clinical trial testing the drug tamsulosin hydrochloride for the treatment of neuropathic bladder secondary to known neurological disorders, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for the treatment of Sjogren's syndrome using rituximab (anti-cd20), with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for atopic dermatitis and eczema, testing the drugs mapracorat and vehicle without active ingredient, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for asthma patients, testing the effectiveness of inhaled tiotropium bromide compared to a placebo, with specific inclusion and exclusion criteria.",
    "This study is testing the effectiveness of sitagliptin, a drug used to treat diabetes, in HIV-infected individuals with stable immunologic and virologic status, and normal blood chemistry, who do not have certain medical conditions or take specific medications.",
    "This phase 2 trial is investigating the effectiveness of alvocidib and docetaxel in treating patients with metastatic adenocarcinoma of the pancreas, recurrent pancreatic cancer, or stage IV pancreatic cancer, who meet specific eligibility criteria.",
    "This sample is a phase 2 trial for patients with previously treated Stage III or Stage IV melanoma, testing the drug ipilimumab (mdx-010, bms-734016) as a potential treatment option.",
    "This sample is a phase 2 clinical trial for the treatment of impetigo using the drug nvc-422, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 clinical trial testing the drug sagopilone for the treatment of non-small-cell lung cancer, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with heart valve diseases, testing the effectiveness of different doses of warfarin and dabigatran etexilate in preventing complications in patients with mechanical heart valves, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for Crohn's disease, testing the effectiveness of azathioprine weight-based dose and azathioprine individualised dose in patients with different steroid-dependent, steroid-refractory, or steroid-naive conditions, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is investigating the efficacy of capecitabine, docetaxel, and gemcitabine hydrochloride in treating patients with carcinoma of unknown primary, who have no symptomatic brain metastases and meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for the drug SAR292833 and placebo in adult patients with chronic peripheral neuropathic pain associated with diabetic polyneuropathy and post-herpetic neuralgia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of lenalidomide, dexamethasone, and aspirin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 2 trial is testing the drug sunitinib malate in patients with advanced, relapsed, or refractory esophageal cancer that is not amenable to curative surgery or other curative therapy, and the eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial testing the drug ilaprazole and lansoprazole for the treatment of erosive esophagitis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with locally unresectable or metastatic biliary tract or gallbladder adenocarcinoma, testing the effectiveness of bevacizumab, gemcitabine, and oxaliplatin as treatment options. The eligibility criteria include histological confirmation of the disease, prior chemotherapy limit, age over 18, ECOG performance status 0-2, life expectancy over 12 weeks, and adequate organ and bone marrow function.",
    "This sample is a phase 2 clinical trial for the drug ataluren in patients with cystic fibrosis, with specific eligibility criteria including diagnosis of CF, presence of a mutation in both alleles, and certain age, weight, and lung function requirements. There are also exclusion criteria such as prior exposure to ataluren, ongoing acute illness, and abnormal liver or renal function.",
    "This sample is a phase 2 clinical trial for small cell lung cancer patients who are c-kit-positive, testing the drug gleevec, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of oxaliplatin/gemcitabine/vinorelbine as a chemotherapy treatment. The eligibility criteria include specific disease stage, measurable lesions, no prior chemotherapy, and satisfactory blood count and organ function.",
    "This sample is a phase 2 trial for lung cancer patients, testing the drug cetuximab, and includes eligibility criteria such as confirmed inoperable or unresectable LA-NSCLC, specific disease stages, age and performance status requirements, and various laboratory values for bone marrow, renal, and liver function.",
    "This sample is a phase 2 clinical trial for patients with aggressive non-Hodgkin's lymphoma, testing the drug lenalidomide, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic colorectal cancer, testing the effectiveness of bevacizumab, capecitabine, and oxaliplatin as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for head and neck cancer, testing the effectiveness of cisplatin, docetaxel, fluorouracil, and cetuximab in patients with specific disease characteristics and patient eligibility criteria.",
    "This sample is a phase 2 clinical trial for the treatment of chronic hepatitis C, testing the drugs viramidine and peginterferon alfa-2b in Caucasian or African-American patients who are treatment-naive, genotype 1 only, and meet specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for HIV infections and hepatitis B, testing the drugs adefovir dipivoxil and tenofovir disoproxil fumarate, with specific inclusion and exclusion criteria for different populations.",
    "This sample is a phase 1/phase 2 clinical trial for patients with prostate cancer, testing the drugs tak-700, docetaxel, and prednisone. The eligibility criteria include having a confirmed diagnosis of prostate adenocarcinoma, radiograph-documented metastatic disease, and prior surgical castration or concurrent use of an agent for medical castration.",
    "This sample is a phase 2 clinical trial for the treatment of skin structure infections, bacterial skin diseases, and staphylococcal skin infections using the drugs delafloxacin and tigecycline, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 clinical trial for patients with advanced solid tumors refractory to standard therapy, testing the drug camptothecin (cpt) conjugated to a linear, cyclodextrin-based polymer, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the efficacy of gemcitabine hydrochloride and paclitaxel albumin-stabilized nanoparticle formulation as treatment options, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for small cell lung carcinoma, testing the drug amuvatinib, with specific eligibility criteria including disease progression or relapse after platinum-etoposide chemotherapy and adequate organ function.",
    "This sample is a phase 1/phase 2 clinical trial for patients with brain and central nervous system tumors, extragonadal germ cell tumor, ovarian cancer, and testicular germ cell tumor. The trial involves the use of drugs such as cisplatin, gemcitabine hydrochloride, ifosfamide, and paclitaxel, and has eligibility criteria related to the disease characteristics and patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the drug gemcitabine hydrochloride. The eligibility criteria include having measurable disease, no progression after multiple forms of chemotherapy, and refractory hormone receptor positive breast cancer. The study aims to enroll patients who are frail or have certain comorbid conditions.",
    "This sample is a phase 2 trial for patients with advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma, testing the effectiveness of the drugs bay 43-9006, docetaxel, and cisplatin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the use of gik and control drugs in patients undergoing cardiac surgery with cardiopulmonary bypass, and the eligibility criteria include age, LVEF, and exclusion criteria such as previous cardiac surgery, diabetes mellitus, and enrollment in another clinical study.",
    "This sample is a phase 2 clinical trial for rheumatoid arthritis patients who have previously been treated with rituximab and are candidates for re-treatment. The study will test the efficacy of atacicept and a placebo matched to atacicept.",
    "This sample is a phase 2 trial for epilepsy, testing the drug diazepam, with inclusion criteria including a diagnosis of epilepsy and exclusion criteria including the use of warfarin or dabigatran, recent use of investigational drugs or blood/plasma donation, and unwillingness or inability to tolerate blood draws.",
    "This sample is a phase 2 trial for patients with metastatic or recurrent endometrial carcinoma, testing the efficacy of arsenic trioxide as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 2 trial aims to evaluate the efficacy of the drug tc-5619 in treating schizophrenia, specifically targeting negative symptoms and cognitive dysfunction, with strict inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for rheumatoid arthritis patients who meet specific criteria, including having a minimum number of swollen and tender joints, certain CRP levels, and being on stable DMARD therapy. The study excludes patients with certain conditions or taking specific medications. The drugs being tested in this trial are prednisolone, dipyridamole, prednisone, and z102.",
    "This sample is a phase 2 trial for breast cancer patients who are at elevated risk of developing the disease, and the drug being tested is celecoxib. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic gastric cancer, testing the efficacy of irinotecan, oxaliplatin, fluorouracil, and leucovorin as a treatment regimen, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck, testing the effectiveness of sunitinib malate as a treatment option.",
    "This sample is a phase 2 trial for the treatment of moderate to severe allergic rhinoconjunctivitis to birch pollen, with inclusion criteria including symptoms score, previous medication use, positive SPT and specific IgE CAP test, and exclusion criteria including uncontrolled asthma, previous SIT, clinical symptoms due to other allergens, history of anaphylaxis, positive skin prick test to AllerT, and other treatments or conditions that may affect the study. The drugs being tested are placebo, allert low dose, and allert full dose.",
    "This phase 2 trial is investigating the efficacy of pemetrexed, carboplatin, gemcitabine, and vinorelbine in treating advanced breast cancer that is not amenable to surgery or radiation, and has specific eligibility criteria including prior chemotherapy with anthracyclines and taxanes, measurable lesions meeting RECIST criteria, and adequate organ function.",
    "This sample is a phase 1/phase 2 clinical trial for patients with proliferative diabetic retinopathy, testing the effectiveness of ranibizumab, an anti-VEGF injection, in treating diabetic neovascularization that has persisted for at least three months after previous laser treatment.",
    "This sample is a phase 2 clinical trial for allergic rhinitis, testing the drug oc000459 and placebo, with inclusion and exclusion criteria specified.",
    "This sample is a phase 2 clinical trial for patients with advanced or metastatic breast cancer, testing the drug pemetrexed. The inclusion criteria include a diagnosis of advanced or metastatic breast cancer, no prior chemotherapy for advanced or metastatic breast cancer, and the ability to carry out light work. The exclusion criteria include prior bone marrow or peripheral stem cell transplantation, current pregnancy or breastfeeding, and inability to take folic acid or vitamin B12.",
    "This study is a phase 2/phase 3 trial investigating the use of fluvastatin, a statin medication, in patients undergoing renal transplantation. The eligibility criteria include specific age range, type of kidney transplantation, LDL-cholesterol levels, immunosuppression regimen, and exclusion criteria such as previous statin use and certain medical conditions.",
    "This sample is a phase 2 clinical trial for the treatment of dry eye, Sjogren's syndrome, and graft vs. host disease using thymosin beta 4 eye drops and a vehicle control, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 trial for contraception, testing the effectiveness of cellulose sulfate vaginal gel as a method of contraception for couples in stable, monogamous relationships who are not actively desiring pregnancy and are willing to accept an unknown risk of pregnancy for the next 30 weeks.",
    "This sample is a phase 2 trial for asthma patients, testing the effectiveness of budesonide and placebo drugs on patients who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for the drug ecopipam in patients with Tourette's Syndrome, with specific inclusion and exclusion criteria, including the requirement for subjects to have exhibited tics for >5 years and a minimum score of 20 on the Yale Global Tic Severity Score.",
    "This sample is a phase 1/phase 2 clinical trial for kidney transplantation, testing the drugs aeb071 and mycophenolic acid, with inclusion criteria including adult recipients of a functioning kidney transplant, and exclusion criteria including patients infected with hepatitis B or C, or with HIV, and patients with a history of cancer or severe systemic infections.",
    "This sample is a phase 2 trial for patients with hypercholesterolemia and dyslipidemia, testing the effectiveness of statin drugs (atorvastatin, rosuvastatin, and simvastatin) in reducing LDL-C levels and fasting TG levels. The inclusion criteria require patients to be on a stable daily dose of one of the statin drugs, while the exclusion criteria include a history of cardiovascular or cerebrovascular events, poorly controlled diabetes mellitus, and poorly controlled hypertension.",
    "This sample is a phase 2 clinical trial for patients with HER2/neu positive breast cancer, testing the effectiveness of trastuzumab and oxaliplatin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), testing the effectiveness of lenalidomide as a treatment option. The eligibility criteria include age 65 or older, specific performance status, adequate renal and hepatic function, and understanding and signing of informed consent. The study also includes exclusion criteria such as known sensitivity to thalidomide, HIV or active hepatitis, serious medical conditions, and concurrent use of other chemotherapy agents.",
    "This sample is a phase 2 trial for patients with advanced colorectal carcinoma, testing the effectiveness of intensified chemotherapy (folfoxiri/bevacizumab) in combination with eligibility criteria including age, disease stage, measurable disease, performance status, laboratory parameters, and exclusion criteria such as previous chemotherapy, metastases, CNS disease, and cardiovascular disease.",
    "This sample is a phase 2 clinical trial for patients with advanced cutaneous T-cell lymphoma (CTCL), testing the drug sapacitabine. The inclusion criteria include having had at least 2 systemic therapies, evaluable disease, and Eastern Cooperative Oncology Group performance status 0-2, among others. The exclusion criteria include receiving systemic steroids, retinoids, or vitamin A, and having uncontrolled intercurrent illness or active hepatitis B and/or hepatitis C infection.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the efficacy of multiple drugs including pt005 mdi, pt001 mdi, pt003 mdi, and formoterol fumarate 12 \u03bcg (foradil\u00ae aerolizer\u00ae), with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with ocular hypertension or open angle glaucoma, testing the effectiveness of ar-13324 ophthalmic solution 0.01%, ar-13324 ophthalmic solution 0.02%, and latanoprost ophthalmic solution 0.005% in reducing intraocular pressure, with specific eligibility and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for kidney transplantation, testing the drugs cp-690,550 and tacrolimus, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the efficacy of different doses of bi 1356 bs compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with Philadelphia chromosome positive accelerated or blast phase chronic myeloid leukemia, testing the drug panobinostat. The eligibility criteria include prior treatment with at least two BCR-ABL tyrosine kinase inhibitors and resistance to the most recent therapy. Exclusion criteria include being a candidate for hematopoietic stem cell transplantation and impaired cardiac function.",
    "This sample is a phase 2 trial for patients with advanced kidney cancer, testing the drug sunitinib malate, and the eligibility criteria include excluding patients who have previously been treated for kidney cancer.",
    "This sample is a phase 2 clinical trial for patients diagnosed with paranoid, residual, or undifferentiated schizophrenia, testing the effectiveness of risperidone and rbp-7000 in clinically stable subjects with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial testing the drug simvastatin 20 mg/ezetimibe in moderately obese individuals with hyperlipidemia, with exclusion criteria including recent unstable heart or lung condition, current use of other lipid modifying drugs, hepatic disease, and pregnancy or lactation.",
    "This sample is a phase 2/phase 3 trial for the treatment of migraine, testing the drugs telcagepant and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with rheumatoid arthritis, testing the effectiveness of the drugs ch-4051, methotrexate (mtx), and folic acid, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with glioblastoma multiforme, testing the combination of poly iclc and temozolomide as a treatment option, with specific eligibility criteria and restrictions on prior therapies.",
    "This sample is a phase 2 clinical trial for the treatment of hepatitis C. The trial is testing the drugs inx-08189, placebo matching with inx-08189, ribavirin, and daclatasvir. The eligibility criteria include being diagnosed with chronic HCV, having a positive HCV viral load, being treatment-na\u00efve, and having a non-cirrhotic liver biopsy.",
    "This sample is a phase 2 clinical trial for small cell lung cancer (SCLC) patients, testing the effectiveness of pemetrexed and cisplatin as a treatment option, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for the drug LX4211 in patients with type 2 diabetes mellitus, with specific inclusion and exclusion criteria, and the study aims to evaluate the drug's efficacy and safety in combination with metformin therapy.",
    "This sample is a phase 2 trial for patients with inoperable locally advanced or metastatic colorectal carcinoma, testing the drug Velcade (bortezomib) for injection as a treatment option. The eligibility criteria include having received no more than 2 prior treatment regimens for metastatic disease, relapsed or progressed while receiving an irinotecan-containing regimen, and having a KPS of 70% or greater.",
    "This sample is a phase 2 trial for coronary artery disease, testing the drug ono-1101, with inclusion criteria of being 20 years or older and having a heart rate between 70 and 90 beats/min, and exclusion criteria including previous allergic reactions to contrast agent, renal failure, asthma, and concomitant beta-receptor blocking agent.",
    "This sample is a phase 1/phase 2 trial for rheumatoid arthritis, testing the drugs belatacept and abatacept in patients who have been diagnosed with RA for less than 5 years, meet certain functional class criteria, have failed at least 1 DMARD, and have specific joint count and ESR criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the effectiveness of docetaxel and capecitabine as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the treatment of heavy uterine bleeding and uterine fibroids, using drugs such as elagolix, placebo, estradiol/norethindrone acetate, estradiol, and progesterone, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 trial testing the effectiveness of ramosetron, aprepitant, and dexamethasone in preventing postoperative nausea and vomiting in patients with solid tumors who are chemotherapy-na\u00efve and planned to receive cisplatin-based chemotherapy.",
    "This sample is a phase 2 clinical trial for patients with metastatic prostate cancer, testing the drug trabectedin. The inclusion criteria include confirmed adenocarcinoma of the prostate, radiographically documented metastatic disease, and a prostate-specific antigen level of 5 ng/ml or higher. The exclusion criteria include recent chemotherapy or radiation therapy, inadequate contraception, and certain serious medical conditions.",
    "This sample is a phase 2 clinical trial for patients with mantle cell lymphoma, testing the effectiveness of gemcitabine hydrochloride as a treatment option, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 2/phase 3 trial for patients with type 2 diabetes and inadequate glycemic control, testing the drugs dapagliflozin and placebo, with inclusion criteria including a clinical diagnosis of moderate renal impairment and exclusion criteria such as severely uncontrolled diabetes and unstable or serious cardiovascular, hepatic, hematological, oncological, endocrine, psychiatric, or rheumatic diseases.",
    "This sample is a phase 2 clinical trial for chronic abacterial prostatitis and chronic pelvic pain syndrome, testing the drugs asp3652 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with asymptomatic multiple myeloma, testing the effectiveness of zoledronic acid in preventing bone loss and improving bone density.",
    "This sample is a phase 1/phase 2 trial for squamous cell cancer, testing the drugs cilengitide, cetuximab, 5-fluorouracil (5-fu), and cisplatin, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with kidney cancer, testing the drugs il2 and zoledronic acid, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 clinical trial for the treatment of schizophrenia, memory disorders, and cognition disorders using the drugs atomoxetine and placebo, with specific eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with mild to moderate allergic asthma, testing the drugs chf6001 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2/phase 3 clinical trial for the treatment of hepatitis C, using the drugs Algeron, Pegintron, and Ribavirin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with type 2 diabetes mellitus, testing the effectiveness of colesevelam hydrochloride compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for the treatment of moderate-to-severe chronic plaque-type psoriasis, testing the efficacy of the drug cf101 at different doses compared to a placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for atopic dermatitis, testing the effectiveness of dupilumab compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for the drug \"rta 402 (bardoxolone methyl)\" in patients with diabetic nephropathy, with inclusion criteria including a diagnosis of type 2 diabetes and specific serum creatinine levels, and exclusion criteria including type 1 diabetes, non-diabetic renal disease, and cardiovascular disease.",
    "This sample is a phase 2 trial for the drug peficitinib and placebo in patients with rheumatoid arthritis, with specific inclusion and exclusion criteria, such as the number of tender/painful and swollen joints, CRP or ESR levels, and washout criteria for certain RA medications.",
    "This sample is a phase 2 clinical trial for patients with metastatic adenocarcinoma of the lung, testing the efficacy of cyclophosphamide and all-trans retinoic acid (ATRA) as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for irritable bowel syndrome (IBS) with constipation (IBS-C), testing the efficacy of itopride HCI and placebo in patients who meet the Rome III criteria for IBS-C, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with leukemia or myelodysplastic syndromes, testing the use of fludarabine and treosulfan drugs in combination with bone marrow or peripheral blood stem cell transplantation. The eligibility criteria include specific disease characteristics, availability of a donor, and various patient characteristics such as performance status, organ function, and absence of certain medical conditions.",
    "This sample is a phase 2 trial for the drug LY3009104 in patients with active rheumatoid arthritis, who must regularly use methotrexate and meet specific inclusion criteria, while also excluding those with certain medical conditions or recent treatments.",
    "This phase 2 trial is testing the effectiveness of carboplatin and docetaxel in treating patients with HER2/neu-positive breast cancer, meeting specific disease and patient criteria.",
    "This sample is a phase 2 trial for patients with severe persistent asthma, testing the drugs cnto148 and placebo, with eligibility criteria including a physician diagnosis of asthma for at least 3 years, continuous treatment with high dose inhaled corticosteroids and long-acting beta-agonist, and evidence of reversible airway obstruction and airway hyperresponsiveness.",
    "This sample is a phase 2 clinical trial testing the effectiveness of sildenafil 100 mg and placebo in pre-menopausal women with female sexual arousal disorder, and the eligibility criteria include excluding subjects with hypoactive sexual desire disorder and those not using acceptable contraception.",
    "This sample is a phase 2 trial for liver cancer patients, testing the drug sorafenib tosylate, with eligibility criteria including confirmed hepatocellular carcinoma, specific laboratory values, and exclusion of certain medical conditions.",
    "This sample is a phase 2 trial for heart failure patients with known kidney damage, testing the drug bay94-8862 and spironolactone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with acute myeloid leukemia (AML) and includes eligibility criteria, such as confirmed diagnosis of AML, performance status, no hypersensitivity to certain drugs, and prior treatment history. The study will test the effectiveness of azacitidine and gemtuzumab ozogamicin as potential treatments for AML.",
    "This sample is a phase 2 trial for patients with HER2-positive metastatic breast cancer, testing the combination of bevacizumab, vinorelbine, and trastuzumab as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for HIV-1 infection, testing the drug rifaximin, with eligibility criteria including being on antiretroviral therapy for at least 96 weeks, having a CD4+ cell count below 350 cells/mm3, and having undetectable HIV-1 RNA levels.",
    "This sample is a phase 2 trial for patients with prostatic neoplasms, testing the drugs abraxane, leuprolide, and bicalutamide, with eligibility criteria including histologic proof of adenocarcinoma of the prostate and specific PSA levels.",
    "This phase 2 trial is testing the drug dasatinib in patients with metastatic colorectal cancer who have not responded to prior chemotherapy, and have specific eligibility criteria including measurable disease, certain blood counts, and no history of certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with malignant mesothelioma, testing the effectiveness of cisplatin and pemetrexed disodium as treatment options, with specific eligibility criteria for patients including age, performance status, hematopoietic, hepatic, renal, and pulmonary conditions, as well as prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with moderate to very severe Chronic Obstructive Pulmonary Disease (COPD), testing the effectiveness of tiotropium medium, tiotropium low, tiotropium high, tiotropium 18mcg, and tiotropium placebo inhalers, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic melanoma, testing the effectiveness of vinblastine, cyclophosphamide, and dacarbazine as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the treatment of osteoarthritis, testing the drug rn624 (pf-04383119) and a placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer who have progressed on or are intolerant to docetaxel chemotherapy, and it aims to evaluate the effectiveness of cytarabine as a treatment option.",
    "This sample is a phase 2 trial for patients with various hematopoietic disorders, including chronic myelogenous leukemia, acute myeloid leukemia, myelodysplasia, acute lymphocytic leukemia, severe aplastic anemia, non-Hodgkin's lymphoma, lymphoproliferative disease, multiple myeloma, and advanced myeloproliferative disease. The trial aims to evaluate the efficacy of busulfan, fludarabine phosphate, methotrexate, and tacrolimus as treatment options. Eligibility criteria include specific disease diagnoses, HLA-matched unrelated donor availability, and certain patient characteristics such as ECOG performance status and organ function.",
    "This sample is a phase 1/phase 2 trial for patients with head and neck neoplasms and cancer of the head and neck, testing the drugs carboplatin, cetuximab, and rad001, with eligibility criteria including histologically proven squamous cell carcinoma of the head and neck, evaluable locoregional and/or metastatic disease, and adequate bone marrow, liver, and renal function.",
    "This sample is a phase 2 trial for patients with advanced breast cancer or metastatic breast cancer, testing the drugs larotaxel and trastuzumab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of venous thromboembolism using rivaroxaban and enoxaparine, with specific eligibility criteria and exclusion criteria related to medical history, current symptoms or findings, current treatment, and miscellaneous factors.",
    "This sample is a phase 2 clinical trial for patients with advanced non-small-cell lung carcinoma, testing the effectiveness of capecitabine and docetaxel as chemotherapy drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with coronary artery disease, testing the drugs cangrelor and ticagrelor, with inclusion criteria including previous myocardial infarction or revascularization and treatment with aspirin.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes mellitus, testing the effectiveness of ipragliflozin compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the drugs entinostat and azacitidine for the treatment of metastatic colorectal cancer that has failed prior chemotherapy regimens, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for metastatic breast cancer, testing the drugs ct-p6, herceptin, and paclitaxel, with inclusion criteria including females with Her 2 over-expression and ECOG 0 or 1, and exclusion criteria including current CNS metastases, known infection, and pregnancy or nursing.",
    "This sample is a phase 2 clinical trial testing the drugs lapatinib and paclitaxel on patients with breast neoplasms, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with gastrointestinal stromal tumor (GIST), testing the drug dasatinib, and includes eligibility criteria such as confirmed GIST, measurable disease, and specific patient characteristics.",
    "This sample is a phase 2 clinical trial for major depressive disorder, testing the drug cp-601,927, and includes inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic pancreatic cancer, testing the drug erlotinib hydrochloride. The eligibility criteria include specific disease characteristics and patient characteristics, and prior concurrent therapy is also considered.",
    "This sample is a phase 2 clinical trial for the drug bavituximab in adult females with locally advanced or metastatic breast cancer, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for asthma patients, testing the drugs bi 671800 and placebo, with eligibility criteria including a history of reversible asthma, stable inhaled corticosteroid dose, and a diagnosis prior to 40 years.",
    "This sample is a phase 2 clinical trial for patients with non-small-cell lung cancer, testing the drugs erlotinib and bevacizumab, with specific eligibility criteria including disease stage, performance status, and organ function.",
    "This sample is a phase 2 trial for restless legs syndrome, testing the drugs gen (xp13512/gsk1838262) and placebo, with inclusion criteria including RLS symptoms, severity score, and stable medication use, and exclusion criteria including sleep disorders, neurologic diseases, and low serum ferritin levels.",
    "This sample is a phase 2 clinical trial for patients with invasive breast cancer, testing the effectiveness of anastrozole and anastrozole plus tegafur-uracil in postmenopausal women with ER-positive, HER2-negative tumors who are candidates for mastectomy or breast-conserving surgery.",
    "This sample is a phase 2/phase 3 trial for the drug cx516 (ampakine) in patients with schizophrenia, with specific inclusion and exclusion criteria, such as a stable dose of clozapine, olanzapine or risperidone for at least 6 months.",
    "This sample is a phase 2 clinical trial for patients with anaplastic large cell lymphoma, testing the effectiveness of cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, prednisone, and sgn-30 in combination therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with non-Hodgkin lymphoma, testing the effectiveness of fludarabine, velcade, and rituximab as a treatment option, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 2 clinical trial for patients with chronic lymphocytic leukemia, testing the effectiveness of cyclophosphamide, fludarabine phosphate, and mitoxantrone hydrochloride as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 1/phase 2 trial for the drug ccx 354-c in patients with rheumatoid arthritis, who must meet specific inclusion criteria such as being on a stable dose of methotrexate and negative results for HIV, hepatitis B, and hepatitis C. There are also exclusion criteria, including recent use of certain medications and presence of certain medical conditions.",
    "This sample is a phase 2 trial for patients with B-cell chronic lymphocytic leukemia, testing the drug \"fccam\" for those who have had one or two prior therapies, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with recurrent or advanced borderline or low-grade epithelial ovarian, fallopian tube, or primary peritoneal tumors, testing the effectiveness of letrozole, a drug used in hormone therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drugs pentostatin, tacrolimus, and methotrexate on patients with leukemia and lymphoma who are receiving allogeneic hematopoietic transplants. The eligibility criteria include specific disease types, certain health parameters, and restrictions on prior chemotherapy.",
    "This sample is a phase 2 clinical trial for patients with stage III or IV ovarian, primary peritoneal cavity, or fallopian tube cancer, testing the drugs carboplatin and paclitaxel, with eligibility criteria including specific disease characteristics and patient characteristics.",
    "This sample is a phase 2 clinical trial testing the drug dasatinib in patients with various types of glioblastoma, and it includes detailed eligibility criteria for patient enrollment.",
    "This sample is a phase 2 trial for the drug itacitinib and placebo in subjects with chronic plaque psoriasis who have had insufficient response to topical agents, and the study excludes pregnant or breastfeeding females, subjects treated with leflunomide or other biological therapies, and all JAK-STAT inhibitors within 12 weeks prior to the first dose of study drug.",
    "This sample is a phase 2 clinical trial for the treatment of oral mucositis using 0.9% saline, with specific eligibility criteria including recent diagnosis of non-metastatic SCC of the oral cavity, oropharynx, hypopharynx or larynx, and plans for radiation therapy and chemotherapy.",
    "This sample is a phase 1/phase 2 trial for pancreatic cancer, testing the effectiveness of gemcitabine, capecitabine, erlotinib, and bevacizumab in patients with locally advanced or metastatic disease who are not eligible for curative resection. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2/phase 3 trial testing the effectiveness of pegylated interferon alfa-2a and ribavirin in HIV-infected patients with compensated liver cirrhosis caused by hepatitis C virus genotype 1 or 4, who have not responded to previous standard treatment.",
    "This sample is a phase 2 clinical trial for the treatment of breast cancer using the drugs pazopanib and lapatinib, with specific eligibility criteria for patients, including disease stage, prior treatments, and organ function.",
    "This sample is a phase 2 clinical trial for patients with coronary artery disease, testing the effectiveness of the drugs rvx000222 and placebo rvx000222 in combination with statin therapy, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 trial for patients with clear cell renal cell carcinoma, recurrent renal cell cancer, stage III renal cell cancer, or stage IV renal cell cancer, testing the drug ixabepilone, with eligibility criteria including measurable disease, performance status, blood counts, liver and kidney function, and no active brain metastases or other active malignancies.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients, testing the drugs imetelstat and bevacizumab, with eligibility criteria including confirmed diagnosis of NSCLC, completed cycles of platinum-based chemotherapy, and specific laboratory values within normal range.",
    "This sample is a phase 2 clinical trial for multiple myeloma patients who have failed previous treatments, and it aims to evaluate the efficacy of carfilzomib in combination with other myeloma treatments. The eligibility criteria include measurable disease, prior treatment with bortezomib and either thalidomide or lenalidomide, and adequate hepatic and renal function. The exclusion criteria include certain disease characteristics, recent glucocorticoid therapy, and concurrent conditions such as congestive heart failure and active infections.",
    "This sample is a phase 2 trial for patients with type 2 diabetes, testing the efficacy of mitoglitazone and pioglitazone compared to a placebo, with inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for the treatment of diabetic retinopathy and diabetic macular edema using ranibizumab (lucentis), with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with metastatic colorectal cancer who have failed a first-line chemotherapeutic regimen, and it aims to evaluate the efficacy and safety of the drug CP-4055. The inclusion criteria include measurable disease, performance status 0-2, age 18 or more, and signed informed consent. The exclusion criteria include known brain metastases, radiotherapy to more than 30% of bone marrow, and participation in another therapeutic clinical study within 30 days.",
    "This sample is a phase 1/phase 2 trial for Crohn's disease, testing the efficacy of delayed release 6mp or calcitriol versus purinethol, with specific inclusion and exclusion criteria for eligible patients.",
    "This sample is a phase 2 trial for patients with acromegaly, testing the effectiveness of pasireotide and octreotide in treating the disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for ovarian, fallopian, and peritoneal cancer patients who are platinum resistant, testing the drug enmd-2076, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial testing the effectiveness of guaifenesin (mucinex) and placebo in treating common cold symptoms, with specific inclusion and exclusion criteria for participants.",
    "This phase 2 trial is testing the effectiveness of omalizumab and placebo in treating esophagitis, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1/phase 2 trial testing the drugs entinostat and imatinib mesylate for the treatment of Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia and recurrent adult acute lymphoblastic leukemia, with specific eligibility criteria for patients to be included in the study.",
    "This sample is a phase 2 trial for patients with active rheumatoid arthritis, testing the effectiveness of abatacept and placebo drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the drug memantine hcl in patients with autism, specifically pediatric autism, and the eligibility criteria include completing a lead-in study and having a knowledgeable caregiver.",
    "This sample is a phase 2 trial for patients with atherosclerosis undergoing primary multi-vessel CABG, testing the effectiveness of clopidogrel and a water pill daily, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for rheumatoid arthritis patients who have failed TNFa antagonist therapy, and the study will test the efficacy of atacicept and placebo in treating the disease.",
    "This sample is a phase 2 clinical trial for patients with platinum refractory or resistant ovarian cancer, testing the effectiveness of paclitaxel and lovastatin as treatment options, with specific eligibility criteria including measurable disease, prior treatment history, normal hepatic function, and exclusion criteria such as other serious illnesses and currently active second malignancy.",
    "This sample is a phase 2 clinical trial for patients with extensive stage small-cell lung cancer (ES-SCLC), testing the drugs carboplatin and abraxane, with eligibility criteria including a histological or cytological diagnosis of ES-SCLC, no prior systemic chemotherapy for SCLC, and adequate organ function.",
    "This sample is a phase 2 trial for patients with recurrent melanoma, stage IV melanoma, or tumors metastatic to the brain, testing the drugs temozolomide and thalidomide, with eligibility criteria including specific disease characteristics, performance status, blood counts, liver and kidney function, and exclusion of certain medical conditions and medications.",
    "This sample is a phase 2 trial for patients with coronary heart disease, testing the drug mpsk3169a and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with refractory chronic lymphocytic leukemia, testing the drug cediranib maleate, and includes eligibility criteria such as specific disease confirmation, previous treatment history, and various health parameters.",
    "This sample is a phase 2 trial for patients with metastatic breast cancer, testing the combination of carboplatin, bevacizumab, and herceptin, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for the drug ONO-2506PO in patients with amyotrophic lateral sclerosis (ALS), with specific inclusion and exclusion criteria, including a requirement for concomitant standard Riluzole therapy.",
    "This sample is a phase 2 trial for HIV patients with neuropathy, testing the effectiveness of epoetin alfa in reducing neuropathic pain.",
    "This sample is a phase 2 clinical trial for patients with recurrent or metastatic non-small-cell lung carcinoma, testing the effectiveness of irinotecan and docetaxel as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic or unresectable gastrointestinal stromal tumor (GIST) who have failed or are intolerant to Imatinib and sunitinib. The drug being tested is pazopanib, and the eligibility criteria include age >= 18 years, Eastern Cooperative Oncology Group (ECOG) performance status of 0-2, and adequate organ system function.",
    "This sample is a phase 2 clinical trial for patients with nasopharyngeal neoplasms, testing the effectiveness of docetaxel and cisplatin as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD) and includes eligibility criteria such as age, smoking history, lung function measurements, and exclusion criteria such as respiratory conditions, cardiovascular conditions, and medication allergies. The trial involves the use of aclidinium bromide and formoterol, along with a placebo, as the drugs being tested.",
    "This sample is a phase 2 clinical trial for patients with stage IIIB/IV adenocarcinoma in non-small cell lung cancer, testing the drug afatinib (bibw 2992) in patients who have had progressive disease following a second-line cytotoxic chemotherapy.",
    "This sample is a phase 2 clinical trial for patients with gastric cancer, testing the effectiveness of cetuximab, cisplatin, and capecitabine as treatment options. The eligibility criteria include age, disease confirmation, previous treatment history, performance status, and various laboratory values. Exclusion criteria include brain metastasis, previous systemic therapy, inability to take oral medication, and other medical conditions.",
    "This sample is a phase 2 clinical trial for patients with relapsing-remitting multiple sclerosis (MS), testing the drug bg00012. The inclusion criteria include age between 18 and 55, confirmed diagnosis of relapsing-remitting MS, baseline EDSS between 0.0 and 5.0, and recent relapse or evidence of MS lesions on MRI. Exclusion criteria include progressive forms of MS, history of malignancy or severe allergic reactions, abnormal laboratory results, HIV infection, drug or alcohol abuse, recent MS relapse, and certain medical conditions.",
    "This sample is a phase 2 trial for patients with rheumatoid arthritis, testing the effectiveness of a p38 inhibitor drug in patients who have an inadequate response to methotrexate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with bronchiectasis, lung disease, and respiratory diseases, testing the drugs azd5069 and placebo. The eligibility criteria include age range, diagnosis of bronchiectasis, sputum production, and stable treatment regimen. Exclusion criteria include other significant pulmonary diseases and recent vaccinations.",
    "This sample is a phase 2 trial for breast cancer patients who have received neoadjuvant chemotherapy, and it aims to evaluate the efficacy of gemcitabine, capecitabine, and avastin as a treatment option based on specific eligibility criteria.",
    "This sample is a phase 2 clinical trial for patients with osteoarthritis of the knee, testing the effectiveness of the drug nktr-181 compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with advanced hepatocellular carcinoma (liver cancer), testing the effectiveness of the drugs alvocidib and irinotecan hydrochloride, with specific eligibility criteria including measurable disease, prior local therapy, liver cirrhosis status, and various health parameters.",
    "This sample is a phase 2 clinical trial for patients with nasopharyngeal neoplasms and carcinoma, testing the effectiveness of docetaxel, cisplatin, and 5-fluorouracil as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 2 trial for postmenopausal women with an increased risk of breast cancer, testing the drug letrozole, and the eligibility criteria include specific disease characteristics and patient characteristics.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer, testing the effectiveness of paclitaxel albumin nanoparticle for injectable suspension as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial for macular edema associated with diabetes mellitus, testing the drugs standard of care and macugen, with inclusion criteria including visual acuity between 20/50 and 20/200, and exclusion criteria such as recent laser therapy in the eye and severe cardiac disease.",
    "This sample is a phase 2 trial for patients with metastatic melanoma and brain metastases, testing the drug GSK2118436. The eligibility criteria include having BRAF V600E- or V600K-mutation, measurable intracranial target lesions, and adequate organ function.",
    "This sample is a phase 2 clinical trial for patients with myelodysplastic syndrome (MDS), testing the drug ezatiostat hydrochloride, and includes eligibility criteria such as specific MDS type, performance status, anemia, and adequate organ function.",
    "This sample is a phase 2 trial for patients with relapsed/refractory Hodgkin's lymphoma, testing the drug vorinostat, and includes eligibility criteria such as previous treatments, disease measurements, and performance status.",
    "This phase 2 trial aims to evaluate the efficacy of sunitinib malate in patients with intermediate or high-risk, clinically localized prostate cancer who are deemed candidates for curative radical retropubic prostatectomy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for HIV-positive children at risk for developing pneumonia, testing the effectiveness of azithromycin, atovaquone, and sulfamethoxazole-trimethoprim in preventing pneumonia.",
    "This sample is a phase 2 clinical trial for patients with thyroid cancer that is unresponsive or refractory to radioactive iodine, testing the drug gefitinib, and includes eligibility criteria such as measurable disease, Eastern Cooperative Oncology Group performance status of 0-2, and exclusion criteria such as concurrent chemotherapy or radiation therapy.",
    "This sample is a phase 2 trial testing the effectiveness of natrecor (nesiritide) in combination with standard care and dobutamine or milrinone, compared to placebo in combination with standard care and dobutamine or milrinone, for patients with congestive heart failure, cardiac transplantation, renal insufficiency, or renal failure. The eligibility criteria include being a primary transplant candidate, receiving continuous intravenous infusion of dobutamine or milrinone, and willingness to participate in study assessments and follow-up procedures.",
    "This sample is a phase 2 clinical trial for patients with metastatic renal cell carcinoma, testing the efficacy of bevacizumab, sunitinib, and placebo as potential treatments, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for breast cancer patients with locally advanced or inflammatory breast cancer, testing the effectiveness of sunitinib malate, paclitaxel, doxorubicin hydrochloride, and cyclophosphamide as neoadjuvant treatment, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for breast cancer patients with metastatic disease who have not responded to previous chemotherapy regimens, and are eligible for allogeneic stem cell transplantation with an HLA-identical sibling donor. The study aims to evaluate the efficacy of cyclosporine, fludarabine phosphate, melphalan, and methotrexate as treatment options.",
    "This sample is a phase 2 clinical trial for the treatment of migraine headache using the drugs ly2951742 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with metastatic breast cancer and overexpression of the Her-2 oncogene, testing the effectiveness of docetaxel, vinorelbine, and trastuzumab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial testing the effectiveness of nomegestrol acetate, etonogestrel, ethinyl estradiol, and estradiol in contraception for women with regular cycles and good physical and mental health, while excluding those with certain medical conditions or recent participation in other drug studies.",
    "This sample is a phase 2 clinical trial for patients with recurrent anaplastic astrocytoma or glioblastoma, testing the drug sunitinib malate. The eligibility criteria include resolution of prior treatment effects, adequate organ function, histologically confirmed tumor, and a Karnofsky performance status of at least 60%. Exclusion criteria include recent major surgery or radiation therapy, certain medical conditions, and concurrent participation in another clinical trial.",
    "This sample is a phase 2 trial for asthma, testing the drugs jnj-18054478 and sham comparator, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial that aims to test the effectiveness of levetiracetam, a drug used to treat epilepsy, in individuals with alcohol dependence and comorbid anxiety disorders such as panic disorder, social phobia, and generalized anxiety disorder. The study includes specific inclusion and exclusion criteria, such as age range, diagnostic criteria, alcohol use, and pregnancy status, to select eligible participants.",
    "This sample is a phase 2 trial for patients with diabetes mellitus type 2, testing the drugs aleglitazar and pioglitazone in patients with moderately impaired kidney function and a BMI of 25-35, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drug epoetin alfa in elderly patients with anemia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with recurrent non-small cell lung cancer, testing the combination of itraconazole and pemetrexed as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 2 trial is investigating the effectiveness of vorinostat, a drug known to act through histone deacetylation or demethylation, in patients with various stages of transitional cell carcinoma of the bladder who have recurred or progressed on platinum-based chemotherapy, and have measurable disease.",
    "This sample is a phase 2 trial for sickle cell disease, testing the drug prasugrel, and includes eligibility criteria for participants.",
    "This sample is a phase 2 clinical trial for individuals with moderate to severe chronic obstructive pulmonary disease (COPD), testing the effectiveness of sodium pyruvate in 0.9% sodium chloride solution as a treatment option. The eligibility criteria include specific requirements related to pulmonary disease, cardiac health, age, medication history, and substance use.",
    "This sample is a phase 2 trial testing the drug \"r256918\" and placebo for the treatment of obesity, with eligibility criteria including liver fat content between 3% and 15%, BMI between 30 and 50 kg/square meter, and fasting plasma glucose below 7.0 mmol/liter.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer (NSCLC) patients, testing the effectiveness of paclitaxel and carboplatin as treatment options, with specific eligibility criteria and exclusion criteria listed.",
    "This sample is a phase 2 trial for patients with persistent asthma, testing the effectiveness of indacaterol and placebo to indacaterol in patients who are already receiving daily treatment with inhaled corticosteroids. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 2 clinical trial for patients with Parkinson's disease who have motor fluctuations and dyskinesias, and are taking levodopa, with the aim of evaluating the efficacy and safety of the drug e2007.",
    "This sample is a phase 2 clinical trial for diabetic peripheral neuropathy, testing the efficacy of ds-5565 tablet, pregabalin capsule, and placebo tablet and capsule, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial testing the effectiveness of a placebo and 2 mg nicotine polacrilex in treating tobacco use disorder in pregnant patients who are 26 weeks or less gestational age, at least 16 years old, able to speak English or Spanish, intend to carry to term, have stable residence, and have smoked five or more cigarettes everyday for the past seven days.",
    "This sample is a phase 2 clinical trial for multiple sclerosis, testing the drugs teriflunomide, placebo (for teriflunomide), and glatiramer acetate (GA), with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with type 2 diabetes, testing the effectiveness of teneligliptin at different doses compared to a placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 2 clinical trial for patients with metastatic pancreatic adenocarcinoma, testing the effectiveness of gemcitabine - trastuzumab - erlotinib combination therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs gsk573719, tiotropium, and placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 2 trial for the treatment of psoriasis vulgaris, testing the efficacy of various drugs including leo90100 cutaneous spray, ointment, daivobet\u00ae ointment, and others, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 2 clinical trial for chronic obstructive pulmonary disease (COPD) patients, testing the efficacy of various drugs including pt003 mdi, pt005 mdi, placebo mdi, tiotropium bromide 18 \u03bcg (spiriva handihaler\u00ae), formoterol fumarate 12 \u03bcg (foradil\u00ae aerolizer\u00ae), and pt001 mdi, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for chronic myeloid leukemia (CML) patients who have resistance or intolerance to imatinib mesylate, and it will test the effectiveness of dasatinib in treating the disease.",
    "This sample is a phase 2 clinical trial for patients with geographic atrophy and dry age-related macular degeneration, testing the drug fenretinide, and includes specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with peripheral T-cell lymphoma, testing the effectiveness of pralatrexate injection as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with recurrent or persistent ovarian, fallopian tube, or primary peritoneal carcinoma, testing the drug motesanib diphosphate, and includes eligibility criteria such as prior platinum-based chemotherapy, performance status, and various medical conditions.",
    "This sample is a phase 2 clinical trial for patients with relapsed or refractory non-small cell lung cancer (NSCLC), testing the effectiveness of the drugs velcade and alimta in combination therapy, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2/phase 3 trial for breast cancer patients with distant metastases or inoperable locally advanced disease, testing the efficacy of capecitabine and hormonal treatment (tamoxifen, exemestane, anastrozole or letrozole) as second-line therapy after progression on first-line hormonal therapy.",
    "This sample is a phase 2 trial for patients with sickle cell anemia, hemoglobinopathy, or thalassemia, testing the effectiveness of drugs such as campath-1h, dilantin, busulfan, and cyclophosphamide, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 trial testing the drug tesofensine on obese patients with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for lung cancer patients, testing the drugs enzastaurin and placebo, with inclusion criteria including metaplasia or dysplasia on bronchoscopy specimen and a history of cigarette smoking \u226530 Pack Years, and exclusion criteria including evidence for lung cancer or carcinoma in situ and current illicit drug or alcohol abuse.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the drug enzalutamide, and includes eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 2 trial for patients with metastatic colorectal cancer, testing the drugs irinotecan and folfiri, along with pre-emptive and reactive skin treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of respiratory syncytial virus infections in lung transplant recipients, using the drugs aln-rsv01 and normal saline, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with recurrent or metastatic squamous cell carcinoma of the head and neck. The drug being tested is dasatinib, and the eligibility criteria include having measurable disease, specific blood counts, and normal organ function.",
    "This sample is a phase 2 trial for chronic genotype 1 Hepatitis C infection, testing the drugs tmc435, placebo, peginterferon (pegifn\u03b1-2a), and ribavirin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 trial for diabetic foot infections, testing the drug tg-873870 (nemonoxacin), and includes eligibility criteria such as body weight, diabetes control, infection severity, and Gram-positive pathogen infection.",
    "This sample is a phase 2 trial for patients with advanced or metastatic colorectal carcinoma, testing the efficacy of panitumumab monotherapy after failure of previous chemotherapy regimens, with eligibility criteria including non-mutated KRAS, specific performance status, and liver function requirements.",
    "This sample is a phase 2 trial for patients with rheumatoid arthritis, testing the drugs jnj-40346527 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with inoperable esophageal carcinoma, testing the effectiveness of the drugs folfox 4 and 5-fu/cisplatin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for patients with metastatic adenocarcinoma or poorly differentiated carcinoma of the pancreas, testing the drug sta-9090, with specific eligibility criteria including prior chemotherapy regimens, measurable disease, ECOG PS 0 or 1, and various laboratory values within specified ranges.",
    "This sample is a phase 2 trial for patients with previously treated follicle center cell lymphoma, testing the drug lenalidomide, with specific eligibility criteria including confirmation of CD20 antigen expression, prior treatment with rituximab, and certain laboratory values.",
    "This sample is a phase 1/phase 2 trial that aims to evaluate the drug pd-0325901 in patients with metastatic or inoperable breast cancer, colon cancer, or melanoma, who meet specific eligibility criteria related to age, prior treatment, renal/liver/bone marrow function, reproductive potential, ECOG status, ability to swallow medication, and ability to follow protocol procedures.",
    "This sample is a phase 2 clinical trial for mesothelioma patients who have previously been treated with chemotherapy, and it will test the effectiveness of erlotinib and bevacizumab drugs in improving patient outcomes.",
    "This sample is a phase 1/phase 2 trial for patients with head and neck cancer, testing the drugs placebo, palifermin, and cisplatin, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial for patients with chronic myeloid leukemia (CML) who have resistance or suboptimal response to imatinib, dasatinib, or nilotinib and no known T315I/A Abl-kinase mutation. The study will test the efficacy of dasatinib and bms-833923 in treating CML patients with advanced-phase CML or chronic-phase CML.",
    "This sample is a phase 2/phase 3 trial for patients with type 2 diabetes, testing the effectiveness of sitagliptin, metformin, and placebo drugs in managing the disease, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is investigating the effectiveness of dacarbazine, doxorubicin hydrochloride, ifosfamide, and thalidomide in treating patients with recurrent adult soft tissue sarcoma, stage I or II adult soft tissue sarcoma, or stage III adult soft tissue sarcoma. The eligibility criteria include specific tumor characteristics, performance status, blood counts, liver and kidney function, cardiovascular health, and absence of other significant illnesses or infections.",
    "This sample is a phase 1/phase 2 trial for HIV infection, testing the drug panobinostat in patients who meet specific eligibility criteria, including having documented HIV-1 infection, receiving HAART, and having a CD4+ T-cell count >500/mm3.",
    "This sample is a phase 1/phase 2 clinical trial for patients with head and neck cancer, testing the drugs docetaxel and everolimus. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 2 clinical trial for patients with metastatic melanoma, testing the effectiveness of cyclophosphamide and fludarabine phosphate as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 1/phase 2 trial testing the drug vildagliptin in healthy volunteers and patients with type 2 diabetes, who are on metformin and/or sufonylurea, to evaluate its effectiveness in treating diabetes mellitus, type 2.",
    "This sample is a phase 2/phase 3 trial for patients with multiple sclerosis (PP-MS) using hydroxyurea as the drug, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with non-small-cell lung carcinoma, testing the efficacy of a study treatment drug in combination with previous platinum-based chemotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of overactive bladder using a placebo drug, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with chronic kidney failure, testing the effectiveness of the drug fermagate compared to a placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 2 clinical trial for patients with gastrointestinal stromal tumors, testing the drug amn107, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for postmenopausal female patients with relapsed or progressed estrogen receptor-positive breast cancer, testing the efficacy of entinostat and exemestane compared to placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 clinical trial for patients with metastatic prostate cancer, testing the effectiveness of abiraterone and prednisone as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 trial for patients with advanced or metastatic colorectal cancer, testing the effectiveness of fluorouracil, leucovorin calcium, and oxaliplatin in combination with bevacizumab, with specific eligibility criteria for patients and prior concurrent therapy requirements.",
    "This sample is a phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) testing the effectiveness of the drugs pemetrexed and best supportive care, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 2 clinical trial for patients with locally advanced or metastatic dermatofibrosarcoma protuberans or giant cell fibroblastoma, testing the efficacy of imatinib mesylate as a treatment option, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 2 clinical trial for patients with metastatic squamous cell carcinoma of the head and neck, testing the drug eribulin mesylate, and includes eligibility criteria such as measurable disease, performance status, blood counts, and prior therapy restrictions.",
    "This sample is a phase 2 clinical trial testing the drugs azacitidine and entinostat for patients with stage IA or IB non-small cell lung carcinoma who have undergone complete surgical resection, with specific eligibility criteria and exclusion criteria outlined.",
    "This phase 2 trial is testing the effectiveness of capecitabine and vinorelbine tartrate in treating patients with metastatic breast cancer who have previously received anthracycline or taxane therapy, and have measurable disease.",
    "This sample is a phase 2 clinical trial for patients with prostate cancer, testing the drug asp3550, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for adult and childhood acute myeloid leukemia (AML) patients, testing the efficacy of idarubicin, cytarabine, bortezomib, and etoposide as treatment options, with specific eligibility criteria for relapsed and refractory patients.",
    "This sample is a phase 2/phase 3 trial testing the use of propranolol, a beta-blocker, in patients with acute ischemic MCA-territory stroke, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial testing the drugs azd9773 and placebo on adults with severe sepsis and septic shock, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic breast cancer, testing the drug amrubicin, and includes eligibility criteria such as age, HER2-negative diagnosis, prior chemotherapy regimens, organ function requirements, and exclusion criteria such as concurrent therapy, previous high-dose chemotherapy, uncontrolled brain metastases, and certain medical conditions.",
    "This sample is a phase 2 clinical trial for patients with grade IV astrocytoma (glioblastoma multiforme [GBM]) or other related brain tumors, testing the efficacy of sunitinib malate, a targeted therapy drug, with specific eligibility criteria for patient selection.",
    "This sample is a phase 2 clinical trial for Alzheimer's disease, testing the drugs gsk239512 and placebo, with eligibility criteria including a clinical diagnosis of probable Alzheimer's disease, specific medical test results, and the need for a permanent caregiver.",
    "This sample is a phase 2 clinical trial for non-small cell lung cancer patients, testing the effectiveness of carboplatin, paclitaxel, and bevacizumab as a chemotherapy regimen followed by surgical resection, with specific eligibility criteria including tumor stage, histology, and laboratory values.",
    "This sample is a phase 2 trial for patients with paroxysmal atrial fibrillation, testing the drugs ati-2042 and ati-2042 200 mg, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for patients with moderate to severe rheumatoid arthritis who have failed previous DMARDs and currently have a partial response to methotrexate treatment. The study will test the effectiveness of cyclophosphamide, methotrexate, and rituximab as potential treatments.",
    "This sample is a phase 2 trial for patients with lymphoma, specifically histologically confirmed mycosis fungoides, who have refractory or recurrent disease after multiple prior therapies. The drug being tested is pegylated liposomal doxorubicin hydrochloride. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2/phase 3 trial for diabetes mellitus, type 2, testing the drugs ly2189265, sitagliptin, placebo solution, placebo tablet, and metformin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 2 clinical trial for patients with metastatic or locally advanced breast cancer, testing the effectiveness of gemcitabine and bevacizumab in combination with taxane and hormone therapy, while excluding patients with HER2 gene amplification and prior treatment with certain drugs.",
    "This sample is a phase 2 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the effectiveness of the drug GSK573719 in improving lung function. The study includes specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1/phase 2 clinical trial for non-small cell lung cancer (NSCLC) patients, testing the effectiveness of docetaxel and pemetrexed drugs in combination with platinum compounds and taxanes chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2 trial for the treatment of seasonal allergic rhinitis using bepotastine besilate nasal spray at different concentrations and a placebo, with inclusion criteria being a history of mountain cedar allergy and exclusion criteria being the absence of nasal infection or abnormality.",
    "This sample is a phase 2 trial for the treatment of choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) using drugs such as verteporfin, ranibizumab, and dexamethasone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 trial for HIV infections, testing the drugs emtricitabine/tenofovir disoproxil fumarate and lopinavir/ritonavir, with inclusion criteria including recent HIV infection, no prior antiretroviral therapy, and specific laboratory values, and exclusion criteria including pregnancy, history of pancreatitis or coronary artery disease, and known resistance to study drugs.",
    "This sample is a phase 2 clinical trial for breast cancer patients with overexpression of Her2neu, testing the effectiveness of liposomal doxorubicin, cyclophosphamide, and trastuzumab as chemotherapy drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drugs yspsl and placebo for patients undergoing primary cadaver renal transplants, with the disease being kidney diseases. The eligibility criteria include exclusion of patients receiving non-heart beating donor kidneys or kidneys from donors < 6 years of age, as well as patients receiving living donor kidneys or ABO-incompatible donor kidneys.",
    "This sample is a phase 2 trial for patients with metastatic melanoma, testing the drugs fludarabine phosphate and cyclophosphamide, with eligibility criteria including measurable disease, previous non-response to high dose aldesleukin, positive for gp100 by immunohistochemistry, and specific serology, hematology, and chemistry requirements.",
    "In this sample, the phase 2 trial is testing the drugs ecabet and placebo for the treatment of dry eye syndromes, with specific inclusion and exclusion criteria.",
    "This phase 2 trial is testing the effectiveness of multiple drug combinations, including velcade, melphalan, and prednisone, in treating newly diagnosed multiple myeloma patients who are 75 years or older or have abnormal cardiac, pulmonary, renal, or hepatic function. The study also includes specific eligibility criteria, such as measurable disease, Karnofsky performance status, and pretreatment laboratory values.",
    "This sample is a phase 2 clinical trial for patients with unresectable or metastatic gallbladder cancer, testing the effectiveness of the drugs triapine and gemcitabine, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 2/phase 3 trial for patients with moderate to severe ankylosing spondylitis, testing the effectiveness of rituximab, a drug used to treat certain autoimmune diseases, in reducing disease activity. The eligibility criteria include age range, disease severity, and stable use of certain medications, as well as requirements for contraception for women of childbearing potential and sexual active men. The exclusion criteria include various health conditions, medication history, and lab findings.",
    "This sample is a phase 1/phase 2 trial testing the drugs capecitabine, epirubicin, amg 102, cisplatin, and placebo on patients with unresectable locally advanced or metastatic gastric or esophagogastric junction adenocarcinoma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for major depressive disorder, testing the efficacy of bci-024 (buspirone) and melatonin tablets as compared to a placebo, with specific inclusion and exclusion criteria for subjects.",
    "This phase 2 trial is testing the drug capecitabine in patients with high-risk breast cancer who have completed surgical excision and are candidates for radiotherapy, with specific eligibility criteria including tumor size, lymph node involvement, and absence of metastasis.",
    "This sample is a phase 2 trial for patients with advanced idiopathic Parkinson's disease and predictable wearing-off motor fluctuations, testing the drugs dm-1992 and sinemet ir, with inclusion criteria including age, daily \"OFF\" time, stable LD dose, and MMSE score, and exclusion criteria including atypical or drug-induced Parkinson's disease, hypersensitivity to levodopa or carbidopa, and history of seizures or dementia.",
    "This phase 2 trial is testing the effectiveness of velcade, lh-rh agonist, and androgen receptor antagonists in treating relapsed prostate cancer patients who are ineligible for curative therapy, with specific eligibility criteria including PSA levels, disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 2 trial for patients with metastatic colorectal cancer who have failed previous treatments, testing the drugs bibw 2992 and cetuximab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 2 clinical trial for amyotrophic lateral sclerosis (ALS) patients, testing the efficacy of the drug CK-2017357 at two different doses compared to a placebo, with specific inclusion and exclusion criteria for patient enrollment.",
    "This sample is a phase 2 clinical trial for patients with recurrent or unresectable malignant meningioma, intracranial hemangiopericytoma, primary central nervous system sarcoma, including fibrosarcoma, rhabdomyosarcoma, chondrosarcoma, and leiomyosarcoma. The only drug being tested is ifosfamide, and the eligibility criteria include age 18 and over, SWOG performance status 0-2, and specific hematopoietic, renal, cardiovascular, and other health requirements."
]